--
-- PostgreSQL database dump
--

-- Dumped from database version 9.5.1
-- Dumped by pg_dump version 9.5.1

SET statement_timeout = 0;
SET lock_timeout = 0;
SET client_encoding = 'UTF8';
SET standard_conforming_strings = on;
SET check_function_bodies = false;
SET client_min_messages = warning;
SET row_security = off;

SET search_path = public, pg_catalog;

--
-- Data for Name: amino_acids; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY amino_acids (id, name) FROM stdin;
1	p.Q61H
2	p.Q61L
3	p.Q61*
4	p.Q61E
5	p.Q61K
6	p.G13V
7	p.G13A
8	p.G13D
9	p.G13C
10	p.G13R
11	p.G12V
12	p.G12A
13	p.G12D
14	p.G12C
15	p.G12R
16	p.G12S
17	p.S768R
18	p.T618I
19	p.M918T
20	p.R130G
21	p.R130*
22	p.R130Q
23	p.R159S
24	p.R233*
25	p.K267fs
26	p.A382fs
27	p.Q61R
28	p.A146V
29	p.A146P
30	p.A146T
31	p.K117N
32	p.Q61P
33	p.G13S
34	p.D839G
35	p.I836M
36	p.I836L
37	p.D835E
38	p.D835V
39	p.D835A
40	p.D835Y
41	p.D835H
42	p.D835N
43	p.E17K
44	p.DTKH759in_frame_delEPNT
45	p.L755S
46	p.A309G
47	p.F53L
48	p.Q56P
49	p.K57N
50	p.D67N
51	p.I111S
52	p.C121S
53	p.P124S
54	p.P124L
55	p.E203K
56	p.P264S
57	p.N382H
58	p.R172S
59	p.R172M
60	p.R172K
61	p.R140L
62	p.R140Q
63	p.R140W
64	p.G309A
65	p.LREN755in_frame_del*
66	p.D769H
67	p.D769Y
68	p.V777L
69	p.779in_frame_insLPS
70	p.V842I
71	p.R896C
72	p.R273H
73	p.R273C
74	p.R249T
75	p.R249W
76	p.R248Q
77	p.Y220C
78	p.V173G
79	p.V173A
80	p.E330A
81	p.D351N
82	p.D351H
83	p.D355E
84	p.R361S
85	p.R361C
86	p.R361H
87	p.D537Y
88	p.Q209P
89	p.Q209L
90	p.K700N
91	p.K700I
92	p.K700R
93	p.K700T
94	p.K700*
95	p.K700E
96	p.K700Q
97	p.K666N
98	p.K666R
99	p.K666T
100	p.K666E
101	p.R132L
102	p.R132P
103	p.R132H
104	p.R132C
105	p.R132G
106	p.R132S
107	p.R882L
108	p.R882P
109	p.R882H
110	p.R882C
111	p.R882G
112	p.R882S
113	p.Y1278S
114	p.R1275Q
115	p.F1245L
116	p.F1245C
117	p.F1245V
118	p.D1225N
119	p.F1174L
120	p.F1174C
121	p.F1174V
122	p.F1174I
123	p.I1171N
124	p.T1151M
125	p.D1091N
126	p.R201*
127	p.R162S
128	p.R162K
129	p.R162G
130	p.Q157R
131	p.Q157P
132	p.S34F
133	p.S34Y
134	p.R398W
135	p.T354M
136	p.E542K
137	p.E545K
138	p.E545Q
139	p.E545A
140	p.E545G
141	p.E545V
142	p.Q546K
143	p.Q546E
144	p.Q546P
145	p.Q546R
146	p.Q546L
147	p.D549N
148	p.H1047R
149	p.H1047L
150	p.S37Y
151	p.S37F
152	p.S45P
153	p.S45Y
154	p.S45F
155	p.V561D
156	p.N659K
157	p.D842V
158	p.E490K
159	p.F504L
160	p.K550N
161	p.Y553N
162	p.EVQW554in_frame_delKYSG
163	p.Q556in_frame_insPK
164	p.556in_frame_insP
165	p.Q556in_frame_insPE
166	p.QWKV556in_frame_insP*
167	p.Q556in_frame_insLK
168	p.Q556in_frame_insLE
169	p.W557R
170	p.K558N
171	p.V560in_frame_del
172	p.V559D
173	p.V559A
174	p.V559G
175	p.VEEI560in_frame_delLRR
176	p.V560D
177	p.V560A
178	p.V560G
179	p.G565V
180	p.N566D
181	p.NNYVYI566in_frame_del
182	p.NNYVYIDPT566in_frame_del
183	p.V569G
184	p.Q575in_frame_insPRK
185	p.Q575in_frame_insPRE
186	p.Q575in_frame_insPGK
187	p.Q575in_frame_insPGE
188	p.QLPY575in_frame_insP*
189	p.L576P
190	p.PYDH577in_frame_delLMIT
191	p.D579in_frame_del
192	p.R634W
193	p.K642E
194	p.V654E
195	p.V654A
196	p.N655S
197	p.N655K
198	p.H697Y
199	p.D816H
200	p.D816Y
201	p.D816I
202	p.D816V
203	p.D820H
204	p.D820Y
205	p.D820V
206	p.D820E
207	p.N822Y
208	p.N822I
209	p.N822K
210	p.Y823D
211	p.A829P
212	p.I841V
213	p.S864F
214	p.W288fs
215	p.S463P
216	p.V534E
217	p.P535H
218	p.L536R
219	p.Y537N
220	p.Y537S
221	p.Y537C
222	p.D538G
223	p.A68V
224	p.R199W
225	p.T349I
226	p.D473H
227	p.R485W
228	p.L515F
229	p.W535L
230	p.R562Q
231	p.A652V
232	p.P755F
233	p.K601E
234	p.V600D
235	p.V600G
236	p.V600E
237	p.V600R
238	p.V600K
239	p.L597R
240	p.D594E
241	p.D594V
242	p.D594G
243	p.D594A
244	p.D594Y
245	p.D594H
246	p.D594N
247	p.Y472C
248	p.E77*
249	p.G469A
250	p.G469E
251	p.LEQ76F*
252	p.G466V
253	p.G719S
254	p.G719C
255	p.G719A
256	p.T790M
257	p.L858R
258	p.L861Q
259	p.V617F
260	p.R683G
261	p.R683T
262	p.R683S
263	p.Q209R
264	p.F232C
265	p.Y272H
266	p.T334I
267	p.S185C
268	p.S646F
269	p.V658F
270	p.R876*
271	p.R1114*
272	p.E1306*
273	p.Q1338*
274	p.Q1367*
275	p.Q1378*
276	p.E1379*
277	p.Q1429*
278	p.R1450*
279	p.G596R
280	p.S492G
281	p.V559I
282	p.T670I
283	p.Y842C
284	p.Y842H
285	p.D835F
286	p.F691L
287	p.I687F
288	p.N676K
289	p.N676D
290	p.D651G
291	p.G619C
292	p.R657Q
293	p.Q501H
294	p.I87T
295	p.M263V
296	p.L267V
297	p.G269E
298	p.Q271H
299	p.Y272F
300	p.E274K
301	p.E274V
302	p.F302V
303	p.F336L
304	p.M370T
305	p.E374G
306	p.F378V
307	p.H415R
308	p.E255K
309	p.V318L
310	p.T334A
311	p.F336I
312	p.F336V
313	p.F336C
314	p.F378I
315	p.F378L
316	p.F378C
317	p.T615A
318	p.S505N
319	p.H1112R
320	p.M1268T
321	p.R2505P
322	p.Q2223K
323	p.S2215Y
324	p.L1460P
325	p.E2419K
326	p.E2014K
327	p.G1269A
328	p.S1206Y
329	p.G1202R
330	p.L1196M
331	p.L1152R
332	p.S214C
333	p.G309E
334	p.G2032R
335	p.R371H
336	p.L63V
337	p.L239R
338	p.G253C
339	p.G505S
340	p.I638F
341	p.G774V
342	p.G719D
343	p.L747S
344	p.S768I
345	p.L861P
346	p.L861R
347	p.G391R
348	p.S320C
349	p.W290C
350	p.N535K
351	p.V550E
352	p.E690K
353	p.K660E
354	p.L618M
355	p.E566G
356	p.V565I
357	p.N550K
358	p.N550H
359	p.I548V
360	p.M538I
361	p.M536I
362	p.S252W
363	p.N561D
364	p.Y371H
365	p.C384R
366	p.Y571D
367	p.W515L
368	p.G466R
369	p.S505C
370	p.G284R
371	p.Q79K
372	p.K601R
373	p.V600L
374	p.V600M
375	p.L597Q
376	p.L597S
377	p.L597V
378	p.E872K
379	p.R544W
380	p.E452K
381	p.R393W
382	p.E317K
383	p.K57E
384	p.G128D
385	p.F129L
386	p.N126D
387	p.C125S
388	p.Q60P
389	p.L46F
390	p.V35M
391	p.P577S
392	p.V658A
393	p.R841K
394	p.H845Y
395	p.G853D
396	p.W388S
397	p.S257P
398	p.D194E
399	p.C634W
400	p.S310Y
401	p.S310F
402	p.P262H
403	p.Q809R
404	p.R202C
405	p.R202H
406	p.R202L
407	p.I99T
408	p.I103N
409	p.I111N
410	p.H119P
411	p.E120D
412	p.V211D
413	p.L215P
414	p.R988C
415	p.T1010I
416	p.V1110I
417	p.Y1248C
418	p.Y1253D
419	p.M1268I
420	p.G464V
421	p.C481S
422	p.E380Q
423	p.R1192P
424	p.G1128A
425	p.R108K
426	p.T263P
427	p.A289V
428	p.G598V
429	p.P546S
430	p.P753S
431	p.V843I
432	p.P253R
433	p.G464E
434	p.R665W
435	p.L845F
436	p.Y375C
437	p.V555M
438	p.Y646H
439	p.Y646N
440	p.Y646F
441	p.Y646S
442	p.A682G
443	p.L273P
444	p.S302G
445	p.K1310fs
446	p.G1466fs
447	p.I1557fs
448	p.R444W
449	p.G464R
450	p.G466A
451	p.G466E
452	p.G469R
453	p.G469S
454	p.V471F
455	p.N581S
456	p.E586K
457	p.D587A
458	p.D587E
459	p.I592M
460	p.I592V
461	p.F595L
462	p.L203*
463	p.F595S
464	p.Q207*
465	p.V600A
466	p.K601in_frame_del
467	p.K601N
468	p.S605F
469	p.S605N
470	p.R24H
471	p.R58*
472	p.E61*
473	p.E69*
474	p.R80*
475	p.A138V
476	p.R139L
477	p.E88*
478	p.R163L
479	p.W110*
480	p.P114L
481	p.L301S
482	p.L301*
483	p.Y969C
484	p.Y969F
485	p.Y969H
486	p.Y969*
487	p.A13T
488	p.A21T
489	p.V22A
490	p.VSHWQQQSYLDSGIHSG22in_frame_del
491	p.WQQQSYLD25in_frame_del
492	p.D32A
493	p.D32G
494	p.D32H
495	p.D32N
496	p.D32V
497	p.D32Y
498	p.S33C
499	p.S33Y
500	p.G34E
501	p.G34R
502	p.G34V
503	p.S37A
504	p.S37C
505	p.S37P
506	p.T40A
507	p.T40I
508	p.T40P
509	p.T40S
510	p.S45A
511	p.S45C
512	p.W731*
513	p.P733L
514	p.E734K
515	p.G735S
516	p.V742A
517	p.K745R
518	p.E746K
519	p.A750P
520	p.S752Y
521	p.D761N
522	p.D761Y
523	p.H773R
524	p.G810D
525	p.G810S
526	p.L858M
527	p.L858Q
528	p.L785P
529	p.G776S
530	p.G776in_frame_insVC
531	p.S158L
532	p.P283T
533	p.K310R
534	p.S373C
535	p.Y376C
536	p.Y382H
537	p.N639K
538	p.R248C
539	p.S249C
540	p.G372C
541	p.K652Q
542	p.G699C
543	p.Y572C
544	p.D835in_frame_del
545	p.I836in_frame_del
546	p.Q228L
547	p.P132T
548	p.A572V
549	p.V722I
550	p.D52N
551	p.V825A
552	p.E839K
553	p.L19F
554	p.Q22K
555	p.A59T
556	p.H1112Y
557	p.Y1248H
558	p.V384D
559	p.P57S
560	p.A59V
561	p.T73I
562	p.S77F
563	p.N101T
564	p.P260A
565	p.A18T
566	p.RD841in_frame_del
567	p.D842I
568	p.D842Y
569	p.DIM842in_frame_del
570	p.IMHD843in_frame_del
571	p.D846Y
572	p.R88Q
573	p.N345K
574	p.C420R
575	p.P539R
576	p.E542Q
577	p.E545D
578	p.H701P
579	p.Y1021C
580	p.M1043I
581	p.H1047Y
582	p.G1049S
583	p.G1049R
584	p.G376R
585	p.EDN439in_frame_delKI
586	p.R461*
587	p.D560Y
588	p.DKRMNS560in_frame_del
589	p.N564D
590	p.N564K
591	p.T576in_frame_del
592	p.WLTQ583in_frame_delG*
593	p.R173C
594	p.R173H
595	p.R234W
596	p.R335*
597	p.E137*
598	p.L199*
599	p.R320*
600	p.R358*
601	p.R455*
602	p.R552*
603	p.R556*
604	p.R579*
605	p.C706F
606	p.E748*
607	p.FPEEEKCFC612in_frame_del
608	p.D631G
609	p.EL632in_frame_del
610	p.C634R
611	p.C634Y
612	p.E768D
613	p.A883F
614	p.DVYE898in_frame_del
615	p.Q537*
616	p.Q37*
617	p.Q170*
618	p.D194N
619	p.D194V
620	p.G196V
621	p.E199K
622	p.E199*
623	p.P281L
624	p.W332*
625	p.R175H
626	p.G245S
627	p.R248W
628	p.R306*
629	p.P81S
630	p.L85P
631	p.L89H
632	p.L158Q
633	p.R161*
634	p.R167W
635	p.P29S
636	p.D1642H
637	p.F877L
638	p.G870S
639	p.M541L
640	p.V561A
641	p.R194W
642	p.I105V
643	p.K751Q
644	p.F2108L
645	p.S893A
646	p.L755W
647	p.F317L
648	p.S893T
649	p.P2213S
650	p.P471L
651	p.R451C
652	p.A216V
653	p.G724S
654	p.I1145
655	p.K359Q
656	p.T315I
657	p.C797S
658	p.Q1178*
659	p.R678Q
660	p.R2327W
661	p.I774X
662	p.C1156Y
663	p.L218P
664	p.R367Q
665	p.D407A
666	p.C134W
667	p.N2875H
668	p.H1968Y
669	p.Q141K
671	p.S492R
\.


--
-- Name: amino_acids_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('amino_acids_id_seq', 671, true);


--
-- Data for Name: data_versions; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY data_versions (id, version) FROM stdin;
1	9
2	9
\.


--
-- Name: data_versions_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('data_versions_id_seq', 2, true);


--
-- Data for Name: diseases; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY diseases (id, name, doid) FROM stdin;
1	melanoma	1909
2	acute myeloid leukemia	9119
3	non-small cell lung carcinoma	3908
4	thyroid cancer	1781
5	colorectal cancer	9256
6	squamous cell carcinoma	1749
7	ovarian cancer	2394
8	breast cancer	1612
9	neuroblastoma	769
10	rhabdomyosarcoma	3247
11	gastrointestinal stromal tumor	9253
12	thymic carcinoma	3284
13	progesterone-receptor positive breast cancer	0060077
14	basal cell carcinoma	2513
15	medulloblastoma	0050902
16	lung cancer	1324
17	lymphoblastic leukemia	1037
18	acute lymphocytic leukemia	9952
19	polycythemia vera	8997
20	megakaryocytic leukemia	8761
21	chronic myeloid leukemia	8552
22	lung small cell carcinoma	5409
23	myelofibrosis	4971
24	renal carcinoma	4451
25	urinary bladder urothelial carcinoma	4006
26	lung adenocarcinoma	3910
27	lung squamous cell carcinoma	3907
28	meningioma	3565
29	systemic mastocytosis	349
30	osteosarcoma	3347
31	endometrial adenocarcinoma	2870
32	hematologic cancer	2531
33	chronic myeloproliferative disease	2226
34	hemorrhagic thrombocythemia	2224
35	colon cancer	219
36	pancreatic cancer	1793
37	cancer	162
38	brain cancer	1319
39	head and neck cancer	11934
40	stomach cancer	10534
41	chronic lymphocytic leukemia	1040
42	prostate cancer	10283
43	myeloma	0070004
44	lymphoma	0060058
45	esophagus squamous cell carcinoma	3748
46	endometrial carcinoma	2871
47	craniopharyngioma	3840
48	parathyroid carcinoma	1540
49	hepatocellular carcinoma	684
50	pilomatrixoma	5374
51	adrenal cortical adenoma	0050891
52	head and neck squamous cell carcinoma	5520
53	esophageal carcinoma	1107
54	tongue squamous cell carcinoma	0050865
55	bladder carcinoma	4007
56	uveal melanoma	6039
57	skin squamous cell carcinoma	3151
58	astrocytoma	3069
59	mast-cell leukemia	9254
60	angiosarcoma	0001816
61	gastric adenocarcinoma	3717
62	oral squamous cell carcinoma	0050866
63	retinoblastoma	768
64	thyroid medullary carcinoma	3973
65	renal clear cell carcinoma	4467
66	inflammatory myofibroblastic tumor	0050905
67	glioblastoma multiforme	3068
68	thyroid carcinoma	3963
70	Merkel cell carcinoma	3965
71	acute promyelocytic leukemia	0060318
72	myelodysplastic syndrome	0050908
73	acute T cell leukemia	5603
74	pancreatic carcinoma	4905
75	papillary thyroid carcinoma	3969
77	endometrial cancer	1380
78	oligodendroglioma	3181
79	granulosa cell tumor	2999
80	bone marrow cancer	4960
81	lymphoid leukemia	10747
69	medulloblastoma	0050902
76	myeloma	0070004
83	medulloblastoma	0050902
84	myeloma	0070004
\.


--
-- Data for Name: genes; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY genes (id, name, ensembl_id, entrez_id) FROM stdin;
1	NRAS	ENSG00000213281	\N
2	DDR2	ENSG00000162733	\N
3	CSF3R	ENSG00000119535	\N
4	RET	ENSG00000165731	\N
5	PTEN	ENSG00000171862	\N
6	WT1	ENSG00000184937	\N
7	HRAS	ENSG00000174775	\N
8	KRAS	ENSG00000133703	\N
9	FLT3	ENSG00000122025	\N
10	AKT1	ENSG00000142208	\N
11	HERC2	ENSG00000128731	\N
12	MAP2K1	ENSG00000169032	\N
13	IDH2	ENSG00000182054	\N
14	ERBB2	ENSG00000141736	\N
15	TP53	ENSG00000141510	\N
16	SMAD4	ENSG00000141646	\N
17	GNA11	ENSG00000088256	\N
18	SF3B1	ENSG00000115524	\N
19	IDH1	ENSG00000138413	\N
20	DNMT3A	ENSG00000119772	\N
21	ALK	ENSG00000171094	\N
22	RUNX1	ENSG00000159216	\N
23	U2AF1	ENSG00000160201	\N
24	GATA2	ENSG00000179348	\N
25	PIK3CA	ENSG00000121879	\N
26	CTNNB1	ENSG00000168036	\N
27	PDGFRA	ENSG00000134853	\N
28	KIT	ENSG00000157404	\N
29	NPM1	ENSG00000181163	\N
30	ESR1	ENSG00000091831	\N
31	SMO	ENSG00000128602	\N
32	BRAF	ENSG00000157764	\N
33	EGFR	ENSG00000146648	\N
34	JAK2	ENSG00000096968	\N
35	GNAQ	ENSG00000156052	\N
36	CRLF2	ENSG00000205755	\N
39	IL7R	\N	\N
40	JAK1	\N	\N
43	APC	\N	\N
65	JAK3	\N	\N
67	MPL	\N	\N
68	MET	\N	\N
73	AKT2	\N	\N
76	EPHA2	\N	\N
77	FGFR2	\N	\N
78	FGFR4	\N	\N
79	PIK3R2	\N	\N
80	CBL	\N	\N
81	CSF1R	\N	\N
83	ERBB3	\N	\N
85	ERBB4	\N	\N
88	MAP2K2	\N	\N
89	RAF1	\N	\N
90	STK11	\N	\N
93	GNAS	\N	\N
97	PLCG2	\N	\N
99	EZH2	\N	\N
100	MYD88	\N	\N
101	CDK4	\N	\N
102	CDKN2A	\N	\N
103	FGFR1	\N	\N
104	MLH1	\N	\N
105	MYC	\N	\N
106	PIK3R1	\N	\N
107	RB1	\N	\N
108	SRC	\N	\N
109	VHL	\N	\N
110	ABL1	ENSG00000097007	\N
111	RAC1	ENSG00000136238	\N
112	NOTCH1	ENSG00000148400	\N
113	AR	ENSG00000169083	\N
114	SETBP1	ENSG00000152217	\N
115	XRCC1	ENSG00000073050	\N
116	GSTP1	ENSG00000084207	\N
117	ERCC2	ENSG00000104884	\N
118	MTOR	ENSG00000198793	\N
119	ABCB1	ENSG00000085563	\N
120	ROS1	ENSG00000047936	\N
121	PML	ENSG00000140464	\N
122	NT5C2	ENSG00000076685	\N
123	TSC2	ENSG00000103197	\N
124	ARAF	ENSG00000078061	\N
125	BTK	ENSG00000010671	\N
126	FGFR3	ENSG00000068078	\N
127	ATR	ENSG00000175054	\N
128	FOXL2	ENSG00000183770	\N
129	ATM	ENSG00000149311	\N
130	ABCG2	ENSG00000118777	\N
\.


--
-- Data for Name: locations; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY locations (id, chromosome, reference_build, reference_read, start, stop, previous_reference_base, reference_sequence_version) FROM stdin;
1	1	\N	T	115256528	115256528	\N	GRCh37
2	1	\N	T	115256529	115256529	\N	GRCh37
3	1	\N	G	115256530	115256530	\N	GRCh37
4	1	\N	C	115258744	115258744	\N	GRCh37
5	1	\N	C	115258745	115258745	\N	GRCh37
6	1	\N	C	115258747	115258747	\N	GRCh37
7	1	\N	C	115258748	115258748	\N	GRCh37
8	1	\N	T	162748390	162748390	\N	GRCh37
9	1	\N	G	36933434	36933434	\N	GRCh37
10	10	\N	T	43617416	43617416	\N	GRCh37
11	10	\N	C	89692904	89692904	\N	GRCh37
12	10	\N	G	89692905	89692905	\N	GRCh37
13	10	\N	G	89692993	89692993	\N	GRCh37
14	10	\N	C	89717672	89717672	\N	GRCh37
17	11	\N	T	533874	533874	\N	GRCh37
18	11	\N	C	534286	534286	\N	GRCh37
19	11	\N	C	534288	534288	\N	GRCh37
20	11	\N	C	534289	534289	\N	GRCh37
21	12	\N	G	25378561	25378561	\N	GRCh37
22	12	\N	C	25378562	25378562	\N	GRCh37
23	12	\N	T	25378647	25378647	\N	GRCh37
24	12	\N	T	25380275	25380275	\N	GRCh37
25	12	\N	T	25380276	25380276	\N	GRCh37
26	12	\N	G	25380277	25380277	\N	GRCh37
27	12	\N	C	25398281	25398281	\N	GRCh37
28	12	\N	C	25398282	25398282	\N	GRCh37
29	12	\N	C	25398284	25398284	\N	GRCh37
30	12	\N	C	25398285	25398285	\N	GRCh37
31	13	\N	T	28592629	28592629	\N	GRCh37
32	13	\N	G	28592637	28592637	\N	GRCh37
33	13	\N	T	28592639	28592639	\N	GRCh37
34	13	\N	A	28592640	28592640	\N	GRCh37
35	13	\N	T	28592641	28592641	\N	GRCh37
36	13	\N	C	28592642	28592642	\N	GRCh37
37	14	\N	C	105246551	105246551	\N	GRCh37
39	15	\N	A	28505975	28505975	\N	GRCh37
40	15	\N	G	28517518	28517518	\N	GRCh37
41	15	\N	T	66727441	66727441	\N	GRCh37
42	15	\N	A	66727451	66727451	\N	GRCh37
43	15	\N	G	66727455	66727455	\N	GRCh37
44	15	\N	G	66727483	66727483	\N	GRCh37
45	15	\N	T	66729124	66729124	\N	GRCh37
46	15	\N	G	66729154	66729154	\N	GRCh37
47	15	\N	C	66729162	66729162	\N	GRCh37
48	15	\N	C	66729163	66729163	\N	GRCh37
49	15	\N	G	66774131	66774131	\N	GRCh37
50	15	\N	C	66777424	66777424	\N	GRCh37
51	15	\N	A	66782915	66782915	\N	GRCh37
52	15	\N	C	90631837	90631837	\N	GRCh37
53	15	\N	C	90631838	90631838	\N	GRCh37
54	15	\N	C	90631934	90631934	\N	GRCh37
55	15	\N	G	90631935	90631935	\N	GRCh37
56	17	\N	G	37868205	37868205	\N	GRCh37
58	17	\N	T	37880220	37880220	\N	GRCh37
59	17	\N	G	37880261	37880261	\N	GRCh37
60	17	\N	G	37881000	37881000	\N	GRCh37
62	17	\N	G	37881332	37881332	\N	GRCh37
63	17	\N	C	37881616	37881616	\N	GRCh37
64	17	\N	C	7577120	7577120	\N	GRCh37
65	17	\N	G	7577121	7577121	\N	GRCh37
66	17	\N	C	7577535	7577535	\N	GRCh37
67	17	\N	T	7577536	7577536	\N	GRCh37
68	17	\N	C	7577538	7577538	\N	GRCh37
69	17	\N	T	7578190	7578190	\N	GRCh37
70	17	\N	A	7578412	7578412	\N	GRCh37
71	18	\N	A	48591826	48591826	\N	GRCh37
72	18	\N	G	48591888	48591888	\N	GRCh37
73	18	\N	C	48591902	48591902	\N	GRCh37
74	18	\N	C	48591918	48591918	\N	GRCh37
75	18	\N	G	48591919	48591919	\N	GRCh37
76	18	\N	G	48604787	48604787	\N	GRCh37
77	19	\N	A	3118942	3118942	\N	GRCh37
78	2	\N	T	198266832	198266832	\N	GRCh37
79	2	\N	T	198266833	198266833	\N	GRCh37
80	2	\N	T	198266834	198266834	\N	GRCh37
81	2	\N	C	198267359	198267359	\N	GRCh37
82	2	\N	T	198267360	198267360	\N	GRCh37
83	2	\N	T	198267361	198267361	\N	GRCh37
84	2	\N	C	209113112	209113112	\N	GRCh37
85	2	\N	G	209113113	209113113	\N	GRCh37
86	2	\N	C	25457242	25457242	\N	GRCh37
87	2	\N	G	25457243	25457243	\N	GRCh37
88	2	\N	T	29432655	29432655	\N	GRCh37
89	2	\N	C	29432664	29432664	\N	GRCh37
90	2	\N	G	29436858	29436858	\N	GRCh37
91	2	\N	A	29436859	29436859	\N	GRCh37
92	2	\N	A	29436860	29436860	\N	GRCh37
93	2	\N	C	29436920	29436920	\N	GRCh37
94	2	\N	G	29443695	29443695	\N	GRCh37
95	2	\N	A	29443696	29443696	\N	GRCh37
96	2	\N	A	29443697	29443697	\N	GRCh37
97	2	\N	A	29445213	29445213	\N	GRCh37
98	2	\N	G	29445273	29445273	\N	GRCh37
99	2	\N	C	29446296	29446296	\N	GRCh37
100	21	\N	G	36231783	36231783	\N	GRCh37
101	21	\N	C	36252876	36252876	\N	GRCh37
102	21	\N	C	36252877	36252877	\N	GRCh37
103	21	\N	T	36252878	36252878	\N	GRCh37
104	21	\N	T	44514777	44514777	\N	GRCh37
105	21	\N	G	44524456	44524456	\N	GRCh37
106	3	\N	G	128200113	128200113	\N	GRCh37
107	3	\N	G	128200744	128200744	\N	GRCh37
108	3	\N	G	178936082	178936082	\N	GRCh37
109	3	\N	G	178936091	178936091	\N	GRCh37
110	3	\N	A	178936092	178936092	\N	GRCh37
111	3	\N	C	178936094	178936094	\N	GRCh37
112	3	\N	A	178936095	178936095	\N	GRCh37
113	3	\N	G	178936103	178936103	\N	GRCh37
114	3	\N	A	178952085	178952085	\N	GRCh37
115	3	\N	C	41266113	41266113	\N	GRCh37
116	3	\N	T	41266136	41266136	\N	GRCh37
117	3	\N	C	41266137	41266137	\N	GRCh37
118	4	\N	T	55141036	55141036	\N	GRCh37
119	4	\N	C	55144148	55144148	\N	GRCh37
120	4	\N	A	55152093	55152093	\N	GRCh37
121	4	\N	G	55592144	55592144	\N	GRCh37
122	4	\N	T	55592186	55592186	\N	GRCh37
123	4	\N	A	55593584	55593584	\N	GRCh37
124	4	\N	T	55593591	55593591	\N	GRCh37
128	4	\N	T	55593603	55593603	\N	GRCh37
129	4	\N	G	55593608	55593608	\N	GRCh37
131	4	\N	T	55593610	55593610	\N	GRCh37
133	4	\N	T	55593613	55593613	\N	GRCh37
134	4	\N	G	55593628	55593628	\N	GRCh37
135	4	\N	A	55593630	55593630	\N	GRCh37
138	4	\N	T	55593640	55593640	\N	GRCh37
140	4	\N	T	55593661	55593661	\N	GRCh37
143	4	\N	C	55594197	55594197	\N	GRCh37
144	4	\N	A	55594221	55594221	\N	GRCh37
145	4	\N	T	55594258	55594258	\N	GRCh37
146	4	\N	A	55594261	55594261	\N	GRCh37
147	4	\N	T	55594262	55594262	\N	GRCh37
148	4	\N	C	55595599	55595599	\N	GRCh37
149	4	\N	G	55599320	55599320	\N	GRCh37
150	4	\N	GA	55599320	55599321	\N	GRCh37
151	4	\N	A	55599321	55599321	\N	GRCh37
152	4	\N	G	55599332	55599332	\N	GRCh37
153	4	\N	A	55599333	55599333	\N	GRCh37
154	4	\N	T	55599334	55599334	\N	GRCh37
155	4	\N	A	55599338	55599338	\N	GRCh37
156	4	\N	A	55599339	55599339	\N	GRCh37
157	4	\N	T	55599340	55599340	\N	GRCh37
158	4	\N	T	55599341	55599341	\N	GRCh37
159	4	\N	G	55602664	55602664	\N	GRCh37
160	4	\N	A	55602700	55602700	\N	GRCh37
161	4	\N	C	55602770	55602770	\N	GRCh37
163	6	\N	T	152415537	152415537	\N	GRCh37
164	6	\N	T	152419914	152419914	\N	GRCh37
165	6	\N	C	152419917	152419917	\N	GRCh37
166	6	\N	T	152419920	152419920	\N	GRCh37
167	6	\N	T	152419922	152419922	\N	GRCh37
168	6	\N	A	152419923	152419923	\N	GRCh37
169	6	\N	A	152419926	152419926	\N	GRCh37
170	7	\N	CC	128829195	128829196	\N	GRCh37
171	7	\N	C	128845101	128845101	\N	GRCh37
172	7	\N	CC	128846116	128846117	\N	GRCh37
173	7	\N	G	128849189	128849189	\N	GRCh37
174	7	\N	CC	128849224	128849225	\N	GRCh37
175	7	\N	CC	128850279	128850280	\N	GRCh37
176	7	\N	G	128850341	128850341	\N	GRCh37
177	7	\N	G	128850838	128850838	\N	GRCh37
178	7	\N	C	128851883	128851883	\N	GRCh37
179	7	\N	CC	128852191	128852192	\N	GRCh37
180	7	\N	T	140453134	140453134	\N	GRCh37
181	7	\N	CA	140453135	140453136	\N	GRCh37
182	7	\N	A	140453136	140453136	\N	GRCh37
183	7	\N	AC	140453136	140453137	\N	GRCh37
184	7	\N	A	140453145	140453145	\N	GRCh37
185	7	\N	A	140453153	140453153	\N	GRCh37
186	7	\N	T	140453154	140453154	\N	GRCh37
187	7	\N	C	140453155	140453155	\N	GRCh37
188	7	\N	CA	140453155	140453156	\N	GRCh37
189	7	\N	T	140481393	140481393	\N	GRCh37
190	7	\N	C	140481402	140481402	\N	GRCh37
191	7	\N	CC	140481402	140481403	\N	GRCh37
192	7	\N	C	140481411	140481411	\N	GRCh37
193	7	\N	G	55241707	55241707	\N	GRCh37
194	7	\N	G	55241708	55241708	\N	GRCh37
195	7	\N	C	55249071	55249071	\N	GRCh37
196	7	\N	T	55259515	55259515	\N	GRCh37
197	7	\N	T	55259524	55259524	\N	GRCh37
198	9	\N	G	5073770	5073770	\N	GRCh37
199	9	\N	A	5078360	5078360	\N	GRCh37
200	9	\N	G	5078361	5078361	\N	GRCh37
201	9	\N	A	5078362	5078362	\N	GRCh37
202	9	\N	T	80409488	80409488	\N	GRCh37
203	X	\N	A	1314966	1314966	\N	GRCh37
15	10	\N	A	89717775	89717775	A	GRCh37
16	11	\N	-	32417909	32417910	C	GRCh37
38	15	\N	CAGGTCAGGACCGTT	28505962	28505962	T	GRCh37
57	17	\N	TTGAGGGAAAACACA	37880219	37880219	G	GRCh37
61	17	\N	-	37881003	37881004	G	GRCh37
125	4	\N	GAAGTACAGTGGAAG	55593594	55593594	T	GRCh37
126	4	\N	GAAGTACAGTGGAAGGTT	55593594	55593594	T	GRCh37
208	1	\N	C	65312347	65312347	\N	GRCh37
209	5	\N	C	112173917	112173917	\N	GRCh37
210	5	\N	C	112174631	112174631	\N	GRCh37
211	5	\N	G	112175207	112175207	\N	GRCh37
212	5	\N	C	112175303	112175303	\N	GRCh37
127	4	\N	-	55593600	55593601	A	GRCh37
130	4	\N	GTT	55593609	55593611	G	GRCh37
132	4	\N	GTT	55593612	55593612	T	GRCh37
136	4	\N	AACAATTATGTTACAGAC	55593630	55593647	A	GRCh37
137	4	\N	AACAATTATGTTACAGACCCAACA	55593630	55593656	A	GRCh37
213	5	\N	C	112175390	112175390	\N	GRCh37
214	5	\N	C	112175423	112175423	\N	GRCh37
215	5	\N	G	112175426	112175426	\N	GRCh37
216	5	\N	C	112175576	112175576	\N	GRCh37
217	5	\N	C	112175639	112175639	\N	GRCh37
218	7	\N	C	140453149	140453149	\N	GRCh37
219	7	\N	A	55228007	55228007	\N	GRCh37
139	4	\N	-	55593657	55593658	A	GRCh37
141	4	\N	CTTATGATC	55593664	55593664	C	GRCh37
142	4	\N	GAT	55593669	55593671	T	GRCh37
220	4	\N	G	55593609	55593609	\N	GRCh37
221	4	\N	C	55595519	55595519	\N	GRCh37
222	13	\N	T	28592620	28592620	\N	GRCh37
162	5	\N	-	170837546	170837547	C	GRCh37
204	9	\N	T	133738357	133738357	\N	GRCh37
205	9	\N	C	133748283	133748283	\N	GRCh37
206	5	\N	A	35873597	35873597	\N	GRCh37
207	1	\N	G	65312382	65312382	\N	GRCh37
223	13	\N	A	28592621	28592621	\N	GRCh37
224	13	\N	TC	28592641	28592642	\N	GRCh37
225	13	\N	A	28601359	28601359	\N	GRCh37
226	13	\N	T	28601373	28601373	\N	GRCh37
227	13	\N	G	28602340	28602340	\N	GRCh37
228	13	\N	T	28602342	28602342	\N	GRCh37
229	13	\N	T	28602416	28602416	\N	GRCh37
230	13	\N	C	28608111	28608111	\N	GRCh37
231	19	\N	C	17945969	17945969	\N	GRCh37
232	19	\N	C	17949138	17949138	\N	GRCh37
233	19	\N	A	17954634	17954634	\N	GRCh37
234	9	\N	A	133738330	133738330	\N	GRCh37
235	9	\N	C	133738342	133738342	\N	GRCh37
236	9	\N	G	133738349	133738349	\N	GRCh37
237	9	\N	G	133738356	133738356	\N	GRCh37
238	9	\N	A	133738358	133738358	\N	GRCh37
239	9	\N	G	133738363	133738363	\N	GRCh37
240	9	\N	A	133738364	133738364	\N	GRCh37
241	9	\N	T	133747540	133747540	\N	GRCh37
242	9	\N	C	133748290	133748290	\N	GRCh37
243	9	\N	T	133748391	133748391	\N	GRCh37
244	9	\N	A	133748403	133748403	\N	GRCh37
245	9	\N	T	133748414	133748414	\N	GRCh37
246	9	\N	A	133750356	133750356	\N	GRCh37
247	9	\N	G	133738306	133738306	\N	GRCh37
248	9	\N	G	133747588	133747588	\N	GRCh37
249	9	\N	A	133748282	133748282	\N	GRCh37
250	9	\N	T	133748288	133748288	\N	GRCh37
251	9	\N	T	133748289	133748289	\N	GRCh37
252	9	\N	T	133748415	133748415	\N	GRCh37
253	1	\N	T	36933444	36933444	\N	GRCh37
254	1	\N	G	43814979	43814979	\N	GRCh37
255	7	\N	A	116417464	116417464	\N	GRCh37
256	7	\N	T	116423474	116423474	\N	GRCh37
257	1	\N	C	11169361	11169361	\N	GRCh37
258	1	\N	G	11182179	11182179	\N	GRCh37
259	1	\N	G	11184573	11184573	\N	GRCh37
260	1	\N	A	11217299	11217299	\N	GRCh37
261	1	\N	C	11174420	11174420	\N	GRCh37
262	1	\N	C	11187857	11187857	\N	GRCh37
263	2	\N	C	29432682	29432682	\N	GRCh37
264	2	\N	G	29443600	29443600	\N	GRCh37
265	2	\N	C	29443613	29443613	\N	GRCh37
266	2	\N	G	29443631	29443631	\N	GRCh37
267	2	\N	A	29445270	29445270	\N	GRCh37
268	X	\N	C	47426121	47426121	\N	GRCh37
269	6	\N	C	117638347	117638347	\N	GRCh37
270	19	\N	C	40741860	40741860	\N	GRCh37
271	1	\N	C	162724415	162724415	\N	GRCh37
272	1	\N	T	162729630	162729630	\N	GRCh37
273	1	\N	G	162729671	162729671	\N	GRCh37
274	1	\N	G	162741822	162741822	\N	GRCh37
275	1	\N	A	162745497	162745497	\N	GRCh37
276	1	\N	G	162748407	162748407	\N	GRCh37
277	7	\N	T	55242470	55242470	\N	GRCh37
278	7	\N	G	55249005	55249005	\N	GRCh37
279	1	\N	C	16464489	16464489	\N	GRCh37
280	10	\N	G	123278324	123278324	\N	GRCh37
281	10	\N	C	123279562	123279562	\N	GRCh37
282	5	\N	C	176522416	176522416	\N	GRCh37
283	5	\N	T	176522552	176522552	\N	GRCh37
284	7	\N	G	55241620	55241620	\N	GRCh37
285	10	\N	T	123247516	123247516	\N	GRCh37
286	10	\N	A	123256060	123256060	\N	GRCh37
287	10	\N	T	123256215	123256215	\N	GRCh37
288	10	\N	C	123256219	123256219	\N	GRCh37
289	10	\N	A	123258034	123258034	\N	GRCh37
290	10	\N	T	123258036	123258036	\N	GRCh37
291	10	\N	T	123258042	123258042	\N	GRCh37
292	10	\N	C	123258070	123258070	\N	GRCh37
293	10	\N	C	123258076	123258076	\N	GRCh37
294	10	\N	G	123279677	123279677	\N	GRCh37
295	19	\N	A	18278061	18278061	\N	GRCh37
296	11	\N	T	119148891	119148891	\N	GRCh37
297	11	\N	T	119148930	119148930	\N	GRCh37
298	5	\N	A	149441328	149441328	\N	GRCh37
299	1	\N	G	43815009	43815009	\N	GRCh37
300	7	\N	C	140481412	140481412	\N	GRCh37
301	1	\N	A	43814978	43814978	\N	GRCh37
302	12	\N	G	56481922	56481922	\N	GRCh37
303	14	\N	G	105243048	105243048	\N	GRCh37
304	7	\N	T	140453133	140453133	\N	GRCh37
305	7	\N	C	140453137	140453137	\N	GRCh37
306	7	\N	AG	140453145	140453146	\N	GRCh37
307	7	\N	G	140453146	140453146	\N	GRCh37
308	2	\N	C	212295699	212295699	\N	GRCh37
309	2	\N	G	212537975	212537975	\N	GRCh37
310	2	\N	C	212537981	212537981	\N	GRCh37
311	2	\N	C	212566827	212566827	\N	GRCh37
312	2	\N	G	212570064	212570064	\N	GRCh37
313	2	\N	C	212578308	212578308	\N	GRCh37
314	15	\N	A	66727453	66727453	\N	GRCh37
315	15	\N	G	66729175	66729175	\N	GRCh37
316	15	\N	T	66729177	66729177	\N	GRCh37
317	19	\N	T	4110581	4110581	\N	GRCh37
318	19	\N	A	4110584	4110584	\N	GRCh37
319	19	\N	T	4117541	4117541	\N	GRCh37
320	19	\N	G	4117584	4117584	\N	GRCh37
321	19	\N	C	4117617	4117617	\N	GRCh37
322	1	\N	TT	115256528	115256529	\N	GRCh37
323	4	\N	C	55141083	55141083	\N	GRCh37
324	4	\N	T	55144144	55144144	\N	GRCh37
325	4	\N	G	55152090	55152090	\N	GRCh37
326	4	\N	C	55152101	55152101	\N	GRCh37
327	4	\N	G	55152126	55152126	\N	GRCh37
328	3	\N	C	12641195	12641195	\N	GRCh37
329	3	\N	A	12645700	12645700	\N	GRCh37
330	19	\N	C	1220489	1220489	\N	GRCh37
331	10	\N	C	43609950	43609950	\N	GRCh37
332	17	\N	C	37868208	37868208	\N	GRCh37
333	12	\N	C	56481857	56481857	\N	GRCh37
334	12	\N	A	56490980	56490980	\N	GRCh37
335	20	\N	C	57484420	57484420	\N	GRCh37
336	20	\N	G	57484421	57484421	\N	GRCh37
337	15	\N	T	66729088	66729088	\N	GRCh37
338	15	\N	T	66729100	66729100	\N	GRCh37
339	15	\N	A	66729148	66729148	\N	GRCh37
340	15	\N	G	66729152	66729152	\N	GRCh37
341	15	\N	T	66774156	66774156	\N	GRCh37
342	15	\N	T	66774168	66774168	\N	GRCh37
343	7	\N	C	116411923	116411923	\N	GRCh37
344	7	\N	C	116411990	116411990	\N	GRCh37
345	7	\N	G	116417457	116417457	\N	GRCh37
346	7	\N	A	116423414	116423414	\N	GRCh37
347	7	\N	T	116423428	116423428	\N	GRCh37
348	7	\N	G	116423475	116423475	\N	GRCh37
349	7	\N	C	140481417	140481417	\N	GRCh37
350	X	\N	C	100611164	100611164	\N	GRCh37
351	X	\N	A	100611165	100611165	\N	GRCh37
352	6	\N	G	152332832	152332832	\N	GRCh37
353	2	\N	C	29443642	29443642	\N	GRCh37
354	2	\N	C	29445450	29445450	\N	GRCh37
355	7	\N	G	55211080	55211080	\N	GRCh37
356	7	\N	A	55221743	55221743	\N	GRCh37
357	7	\N	C	55221822	55221822	\N	GRCh37
358	7	\N	G	55233043	55233043	\N	GRCh37
359	7	\N	C	55231430	55231430	\N	GRCh37
360	7	\N	C	55242487	55242487	\N	GRCh37
361	7	\N	G	55259469	55259469	\N	GRCh37
362	10	\N	G	123279674	123279674	\N	GRCh37
363	16	\N	C	81946260	81946260	\N	GRCh37
364	16	\N	A	81962183	81962183	\N	GRCh37
365	4	\N	A	1806099	1806099	\N	GRCh37
366	4	\N	G	1807488	1807488	\N	GRCh37
367	7	\N	A	148508728	148508728	\N	GRCh37
368	7	\N	T	148508727	148508727	\N	GRCh37
369	7	\N	G	148506467	148506467	\N	GRCh37
370	3	\N	T	38182641	38182641	\N	GRCh37
371	19	\N	T	40742220	40742220	\N	GRCh37
376	7	\N	G	140481478	140481478	\N	GRCh37
377	7	\N	C	140481418	140481418	\N	GRCh37
378	7	\N	C	140481403	140481403	\N	GRCh37
379	7	\N	C	140481397	140481397	\N	GRCh37
380	7	\N	T	140453193	140453193	\N	GRCh37
381	7	\N	C	140453179	140453179	\N	GRCh37
382	7	\N	T	140453175	140453175	\N	GRCh37
383	7	\N	G	140453174	140453174	\N	GRCh37
384	7	\N	T	140453159	140453159	\N	GRCh37
385	7	\N	T	140453161	140453161	\N	GRCh37
386	7	\N	A	140453152	140453152	\N	GRCh37
387	7	\N	A	140453150	140453150	\N	GRCh37
388	7	\N	A	140453151	140453151	\N	GRCh37
389	7	\N	G	140453139	140453139	\N	GRCh37
391	7	\N	T	140453132	140453132	\N	GRCh37
392	7	\N	CT	140453121	140453122	\N	GRCh37
393	7	\N	C	140453121	140453121	\N	GRCh37
394	12	\N	C	58145430	58145430	\N	GRCh37
395	9	\N	G	21971186	21971186	\N	GRCh37
396	9	\N	C	21971177	21971177	\N	GRCh37
397	9	\N	C	21971153	21971153	\N	GRCh37
398	9	\N	G	21971120	21971120	\N	GRCh37
399	9	\N	G	21971111	21971111	\N	GRCh37
400	9	\N	C	21971108	21971108	\N	GRCh37
401	9	\N	C	21971096	21971096	\N	GRCh37
402	9	\N	C	21971036	21971036	\N	GRCh37
403	9	\N	C	21971029	21971029	\N	GRCh37
404	9	\N	C	21971028	21971028	\N	GRCh37
405	9	\N	G	21971017	21971017	\N	GRCh37
406	5	\N	A	149453044	149453044	\N	GRCh37
407	5	\N	T	149433645	149433645	\N	GRCh37
408	5	\N	A	149433646	149433646	\N	GRCh37
409	5	\N	A	149433644	149433644	\N	GRCh37
410	3	\N	G	41266040	41266040	\N	GRCh37
411	3	\N	G	41266064	41266064	\N	GRCh37
412	3	\N	T	41266068	41266068	\N	GRCh37
415	3	\N	A	41266098	41266098	\N	GRCh37
416	3	\N	G	41266097	41266097	\N	GRCh37
417	3	\N	C	41266101	41266101	\N	GRCh37
418	3	\N	G	41266104	41266104	\N	GRCh37
419	3	\N	G	41266103	41266103	\N	GRCh37
420	3	\N	T	41266112	41266112	\N	GRCh37
421	3	\N	A	41266121	41266121	\N	GRCh37
422	3	\N	C	41266122	41266122	\N	GRCh37
423	7	\N	G	55242423	55242423	\N	GRCh37
424	7	\N	C	55242428	55242428	\N	GRCh37
425	7	\N	G	55242430	55242430	\N	GRCh37
426	7	\N	G	55242433	55242433	\N	GRCh37
427	7	\N	T	55242455	55242455	\N	GRCh37
428	7	\N	A	55242464	55242464	\N	GRCh37
429	7	\N	G	55242466	55242466	\N	GRCh37
430	7	\N	G	55242478	55242478	\N	GRCh37
431	7	\N	C	55242485	55242485	\N	GRCh37
432	7	\N	G	55242511	55242511	\N	GRCh37
433	7	\N	A	55249020	55249020	\N	GRCh37
434	7	\N	G	55249131	55249131	\N	GRCh37
435	7	\N	G	55249130	55249130	\N	GRCh37
436	7	\N	C	55259514	55259514	\N	GRCh37
437	7	\N	TG	55259515	55259516	\N	GRCh37
438	7	\N	CT	55259514	55259515	\N	GRCh37
439	17	\N	T	37881025	37881025	\N	GRCh37
440	17	\N	G	37880997	37880997	\N	GRCh37
442	8	\N	G	38285938	38285938	\N	GRCh37
443	8	\N	G	38282209	38282209	\N	GRCh37
444	10	\N	T	123279503	123279503	\N	GRCh37
445	10	\N	G	123274803	123274803	\N	GRCh37
446	10	\N	T	123274794	123274794	\N	GRCh37
447	10	\N	A	123274777	123274777	\N	GRCh37
448	10	\N	A	123247577	123247577	\N	GRCh37
449	4	\N	C	1803564	1803564	\N	GRCh37
450	4	\N	C	1803568	1803568	\N	GRCh37
451	4	\N	G	1806089	1806089	\N	GRCh37
452	4	\N	A	1806092	1806092	\N	GRCh37
453	4	\N	A	1807889	1807889	\N	GRCh37
454	4	\N	G	1808331	1808331	\N	GRCh37
455	13	\N	T	28608341	28608341	\N	GRCh37
458	9	\N	TG	80409488	80409489	\N	GRCh37
459	20	\N	A	57484596	57484596	\N	GRCh37
460	11	\N	C	534285	534285	\N	GRCh37
461	11	\N	C	533873	533873	\N	GRCh37
462	11	\N	G	533875	533875	\N	GRCh37
463	11	\N	CT	533873	533874	\N	GRCh37
464	19	\N	G	17954215	17954215	\N	GRCh37
465	19	\N	G	17948009	17948009	\N	GRCh37
466	19	\N	C	17945696	17945696	\N	GRCh37
467	4	\N	G	55561764	55561764	\N	GRCh37
468	4	\N	T	55599348	55599348	\N	GRCh37
469	4	\N	G	55602694	55602694	\N	GRCh37
470	12	\N	C	25398262	25398262	\N	GRCh37
471	12	\N	G	25398255	25398255	\N	GRCh37
472	12	\N	C	25380283	25380283	\N	GRCh37
473	15	\N	T	66729153	66729153	\N	GRCh37
474	7	\N	C	116417463	116417463	\N	GRCh37
475	7	\N	T	116423413	116423413	\N	GRCh37
476	3	\N	T	37067240	37067240	\N	GRCh37
477	8	\N	C	128750632	128750632	\N	GRCh37
478	8	\N	C	128750639	128750639	\N	GRCh37
479	8	\N	C	128750681	128750681	\N	GRCh37
480	8	\N	C	128750693	128750693	\N	GRCh37
481	8	\N	A	128750765	128750765	\N	GRCh37
482	8	\N	C	128751241	128751241	\N	GRCh37
483	1	\N	C	115258730	115258730	\N	GRCh37
484	1	\N	TG	115256529	115256530	\N	GRCh37
486	4	\N	GA	55152092	55152093	\N	GRCh37
487	4	\N	G	55152092	55152092	\N	GRCh37
491	4	\N	G	55152104	55152104	\N	GRCh37
492	3	\N	G	178916876	178916876	\N	GRCh37
493	3	\N	T	178921553	178921553	\N	GRCh37
494	3	\N	T	178927980	178927980	\N	GRCh37
495	3	\N	C	178936074	178936074	\N	GRCh37
496	3	\N	G	178936093	178936093	\N	GRCh37
497	3	\N	A	178938860	178938860	\N	GRCh37
498	3	\N	A	178952007	178952007	\N	GRCh37
499	3	\N	G	178952074	178952074	\N	GRCh37
500	3	\N	C	178952084	178952084	\N	GRCh37
501	3	\N	G	178952090	178952090	\N	GRCh37
502	5	\N	G	67589138	67589138	\N	GRCh37
504	5	\N	C	67589618	67589618	\N	GRCh37
505	5	\N	G	67591085	67591085	\N	GRCh37
507	5	\N	A	67591097	67591097	\N	GRCh37
508	5	\N	C	67591099	67591099	\N	GRCh37
511	10	\N	C	89711899	89711899	\N	GRCh37
512	10	\N	G	89711900	89711900	\N	GRCh37
513	10	\N	C	89717675	89717675	\N	GRCh37
514	10	\N	C	89720852	89720852	\N	GRCh37
515	13	\N	G	48919244	48919244	\N	GRCh37
516	13	\N	T	48923148	48923148	\N	GRCh37
517	13	\N	C	48941648	48941648	\N	GRCh37
518	13	\N	C	48942685	48942685	\N	GRCh37
519	13	\N	C	48953760	48953760	\N	GRCh37
520	13	\N	C	48955538	48955538	\N	GRCh37
521	13	\N	C	48955550	48955550	\N	GRCh37
522	13	\N	C	49027168	49027168	\N	GRCh37
523	13	\N	G	49037877	49037877	\N	GRCh37
524	13	\N	G	49039164	49039164	\N	GRCh37
526	10	\N	A	43609940	43609940	\N	GRCh37
528	10	\N	T	43609948	43609948	\N	GRCh37
529	10	\N	G	43609949	43609949	\N	GRCh37
530	10	\N	G	43613840	43613840	\N	GRCh37
531	10	\N	GC	43615568	43615569	\N	GRCh37
533	20	\N	C	36031762	36031762	\N	GRCh37
534	19	\N	C	1207021	1207021	\N	GRCh37
535	19	\N	C	1220415	1220415	\N	GRCh37
536	19	\N	G	1220487	1220487	\N	GRCh37
537	19	\N	A	1220488	1220488	\N	GRCh37
538	19	\N	G	1220494	1220494	\N	GRCh37
539	19	\N	G	1220502	1220502	\N	GRCh37
540	19	\N	C	1221319	1221319	\N	GRCh37
541	19	\N	G	1223059	1223059	\N	GRCh37
542	17	\N	C	7578406	7578406	\N	GRCh37
543	17	\N	C	7577548	7577548	\N	GRCh37
544	17	\N	G	7577539	7577539	\N	GRCh37
545	17	\N	G	7577022	7577022	\N	GRCh37
546	3	\N	C	10183772	10183772	\N	GRCh37
547	3	\N	T	10183785	10183785	\N	GRCh37
548	3	\N	T	10183797	10183797	\N	GRCh37
549	3	\N	T	10191480	10191480	\N	GRCh37
550	3	\N	C	10191488	10191488	\N	GRCh37
551	3	\N	C	10191506	10191506	\N	GRCh37
372	5	\N	AAGATTGGAAC	112175219	112175229	A	GRCh37
373	5	\N	AAGATTGGAACTAGGTCAGC	112175219	112175238	A	GRCh37
374	5	\N	GGACC	112175687	112175691	T	GRCh37
375	5	\N	ATTGATTC	112175960	112175967	T	GRCh37
390	7	\N	TTT	140453132	140453134	A	GRCh37
413	3	\N	GTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGT	41266067	41266117	T	GRCh37
414	3	\N	TGGCAGCAACAGTCTTACCTGGAC	41266076	41266099	C	GRCh37
441	17	\N	-	37880997	37880998	T	GRCh37
456	13	\N	ATC	28592640	28592642	T	GRCh37
457	13	\N	GAT	28592637	28592639	T	GRCh37
485	4	\N	AGAGAC	55152089	55152094	C	GRCh37
488	4	\N	GACATCATG	55152092	55152100	A	GRCh37
489	4	\N	GACATCATGCAT	55152092	55152103	A	GRCh37
490	4	\N	ATCATGCATGAT	55152095	55152106	C	GRCh37
503	5	\N	GAA	67589552	67589552	A	GRCh37
506	5	\N	GACAAACGTATGAACAGC	67591085	67591102	T	GRCh37
509	5	\N	ACG	67591133	67591135	G	GRCh37
510	5	\N	TGG	67591249	67591249	G	GRCh37
525	10	\N	TTCCCTGAGGAGGAGAAGTGCTTCTGC	43609078	43609104	C	GRCh37
527	10	\N	GAGCTG	43609942	43609947	C	GRCh37
532	10	\N	GATGTTTATGAA	43615613	43615624	A	GRCh37
552	7	\N	C	6426892	6426892	\N	GRCh37
553	9	\N	C	139399219	139399219	\N	GRCh37
554	X	\N	T	66943549	66943549	\N	GRCh37
555	18	\N	G	42531913	42531913	\N	GRCh37
556	4	\N	A	55593464	55593464	\N	GRCh37
557	19	\N	G	44057574	44057574	\N	GRCh37
558	11	\N	A	67352689	67352689	\N	GRCh37
559	19	\N	T	45854919	45854919	\N	GRCh37
560	1	\N	G	11187094	11187094	\N	GRCh37
561	7	\N	A	87160618	87160618	\N	GRCh37
562	1	\N	G	11184580	11184580	\N	GRCh37
563	3	\N	C	178928226	178928226	\N	GRCh37
564	7	\N	C	55227884	55227884	\N	GRCh37
565	15	\N	C	74315213	74315213	\N	GRCh37
566	7	\N	G	55241722	55241722	\N	GRCh37
567	7	\N	A	87138645	87138645	\N	GRCh37
568	10	\N	T	104852980	104852980	\N	GRCh37
569	7	\N	T	55249091	55249091	\N	GRCh37
570	16	\N	C	2130300	2130300	\N	GRCh37
571	17	\N	G	37879658	37879658	\N	GRCh37
572	9	\N	G	139391212	139391212	\N	GRCh37
574	2	\N	C	29445258	29445258	\N	GRCh37
575	15	\N	T	74315219	74315219	\N	GRCh37
576	10	\N	C	104852955	104852955	\N	GRCh37
577	10	\N	T	104850745	104850745	\N	GRCh37
578	3	\N	G	138665163	138665163	\N	GRCh37
579	11	\N	A	108218044	108218044	\N	GRCh37
580	1	\N	G	11188519	11188519	\N	GRCh37
581	4	\N	G	89052323	89052323	\N	GRCh37
573	3	\N	A	142274740	142274740	A	GRCh37
583	7	\N	C	55228009	55228009	\N	GRCh37
\.


--
-- Data for Name: mutation_types; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY mutation_types (id, name) FROM stdin;
1	missense
2	nonsense
3	frame_shift_del
4	frame_shift_ins
5	in_frame_del
6	in_frame_ins
7	stop
8	synonymous
9	frameshift
\.


--
-- Data for Name: sources; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY sources (id, name, pubmed_id, citation) FROM stdin;
464	\N	20179705	Poulikakos et al., 2010, Nature
465	\N	21107323	Nazarian et al., 2010, Nature
466	\N	24132921	Dai et al., 2013, Clin. Cancer Res.
467	\N	23737487	Antony et al., 2013, Cancer Res.
468	\N	21189378	Klümpen et al., 2011, J. Clin. Oncol.
469	\N	23489023	Kim et al., 2013, Thyroid
470	\N	22241789	Hayes et al., 2012, Clin. Cancer Res.
471	\N	23406027	Ho et al., 2013, N. Engl. J. Med.
472	\N	19255327	Kloos et al., 2009, J. Clin. Oncol.
473	\N	19773371	Hoftijzer et al., 2009, Eur. J. Endocrinol.
474	\N	18541894	Gupta-Abramson et al., 2008, J. Clin. Oncol.
475	\N	20368568	Lam et al., 2010, J. Clin. Oncol.
476	\N	17384584	Schubbert et al., 2007, Nat. Rev. Cancer
477	\N	20065189	Wells et al., 2010, J. Clin. Oncol.
478	\N	22025146	Wells et al., 2012, J. Clin. Oncol.
479	\N	21470995	Verbeek et al., 2011, J. Clin. Endocrinol. Metab.
480	\N	23056499	Couto et al., 2012, PLoS ONE
481	\N	9681850	Santoro et al., 1998, J. Intern. Med.
482	\N	20847059	Carr et al., 2010, Clin. Cancer Res.
483	\N	21455200	Sherman, 2011, Mod. Pathol.
484	\N	23932362	Pitini et al., 2013, Lung Cancer
485	\N	18938156	Day et al., 2008, Eur. J. Pharmacol.
486	\N	21835143	Nault et al., 2012, J. Hepatol.
487	\N	17483355	Zou et al., 2007, Cancer Res.
488	\N	22538770	Santarpia et al., 2012, Breast Cancer Res. Treat.
489	\N	22722201	Stephens et al., 2012, Nature
490	\N	21512767	Boyault et al., 2012, Breast Cancer Res. Treat.
491	\N	19487299	Ricarte-Filho et al., 2009, Cancer Res.
492	\N	19418217	Dunlap et al., 2010, Breast Cancer Res. Treat.
493	\N	23237847	Yi et al., 2013, Oncotarget
494	\N	21464312	Jo et al., 2011, Proc. Natl. Acad. Sci. U.S.A.
495	\N	24869598	Woyach et al., 2014, N. Engl. J. Med.
496	\N	23220880	Bose et al., 2013, Cancer Discov
497	\N	16397024	Lee et al., 2006, Clin. Cancer Res.
498	\N	24185512	Toy et al., 2013, Nat. Genet.
499	\N	24185510	Robinson et al., 2013, Nat. Genet.
500	\N	24398047	Jeselsohn et al., 2014, Clin. Cancer Res.
501	\N	18676830	Stemke-Hale et al., 2008, Cancer Res.
502	\N	15805248	Saal et al., 2005, Cancer Res.
503	\N	24035431	Gautschi et al., 2013, Lung Cancer
504	\N	22038996	Nicolaides et al., 2011, Clin. Cancer Res.
505	\N	22586120	Huillard et al., 2012, Proc. Natl. Acad. Sci. U.S.A.
506	\N	17177598	Lee et al., 2006, PLoS Med.
507	\N	23558169	Rohle et al., 2013, Science
508	\N	23578570	Bahassi et al., 2013, Eur. J. Cancer
509	\N	24934779	Ganesan et al., 2016, J. Clin. Oncol.
510	\N	21274259	Murray et al., 2010, J Oncol
511	\N	22722839	Grasso et al., 2012, Nature
512	\N	22610119	Barbieri et al., 2012, Nat. Genet.
513	\N	23612012	Andrulis et al., 2013, Cancer Discov
514	\N	19331127	Guan et al., 2009, Anticancer Res.
515	\N	21273588	Otsuka et al., 2011, Anticancer Res.
516	\N	22869148	Chell et al., 2013, Oncogene
517	\N	24217577	Merenbakh-Lamin et al., 2013, Cancer Res.
1	\N	18615627	Jones et al., 2008, Cancer
2	\N	11853795	von Bubnoff et al., 2002, Lancet
3	\N	25157968	MacConaill et al., 2014, J Mol Diagn
4	\N	11861307	Hofmann et al., 2002, Blood
5	\N	22772060	Giles et al., 2013, Leukemia
6	\N	19907440	Chapiro et al., 2010, Leukemia
7	\N	19965641	Hertzberg et al., 2010, Blood
8	\N	20018760	Yoda et al., 2010, Proc. Natl. Acad. Sci. U.S.A.
9	\N	22368272	Chen et al., 2012, Blood
10	\N	22897847	Roberts et al., 2012, Cancer Cell
11	\N	22955920	Maude et al., 2012, Blood
12	\N	21680795	Zhang et al., 2011, Blood
13	\N	19470474	Mullighan et al., 2009, Proc. Natl. Acad. Sci. U.S.A.
14	\N	19838194	Mullighan et al., 2009, Nat. Genet.
15	\N	19139102	Hornakova et al., 2009, J. Biol. Chem.
16	\N	22368270	Man et al., 2012, Blood
17	\N	18805579	Bercovich et al., 2008, Lancet
18	\N	23700467	Han et al., 2013, PLoS ONE
19	\N	23934607	Neumann et al., 2013, Virchows Arch.
20	\N	17611497	Carpten et al., 2007, Nature
21	\N	24651453	Drew et al., 2014, Mol. Cancer Res.
22	\N	8187091	Miyaki et al., 1994, Cancer Res.
23	\N	1528264	Powell et al., 1992, Nature
24	\N	2281069	Steinbrugger et al., 1990, Pneumologie
25	\N	21901162	Vasovcak et al., 2011, PLoS ONE
26	\N	24861525	Palacio-Rúa et al., Rev Gastroenterol Mex
27	\N	22810696	2012, Nature
28	\N	23204322	Nikolaev et al., 2012, Cancer Res.
29	\N	1338904	Miyoshi et al., 1992, Hum. Mol. Genet.
30	\N	10737795	Rowan et al., 2000, Proc. Natl. Acad. Sci. U.S.A.
31	\N	24518971	Hasanpour et al., 2014, Cell J
32	\N	17704924	Jeon et al., 2008, Int J Colorectal Dis
33	\N	18992635	Bougatef et al., 2008, Cancer Genet. Cytogenet.
34	\N	22848674	Voorham et al., 2012, PLoS ONE
35	\N	12374230	De Filippo et al., 2002, Scand. J. Gastroenterol.
36	\N	20233444	Fumagalli et al., 2010, BMC Cancer
37	\N	18392055	Kim et al., 2008, Br. J. Cancer
38	\N	19537845	De Roock et al., 2009, Mol Diagn Ther
39	\N	21129611	Rizzo et al., 2010, Cancer Treat. Rev.
40	\N	20350999	Tejpar et al., 2010, Oncologist
41	\N	12068308	Davies et al., 2002, Nature
42	\N	21163703	De Roock et al., 2011, Lancet Oncol.
43	\N	20857202	Mao et al., 2011, Mol. Biol. Rep.
44	\N	20413299	Tol et al., 2010, Eur. J. Cancer
45	\N	21426297	Dienstmann et al., 2011, Anticancer Agents Med Chem
46	\N	22281684	Prahallad et al., 2012, Nature
47	\N	22448344	Corcoran et al., 2012, Cancer Discov
48	\N	22180495	Yang et al., 2012, Cancer Res.
49	\N	20619739	De Roock et al., 2010, Lancet Oncol.
50	\N	23325582	Peeters et al., 2013, Clin. Cancer Res.
51	\N	22608338	Falchook et al., 2012, Lancet
52	\N	23251002	Mao et al., 2013, Clin. Cancer Res.
53	\N	23549875	Coffee et al., 2013, Clin. Cancer Res.
54	\N	24107445	Zecchin et al., 2013, Mol. Cancer Ther.
55	\N	24163374	Faber et al., 2014, Cancer Discov
56	\N	22310681	Bardelli et al., 2012, Nat. Med.
57	\N	14678966	Ikenoue et al., 2003, Cancer Res.
58	\N	15035987	Wan et al., 2004, Cell
59	\N	12438234	Yuen et al., 2002, Cancer Res.
60	\N	18186519	Bentivegna et al., 2008, Hum. Mutat.
61	\N	22270724	Montagut et al., 2012, Nat. Med.
62	\N	18316791	Amado et al., 2008, J. Clin. Oncol.
63	\N	19679400	Neumann et al., 2009, Pathol. Res. Pract.
64	\N	16361624	Rothenberg et al., 2005, J. Clin. Oncol.
65	\N	19114683	Bokemeyer et al., 2009, J. Clin. Oncol.
66	\N	21228335	Bokemeyer et al., 2011, Ann. Oncol.
67	\N	20921465	Douillard et al., 2010, J. Clin. Oncol.
68	\N	16618717	Lièvre et al., 2006, Cancer Res.
69	\N	20921462	Peeters et al., 2010, J. Clin. Oncol.
70	\N	22734028	Tejpar et al., 2012, J. Clin. Oncol.
71	\N	20978259	De Roock et al., 2010, JAMA
72	\N	22392911	Migliardi et al., 2012, Clin. Cancer Res.
73	\N	20736745	Irahara et al., 2010, Diagn. Mol. Pathol.
74	\N	21829508	Janku et al., 2011, PLoS ONE
75	\N	21305640	Vaughn et al., 2011, Genes Chromosomes Cancer
76	\N	21729679	De Mattos-Arruda et al., 2011, Clin Colorectal Cancer
77	\N	17699718	Davies et al., 2007, Mol. Cancer Ther.
78	\N	16273091	Solit et al., 2006, Nature
79	\N	15016963	Samuels et al., 2004, Science
80	\N	15647370	Kang et al., 2005, Proc. Natl. Acad. Sci. U.S.A.
81	\N	15254419	Bachman et al., 2004, Cancer Biol. Ther.
82	\N	20453058	O'Brien et al., 2010, Clin. Cancer Res.
83	\N	18725974	She et al., 2008, PLoS ONE
84	\N	22162589	Bendell et al., 2012, J. Clin. Oncol.
85	\N	22162582	Clarke et al., 2012, J. Clin. Oncol.
86	\N	19903786	He et al., 2009, Clin. Cancer Res.
87	\N	19366826	Prenen et al., 2009, Clin. Cancer Res.
88	\N	14715079	De Bosscher et al., 2004, Biochem. J.
89	\N	10479724	Koyama et al., 1999, Mutat. Res.
90	\N	12821112	Miyaki et al., 2003, Biochem. Biophys. Res. Commun.
91	\N	8898652	Takagi et al., 1996, Gastroenterology
92	\N	9679244	Hata et al., 1998, Mol Med Today
93	\N	17994767	Prokova et al., 2007, Biochemistry
94	\N	10775259	Massagué et al., 2000, EMBO J.
95	\N	19561230	Agaimy et al., 2009, J. Clin. Pathol.
96	\N	20818844	Flaherty et al., 2010, N. Engl. J. Med.
97	\N	21639808	Chapman et al., 2011, N. Engl. J. Med.
98	\N	23470635	Falchook et al., 2013, Oncotarget
99	\N	23582185	Todd et al., 2013, Pigment Cell Melanoma Res
100	\N	21689725	Wasag et al., 2011, Exp. Hematol.
101	\N	17259998	Nakagomi et al., 2007, Lab. Invest.
102	\N	16751810	Tamborini et al., 2006, Oncogene
103	\N	24687822	Serrano et al., 2015, J. Clin. Oncol.
104	\N	19164557	Gajiwala et al., 2009, Proc. Natl. Acad. Sci. U.S.A.
105	\N	14645423	Heinrich et al., 2003, J. Clin. Oncol.
106	\N	15928335	Corless et al., 2005, J. Clin. Oncol.
107	\N	22718859	Cassier et al., 2012, Clin. Cancer Res.
108	\N	16638875	Prenen et al., 2006, Clin. Cancer Res.
109	\N	18794084	Dewaele et al., 2008, Clin. Cancer Res.
110	\N	22745105	Heinrich et al., 2012, Clin. Cancer Res.
111	\N	23634996	2013, N. Engl. J. Med.
112	\N	22160010	Döhner et al., 2011, Hematology Am Soc Hematol Educ Program
113	\N	22898540	McCarthy, 2012, Nat. Rev. Cancer
114	\N	21067377	Ley et al., 2010, N. Engl. J. Med.
115	\N	22898541	Vogt, 2012, Nat. Rev. Cancer
116	\N	22898539	Shih et al., 2012, Nat. Rev. Cancer
117	\N	24656771	Russler-Germain et al., 2014, Cancer Cell
118	\N	24606448	Ahmad et al., 2014, Asian Pac. J. Cancer Prev.
119	\N	22744846	Li et al., 2012, Int. J. Hematol.
120	\N	21518476	Qiao et al., 2011, Zhongguo Shi Yan Xue Ye Xue Za Zhi
121	\N	22504184	Smith et al., 2012, Nature
122	\N	23430109	Smith et al., 2013, Blood
123	\N	24619500	Zhang et al., 2014, Clin. Cancer Res.
124	\N	15667533	Smith et al., 2005, Br. J. Haematol.
125	\N	23261068	Martelli et al., 2013, Blood Rev.
126	\N	23783394	Allen et al., 2013, Leukemia
127	\N	23321257	Jourdan et al., 2013, Blood
128	\N	23714533	Smith et al., 2013, Am Soc Clin Oncol Educ Book
129	\N	22504186	Connors et al., 2012, Ann. Surg.
130	\N	22504183	Eisenhoffer et al., 2012, Nature
131	\N	15256420	Clark et al., 2004, Blood
132	\N	11290608	Yamamoto et al., 2001, Blood
133	\N	19657110	Mardis et al., 2009, N. Engl. J. Med.
134	\N	20733134	Fischer et al., 2010, J. Clin. Oncol.
135	\N	16857985	Knapper et al., 2006, Blood
136	\N	22504185	Wang et al., 2012, Gastroenterology
137	\N	23878140	Opatz et al., 2013, Blood
138	\N	22147895	Kazenwadel et al., 2012, Blood
139	\N	21765025	Dickinson et al., 2011, Blood
140	\N	22417203	Patel et al., 2012, N. Engl. J. Med.
141	\N	22397365	Chotirat et al., 2012, J Hematol Oncol
142	\N	20946881	Zou et al., 2010, Biochem. Biophys. Res. Commun.
143	\N	23949315	Ashraf et al., 2013, Ann. Hematol.
144	\N	23815907	Shang et al., 2013, Zhongguo Shi Yan Xue Ye Xue Za Zhi
145	\N	21436584	Wartman et al., 2011, J. Clin. Invest.
146	\N	24404189	Nagao et al., 2014, PLoS ONE
147	\N	23115274	Paschka et al., 2013, Blood
148	\N	22829971	Novotny-Diermayr et al., 2012, Blood Cancer J
149	\N	22818858	Malak et al., Blood Cells Mol. Dis.
150	\N	22571758	Ismael et al., 2012, Br. J. Haematol.
151	\N	22041374	Yoshiki et al., 2011, Intern. Med.
152	\N	21689158	Roug et al., 2011, Eur. J. Haematol.
153	\N	21120162	Jekarl et al., 2010, Korean J Hematol
154	\N	20339092	Wang et al., 2010, Blood
155	\N	20631743	Passamonti et al., 2010, Leukemia
156	\N	22422826	Eghtedar et al., 2012, Blood
157	\N	24045550	Johnson et al., 2013, Am. J. Clin. Pathol.
158	\N	18986703	Ustun et al., 2009, Leuk. Res.
159	\N	23149070	Mpakou et al., 2013, Leuk. Res.
160	\N	22407852	Sano et al., 2012, Int. J. Hematol.
161	\N	19075190	Tyner et al., 2009, Blood
162	\N	16434492	Bacher et al., 2006, Blood
163	\N	2278970	Vogelstein et al., 1990, Genes Chromosomes Cancer
164	\N	3122217	Janssen et al., 1987, Proc. Natl. Acad. Sci. U.S.A.
165	\N	10508512	Song et al., 1999, Nat. Genet.
166	\N	24659740	Renneville et al., 2014, Oncotarget
167	\N	24616160	Duployez et al., 2014, Am. J. Hematol.
168	\N	24374719	Ismael et al., 2014, Int. J. Hematol.
169	\N	19357396	Preudhomme et al., 2009, Blood
170	\N	23395771	Yang et al., 2013, Clin. Biochem.
171	\N	24641375	Zeichner et al., 2014, Asian Pac. J. Cancer Prev.
172	\N	24487413	Kihara et al., 2014, Leukemia
173	\N	24381225	Stoddart et al., 2014, Blood
174	\N	22158538	Graubert et al., 2012, Nat. Genet.
175	\N	24498085	Brooks et al., 2014, PLoS ONE
176	\N	24671364	Christopeit et al., 2014, Ann. Hematol.
177	\N	24667279	Lyu et al., 2014, PLoS ONE
178	\N	24521058	Rein et al., 2014, Expert Opin Investig Drugs
179	\N	24422723	Uttenthal et al., 2014, Br. J. Haematol.
180	\N	24374862	Ujj et al., 2014, Pathol. Oncol. Res.
181	\N	16239216	Staerk et al., 2005, J. Biol. Chem.
182	\N	18397343	Sato et al., 2008, Br. J. Haematol.
183	\N	23676790	Chahardouli et al., 2013, Hematology
184	\N	21895409	Strhakova et al., 2011, Neoplasma
185	\N	21888027	Bagadi et al., 2011, Clin. Lab.
186	\N	20367437	Sharma et al., 2010, Leuk. Lymphoma
187	\N	18223278	Ernst et al., 2008, Haematologica
188	\N	12623848	Branford et al., 2003, Blood
189	\N	12576318	Corbin et al., 2003, Blood
190	\N	12399961	Hochhaus et al., 2002, Leukemia
191	\N	17008892	Gruber et al., 2006, Leukemia
192	\N	21221851	Gruber et al., 2012, Med. Oncol.
193	\N	18354488	Sherbenou et al., 2008, Leukemia
194	\N	21505103	Eide et al., 2011, Cancer Res.
195	\N	11964322	Branford et al., 2002, Blood
196	\N	22870928	Ferri et al., 2013, Leuk. Lymphoma
197	\N	15256422	O'Hare et al., 2004, Blood
198	\N	24109527	McCarron et al., 2013, Case Rep Hematol
199	\N	19652056	Hughes et al., 2009, J. Clin. Oncol.
200	\N	19466505	Doi et al., 2009, Int. J. Hematol.
201	\N	15381060	Sorel et al., 2004, Biochem. Biophys. Res. Commun.
202	\N	14745431	Al-Ali et al., 2004, Hematol. J.
203	\N	14559829	von Bubnoff et al., 2003, Cancer Res.
204	\N	24456693	Elias et al., 2014, Leuk. Res.
205	\N	20697894	Qin et al., 2011, Ann. Hematol.
206	\N	22210874	Parker et al., 2012, Blood
207	\N	24236021	Tanneeru et al., 2013, PLoS ONE
208	\N	22912393	Cai et al., 2012, Clin. Cancer Res.
209	\N	15194504	Yamamoto et al., 2004, Biochem. Biophys. Res. Commun.
210	\N	21562040	Soverini et al., 2011, Blood
211	\N	11423618	Gorre et al., 2001, Science
212	\N	11567109	Barthe et al., 2001, Science
213	\N	21509757	Jabbour et al., 2011, Cancer
214	\N	18757400	Cramer et al., 2008, Cancer Res.
215	\N	11569495	Hochhaus et al., 2001, Science
216	\N	19264234	Park et al., 2009, Cancer Genet. Cytogenet.
217	\N	19164531	Iacob et al., 2009, Proc. Natl. Acad. Sci. U.S.A.
218	\N	15510211	Piazza et al., 2005, Leukemia
219	\N	23540562	Chahardouli et al., 2013, Hematology
220	\N	23355941	Elias et al., 2012, Hematol Rep
221	\N	22306673	Yin et al., 2012, Diagn. Mol. Pathol.
222	\N	21762985	Soverini et al., 2011, Leuk. Res.
223	\N	20512393	Manrique Arechavaleta et al., 2011, Clin. Exp. Med.
224	\N	20963643	Minami et al., 2010, Int. J. Hematol.
225	\N	12130516	Roche-Lestienne et al., 2002, Blood
226	\N	21872826	Paquette et al., 2011, Cancer Genet
227	\N	21489624	Oyekunle et al., 2011, Leuk. Res.
228	\N	17114651	Soverini et al., 2006, J. Clin. Oncol.
229	\N	18828913	Cang et al., 2008, J Hematol Oncol
230	\N	21605905	Eskazan et al., 2011, Leuk. Res.
231	\N	19768693	Kim et al., 2010, Hematol Oncol
232	\N	19557636	Mascarenhas et al., 2009, Leuk. Lymphoma
233	\N	20607847	Schnittger et al., 2010, Genes Chromosomes Cancer
234	\N	20557306	Yin et al., 2010, Cancer Sci.
235	\N	12783380	Roche-Lestienne et al., 2003, Semin. Hematol.
236	\N	17189410	Soverini et al., 2006, Clin. Cancer Res.
237	\N	20702476	Bennour et al., 2010, J. Clin. Pathol.
238	\N	20010464	Lewandowski et al., 2009, Pol. Arch. Med. Wewn.
239	\N	25152116	Gao et al., 2014, Zhonghua Xue Ye Xue Za Zhi
240	\N	23575252	Cho et al., 2013, Int J Lab Hematol
241	\N	19811824	Faber et al., 2010, Leuk. Res.
242	\N	23656643	Maxson et al., 2013, N. Engl. J. Med.
243	\N	22072639	Bresler et al., 2011, Sci Transl Med
244	\N	21838707	Schönherr et al., 2011, Biochem. J.
245	\N	24657128	Wakuda et al., 2014, Lung Cancer
246	\N	24986690	Rumi et al., 2014, Blood
247	\N	20151976	Boyd et al., 2010, Br. J. Haematol.
248	\N	18528423	Chaligné et al., 2008, Leukemia
249	\N	23213094	Choueiri et al., 2013, J. Clin. Oncol.
250	\N	23610116	Diamond et al., 2013, J. Clin. Oncol.
251	\N	24631838	Grabiner et al., 2014, Cancer Discov
252	\N	24622468	Voss et al., 2014, Clin. Cancer Res.
253	\N	24625776	Wagle et al., 2014, Cancer Discov
254	\N	22980975	Imielinski et al., 2012, Cell
255	\N	18948947	Ding et al., 2008, Nature
256	\N	22277784	Katayama et al., 2012, Sci Transl Med
257	\N	24670165	Shaw et al., 2014, N. Engl. J. Med.
258	\N	24327273	Chen et al., 2014, Clin. Cancer Res.
259	\N	24569458	Imielinski et al., 2014, J. Clin. Invest.
260	\N	22773810	Ohashi et al., 2012, Proc. Natl. Acad. Sci. U.S.A.
261	\N	22908275	Greulich et al., 2012, Proc. Natl. Acad. Sci. U.S.A.
262	\N	23724914	Awad et al., 2013, N. Engl. J. Med.
263	\N	23728071	Trigka et al., 2013, Oncol. Rep.
264	\N	21479466	Sasaki et al., Mol Med Rep
265	\N	18504432	Bleeker et al., 2008, Oncogene
266	\N	18611285	Do et al., 2008, BMC Res Notes
267	\N	18256540	Malanga et al., 2008, Cell Cycle
268	\N	15118073	Lynch et al., 2004, N. Engl. J. Med.
269	\N	15118125	Paez et al., 2004, Science
270	\N	15329413	Pao et al., 2004, Proc. Natl. Acad. Sci. U.S.A.
271	\N	19922469	Mitsudomi et al., 2010, FEBS J.
272	\N	15710947	Han et al., 2005, J. Clin. Oncol.
273	\N	16011858	Rosell et al., 2005, Lung Cancer
274	\N	16115929	Taron et al., 2005, Clin. Cancer Res.
275	\N	20479403	Sequist et al., 2010, J. Clin. Oncol.
276	\N	22753918	Ramalingam et al., 2012, J. Clin. Oncol.
277	\N	23102728	Huang et al., 2013, Mol Oncol
278	\N	16912157	Inukai et al., 2006, Cancer Res.
279	\N	15728811	Kobayashi et al., 2005, N. Engl. J. Med.
280	\N	15737014	Pao et al., 2005, PLoS Med.
281	\N	21430269	Sequist et al., 2011, Sci Transl Med
282	\N	21194487	Watanabe et al., 2011, BMC Cancer
283	\N	21531810	Wu et al., 2011, Clin. Cancer Res.
284	\N	20068085	Girard et al., 2010, Clin. Cancer Res.
285	\N	16258541	Bell et al., 2005, Nat. Genet.
286	\N	22588155	Oxnard et al., 2012, J Thorac Oncol
287	\N	22452896	Miller et al., 2012, Lancet Oncol.
288	\N	23816963	Katakami et al., 2013, J. Clin. Oncol.
289	\N	24729716	Li et al., 2014, Onco Targets Ther
290	\N	21670455	Fukuoka et al., 2011, J. Clin. Oncol.
291	\N	20573926	Maemondo et al., 2010, N. Engl. J. Med.
292	\N	20022809	Mitsudomi et al., 2010, Lancet Oncol.
293	\N	19692680	Mok et al., 2009, N. Engl. J. Med.
294	\N	19692684	Rosell et al., 2009, N. Engl. J. Med.
295	\N	22285168	Rosell et al., 2012, Lancet Oncol.
296	\N	23816960	Sequist et al., 2013, J. Clin. Oncol.
297	\N	22452895	Yang et al., 2012, Lancet Oncol.
298	\N	21783417	Zhou et al., 2011, Lancet Oncol.
299	\N	19096302	Kosaka et al., 2009, J Thorac Oncol
300	\N	18303429	Marks et al., 2008, J Thorac Oncol
301	\N	23948351	Shi et al., 2013, Lancet Oncol.
302	\N	12460918	Brose et al., 2002, Cancer Res.
303	\N	18794081	Riely et al., 2008, Clin. Cancer Res.
304	\N	18632602	Marks et al., 2008, Cancer Res.
305	\N	7651428	Bottorff et al., 1995, Mol. Cell. Biol.
306	\N	18060073	Estep et al., 2007, PLoS ONE
307	\N	23515407	Ohashi et al., 2013, Clin. Cancer Res.
308	\N	24370118	Bar et al., 2014, Clin Lung Cancer
309	\N	16930767	Kawano et al., 2006, Lung Cancer
310	\N	19513541	Zou et al., 2009, Int. J. Mol. Med.
311	\N	19029981	Engelman et al., 2008, Nat. Med.
312	\N	16906227	Engelman et al., 2006, J. Clin. Invest.
313	\N	20018398	Jin et al., 2010, Lung Cancer
314	\N	9598803	Kohno et al., 1998, Genes Chromosomes Cancer
315	\N	20881644	Lee et al., 2010, J Thorac Oncol
316	\N	10555148	Lee et al., 1999, Cell
317	\N	20085938	Courtney et al., 2010, J. Clin. Oncol.
318	\N	11504908	Neshat et al., 2001, Proc. Natl. Acad. Sci. U.S.A.
319	\N	19351834	Sos et al., 2009, Cancer Res.
320	\N	22328973	Hammerman et al., 2011, Cancer Discov
321	\N	20360610	Faoro et al., 2010, J. Biol. Chem.
322	\N	23786770	Liao et al., 2013, Cancer Res.
323	\N	23348505	Clark et al., 2013, Science
324	\N	18559612	Verstovsek et al., 2008, Clin. Cancer Res.
325	\N	24190505	Joseph et al., 2014, Genes Chromosomes Cancer
326	\N	22357254	Schirosi et al., 2012, Ann. Oncol.
327	\N	21325067	Kong et al., 2011, Clin. Cancer Res.
328	\N	21969494	Buti et al., 2011, J. Clin. Oncol.
329	\N	23375402	Rossi et al., 2013, Lung Cancer
330	\N	12960119	Antonescu et al., 2003, Clin. Cancer Res.
331	\N	20736294	Rossi et al., 2010, Mol. Cancer Res.
332	\N	19861435	Girard et al., 2009, Clin. Cancer Res.
333	\N	15201427	Ströbel et al., 2004, N. Engl. J. Med.
334	\N	17372901	Antonescu et al., 2007, Int. J. Cancer
335	\N	15930355	Antonescu et al., 2005, Clin. Cancer Res.
336	\N	18448188	Yoh et al., 2008, Lung Cancer
337	\N	20970876	Dişel et al., 2011, Lung Cancer
338	\N	19461405	Bisagni et al., 2009, J Thorac Oncol
339	\N	17699867	Guo et al., 2007, Clin. Cancer Res.
340	\N	22184391	van Gaal et al., 2012, J. Clin. Oncol.
341	\N	24124571	Li et al., 2013, PLoS ONE
342	\N	19853286	Cohen et al., 2010, Gynecol. Oncol.
343	\N	22885469	Leslie et al., 2012, Gynecol. Oncol.
344	\N	23908597	Byron et al., 2013, Neoplasia
345	\N	18552176	Dutt et al., 2008, Proc. Natl. Acad. Sci. U.S.A.
346	\N	22238366	Gozgit et al., 2012, Mol. Cancer Ther.
347	\N	23002168	Guagnano et al., 2012, Cancer Discov
348	\N	21984976	Cheung et al., 2011, Cancer Discov
349	\N	23696637	Javadi et al., 2013, J. Biol. Chem.
350	\N	18971950	Chase et al., 2009, Leukemia
351	\N	16834459	Pikman et al., 2006, PLoS Med.
352	\N	19726788	Yauch et al., 2009, Science
353	\N	22679179	Rudin, 2012, Clin. Cancer Res.
354	\N	21683865	Kurman et al., 2011, Hum. Pathol.
355	\N	21975775	Haldar et al., 2011, Cochrane Database Syst Rev
356	\N	19018267	Nakayama et al., 2008, Br. J. Cancer
357	\N	22798288	Dahlman et al., 2012, Cancer Discov
358	\N	22271473	Janku et al., 2012, J. Clin. Oncol.
359	\N	18767981	Chalhoub et al., 2009, Annu Rev Pathol
360	\N	18451306	Beer et al., 2008, Blood
361	\N	23970983	Morrell et al., 2013, Case Rep Hematol
362	\N	21228032	Pietra et al., 2011, Haematologica
363	\N	19608689	Liu et al., 2009, Haematologica
364	\N	23680147	Jaiswal et al., 2013, Cancer Cell
365	\N	24265152	Shi et al., 2014, Cancer Discov
366	\N	23248257	Kim et al., 2013, J. Clin. Oncol.
367	\N	14679157	Maldonado et al., 2003, J. Natl. Cancer Inst.
368	\N	22356324	Sosman et al., 2012, N. Engl. J. Med.
369	\N	22663011	Flaherty et al., 2012, N. Engl. J. Med.
370	\N	22805292	Falchook et al., 2012, Lancet Oncol.
371	\N	22048237	Kirkwood et al., 2012, Clin. Cancer Res.
372	\N	22972589	Patel et al., 2013, Cancer
373	\N	20630094	Rubinstein et al., 2010, J Transl Med
374	\N	23020132	Flaherty et al., 2012, N. Engl. J. Med.
375	\N	22735384	Hauschild et al., 2012, Lancet
376	\N	20551065	Yang et al., 2010, Cancer Res.
377	\N	22536370	Lovly et al., 2012, PLoS ONE
378	\N	19404918	Boulalas et al., Int. J. Biol. Markers
379	\N	22389471	Greger et al., 2012, Mol. Cancer Ther.
380	\N	21156289	Villanueva et al., 2010, Cancer Cell
381	\N	22351686	Paraiso et al., 2012, Clin. Cancer Res.
382	\N	22997239	Jalili et al., 2012, J. Natl. Cancer Inst.
383	\N	23614898	Morris et al., 2013, Cancer Discov
384	\N	23237741	Klein et al., 2013, Eur. J. Cancer
385	\N	0	
386	\N	21750866	Buery et al., 2011, Oncol. Rep.
387	\N	23833300	Cardarella et al., 2013, Clin. Cancer Res.
388	\N	12460919	Naoki et al., 2002, Cancer Res.
389	\N	21483012	Paik et al., 2011, J. Clin. Oncol.
390	\N	19010912	Pratilas et al., 2008, Cancer Res.
391	\N	22649091	Sen et al., 2012, Sci Transl Med
392	\N	19238210	Gandhi et al., 2009, PLoS ONE
393	\N	22743296	Gautschi et al., 2012, J Thorac Oncol
394	\N	23524406	Rudin et al., 2013, J Thorac Oncol
395	\N	23715574	Bahadoran et al., 2013, J. Clin. Oncol.
396	\N	18794803	Smalley et al., 2009, Oncogene
397	\N	2872605	Rees et al., Neurobehav Toxicol Teratol
398	\N	20141835	Heidorn et al., 2010, Cell
399	\N	11950921	Demunter et al., 2002, Mod. Pathol.
400	\N	11351304	Omholt et al., 2001, Int. J. Cancer
401	\N	11930117	Pollock et al., 2002, Melanoma Res.
402	\N	12124804	Reifenberger et al., 2002, Int. J. Cancer
403	\N	10027390	Rimm et al., 1999, Am. J. Pathol.
404	\N	9065403	Rubinfeld et al., 1997, Science
405	\N	15133491	Worm et al., 2004, Oncogene
406	\N	19718025	Prickett et al., 2009, Nat. Genet.
407	\N	21083380	Van Raamsdonk et al., 2010, N. Engl. J. Med.
408	\N	22733540	Khalili et al., 2012, Clin. Cancer Res.
409	\N	22808163	Ho et al., 2012, PLoS ONE
410	\N	2549426	Landis et al., 1989, Nature
411	\N	1328859	Kalinec et al., 1992, Mol. Cell. Biol.
412	\N	18719078	Onken et al., 2008, Invest. Ophthalmol. Vis. Sci.
413	\N	22653968	Wu et al., 2012, Mol. Cancer Ther.
414	\N	22253748	Wu et al., 2012, PLoS ONE
415	\N	19078957	Van Raamsdonk et al., 2009, Nature
416	\N	21131919	Langer et al., 2011, Mod. Pathol.
417	\N	24661573	de Jel et al., 2014, Pigment Cell Melanoma Res
418	\N	24531699	Bello et al., 2014, Ann. Surg. Oncol.
419	\N	15790786	Growney et al., 2005, Blood
420	\N	9438854	Hirota et al., 1998, Science
421	\N	11276010	Hirota et al., 2001, J. Pathol.
422	\N	7530509	Kitayama et al., 1995, Blood
423	\N	18980976	Beadling et al., 2008, Clin. Cancer Res.
424	\N	21642685	Carvajal et al., 2011, JAMA
425	\N	18421059	Hodi et al., 2008, J. Clin. Oncol.
426	\N	18510589	Lutzky et al., 2008, Pigment Cell Melanoma Res
427	\N	19812602	Terheyden et al., 2010, J. Invest. Dermatol.
428	\N	22261812	Minor et al., 2012, Clin. Cancer Res.
429	\N	19671763	Woodman et al., 2009, Mol. Cancer Ther.
430	\N	18936790	Quintás-Cardama et al., 2008, Nat Clin Pract Oncol
431	\N	21690468	Guo et al., 2011, J. Clin. Oncol.
432	\N	22160160	Knösel et al., 2012, J. Cancer Res. Clin. Oncol.
433	\N	16908931	Curtin et al., 2006, J. Clin. Oncol.
434	\N	24755198	Xia et al., 2014, Mol. Cancer Ther.
435	\N	19996579	Satzger et al., 2010, Dermatology (Basel)
436	\N	20545949	Yamaguchi et al., 2011, Clin. Exp. Dermatol.
437	\N	22932406	Hong et al., 2012, Zhonghua Bing Li Xue Za Zhi
438	\N	22355224	Tutone et al., 2011, Bioinformation
439	\N	21569090	Yun et al., 2011, APMIS
440	\N	18955458	Heinrich et al., 2008, J. Clin. Oncol.
441	\N	16741525	Willmore-Payne et al., 2006, Mod. Pathol.
442	\N	20088873	Handolias et al., 2010, Pigment Cell Melanoma Res
443	\N	23775962	Hodi et al., 2013, J. Clin. Oncol.
444	\N	21159146	McDonnell et al., 2011, Pigment Cell Melanoma Res
445	\N	22197931	Nikolaev et al., 2012, Nat. Genet.
446	\N	23569304	Trunzer et al., 2013, J. Clin. Oncol.
447	\N	19915144	Emery et al., 2009, Proc. Natl. Acad. Sci. U.S.A.
448	\N	23444215	Catalanotti et al., 2013, Clin. Cancer Res.
449	\N	22588879	Shi et al., 2012, Cancer Discov
450	\N	21383288	Wagle et al., 2011, J. Clin. Oncol.
451	\N	24448821	Narita et al., 2014, Mol. Cancer Ther.
452	\N	21107320	Johannessen et al., 2010, Nature
453	\N	22622578	Berger et al., 2012, Nature
454	\N	24265153	Van Allen et al., 2014, Cancer Discov
455	\N	24265154	Wagle et al., 2014, Cancer Discov
456	\N	8120410	Ball et al., 1994, J. Invest. Dermatol.
457	\N	23414587	Ascierto et al., 2013, Lancet Oncol.
458	\N	18390968	Adjei et al., 2008, J. Clin. Oncol.
459	\N	22761467	Martinez-Garcia et al., 2012, Clin. Cancer Res.
460	\N	23538902	Haarberg et al., 2013, Mol. Cancer Ther.
461	\N	16291983	Curtin et al., 2005, N. Engl. J. Med.
462	\N	2674680	van 't Veer et al., 1989, Mol. Cell. Biol.
463	\N	20130576	Hatzivassiliou et al., 2010, Nature
518	\N	23023262	Knutson et al., 2012, Nat. Chem. Biol.
519	\N	24563539	Knutson et al., 2014, Mol. Cancer Ther.
520	\N	21179087	Ngo et al., 2011, Nature
521	\N	16094359	Parsons et al., 2005, Nature
522	\N	24918823	Carlino et al., 2014, Br. J. Cancer
523	\N	23273605	Greaves et al., 2013, J Mol Diagn
524	\N	16096377	Libra et al., 2005, Cell Cycle
525	\N	24446311	Zhang et al., 2014, Am. J. Hematol.
526	\N	24926260	Shackelford et al., 2014, Case Rep Oncol
527	\N	24710085	Chiappetta et al., 2015, Appl. Immunohistochem. Mol. Morphol.
528	\N	24345920	Hutchinson et al., 2013, Clin. Cancer Res.
529	\N	2493360	Müller-Gärtner et al., 1989, Chirurg
530	\N	23317446	Gentilcore et al., 2013, BMC Cancer
531	\N	23918947	Ascierto et al., 2013, J. Clin. Oncol.
532	\N	24508103	McArthur et al., 2014, Lancet Oncol.
533	\N	23031422	Ponti et al., 2012, J Hematol Oncol
534	\N	21609436	Niehr et al., 2011, J Transl Med
535	\N	19234609	Halaban et al., 2009, PLoS ONE
536	\N	24788118	Hamada et al., 2014, PLoS ONE
537	\N	2302402	Schick et al., 1990, Biochim. Biophys. Acta
538	\N	23242437	Kobayashi et al., 2013, J Thorac Oncol
539	\N	18458038	Sequist et al., 2008, J. Clin. Oncol.
540	\N	18199554	Gilmer et al., 2008, Cancer Res.
541	\N	19671738	Tam et al., 2009, Mol. Cancer Ther.
542	\N	23945392	Berge et al., 2013, J Thorac Oncol
543	\N	16204070	Jiang et al., 2005, Cancer Res.
544	\N	16187797	Greulich et al., 2005, PLoS Med.
545	\N	23485129	Massarelli et al., 2013, Lung Cancer
546	\N	19455431	Rajasekaran et al., 2010, Appl. Biochem. Biotechnol.
547	\N	19147750	Kancha et al., 2009, Clin. Cancer Res.
548	\N	21531084	Uribe et al., 2011, Pathol. Res. Pract.
549	\N	20415598	Cassell et al., 2010, Expert Opin Investig Drugs
550	\N	22622260	Lee et al., 2012, Lung Cancer
551	\N	18089823	Engelman et al., 2007, Cancer Res.
552	\N	23800712	Wheler et al., 2013, Oncotarget
553	\N	17545553	Toyooka et al., 2007, Clin. Cancer Res.
554	\N	16730855	Tokumo et al., 2006, Lung Cancer
555	\N	16707764	Guo et al., 2006, N. Engl. J. Med.
556	\N	17653080	Fu et al., 2008, Oncogene
557	\N	18628075	González Manzano et al., 2008, Clin Transl Oncol
558	\N	20033049	Zhou et al., 2009, Nature
559	\N	22215752	Su et al., 2012, J. Clin. Oncol.
560	\N	21233402	Rosell et al., 2011, Clin. Cancer Res.
561	\N	21718596	Chen et al., 2011, Chin J Cancer
562	\N	22046346	Kancha et al., 2011, PLoS ONE
563	\N	18413839	Trowe et al., 2008, Clin. Cancer Res.
564	\N	24516025	Ali et al., 2014, J. Clin. Oncol.
565	\N	21367659	Greulich et al., 2011, Trends Mol Med
566	\N	19381019	Qing et al., 2009, J. Clin. Invest.
567	\N	15374878	Brown et al., 2005, Blood
568	\N	14604974	Bagrintseva et al., 2004, Blood
569	\N	17047150	Piloto et al., 2007, Blood
570	\N	24046014	Zimmerman et al., 2013, Blood
571	\N	17606455	Mathews et al., 2007, Haematologica
572	\N	17889720	Kancha et al., 2007, Exp. Hematol.
573	\N	24141786	Chen et al., 2014, Oncogene
574	\N	21444680	Patel et al., 2011, Clin. Cancer Res.
575	\N	16478791	Park et al., 2006, J. Cell. Sci.
576	\N	20859122	Girard, 2010, J Thorac Oncol
577	\N	22256804	Su et al., 2012, N. Engl. J. Med.
578	\N	22726224	Anforth et al., 2012, Pigment Cell Melanoma Res
579	\N	19798509	Capper et al., 2009, Acta Neuropathol.
580	\N	19818334	Kato et al., 2009, Biochem. Biophys. Res. Commun.
581	\N	21352804	Kaneko et al., 2011, Biochem. Biophys. Res. Commun.
582	\N	23558173	Wang et al., 2013, Science
583	\N	21250968	Pichler et al., 2011, Br. J. Haematol.
584	\N	16293597	Campbell et al., 2006, Blood
585	\N	20372971	Quintás-Cardama et al., 2011, Invest New Drugs
586	\N	22271575	Weigert et al., 2012, J. Exp. Med.
587	\N	20385788	Tyner et al., 2010, Blood
588	\N	16046538	Carter et al., 2005, Proc. Natl. Acad. Sci. U.S.A.
589	\N	16624552	Debiec-Rychter et al., 2006, Eur. J. Cancer
590	\N	19175693	Tefferi, 2009, J. Cell. Mol. Med.
591	\N	16397263	Schittenhelm et al., 2006, Cancer Res.
592	\N	19737976	Bougherara et al., 2009, Mol. Cancer Res.
593	\N	17824795	Graham et al., 2007, Arch. Pathol. Lab. Med.
594	\N	11526490	Tuveson et al., 2001, Oncogene
595	\N	15685537	Debiec-Rychter et al., 2005, Gastroenterology
596	\N	17363509	Roberts et al., 2007, Mol. Cancer Ther.
597	\N	15236194	Tamborini et al., 2004, Gastroenterology
598	\N	20147452	DiNitto et al., 2010, J. Biochem.
599	\N	15972446	Gotlib et al., 2005, Blood
600	\N	18024392	Gleixner et al., 2007, Haematologica
601	\N	16912224	Pan et al., 2007, Blood
602	\N	22282465	Miranda et al., 2012, Clin. Cancer Res.
603	\N	23182985	Peeters et al., 2013, J. Clin. Oncol.
604	\N	25044103	Chaft et al., 2014, Clin Lung Cancer
605	\N	22722830	Misale et al., 2012, Nature
606	\N	18594010	Koivunen et al., 2008, Clin. Cancer Res.
607	\N	22897852	Maraver et al., 2012, Cancer Cell
608	\N	22235099	Doebele et al., 2012, Clin. Cancer Res.
609	\N	21398618	Lee et al., 2011, J. Natl. Cancer Inst.
610	\N	19881948	Oikonomou et al., 2009, Neoplasia
611	\N	24558511	Kumar et al., 2014, Gastrointest Cancer Res
612	\N	24628546	Isham et al., 2014, J. Clin. Endocrinol. Metab.
613	\N	24740626	Jeng et al., 2014, Pediatr Blood Cancer
614	\N	18829470	Toschi et al., 2008, Clin. Cancer Res.
615	\N	11750879	Maulik et al., 2002, Cytokine Growth Factor Rev.
616	\N	24121490	Miyajima et al., 2013, Cancer Res.
617	\N	25823662	Chiu et al., 2015, Oncotarget
618	\N	24553387	Misale et al., 2014, Sci Transl Med
619	\N	22144181	Xu et al., 2012, Blood
620	\N	23134356	Callahan et al., 2012, N. Engl. J. Med.
621	\N	23431193	Posch et al., 2013, Proc. Natl. Acad. Sci. U.S.A.
622	\N	22962325	Wilmott et al., 2012, Mol. Cancer Ther.
623	\N	23076151	Kaplan et al., 2012, J. Biol. Chem.
624	\N	20406486	Søndergaard et al., 2010, J Transl Med
625	\N	20149136	Halaban et al., 2010, Pigment Cell Melanoma Res
626	\N	16954519	Heinrich et al., 2006, J. Clin. Oncol.
627	\N	17087936	Weisberg et al., 2006, Gastroenterology
628	\N	23066039	Janku et al., 2013, Cancer Res.
629	\N	24265155	Shi et al., 2014, Cancer Discov
630	\N	23408298	Fury et al., 2013, Cancer
631	\N	15930273	Ikenoue et al., 2005, Cancer Res.
632	\N	21824802	Cohen et al., 2011, Oral Oncol.
633	\N	19962457	Gabelli et al., 2010, Biochim. Biophys. Acta
634	\N	24459181	Liu et al., 2014, Cancer Res.
635	\N	11274365	Wen et al., 2001, Proc. Natl. Acad. Sci. U.S.A.
636	\N	24721394	Xu et al., 2014, Transl Oncol
637	\N	25754945	Sagi et al., 2015, Fam. Cancer
638	\N	15184865	Carlomagno et al., 2004, Oncogene
639	\N	20943719	Vitagliano et al., 2011, Endocr. Relat. Cancer
640	\N	11351254	Frisk et al., 2001, Int. J. Oncol.
641	\N	11101847	Stiewe et al., 2000, Nat. Genet.
642	\N	18391940	Kawauchi et al., 2008, Nat. Cell Biol.
643	\N	17015838	Joerger et al., 2006, Proc. Natl. Acad. Sci. U.S.A.
644	\N	24651012	Muller et al., 2014, Cancer Cell
645	\N	15004724	Chan et al., 2004, Cancer Chemother. Pharmacol.
646	\N	20013323	Ikezoe et al., 2010, Int. J. Hematol.
647	\N	11921283	Kondo et al., 2002, Genes Chromosomes Cancer
648	\N	7660122	Duan et al., 1995, Science
649	\N	25056119	Watson et al., 2014, Cancer Res.
650	\N	20007775	Westhoff et al., 2009, Proc. Natl. Acad. Sci. U.S.A.
651	\N	19794967	Marchetti et al., 2009, Neoplasia
652	\N	21030459	Sasaki et al., 2010, Cancer Res.
653	\N	21575866	Sakamoto et al., 2011, Cancer Cell
654	\N	21948233	Heuckmann et al., 2011, Clin. Cancer Res.
655	\N	18923525	George et al., 2008, Nature
656	\N	23779130	Joseph et al., 2013, Cancer Discov
657	\N	21576590	Soon et al., 2011, Arch Dermatol
658	\N	22479427	Carico et al., 2012, PLoS ONE
659	\N	21422803	Coxon et al., 2012, J. Endocrinol. Invest.
660	\N	23222956	Piazza et al., 2013, Nat. Genet.
661	\N	21558396	Tanaka et al., 2011, Clin. Cancer Res.
662	\N	19223544	Sartore-Bianchi et al., 2009, Cancer Res.
663	\N	22357840	Liao et al., 2012, Clin. Cancer Res.
664	\N	24559322	Sartore-Bianchi et al., 2014, Expert Rev Anticancer Ther
665	\N	16307017	Krüger et al., 2006, Leukemia
666	\N	12949711	Hirota et al., 2003, Gastroenterology
667	\N	19157633	Sun et al., 2009, Lung Cancer
668	\N	19922504	Chen et al., 2010, Cancer Sci.
669	\N	19434073	Caronia et al., 2009, Pharmacogenomics J.
670	\N	19470925	Gandara et al., 2009, J. Clin. Oncol.
671	\N	26561417	Boidot et al., 2015, Int J Colorectal Dis
672	\N	25295501	Wagle et al., 2014, N. Engl. J. Med.
673	\N	24836576	Van Allen et al., 2014, Nat. Med.
674	\N	22906996	Kim et al., 2012, Oncology
675	\N	17940205	Whitman et al., 2008, Blood
676	\N	18230792	Zhang et al., 2008, J. Natl. Cancer Inst.
677	\N	17965322	Bacher et al., 2008, Blood
678	\N	22550175	Lee et al., 2012, Proc. Natl. Acad. Sci. U.S.A.
679	\N	25759020	Atwood et al., 2015, Cancer Cell
680	\N	9569050	Berns et al., 1998, Br. J. Cancer
681	\N	23888070	Beaver et al., 2013, Clin. Cancer Res.
682	\N	24735930	Lassen et al., 2014, Mol. Cancer
683	\N	26351323	Davies et al., 2015, Mol. Cancer Ther.
684	\N	16489069	Olivier et al., 2006, Clin. Cancer Res.
685	\N	25351743	Katayama et al., 2015, Clin. Cancer Res.
686	\N	25349473	Miller et al., 2014, Biologics
687	\N	18818391	Jabbour et al., 2008, Blood
688	\N	26130666	Yoo et al., 2015, Cancer Res Treat
689	\N	15146165	Lasota et al., 2004, Lab. Invest.
690	\N	16467099	Gréen et al., 2006, Clin. Cancer Res.
691	\N	26490311	Kong et al., 2016, Clin. Cancer Res.
692	\N	26466009	Shiver et al., 2015, N. Engl. J. Med.
693	\N	20979473	Choi et al., 2010, N. Engl. J. Med.
694	\N	26888827	Sanchez-Martín et al., 2016, Clin. Cancer Res.
695	\N	21613260	Goto et al., 2011, Blood
696	\N	24894453	Cho et al., 2014, Mol. Cancer
697	\N	16384925	Cairoli et al., 2006, Blood
698	\N	18375819	Banerji et al., 2008, Mol. Cancer Ther.
699	\N	22296372	Yan et al., 2011, Asian Pac. J. Cancer Prev.
700	\N	21995386	Papaemmanuil et al., 2011, N. Engl. J. Med.
701	\N	23029227	Qian et al., 2012, PLoS ONE
702	\N	23861105	Wu et al., 2013, Am. J. Hematol.
703	\N	23377281	Tzoneva et al., 2013, Nat. Med.
704	\N	21791641	Sasaki et al., 2011, Cancer Res.
705	\N	20537386	An et al., 2010, Leuk. Res.
706	\N	25923549	Jänne et al., 2015, N. Engl. J. Med.
707	\N	24893891	Cross et al., 2014, Cancer Discov
708	\N	18227510	Yun et al., 2008, Proc. Natl. Acad. Sci. U.S.A.
709	\N	24065731	Walter et al., 2013, Cancer Discov
710	\N	26515464	Hirano et al., 2015, Oncotarget
711	\N	24636847	Li et al., 2014, Lung Cancer
712	\N	26720284	Sequist et al., 2015, JAMA Oncol
713	\N	25923550	Sequist et al., 2015, N. Engl. J. Med.
714	\N	25668228	Denis et al., 2015, Clin. Chim. Acta
715	\N	24623981	Ding et al., 2014, Onco Targets Ther
716	\N	24658966	Ai et al., 2014, Amino Acids
717	\N	25939061	Thress et al., 2015, Nat. Med.
718	\N	20609353	Puyol et al., 2010, Cancer Cell
719	\N	26372703	Renaud et al., 2015, Br. J. Cancer
720	\N	19318574	von Bubnoff et al., 2009, Cancer Res.
721	\N	26125448	Jänne et al., 2015, Br. J. Cancer
722	\N	23014527	Dogan et al., 2012, Clin. Cancer Res.
723	\N	22025163	Yap et al., 2011, J. Clin. Oncol.
724	\N	26623049	Osumi et al., 2015, Mol Clin Oncol
725	\N	9839497	Egawa et al., 1998, Jpn. J. Clin. Oncol.
726	\N	18073307	Elisei et al., 2008, J. Clin. Endocrinol. Metab.
727	\N	22698404	Jackson et al., 2012, Cancer Cell
728	\N	20542753	Bodoor et al., 2010, Cancer Epidemiol
729	\N	25989278	Rowland et al., 2015, Br. J. Cancer
730	\N	24576830	Nissan et al., 2014, Cancer Res.
731	\N	19001320	Di Nicolantonio et al., 2008, J. Clin. Oncol.
732	\N	23845441	Rad et al., 2013, Cancer Cell
733	\N	23812671	Ji et al., 2013, Clin. Cancer Res.
734	\N	26678033	Penna et al., 2015, Oncotarget
735	\N	25370471	Sarker et al., 2015, Clin. Cancer Res.
736	\N	25024077	Xing et al., 2014, J. Clin. Oncol.
737	\N	24583796	Menzies et al., 2014, Clin. Cancer Res.
738	\N	21594703	Howell et al., 2011, Ann. Surg. Oncol.
739	\N	24396464	He et al., 2014, Oncol Lett
740	\N	24388723	Nagore et al., 2014, J. Am. Acad. Dermatol.
741	\N	24594804	Chen et al., 2014, PLoS ONE
742	\N	24354346	Walczyk et al., 2014, Clin. Endocrinol. (Oxf)
743	\N	24586605	Meckbach et al., 2014, PLoS ONE
744	\N	24570209	Crescenzi et al., 2014, Horm. Metab. Res.
745	\N	19470935	Zighelboim et al., 2009, J. Clin. Oncol.
746	\N	21596855	Green et al., 2011, Blood
747	\N	21997850	Lin et al., 2012, Ann. Hematol.
748	\N	22616558	Zhou et al., 2012, Leuk. Lymphoma
749	\N	23344087	Kim et al., 2013, J Thorac Oncol
750	\N	26821351	Kiessling et al., 2016, PLoS ONE
751	\N	26436839	Okoye-Okafor et al., 2015, Nat. Chem. Biol.
752	\N	20538800	Abbas et al., 2010, Blood
753	\N	26698910	Shaw et al., 2016, N. Engl. J. Med.
754	\N	20693978	Jamieson et al., 2010, Mod. Pathol.
755	\N	26510020	Mateo et al., 2015, N. Engl. J. Med.
756	\N	18394554	Wernig et al., 2008, Cancer Cell
757	\N	16709929	Kiladjian et al., 2006, Blood
758	\N	19287384	Kilpivaara et al., 2009, Nat. Genet.
759	\N	16081687	Levine et al., 2005, Blood
760	\N	22112610	Tian et al., 2012, Gynecol. Oncol.
\.


--
-- Data for Name: transcripts; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY transcripts (id, name, source, version) FROM stdin;
1	ENST00000369535	ensembl	74_37
2	ENST00000367921	ensembl	74_37
3	ENST00000373103	ensembl	74_37
4	ENST00000355710	ensembl	74_37
5	ENST00000371953	ensembl	74_37
6	ENST00000332351	ensembl	74_37
7	ENST00000311189	ensembl	74_37
8	ENST00000256078	ensembl	74_37
9	ENST00000380982	ensembl	74_37
10	ENST00000349310	ensembl	74_37
11	ENST00000261609	ensembl	74_37
12	ENST00000307102	ensembl	74_37
13	ENST00000330062	ensembl	74_37
14	ENST00000269571	ensembl	74_37
15	ENST00000269305	ensembl	74_37
16	ENST00000342988	ensembl	74_37
17	ENST00000078429	ensembl	74_37
18	ENST00000335508	ensembl	74_37
19	ENST00000345146	ensembl	74_37
20	ENST00000264709	ensembl	74_37
21	ENST00000389048	ensembl	74_37
22	ENST00000300305	ensembl	74_37
23	ENST00000291552	ensembl	74_37
24	ENST00000341105	ensembl	74_37
25	ENST00000263967	ensembl	74_37
26	ENST00000349496	ensembl	74_37
27	ENST00000257290	ensembl	74_37
28	ENST00000288135	ensembl	74_37
29	ENST00000296930	ensembl	74_37
30	ENST00000206249	ensembl	74_37
31	ENST00000249373	ensembl	74_37
32	ENST00000288602	ensembl	74_37
33	ENST00000496384	ensembl	74_37
34	ENST00000275493	ensembl	74_37
35	ENST00000381652	ensembl	74_37
36	ENST00000286548	ensembl	74_37
37	ENST00000381567	ensembl	74_37
38	ENST00000372348	ensembl	74_37
39	ENST00000303115	ensembl	74_37
40	ENST00000342505	ensembl	74_37
41	ENST00000257430	ensembl	74_37
42	ENST00000458235	ensembl	74_37
43	ENST00000372470	ensembl	74_37
44	ENST00000318493	ensembl	74_37
45	ENST00000361445	ensembl	74_37
46	ENST00000377045	ensembl	74_37
47	ENST00000368508	ensembl	74_37
48	ENST00000392038	ensembl	74_37
49	ENST00000358432	ensembl	74_37
50	ENST00000457416	ensembl	74_37
51	ENST00000292408	ensembl	74_37
52	ENST00000222254	ensembl	74_37
53	ENST00000264033	ensembl	74_37
54	ENST00000286301	ensembl	74_37
55	ENST00000267101	ensembl	74_37
56	ENST00000342788	ensembl	74_37
57	ENST00000262948	ensembl	74_37
58	ENST00000442415	ensembl	74_37
59	ENST00000326873	ensembl	74_37
60	ENST00000354359	ensembl	74_37
61	ENST00000308731	ensembl	74_37
62	ENST00000359376	ensembl	74_37
63	ENST00000340107	ensembl	74_37
64	ENST00000320356	ensembl	74_37
65	ENST00000417037	ensembl	74_37
66	\N	\N	\N
67	ENST00000257904	ensembl	74_37
68	ENST00000446177	ensembl	74_37
69	ENST00000361570	ensembl	74_37
70	ENST00000425967	ensembl	74_37
71	ENST00000231790	ensembl	74_37
72	ENST00000377970	ensembl	74_37
73	ENST00000396611	ensembl	74_37
74	ENST00000267163	ensembl	74_37
75	ENST00000360723	ensembl	74_37
76	ENST00000256474	ensembl	74_37
77	ENST00000318560	ensembl	74_37
78	ENST00000356142	ensembl	74_37
79	ENST00000277541	ensembl	74_37
80	ENST00000374690	ensembl	74_37
81	ENST00000282030	ensembl	74_37
82	ENST00000262887	ensembl	74_37
83	ENST00000398606	ensembl	74_37
84	ENST00000391945	ensembl	74_37
85	ENST00000451590	ensembl	74_37
86	ENST00000265724	ensembl	74_37
87	ENST00000241453	ensembl	74_37
88	ENST00000367922	ensembl	74_37
89	ENST00000407796	ensembl	74_37
90	ENST00000268058	ensembl	74_37
91	ENST00000343289	ensembl	74_37
92	ENST00000219476	ensembl	74_37
93	ENST00000350721	ensembl	74_37
94	ENST00000415913	ensembl	74_37
95	ENST00000330315	ensembl	74_37
96	ENST00000278616	ensembl	74_37
97	ENST00000237612	ensembl	74_37
\.


--
-- Data for Name: variant_types; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY variant_types (id, name) FROM stdin;
1	SNP
2	DEL
3	INS
4	DNP
\.


--
-- Data for Name: versions; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY versions (id, name, sort_order, is_current, import_date) FROM stdin;
1	1	\N	f	\N
2	2	\N	f	\N
6	2.1	\N	t	\N
\.


--
-- Data for Name: variants; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY variants (id, cdna_change, variant, strand, location_id, variant_type_id, amino_acid_id, gene_id, mutation_type_id, primary_variant_id, hgvs, tim_ley_annotation, transcript_id, version_id, meta) FROM stdin;
311	c.553	T	1	206	1	267	39	1	\N	ENST00000303115:c.553A>T	\N	39	2	{"Description":"mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib (in SH2B3 deleted)","Status":"preclinical","Evidence":"emerging","PMID":"22897847, 22955920"},{"Association":"sensitivity","Therapeutic_context":"mTOR inhibitors  (in SH2B3 deleted)","Status":"preclinical","Evidence":"emerging","PMID":"22955920"}]}
312	c.1937	A	-1	207	1	268	40	1	\N	ENST00000342505:c.1937C>T	\N	40	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"22955920"}]}
313	c.1972	A	-1	208	1	269	40	1	\N	ENST00000342505:c.1972G>T	\N	40	2	\N
319	c.2626	T	1	209	1	270	43	2	\N	ENST00000257430:c.2626C>T	\N	41	2	\N
320	c.3340	T	1	210	1	271	43	2	\N	ENST00000257430:c.3340C>T	\N	41	2	\N
321	c.3916	T	1	211	1	272	43	2	\N	ENST00000257430:c.3916G>T	\N	41	2	\N
322	c.4012	T	1	212	1	273	43	2	\N	ENST00000257430:c.4012C>T	\N	41	2	\N
323	c.4099	T	1	213	1	274	43	2	\N	ENST00000257430:c.4099C>T	\N	41	2	\N
489	c.1970	T	-1	231	1	292	65	1	\N	ENST00000458235:c.1970G>A	\N	42	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"18397343"}]}
1	c.183	A	-1	1	1	1	1	1	\N	ENST00000369535:c.183A>T	\N	1	1	\N
2	c.182	A	-1	2	1	2	1	1	\N	ENST00000369535:c.182A>T	\N	1	1	\N
3	c.181	A	-1	3	1	3	1	2	\N	ENST00000369535:c.181C>T	\N	1	1	\N
4	c.181	C	-1	3	1	4	1	1	\N	ENST00000369535:c.181C>G	\N	1	1	\N
5	c.181	T	-1	3	1	5	1	1	\N	ENST00000369535:c.181C>A	\N	1	1	\N
6	c.38	A	-1	4	1	6	1	1	\N	ENST00000369535:c.38G>T	\N	1	1	\N
7	c.38	G	-1	4	1	7	1	1	\N	ENST00000369535:c.38G>C	\N	1	1	\N
315	c.2048	C	1	200	1	261	34	1	\N	ENST00000381652:c.2048G>C	\N	35	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"18805579, 22955920"}]}
316	c.2049	C	1	201	1	262	34	1	\N	ENST00000381652:c.2049A>C	\N	35	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"18805579, 22955920"}]}
317	c.2049	T	1	201	1	262	34	1	\N	ENST00000381652:c.2049A>T	\N	35	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"18805579, 22955920"}]}
366	c.1624	A	1	108	1	136	25	1	\N	ENST00000263967:c.1624G>A	\N	25	2	\N
405	c.2645	A	-1	86	1	107	20	1	\N	ENST00000264709:c.2645G>T	\N	20	2	\N
399	c.2485	C	1	159	1	211	28	1	\N	ENST00000288135:c.2485G>C	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
350	c.37	A	-1	28	1	9	8	1	\N	ENST00000256078:c.37G>T	\N	8	2	\N
351	c.37	G	-1	28	1	10	8	1	\N	ENST00000256078:c.37G>C	\N	8	2	\N
352	c.37	T	-1	28	1	33	8	1	\N	ENST00000256078:c.37G>A	\N	8	2	\N
353	c.35	A	-1	29	1	11	8	1	\N	ENST00000256078:c.35G>T	\N	8	2	\N
354	c.35	G	-1	29	1	12	8	1	\N	ENST00000256078:c.35G>C	\N	8	2	\N
355	c.35	T	-1	29	1	13	8	1	\N	ENST00000256078:c.35G>A	\N	8	2	\N
356	c.34	A	-1	30	1	14	8	1	\N	ENST00000256078:c.34G>T	\N	8	2	\N
357	c.34	G	-1	30	1	15	8	1	\N	ENST00000256078:c.34G>C	\N	8	2	\N
358	c.34	T	-1	30	1	16	8	1	\N	ENST00000256078:c.34G>A	\N	8	2	\N
400	c.1682	A	1	118	1	155	27	1	\N	ENST00000257290:c.1682T>A	\N	27	2	\N
401	c.1977	A	1	119	1	156	27	1	\N	ENST00000257290:c.1977C>A	\N	27	2	\N
402	c.1977	G	1	119	1	156	27	1	\N	ENST00000257290:c.1977C>G	\N	27	2	\N
403	c.2525	T	1	120	1	157	27	1	\N	ENST00000257290:c.2525A>T	\N	27	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib, sunitinib","Status":"late trials, preclinical","Evidence":"emerging","PMID":"22718859, 16638875"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"18794084"},{"Association":"sensitivity","Therapeutic_context":"crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"22745105"},{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"18794084"}]}
361	c.35	A	-1	6	1	11	1	1	\N	ENST00000369535:c.35G>T	\N	1	2	\N
362	c.35	G	-1	6	1	12	1	1	\N	ENST00000369535:c.35G>C	\N	1	2	\N
363	c.35	T	-1	6	1	13	1	1	\N	ENST00000369535:c.35G>A	\N	1	2	\N
365	c.34	T	-1	7	1	16	1	1	\N	ENST00000369535:c.34G>A	\N	1	2	\N
421	c.2503	A	-1	36	1	40	9	1	\N	ENST00000380982:c.2503G>T	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"}]}
8	c.38	T	-1	4	1	8	1	1	\N	ENST00000369535:c.38G>A	\N	1	1	\N
9	c.37	A	-1	5	1	9	1	1	\N	ENST00000369535:c.37G>T	\N	1	1	\N
10	c.37	G	-1	5	1	10	1	1	\N	ENST00000369535:c.37G>C	\N	1	1	\N
11	c.35	A	-1	6	1	11	1	1	\N	ENST00000369535:c.35G>T	\N	1	1	\N
12	c.35	G	-1	6	1	12	1	1	\N	ENST00000369535:c.35G>C	\N	1	1	\N
13	c.35	T	-1	6	1	13	1	1	\N	ENST00000369535:c.35G>A	\N	1	1	\N
14	c.34	A	-1	7	1	14	1	1	\N	ENST00000369535:c.34G>T	\N	1	1	\N
15	c.34	G	-1	7	1	15	1	1	\N	ENST00000369535:c.34G>C	\N	1	1	\N
16	c.34	T	-1	7	1	16	1	1	\N	ENST00000369535:c.34G>A	\N	1	1	\N
17	c.2304	A	1	8	1	17	2	1	\N	ENST00000367921:c.2304T>A	\N	2	1	\N
18	c.1853	A	-1	9	1	18	3	1	\N	ENST00000373103:c.1853C>T	\N	3	1	\N
19	c.2753	C	1	10	1	19	4	1	\N	ENST00000355710:c.2753T>C	\N	4	1	\N
20	c.388	G	1	11	1	20	5	1	\N	ENST00000371953:c.388C>G	\N	5	1	\N
21	c.388	T	1	11	1	21	5	2	\N	ENST00000371953:c.388C>T	\N	5	1	\N
22	c.389	A	1	12	1	22	5	1	\N	ENST00000371953:c.389G>A	\N	5	1	\N
23	c.477	T	1	13	1	23	5	1	\N	ENST00000371953:c.477G>T	\N	5	1	\N
24	c.697	T	1	14	1	24	5	2	\N	ENST00000371953:c.697C>T	\N	5	1	\N
25	c.800	-	1	15	2	25	5	3	\N	ENST00000371953:c.800delA	\N	5	1	\N
26	c.1143_1142	ACCGTACA	-1	16	3	26	6	4	\N	ENST00000332351:c.1143_1142insTGTACGGT	\N	6	1	\N
27	c.182	C	-1	17	1	27	7	1	\N	ENST00000311189:c.182A>G	\N	7	1	\N
28	c.37	A	-1	18	1	9	7	1	\N	ENST00000311189:c.37G>T	\N	7	1	\N
29	c.37	G	-1	18	1	10	7	1	\N	ENST00000311189:c.37G>C	\N	7	1	\N
30	c.35	A	-1	19	1	11	7	1	\N	ENST00000311189:c.35G>T	\N	7	1	\N
31	c.34	G	-1	20	1	15	7	1	\N	ENST00000311189:c.34G>C	\N	7	1	\N
32	c.437	A	-1	21	1	28	8	1	\N	ENST00000256078:c.437C>T	\N	8	1	\N
33	c.436	G	-1	22	1	29	8	1	\N	ENST00000256078:c.436G>C	\N	8	1	\N
34	c.436	T	-1	22	1	30	8	1	\N	ENST00000256078:c.436G>A	\N	8	1	\N
35	c.351	A	-1	23	1	31	8	1	\N	ENST00000256078:c.351A>T	\N	8	1	\N
36	c.351	G	-1	23	1	31	8	1	\N	ENST00000256078:c.351A>C	\N	8	1	\N
37	c.183	A	-1	24	1	1	8	1	\N	ENST00000256078:c.183A>T	\N	8	1	\N
38	c.183	G	-1	24	1	1	8	1	\N	ENST00000256078:c.183A>C	\N	8	1	\N
39	c.182	A	-1	25	1	2	8	1	\N	ENST00000256078:c.182A>T	\N	8	1	\N
40	c.182	C	-1	25	1	27	8	1	\N	ENST00000256078:c.182A>G	\N	8	1	\N
41	c.182	G	-1	25	1	32	8	1	\N	ENST00000256078:c.182A>C	\N	8	1	\N
42	c.181	T	-1	26	1	5	8	1	\N	ENST00000256078:c.181C>A	\N	8	1	\N
43	c.38	A	-1	27	1	6	8	1	\N	ENST00000256078:c.38G>T	\N	8	1	\N
44	c.38	G	-1	27	1	7	8	1	\N	ENST00000256078:c.38G>C	\N	8	1	\N
45	c.38	T	-1	27	1	8	8	1	\N	ENST00000256078:c.38G>A	\N	8	1	\N
46	c.37	A	-1	28	1	9	8	1	\N	ENST00000256078:c.37G>T	\N	8	1	\N
47	c.37	G	-1	28	1	10	8	1	\N	ENST00000256078:c.37G>C	\N	8	1	\N
48	c.37	T	-1	28	1	33	8	1	\N	ENST00000256078:c.37G>A	\N	8	1	\N
49	c.35	A	-1	29	1	11	8	1	\N	ENST00000256078:c.35G>T	\N	8	1	\N
50	c.35	G	-1	29	1	12	8	1	\N	ENST00000256078:c.35G>C	\N	8	1	\N
51	c.35	T	-1	29	1	13	8	1	\N	ENST00000256078:c.35G>A	\N	8	1	\N
52	c.34	A	-1	30	1	14	8	1	\N	ENST00000256078:c.34G>T	\N	8	1	\N
53	c.34	G	-1	30	1	15	8	1	\N	ENST00000256078:c.34G>C	\N	8	1	\N
54	c.34	T	-1	30	1	16	8	1	\N	ENST00000256078:c.34G>A	\N	8	1	\N
55	c.2516	C	-1	31	1	34	9	1	\N	ENST00000380982:c.2516A>G	\N	9	1	\N
56	c.2508	C	-1	32	1	35	9	1	\N	ENST00000380982:c.2508C>G	\N	9	1	\N
57	c.2506	G	-1	33	1	36	9	1	\N	ENST00000380982:c.2506A>C	\N	9	1	\N
58	c.2505	C	-1	34	1	37	9	1	\N	ENST00000380982:c.2505T>G	\N	9	1	\N
59	c.2505	T	-1	34	1	37	9	1	\N	ENST00000380982:c.2505T>A	\N	9	1	\N
60	c.2504	A	-1	35	1	38	9	1	\N	ENST00000380982:c.2504A>T	\N	9	1	\N
61	c.2504	G	-1	35	1	39	9	1	\N	ENST00000380982:c.2504A>C	\N	9	1	\N
62	c.2503	A	-1	36	1	40	9	1	\N	ENST00000380982:c.2503G>T	\N	9	1	\N
63	c.2503	G	-1	36	1	41	9	1	\N	ENST00000380982:c.2503G>C	\N	9	1	\N
64	c.2503	T	-1	36	1	42	9	1	\N	ENST00000380982:c.2503G>A	\N	9	1	\N
65	c.49	T	-1	37	1	43	10	1	\N	ENST00000349310:c.49G>A	\N	10	1	\N
66	c.2277	-	-1	38	2	44	11	5	\N	ENST00000261609:c.2277delAACGGTCCTGACCTG	\N	11	1	\N
67	c.2264	G	-1	39	1	45	11	1	\N	ENST00000261609:c.2264T>C	\N	11	1	\N
68	c.926	C	-1	40	1	46	11	1	\N	ENST00000261609:c.926C>G	\N	11	1	\N
69	c.157	C	1	41	1	47	12	1	\N	ENST00000307102:c.157T>C	\N	12	1	\N
70	c.167	C	1	42	1	48	12	1	\N	ENST00000307102:c.167A>C	\N	12	1	\N
71	c.171	T	1	43	1	49	12	1	\N	ENST00000307102:c.171G>T	\N	12	1	\N
72	c.199	A	1	44	1	50	12	1	\N	ENST00000307102:c.199G>A	\N	12	1	\N
73	c.332	G	1	45	1	51	12	1	\N	ENST00000307102:c.332T>G	\N	12	1	\N
74	c.362	C	1	46	1	52	12	1	\N	ENST00000307102:c.362G>C	\N	12	1	\N
75	c.370	T	1	47	1	53	12	1	\N	ENST00000307102:c.370C>T	\N	12	1	\N
76	c.371	T	1	48	1	54	12	1	\N	ENST00000307102:c.371C>T	\N	12	1	\N
77	c.607	A	1	49	1	55	12	1	\N	ENST00000307102:c.607G>A	\N	12	1	\N
78	c.790	T	1	50	1	56	12	1	\N	ENST00000307102:c.790C>T	\N	12	1	\N
79	c.1144	C	1	51	1	57	12	1	\N	ENST00000307102:c.1144A>C	\N	12	1	\N
80	c.516	G	-1	52	1	58	13	1	\N	ENST00000330062:c.516G>C	\N	13	1	\N
81	c.515	A	-1	53	1	59	13	1	\N	ENST00000330062:c.515G>T	\N	13	1	\N
82	c.515	T	-1	53	1	60	13	1	\N	ENST00000330062:c.515G>A	\N	13	1	\N
83	c.419	A	-1	54	1	61	13	1	\N	ENST00000330062:c.419G>T	\N	13	1	\N
84	c.419	T	-1	54	1	62	13	1	\N	ENST00000330062:c.419G>A	\N	13	1	\N
85	c.418	A	-1	55	1	63	13	1	\N	ENST00000330062:c.418C>T	\N	13	1	\N
86	c.926	C	1	56	1	64	14	1	\N	ENST00000269571:c.926G>C	\N	14	1	\N
87	c.2263	-	1	57	2	65	14	5	\N	ENST00000269571:c.2263delTTGAGGGAAAACACA	\N	14	1	\N
88	c.2264	C	1	58	1	45	14	1	\N	ENST00000269571:c.2264T>C	\N	14	1	\N
89	c.2305	C	1	59	1	66	14	1	\N	ENST00000269571:c.2305G>C	\N	14	1	\N
90	c.2305	T	1	59	1	67	14	1	\N	ENST00000269571:c.2305G>T	\N	14	1	\N
91	c.2329	T	1	60	1	68	14	1	\N	ENST00000269571:c.2329G>T	\N	14	1	\N
92	c.2332_2333	GGCTCCCCA	1	61	3	69	14	6	\N	ENST00000269571:c.2332_2333insGGCTCCCCA	\N	14	1	\N
93	c.2524	A	1	62	1	70	14	1	\N	ENST00000269571:c.2524G>A	\N	14	1	\N
94	c.2686	T	1	63	1	71	14	1	\N	ENST00000269571:c.2686C>T	\N	14	1	\N
95	c.818	T	-1	64	1	72	15	1	\N	ENST00000269305:c.818G>A	\N	15	1	\N
96	c.817	A	-1	65	1	73	15	1	\N	ENST00000269305:c.817C>T	\N	15	1	\N
97	c.746	G	-1	66	1	74	15	1	\N	ENST00000269305:c.746G>C	\N	15	1	\N
98	c.745	A	-1	67	1	75	15	1	\N	ENST00000269305:c.745A>T	\N	15	1	\N
99	c.743	T	-1	68	1	76	15	1	\N	ENST00000269305:c.743G>A	\N	15	1	\N
100	c.659	C	-1	69	1	77	15	1	\N	ENST00000269305:c.659A>G	\N	15	1	\N
101	c.518	C	-1	70	1	78	15	1	\N	ENST00000269305:c.518T>G	\N	15	1	\N
102	c.518	G	-1	70	1	79	15	1	\N	ENST00000269305:c.518T>C	\N	15	1	\N
103	c.989	C	1	71	1	80	16	1	\N	ENST00000342988:c.989A>C	\N	16	1	\N
104	c.1051	A	1	72	1	81	16	1	\N	ENST00000342988:c.1051G>A	\N	16	1	\N
105	c.1051	C	1	72	1	82	16	1	\N	ENST00000342988:c.1051G>C	\N	16	1	\N
106	c.1065	A	1	73	1	83	16	1	\N	ENST00000342988:c.1065C>A	\N	16	1	\N
107	c.1081	A	1	74	1	84	16	1	\N	ENST00000342988:c.1081C>A	\N	16	1	\N
108	c.1081	T	1	74	1	85	16	1	\N	ENST00000342988:c.1081C>T	\N	16	1	\N
109	c.1082	A	1	75	1	86	16	1	\N	ENST00000342988:c.1082G>A	\N	16	1	\N
110	c.1609	T	1	76	1	87	16	1	\N	ENST00000342988:c.1609G>T	\N	16	1	\N
111	c.626	C	1	77	1	88	17	1	\N	ENST00000078429:c.626A>C	\N	17	1	\N
112	c.626	T	1	77	1	89	17	1	\N	ENST00000078429:c.626A>T	\N	17	1	\N
113	c.2100	A	-1	78	1	90	18	1	\N	ENST00000335508:c.2100A>T	\N	18	1	\N
114	c.2100	G	-1	78	1	90	18	1	\N	ENST00000335508:c.2100A>C	\N	18	1	\N
115	c.2099	A	-1	79	1	91	18	1	\N	ENST00000335508:c.2099A>T	\N	18	1	\N
116	c.2099	C	-1	79	1	92	18	1	\N	ENST00000335508:c.2099A>G	\N	18	1	\N
117	c.2099	G	-1	79	1	93	18	1	\N	ENST00000335508:c.2099A>C	\N	18	1	\N
118	c.2098	A	-1	80	1	94	18	2	\N	ENST00000335508:c.2098A>T	\N	18	1	\N
119	c.2098	C	-1	80	1	95	18	1	\N	ENST00000335508:c.2098A>G	\N	18	1	\N
120	c.2098	G	-1	80	1	96	18	1	\N	ENST00000335508:c.2098A>C	\N	18	1	\N
121	c.1998	A	-1	81	1	97	18	1	\N	ENST00000335508:c.1998G>T	\N	18	1	\N
122	c.1998	G	-1	81	1	97	18	1	\N	ENST00000335508:c.1998G>C	\N	18	1	\N
123	c.1997	C	-1	82	1	98	18	1	\N	ENST00000335508:c.1997A>G	\N	18	1	\N
124	c.1997	G	-1	82	1	99	18	1	\N	ENST00000335508:c.1997A>C	\N	18	1	\N
125	c.1996	C	-1	83	1	100	18	1	\N	ENST00000335508:c.1996A>G	\N	18	1	\N
126	c.395	A	-1	84	1	101	19	1	\N	ENST00000345146:c.395G>T	\N	19	1	\N
127	c.395	G	-1	84	1	102	19	1	\N	ENST00000345146:c.395G>C	\N	19	1	\N
128	c.395	T	-1	84	1	103	19	1	\N	ENST00000345146:c.395G>A	\N	19	1	\N
129	c.394	A	-1	85	1	104	19	1	\N	ENST00000345146:c.394C>T	\N	19	1	\N
130	c.394	C	-1	85	1	105	19	1	\N	ENST00000345146:c.394C>G	\N	19	1	\N
131	c.394	T	-1	85	1	106	19	1	\N	ENST00000345146:c.394C>A	\N	19	1	\N
132	c.2645	A	-1	86	1	107	20	1	\N	ENST00000264709:c.2645G>T	\N	20	1	\N
133	c.2645	G	-1	86	1	108	20	1	\N	ENST00000264709:c.2645G>C	\N	20	1	\N
134	c.2645	T	-1	86	1	109	20	1	\N	ENST00000264709:c.2645G>A	\N	20	1	\N
135	c.2644	A	-1	87	1	110	20	1	\N	ENST00000264709:c.2644C>T	\N	20	1	\N
136	c.2644	C	-1	87	1	111	20	1	\N	ENST00000264709:c.2644C>G	\N	20	1	\N
137	c.2644	T	-1	87	1	112	20	1	\N	ENST00000264709:c.2644C>A	\N	20	1	\N
138	c.3833	G	-1	88	1	113	21	1	\N	ENST00000389048:c.3833A>C	\N	21	1	\N
139	c.3824	T	-1	89	1	114	21	1	\N	ENST00000389048:c.3824G>A	\N	21	1	\N
140	c.3735	C	-1	90	1	115	21	1	\N	ENST00000389048:c.3735C>G	\N	21	1	\N
141	c.3734	C	-1	91	1	116	21	1	\N	ENST00000389048:c.3734T>G	\N	21	1	\N
142	c.3733	C	-1	92	1	117	21	1	\N	ENST00000389048:c.3733T>G	\N	21	1	\N
143	c.3673	T	-1	93	1	118	21	1	\N	ENST00000389048:c.3673G>A	\N	21	1	\N
144	c.3522	T	-1	94	1	119	21	1	\N	ENST00000389048:c.3522C>A	\N	21	1	\N
145	c.3521	C	-1	95	1	120	21	1	\N	ENST00000389048:c.3521T>G	\N	21	1	\N
146	c.3520	C	-1	96	1	121	21	1	\N	ENST00000389048:c.3520T>G	\N	21	1	\N
147	c.3520	T	-1	96	1	122	21	1	\N	ENST00000389048:c.3520T>A	\N	21	1	\N
148	c.3512	T	-1	97	1	123	21	1	\N	ENST00000389048:c.3512T>A	\N	21	1	\N
149	c.3452	A	-1	98	1	124	21	1	\N	ENST00000389048:c.3452C>T	\N	21	1	\N
150	c.3271	T	-1	99	1	125	21	1	\N	ENST00000389048:c.3271G>A	\N	21	1	\N
151	c.601	A	-1	100	1	126	22	2	\N	ENST00000300305:c.601C>T	\N	22	1	\N
152	c.486	A	-1	101	1	127	22	1	\N	ENST00000300305:c.486G>T	\N	22	1	\N
153	c.486	G	-1	101	1	127	22	1	\N	ENST00000300305:c.486G>C	\N	22	1	\N
154	c.485	T	-1	102	1	128	22	1	\N	ENST00000300305:c.485G>A	\N	22	1	\N
155	c.484	C	-1	103	1	129	22	1	\N	ENST00000300305:c.484A>G	\N	22	1	\N
156	c.470	C	-1	104	1	130	23	1	\N	ENST00000291552:c.470A>G	\N	23	1	\N
157	c.470	G	-1	104	1	131	23	1	\N	ENST00000291552:c.470A>C	\N	23	1	\N
158	c.101	A	-1	105	1	132	23	1	\N	ENST00000291552:c.101C>T	\N	23	1	\N
159	c.101	T	-1	105	1	133	23	1	\N	ENST00000291552:c.101C>A	\N	23	1	\N
160	c.1192	A	-1	106	1	134	24	1	\N	ENST00000341105:c.1192C>T	\N	24	1	\N
161	c.1061	A	-1	107	1	135	24	1	\N	ENST00000341105:c.1061C>T	\N	24	1	\N
162	c.1624	A	1	108	1	136	25	1	\N	ENST00000263967:c.1624G>A	\N	25	1	\N
163	c.1633	A	1	109	1	137	25	1	\N	ENST00000263967:c.1633G>A	\N	25	1	\N
164	c.1633	C	1	109	1	138	25	1	\N	ENST00000263967:c.1633G>C	\N	25	1	\N
165	c.1634	C	1	110	1	139	25	1	\N	ENST00000263967:c.1634A>C	\N	25	1	\N
166	c.1634	G	1	110	1	140	25	1	\N	ENST00000263967:c.1634A>G	\N	25	1	\N
167	c.1634	T	1	110	1	141	25	1	\N	ENST00000263967:c.1634A>T	\N	25	1	\N
168	c.1636	A	1	111	1	142	25	1	\N	ENST00000263967:c.1636C>A	\N	25	1	\N
169	c.1636	G	1	111	1	143	25	1	\N	ENST00000263967:c.1636C>G	\N	25	1	\N
170	c.1637	C	1	112	1	144	25	1	\N	ENST00000263967:c.1637A>C	\N	25	1	\N
171	c.1637	G	1	112	1	145	25	1	\N	ENST00000263967:c.1637A>G	\N	25	1	\N
172	c.1637	T	1	112	1	146	25	1	\N	ENST00000263967:c.1637A>T	\N	25	1	\N
173	c.1645	A	1	113	1	147	25	1	\N	ENST00000263967:c.1645G>A	\N	25	1	\N
174	c.3140	G	1	114	1	148	25	1	\N	ENST00000263967:c.3140A>G	\N	25	1	\N
175	c.3140	T	1	114	1	149	25	1	\N	ENST00000263967:c.3140A>T	\N	25	1	\N
176	c.110	A	1	115	1	150	26	1	\N	ENST00000349496:c.110C>A	\N	26	1	\N
177	c.110	T	1	115	1	151	26	1	\N	ENST00000349496:c.110C>T	\N	26	1	\N
178	c.133	C	1	116	1	152	26	1	\N	ENST00000349496:c.133T>C	\N	26	1	\N
179	c.134	A	1	117	1	153	26	1	\N	ENST00000349496:c.134C>A	\N	26	1	\N
180	c.134	T	1	117	1	154	26	1	\N	ENST00000349496:c.134C>T	\N	26	1	\N
181	c.1682	A	1	118	1	155	27	1	\N	ENST00000257290:c.1682T>A	\N	27	1	\N
182	c.1977	A	1	119	1	156	27	1	\N	ENST00000257290:c.1977C>A	\N	27	1	\N
183	c.1977	G	1	119	1	156	27	1	\N	ENST00000257290:c.1977C>G	\N	27	1	\N
184	c.2525	T	1	120	1	157	27	1	\N	ENST00000257290:c.2525A>T	\N	27	1	\N
185	c.1468	A	1	121	1	158	28	1	\N	ENST00000288135:c.1468G>A	\N	28	1	\N
186	c.1510	C	1	122	1	159	28	1	\N	ENST00000288135:c.1510T>C	\N	28	1	\N
187	c.1650	C	1	123	1	160	28	1	\N	ENST00000288135:c.1650A>C	\N	28	1	\N
188	c.1650	T	1	123	1	160	28	1	\N	ENST00000288135:c.1650A>T	\N	28	1	\N
189	c.1657	A	1	124	1	161	28	1	\N	ENST00000288135:c.1657T>A	\N	28	1	\N
190	c.1660	-	1	125	2	162	28	5	\N	ENST00000288135:c.1660delGAAGTACAGTGGAAG	\N	28	1	\N
191	c.1660	-	1	126	2	162	28	5	\N	ENST00000288135:c.1660delGAAGTACAGTGGAAGGTT	\N	28	1	\N
192	c.1666_1667	CTA	1	127	3	163	28	6	\N	ENST00000288135:c.1666_1667insCTA	\N	28	1	\N
193	c.1666_1667	CTC	1	127	3	164	28	6	\N	ENST00000288135:c.1666_1667insCTC	\N	28	1	\N
194	c.1666_1667	CTG	1	127	3	165	28	6	\N	ENST00000288135:c.1666_1667insCTG	\N	28	1	\N
195	c.1666_1667	CTT	1	127	3	166	28	6	\N	ENST00000288135:c.1666_1667insCTT	\N	28	1	\N
196	c.1666_1667	TTA	1	127	3	167	28	6	\N	ENST00000288135:c.1666_1667insTTA	\N	28	1	\N
197	c.1666_1667	TTG	1	127	3	168	28	6	\N	ENST00000288135:c.1666_1667insTTG	\N	28	1	\N
198	c.1669	A	1	128	1	169	28	1	\N	ENST00000288135:c.1669T>A	\N	28	1	\N
199	c.1669	C	1	128	1	169	28	1	\N	ENST00000288135:c.1669T>C	\N	28	1	\N
200	c.1674	C	1	129	1	170	28	1	\N	ENST00000288135:c.1674G>C	\N	28	1	\N
201	c.1674	T	1	129	1	170	28	1	\N	ENST00000288135:c.1674G>T	\N	28	1	\N
202	c.1675_1677	-	1	130	2	171	28	5	\N	ENST00000288135:c.1675_1677delGTT	\N	28	1	\N
203	c.1676	A	1	131	1	172	28	1	\N	ENST00000288135:c.1676T>A	\N	28	1	\N
204	c.1676	C	1	131	1	173	28	1	\N	ENST00000288135:c.1676T>C	\N	28	1	\N
205	c.1676	G	1	131	1	174	28	1	\N	ENST00000288135:c.1676T>G	\N	28	1	\N
206	c.1678	-	1	132	2	175	28	5	\N	ENST00000288135:c.1678delGTT	\N	28	1	\N
207	c.1679	A	1	133	1	176	28	1	\N	ENST00000288135:c.1679T>A	\N	28	1	\N
208	c.1679	C	1	133	1	177	28	1	\N	ENST00000288135:c.1679T>C	\N	28	1	\N
209	c.1679	G	1	133	1	178	28	1	\N	ENST00000288135:c.1679T>G	\N	28	1	\N
210	c.1694	T	1	134	1	179	28	1	\N	ENST00000288135:c.1694G>T	\N	28	1	\N
211	c.1696	G	1	135	1	180	28	1	\N	ENST00000288135:c.1696A>G	\N	28	1	\N
212	c.1696_1713	-	1	136	2	181	28	5	\N	ENST00000288135:c.1696_1713delAACAATTATGTTACAGAC	\N	28	1	\N
213	c.1696_1722	-	1	137	2	182	28	5	\N	ENST00000288135:c.1696_1722delAACAATTATGTTACAGACCCAACA	\N	28	1	\N
214	c.1706	G	1	138	1	183	28	1	\N	ENST00000288135:c.1706T>G	\N	28	1	\N
215	c.1723_1724	CCAGAA	1	139	3	184	28	6	\N	ENST00000288135:c.1723_1724insCCAGAA	\N	28	1	\N
216	c.1723_1724	CCAGAG	1	139	3	185	28	6	\N	ENST00000288135:c.1723_1724insCCAGAG	\N	28	1	\N
217	c.1723_1724	CCCGAA	1	139	3	184	28	6	\N	ENST00000288135:c.1723_1724insCCCGAA	\N	28	1	\N
218	c.1723_1724	CCCGAG	1	139	3	185	28	6	\N	ENST00000288135:c.1723_1724insCCCGAG	\N	28	1	\N
219	c.1723_1724	CCGGAA	1	139	3	186	28	6	\N	ENST00000288135:c.1723_1724insCCGGAA	\N	28	1	\N
220	c.1723_1724	CCGGAG	1	139	3	187	28	6	\N	ENST00000288135:c.1723_1724insCCGGAG	\N	28	1	\N
221	c.1723_1724	CCTGAA	1	139	3	188	28	6	\N	ENST00000288135:c.1723_1724insCCTGAA	\N	28	1	\N
222	c.1723_1724	CCTGAG	1	139	3	188	28	6	\N	ENST00000288135:c.1723_1724insCCTGAG	\N	28	1	\N
223	c.1727	C	1	140	1	189	28	1	\N	ENST00000288135:c.1727T>C	\N	28	1	\N
224	c.1730	-	1	141	2	190	28	5	\N	ENST00000288135:c.1730delCTTATGATC	\N	28	1	\N
225	c.1735_1737	-	1	142	2	191	28	5	\N	ENST00000288135:c.1735_1737delGAT	\N	28	1	\N
226	c.1900	T	1	143	1	192	28	1	\N	ENST00000288135:c.1900C>T	\N	28	1	\N
227	c.1924	G	1	144	1	193	28	1	\N	ENST00000288135:c.1924A>G	\N	28	1	\N
228	c.1961	A	1	145	1	194	28	1	\N	ENST00000288135:c.1961T>A	\N	28	1	\N
229	c.1961	C	1	145	1	195	28	1	\N	ENST00000288135:c.1961T>C	\N	28	1	\N
230	c.1964	G	1	146	1	196	28	1	\N	ENST00000288135:c.1964A>G	\N	28	1	\N
231	c.1965	A	1	147	1	197	28	1	\N	ENST00000288135:c.1965T>A	\N	28	1	\N
232	c.1965	G	1	147	1	197	28	1	\N	ENST00000288135:c.1965T>G	\N	28	1	\N
233	c.2089	T	1	148	1	198	28	1	\N	ENST00000288135:c.2089C>T	\N	28	1	\N
234	c.2446	C	1	149	1	199	28	1	\N	ENST00000288135:c.2446G>C	\N	28	1	\N
235	c.2446	T	1	149	1	200	28	1	\N	ENST00000288135:c.2446G>T	\N	28	1	\N
236	c.2446_2447	AT	1	150	4	201	28	1	\N	ENST00000288135:c.2446_2447GA>AT	\N	28	1	\N
237	c.2447	T	1	151	1	202	28	1	\N	ENST00000288135:c.2447A>T	\N	28	1	\N
238	c.2458	C	1	152	1	203	28	1	\N	ENST00000288135:c.2458G>C	\N	28	1	\N
239	c.2458	T	1	152	1	204	28	1	\N	ENST00000288135:c.2458G>T	\N	28	1	\N
240	c.2459	T	1	153	1	205	28	1	\N	ENST00000288135:c.2459A>T	\N	28	1	\N
241	c.2460	A	1	154	1	206	28	1	\N	ENST00000288135:c.2460T>A	\N	28	1	\N
242	c.2464	T	1	155	1	207	28	1	\N	ENST00000288135:c.2464A>T	\N	28	1	\N
243	c.2465	T	1	156	1	208	28	1	\N	ENST00000288135:c.2465A>T	\N	28	1	\N
244	c.2466	A	1	157	1	209	28	1	\N	ENST00000288135:c.2466T>A	\N	28	1	\N
245	c.2466	G	1	157	1	209	28	1	\N	ENST00000288135:c.2466T>G	\N	28	1	\N
246	c.2467	G	1	158	1	210	28	1	\N	ENST00000288135:c.2467T>G	\N	28	1	\N
247	c.2485	C	1	159	1	211	28	1	\N	ENST00000288135:c.2485G>C	\N	28	1	\N
248	c.2521	G	1	160	1	212	28	1	\N	ENST00000288135:c.2521A>G	\N	28	1	\N
249	c.2591	T	1	161	1	213	28	1	\N	ENST00000288135:c.2591C>T	\N	28	1	\N
250	c.862_863	CATG	1	162	3	214	29	4	\N	ENST00000296930:c.862_863insCATG	\N	29	1	\N
251	c.862_863	CCTG	1	162	3	214	29	4	\N	ENST00000296930:c.862_863insCCTG	\N	29	1	\N
252	c.862_863	TCAG	1	162	3	214	29	4	\N	ENST00000296930:c.862_863insTCAG	\N	29	1	\N
253	c.862_863	TCTG	1	162	3	214	29	4	\N	ENST00000296930:c.862_863insTCTG	\N	29	1	\N
254	c.1387	C	1	163	1	215	30	1	\N	ENST00000206249:c.1387T>C	\N	30	1	\N
255	c.1601	A	1	164	1	216	30	1	\N	ENST00000206249:c.1601T>A	\N	30	1	\N
256	c.1604	A	1	165	1	217	30	1	\N	ENST00000206249:c.1604C>A	\N	30	1	\N
257	c.1607	G	1	166	1	218	30	1	\N	ENST00000206249:c.1607T>G	\N	30	1	\N
258	c.1609	A	1	167	1	219	30	1	\N	ENST00000206249:c.1609T>A	\N	30	1	\N
259	c.1610	C	1	168	1	220	30	1	\N	ENST00000206249:c.1610A>C	\N	30	1	\N
260	c.1610	G	1	168	1	221	30	1	\N	ENST00000206249:c.1610A>G	\N	30	1	\N
261	c.1613	G	1	169	1	222	30	1	\N	ENST00000206249:c.1613A>G	\N	30	1	\N
262	c.203_204	TT	1	170	4	223	31	1	\N	ENST00000249373:c.203_204CC>TT	\N	31	1	\N
263	c.595	T	1	171	1	224	31	1	\N	ENST00000249373:c.595C>T	\N	31	1	\N
264	c.1046_1047	TT	1	172	4	225	31	1	\N	ENST00000249373:c.1046_1047CC>TT	\N	31	1	\N
265	c.1417	C	1	173	1	226	31	1	\N	ENST00000249373:c.1417G>C	\N	31	1	\N
266	c.1452_1453	TT	1	174	4	227	31	1	\N	ENST00000249373:c.1452_1453CC>TT	\N	31	1	\N
267	c.1542_1543	TT	1	175	4	228	31	1	\N	ENST00000249373:c.1542_1543CC>TT	\N	31	1	\N
268	c.1604	T	1	176	1	229	31	1	\N	ENST00000249373:c.1604G>T	\N	31	1	\N
269	c.1685	A	1	177	1	230	31	1	\N	ENST00000249373:c.1685G>A	\N	31	1	\N
270	c.1955	T	1	178	1	231	31	1	\N	ENST00000249373:c.1955C>T	\N	31	1	\N
271	c.2263_2264	TT	1	179	4	232	31	1	\N	ENST00000249373:c.2263_2264CC>TT	\N	31	1	\N
272	c.1801	C	-1	180	1	233	32	1	\N	ENST00000288602:c.1801A>G	\N	32	1	\N
273	c.1800_1799	AT	-1	181	4	234	32	1	\N	ENST00000288602:c.1800_1799TG>AT	\N	32	1	\N
274	c.1799	C	-1	182	1	235	32	1	\N	ENST00000288602:c.1799T>G	\N	32	1	\N
275	c.1799	T	-1	182	1	236	32	1	\N	ENST00000288602:c.1799T>A	\N	32	1	\N
276	c.1799_1798	CT	-1	183	4	237	32	1	\N	ENST00000288602:c.1799_1798GT>AG	\N	32	1	\N
277	c.1799_1798	TT	-1	183	4	238	32	1	\N	ENST00000288602:c.1799_1798GT>AA	\N	32	1	\N
278	c.1790	C	-1	184	1	239	32	1	\N	ENST00000288602:c.1790T>G	\N	32	1	\N
279	c.1782	T	-1	185	1	240	32	1	\N	ENST00000288602:c.1782T>A	\N	32	1	\N
280	c.1781	A	-1	186	1	241	32	1	\N	ENST00000288602:c.1781A>T	\N	32	1	\N
281	c.1781	C	-1	186	1	242	32	1	\N	ENST00000288602:c.1781A>G	\N	32	1	\N
282	c.1781	G	-1	186	1	243	32	1	\N	ENST00000288602:c.1781A>C	\N	32	1	\N
283	c.1780	A	-1	187	1	244	32	1	\N	ENST00000288602:c.1780G>T	\N	32	1	\N
284	c.1780	G	-1	187	1	245	32	1	\N	ENST00000288602:c.1780G>C	\N	32	1	\N
285	c.1780	T	-1	187	1	246	32	1	\N	ENST00000288602:c.1780G>A	\N	32	1	\N
286	c.1780_1779	TC	-1	188	4	246	32	1	\N	ENST00000288602:c.1780_1779TG>GA	\N	32	1	\N
287	c.1415	C	-1	189	1	247	32	1	\N	ENST00000288602:c.1415A>G	\N	32	1	\N
288	c.229	A	-1	190	1	248	32	2	\N	ENST00000496384:c.229G>T	\N	33	1	\N
289	c.1406	G	-1	190	1	249	32	1	\N	ENST00000288602:c.1406G>C	\N	32	1	\N
290	c.1406	T	-1	190	1	250	32	1	\N	ENST00000288602:c.1406G>A	\N	32	1	\N
291	c.229_228	AA	-1	191	4	251	32	2	\N	ENST00000496384:c.229_228GG>TT	\N	33	1	\N
292	c.1397	A	-1	192	1	252	32	1	\N	ENST00000288602:c.1397G>T	\N	32	1	\N
293	c.2155	A	1	193	1	253	33	1	\N	ENST00000275493:c.2155G>A	\N	34	1	\N
294	c.2155	T	1	193	1	254	33	1	\N	ENST00000275493:c.2155G>T	\N	34	1	\N
295	c.2156	C	1	194	1	255	33	1	\N	ENST00000275493:c.2156G>C	\N	34	1	\N
296	c.2369	T	1	195	1	256	33	1	\N	ENST00000275493:c.2369C>T	\N	34	1	\N
297	c.2573	G	1	196	1	257	33	1	\N	ENST00000275493:c.2573T>G	\N	34	1	\N
298	c.2582	A	1	197	1	258	33	1	\N	ENST00000275493:c.2582T>A	\N	34	1	\N
299	c.1849	T	1	198	1	259	34	1	\N	ENST00000381652:c.1849G>T	\N	35	1	\N
300	c.2047	G	1	199	1	260	34	1	\N	ENST00000381652:c.2047A>G	\N	35	1	\N
301	c.2048	C	1	200	1	261	34	1	\N	ENST00000381652:c.2048G>C	\N	35	1	\N
302	c.2049	C	1	201	1	262	34	1	\N	ENST00000381652:c.2049A>C	\N	35	1	\N
303	c.2049	T	1	201	1	262	34	1	\N	ENST00000381652:c.2049A>T	\N	35	1	\N
304	c.626	A	-1	202	1	89	35	1	\N	ENST00000286548:c.626A>T	\N	36	1	\N
305	c.626	C	-1	202	1	263	35	1	\N	ENST00000286548:c.626A>G	\N	36	1	\N
306	c.626	G	-1	202	1	88	35	1	\N	ENST00000286548:c.626A>C	\N	36	1	\N
307	c.695	C	-1	203	1	264	36	1	\N	ENST00000381567:c.695T>G	\N	37	1	\N
490	c.1503	A	-1	232	1	293	65	1	\N	ENST00000458235:c.1503G>T	\N	42	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"18397343"}]}
491	c.1503	G	-1	232	1	293	65	1	\N	ENST00000458235:c.1503G>C	\N	42	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"18397343"}]}
492	c.260	G	-1	233	1	294	65	1	\N	ENST00000458235:c.260T>C	\N	42	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"18397343"}]}
530	c.1514	A	1	254	1	318	67	1	\N	ENST00000372470:c.1514G>A	\N	43	2	\N
327	c.4348	T	1	217	1	278	43	2	\N	ENST00000257430:c.4348C>T	\N	41	2	\N
518	c.3833	G	-1	88	1	113	21	1	\N	ENST00000389048:c.3833A>C	\N	21	2	\N
520	c.3735	C	-1	90	1	115	21	1	\N	ENST00000389048:c.3735C>G	\N	21	2	\N
522	c.3733	C	-1	92	1	117	21	1	\N	ENST00000389048:c.3733T>G	\N	21	2	\N
524	c.3521	C	-1	95	1	120	21	1	\N	ENST00000389048:c.3521T>G	\N	21	2	\N
525	c.3520	C	-1	96	1	121	21	1	\N	ENST00000389048:c.3520T>G	\N	21	2	\N
526	c.3520	T	-1	96	1	122	21	1	\N	ENST00000389048:c.3520T>A	\N	21	2	\N
527	c.3512	T	-1	97	1	123	21	1	\N	ENST00000389048:c.3512T>A	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"22072639"}]}
528	c.3452	A	-1	98	1	124	21	1	\N	ENST00000389048:c.3452C>T	\N	21	2	\N
529	c.3271	T	-1	99	1	125	21	1	\N	ENST00000389048:c.3271G>A	\N	21	2	\N
544	c.3455	C	-1	267	1	331	21	1	\N	ENST00000389048:c.3455T>G	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"}]}
329	c.1786	G	-1	218	1	279	32	1	\N	ENST00000288602:c.1786G>C	\N	32	2	\N
330	c.1781	A	-1	186	1	241	32	1	\N	ENST00000288602:c.1781A>T	\N	32	2	\N
332	c.229	A	-1	190	1	248	32	2	\N	ENST00000496384:c.229G>T	\N	33	2	\N
557	c.199	A	1	44	1	50	12	1	\N	ENST00000307102:c.199G>A	\N	12	2	\N
493	c.787	G	1	234	1	295	110	1	\N	ENST00000372348:c.787A>G	\N	38	2	\N
560	c.181	A	-1	3	1	3	1	2	\N	ENST00000369535:c.181C>T	\N	1	2	\N
561	c.34	G	-1	7	1	15	1	1	\N	ENST00000369535:c.34G>C	\N	1	2	\N
432	c.1192	A	-1	106	1	134	24	1	\N	ENST00000341105:c.1192C>T	\N	24	2	\N
433	c.1061	A	-1	107	1	135	24	1	\N	ENST00000341105:c.1061C>T	\N	24	2	\N
424	c.2073	C	-1	225	1	286	9	1	\N	ENST00000380982:c.2073T>G	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"}]}
425	c.2073	T	-1	225	1	286	9	1	\N	ENST00000380982:c.2073T>A	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"}]}
430	c.1952	C	-1	229	1	290	9	1	\N	ENST00000380982:c.1952A>G	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
431	c.1855	A	-1	230	1	291	9	1	\N	ENST00000380982:c.1855G>T	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
573	c.1171	G	-1	279	1	347	76	1	\N	ENST00000358432:c.1171G>C	\N	49	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"mTOR inhibitors, dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"20360610"}]}
594	c.1697	C	-1	287	1	355	77	1	\N	ENST00000457416:c.1697A>G	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
595	c.1693	T	-1	288	1	356	77	1	\N	ENST00000457416:c.1693G>A	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
596	c.1650	C	-1	289	1	357	77	1	\N	ENST00000457416:c.1650T>G	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
597	c.1650	T	-1	289	1	357	77	1	\N	ENST00000457416:c.1650T>A	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
610	c.1711	C	-1	298	1	366	81	1	\N	ENST00000286301:c.1711T>G	\N	54	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"18971950"}]}
611	c.1544	T	1	299	1	367	67	1	\N	ENST00000372470:c.1544G>T	\N	43	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"16834459"}]}
618	c.1513	T	1	301	1	369	67	1	\N	ENST00000372470:c.1513A>T	\N	43	2	\N
619	c.850	A	1	302	1	370	83	1	\N	ENST00000267101:c.850G>A	\N	55	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23680147"}]}
613	c.1396	T	-1	300	1	368	32	1	\N	ENST00000288602:c.1396G>A	\N	32	2	\N
621	c.1802	C	-1	304	1	372	32	1	\N	ENST00000288602:c.1802A>G	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"23248257"}]}
622	c.1801	C	-1	180	1	233	32	1	\N	ENST00000288602:c.1801A>G	\N	32	2	\N
623	c.1800_1799	AT	-1	181	4	234	32	1	\N	ENST00000288602:c.1800_1799TG>AT	\N	32	2	\N
624	c.1799	C	-1	182	1	235	32	1	\N	ENST00000288602:c.1799T>G	\N	32	2	\N
627	c.1798	A	-1	305	1	373	32	1	\N	ENST00000288602:c.1798G>T	\N	32	2	\N
331	c.1781	C	-1	186	1	242	32	1	\N	ENST00000288602:c.1781A>G	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function (low activity)","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"sorafenib","Status":"preclinical","Evidence":"emerging","PMID":"18794803"}]}
634	c.1781	G	-1	186	1	243	32	1	\N	ENST00000288602:c.1781A>C	\N	32	2	\N
635	c.1780	G	-1	187	1	245	32	1	\N	ENST00000288602:c.1780G>C	\N	32	2	\N
636	c.1780	T	-1	187	1	246	32	1	\N	ENST00000288602:c.1780G>A	\N	32	2	\N
637	c.1780_1779	TC	-1	188	4	246	32	1	\N	ENST00000288602:c.1780_1779TG>GA	\N	32	2	\N
673	c.157	C	1	41	1	47	12	1	\N	ENST00000307102:c.157T>C	\N	12	2	\N
683	c.790	T	1	50	1	56	12	1	\N	ENST00000307102:c.790C>T	\N	12	2	\N
615	c.388	G	1	11	1	20	5	1	\N	ENST00000371953:c.388C>G	\N	5	2	\N
616	c.388	T	1	11	1	21	5	2	\N	ENST00000371953:c.388C>T	\N	5	2	\N
617	c.389	A	1	12	1	22	5	1	\N	ENST00000371953:c.389G>A	\N	5	2	\N
670	c.1965	G	1	147	1	197	28	1	\N	ENST00000288135:c.1965T>G	\N	28	2	\N
671	c.2458	C	1	152	1	203	28	1	\N	ENST00000288135:c.2458G>C	\N	28	2	\N
672	c.2458	T	1	152	1	204	28	1	\N	ENST00000288135:c.2458G>T	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"imatinib","Status":"case report","Evidence":"emerging","PMID":"23775962"}]}
843	c.95	C	1	415	1	492	26	1	\N	ENST00000349496:c.95A>C	\N	26	2	\N
820	c.172	A	-1	395	1	471	102	2	\N	ENST00000446177:c.172C>T	\N	68	2	\N
729	c.2962	T	1	343	1	414	68	1	\N	ENST00000318493:c.2962C>T	\N	44	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
730	c.3029	T	1	344	1	415	68	1	\N	ENST00000318493:c.3029C>T	\N	44	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
731	c.3328	A	1	345	1	416	68	1	\N	ENST00000318493:c.3328G>A	\N	44	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
324	c.4132	T	1	214	1	275	43	2	\N	ENST00000257430:c.4132C>T	\N	41	2	\N
325	c.4135	T	1	215	1	276	43	2	\N	ENST00000257430:c.4135G>T	\N	41	2	\N
326	c.4285	T	1	216	1	277	43	2	\N	ENST00000257430:c.4285C>T	\N	41	2	\N
755	c.3575	G	-1	353	1	423	21	1	\N	ENST00000389048:c.3575G>C	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"22072639"}]}
756	c.3383	G	-1	354	1	424	21	1	\N	ENST00000389048:c.3383G>C	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"22072639"}]}
712	c.2753	C	1	10	1	19	4	1	\N	ENST00000355710:c.2753T>C	\N	4	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"vandetanib","Status":"FDA-approved","Evidence":"consensus","PMID":"20065189, 22025146"},{"Association":"sensitivity","Therapeutic_context":"cabozantinib, sunitinib","Status":"preclinical","Evidence":"emerging","PMID":"21470995"},{"Association":"sensitivity","Therapeutic_context":"RET inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23056499"}]}
769	c.1124	G	1	365	1	436	126	1	\N	ENST00000340107:c.1124A>G	\N	63	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"bortezomib","Status":"preclinical","Evidence":"emerging","PMID":"19331127, 21273588"},{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22869148"}]}
770	c.1663	A	1	366	1	437	126	1	\N	ENST00000340107:c.1663G>A	\N	63	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22869148"}]}
771	c.1387	C	1	163	1	215	30	1	\N	ENST00000206249:c.1387T>C	\N	30	2	\N
772	c.1601	A	1	164	1	216	30	1	\N	ENST00000206249:c.1601T>A	\N	30	2	\N
753	c.1415	C	-1	189	1	247	32	1	\N	ENST00000288602:c.1415A>G	\N	32	2	{"Description":"missense mutation","Effect":"reduced kinase activity","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib","Status":"case report","Evidence":"emerging","PMID":"22649091"}]}
754	c.229_228	AA	-1	191	4	251	32	2	\N	ENST00000496384:c.229_228GG>TT	\N	33	2	\N
335	c.1397	A	-1	192	1	252	32	1	\N	ENST00000288602:c.1397G>T	\N	32	2	{"Description":"missense mutation","Effect":"reduced kinase activity","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22649091"}]}
765	c.1391	T	-1	349	1	433	32	1	\N	ENST00000288602:c.1391G>A	\N	32	2	\N
728	c.644	C	1	342	1	413	12	1	\N	ENST00000307102:c.644T>C	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
705	c.182	C	-1	17	1	27	7	1	\N	ENST00000311189:c.182A>G	\N	7	2	\N
706	c.37	A	-1	18	1	9	7	1	\N	ENST00000311189:c.37G>T	\N	7	2	\N
693	c.38	G	-1	4	1	7	1	1	\N	ENST00000369535:c.38G>C	\N	1	2	\N
694	c.37	A	-1	5	1	9	1	1	\N	ENST00000369535:c.37G>T	\N	1	2	\N
695	c.37	G	-1	5	1	10	1	1	\N	ENST00000369535:c.37G>C	\N	1	2	\N
757	c.323	A	1	355	1	425	33	1	\N	ENST00000275493:c.323G>A	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"erlotinib","Status":"preclinical","Evidence":"emerging","PMID":"17177598"}]}
382	c.989	C	1	71	1	80	16	1	\N	ENST00000342988:c.989A>C	\N	16	2	\N
383	c.1051	A	1	72	1	81	16	1	\N	ENST00000342988:c.1051G>A	\N	16	2	\N
384	c.1051	C	1	72	1	82	16	1	\N	ENST00000342988:c.1051G>C	\N	16	2	\N
385	c.1065	A	1	73	1	83	16	1	\N	ENST00000342988:c.1065C>A	\N	16	2	\N
386	c.1081	A	1	74	1	84	16	1	\N	ENST00000342988:c.1081C>A	\N	16	2	\N
387	c.1081	T	1	74	1	85	16	1	\N	ENST00000342988:c.1081C>T	\N	16	2	\N
388	c.1082	A	1	75	1	86	16	1	\N	ENST00000342988:c.1082G>A	\N	16	2	\N
389	c.1609	T	1	76	1	87	16	1	\N	ENST00000342988:c.1609G>T	\N	16	2	\N
367	c.1633	A	1	109	1	137	25	1	\N	ENST00000263967:c.1633G>A	\N	25	2	\N
368	c.1633	C	1	109	1	138	25	1	\N	ENST00000263967:c.1633G>C	\N	25	2	\N
369	c.1634	C	1	110	1	139	25	1	\N	ENST00000263967:c.1634A>C	\N	25	2	\N
370	c.1634	G	1	110	1	140	25	1	\N	ENST00000263967:c.1634A>G	\N	25	2	\N
371	c.1634	T	1	110	1	141	25	1	\N	ENST00000263967:c.1634A>T	\N	25	2	\N
372	c.1636	A	1	111	1	142	25	1	\N	ENST00000263967:c.1636C>A	\N	25	2	\N
373	c.1636	G	1	111	1	143	25	1	\N	ENST00000263967:c.1636C>G	\N	25	2	\N
374	c.1637	C	1	112	1	144	25	1	\N	ENST00000263967:c.1637A>C	\N	25	2	\N
375	c.1637	G	1	112	1	145	25	1	\N	ENST00000263967:c.1637A>G	\N	25	2	\N
376	c.1645	A	1	113	1	147	25	1	\N	ENST00000263967:c.1645G>A	\N	25	2	\N
377	c.3140	G	1	114	1	148	25	1	\N	ENST00000263967:c.3140A>G	\N	25	2	\N
378	c.3140	T	1	114	1	149	25	1	\N	ENST00000263967:c.3140A>T	\N	25	2	\N
406	c.2645	G	-1	86	1	108	20	1	\N	ENST00000264709:c.2645G>C	\N	20	2	\N
407	c.2645	T	-1	86	1	109	20	1	\N	ENST00000264709:c.2645G>A	\N	20	2	\N
408	c.2644	A	-1	87	1	110	20	1	\N	ENST00000264709:c.2644C>T	\N	20	2	\N
409	c.2644	C	-1	87	1	111	20	1	\N	ENST00000264709:c.2644C>G	\N	20	2	\N
410	c.2644	T	-1	87	1	112	20	1	\N	ENST00000264709:c.2644C>A	\N	20	2	\N
379	c.477	T	1	13	1	23	5	1	\N	ENST00000371953:c.477G>T	\N	5	2	\N
380	c.697	T	1	14	1	24	5	2	\N	ENST00000371953:c.697C>T	\N	5	2	\N
381	c.800	-	1	15	2	25	5	3	\N	ENST00000371953:c.800delA	\N	5	2	\N
391	c.1676	A	1	131	1	172	28	1	\N	ENST00000288135:c.1676T>A	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
392	c.1961	C	1	145	1	195	28	1	\N	ENST00000288135:c.1961T>C	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"decreased sensitivity","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"16751810"}]}
393	c.2009	T	1	221	1	282	28	1	\N	ENST00000288135:c.2009C>T	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
394	c.2446	C	1	149	1	199	28	1	\N	ENST00000288135:c.2446G>C	\N	28	2	\N
395	c.2446	T	1	149	1	200	28	1	\N	ENST00000288135:c.2446G>T	\N	28	2	\N
397	c.2465	T	1	156	1	208	28	1	\N	ENST00000288135:c.2465A>T	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
398	c.2467	G	1	158	1	210	28	1	\N	ENST00000288135:c.2467T>G	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
337	c.437	A	-1	21	1	28	8	1	\N	ENST00000256078:c.437C>T	\N	8	2	\N
338	c.436	G	-1	22	1	29	8	1	\N	ENST00000256078:c.436G>C	\N	8	2	\N
339	c.436	T	-1	22	1	30	8	1	\N	ENST00000256078:c.436G>A	\N	8	2	\N
340	c.351	A	-1	23	1	31	8	1	\N	ENST00000256078:c.351A>T	\N	8	2	\N
341	c.351	G	-1	23	1	31	8	1	\N	ENST00000256078:c.351A>C	\N	8	2	\N
342	c.183	A	-1	24	1	1	8	1	\N	ENST00000256078:c.183A>T	\N	8	2	\N
343	c.183	G	-1	24	1	1	8	1	\N	ENST00000256078:c.183A>C	\N	8	2	\N
344	c.182	A	-1	25	1	2	8	1	\N	ENST00000256078:c.182A>T	\N	8	2	\N
345	c.182	C	-1	25	1	27	8	1	\N	ENST00000256078:c.182A>G	\N	8	2	\N
346	c.181	T	-1	26	1	5	8	1	\N	ENST00000256078:c.181C>A	\N	8	2	\N
347	c.38	A	-1	27	1	6	8	1	\N	ENST00000256078:c.38G>T	\N	8	2	\N
348	c.38	G	-1	27	1	7	8	1	\N	ENST00000256078:c.38G>C	\N	8	2	\N
505	c.1121	G	1	244	1	305	110	1	\N	ENST00000372348:c.1121A>G	\N	38	2	\N
506	c.1132	G	1	245	1	306	110	1	\N	ENST00000372348:c.1132T>G	\N	38	2	\N
508	c.763	A	1	247	1	308	110	1	\N	ENST00000372348:c.763G>A	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
486	c.101	A	-1	105	1	132	23	1	\N	ENST00000291552:c.101C>T	\N	23	2	\N
487	c.101	T	-1	105	1	133	23	1	\N	ENST00000291552:c.101C>A	\N	23	2	\N
412	c.2524	G	-1	223	1	284	9	1	\N	ENST00000380982:c.2524T>C	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
413	c.2516	C	-1	31	1	34	9	1	\N	ENST00000380982:c.2516A>G	\N	9	2	\N
414	c.2508	C	-1	32	1	35	9	1	\N	ENST00000380982:c.2508C>G	\N	9	2	\N
415	c.2506	G	-1	33	1	36	9	1	\N	ENST00000380982:c.2506A>C	\N	9	2	\N
417	c.2505	T	-1	34	1	37	9	1	\N	ENST00000380982:c.2505T>A	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
418	c.2504	A	-1	35	1	38	9	1	\N	ENST00000380982:c.2504A>T	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"}]}
419	c.2504	G	-1	35	1	39	9	1	\N	ENST00000380982:c.2504A>C	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
420	c.2504_2503	AA	-1	224	4	285	9	1	\N	ENST00000380982:c.2504_2503GA>TT	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"}]}
422	c.2503	G	-1	36	1	41	9	1	\N	ENST00000380982:c.2503G>C	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
423	c.2503	T	-1	36	1	42	9	1	\N	ENST00000380982:c.2503G>A	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
426	c.2059	A	-1	226	1	287	9	1	\N	ENST00000380982:c.2059A>T	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
427	c.2028	C	-1	227	1	288	9	1	\N	ENST00000380982:c.2028C>G	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"23878140"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
428	c.2028	T	-1	227	1	288	9	1	\N	ENST00000380982:c.2028C>A	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"23878140"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
435	c.395	G	-1	84	1	102	19	1	\N	ENST00000345146:c.395G>C	\N	19	2	\N
437	c.394	A	-1	85	1	104	19	1	\N	ENST00000345146:c.394C>T	\N	19	2	\N
438	c.394	C	-1	85	1	105	19	1	\N	ENST00000345146:c.394C>G	\N	19	2	\N
439	c.394	T	-1	85	1	106	19	1	\N	ENST00000345146:c.394C>A	\N	19	2	\N
451	c.862_863	CCTG	1	162	3	214	29	4	\N	ENST00000296930:c.862_863insCCTG	\N	29	2	\N
452	c.862_863	TCAG	1	162	3	214	29	4	\N	ENST00000296930:c.862_863insTCAG	\N	29	2	\N
453	c.862_863	TCTG	1	162	3	214	29	4	\N	ENST00000296930:c.862_863insTCTG	\N	29	2	\N
440	c.516	G	-1	52	1	58	13	1	\N	ENST00000330062:c.516G>C	\N	13	2	\N
441	c.515	A	-1	53	1	59	13	1	\N	ENST00000330062:c.515G>T	\N	13	2	\N
443	c.419	A	-1	54	1	61	13	1	\N	ENST00000330062:c.419G>T	\N	13	2	\N
444	c.419	T	-1	54	1	62	13	1	\N	ENST00000330062:c.419G>A	\N	13	2	{"Description":"missense mutation","Effect":"switch-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"IDH inhibitor","Status":"early trials","Evidence":"emerging","PMID":"AACR 2014; abstr CT103"}]}
445	c.418	A	-1	55	1	63	13	1	\N	ENST00000330062:c.418C>T	\N	13	2	\N
463	c.2100	A	-1	78	1	90	18	1	\N	ENST00000335508:c.2100A>T	\N	18	2	\N
464	c.2100	G	-1	78	1	90	18	1	\N	ENST00000335508:c.2100A>C	\N	18	2	\N
465	c.2099	A	-1	79	1	91	18	1	\N	ENST00000335508:c.2099A>T	\N	18	2	\N
466	c.2099	C	-1	79	1	92	18	1	\N	ENST00000335508:c.2099A>G	\N	18	2	\N
467	c.2099	G	-1	79	1	93	18	1	\N	ENST00000335508:c.2099A>C	\N	18	2	\N
468	c.2098	A	-1	80	1	94	18	2	\N	ENST00000335508:c.2098A>T	\N	18	2	\N
469	c.2098	C	-1	80	1	95	18	1	\N	ENST00000335508:c.2098A>G	\N	18	2	\N
470	c.2098	G	-1	80	1	96	18	1	\N	ENST00000335508:c.2098A>C	\N	18	2	\N
471	c.1998	A	-1	81	1	97	18	1	\N	ENST00000335508:c.1998G>T	\N	18	2	\N
472	c.1998	G	-1	81	1	97	18	1	\N	ENST00000335508:c.1998G>C	\N	18	2	\N
473	c.1997	C	-1	82	1	98	18	1	\N	ENST00000335508:c.1997A>G	\N	18	2	\N
474	c.1997	G	-1	82	1	99	18	1	\N	ENST00000335508:c.1997A>C	\N	18	2	\N
475	c.1996	C	-1	83	1	100	18	1	\N	ENST00000335508:c.1996A>G	\N	18	2	\N
447	c.2446_2447	AT	1	150	4	201	28	1	\N	ENST00000288135:c.2446_2447GA>AT	\N	28	2	\N
396	c.2447	T	1	151	1	202	28	1	\N	ENST00000288135:c.2447A>T	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"}]}
448	c.2466	A	1	157	1	209	28	1	\N	ENST00000288135:c.2466T>A	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"23149070"}]}
449	c.2466	G	1	157	1	209	28	1	\N	ENST00000288135:c.2466T>G	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"23149070"}]}
494	c.799	G	1	235	1	296	110	1	\N	ENST00000372348:c.799C>G	\N	38	2	\N
495	c.806	A	1	236	1	297	110	1	\N	ENST00000372348:c.806G>A	\N	38	2	\N
496	c.813	C	1	237	1	298	110	1	\N	ENST00000372348:c.813G>C	\N	38	2	\N
497	c.813	T	1	237	1	298	110	1	\N	ENST00000372348:c.813G>T	\N	38	2	\N
498	c.815	T	1	238	1	299	110	1	\N	ENST00000372348:c.815A>T	\N	38	2	\N
499	c.820	A	1	239	1	300	110	1	\N	ENST00000372348:c.820G>A	\N	38	2	\N
500	c.821	T	1	240	1	301	110	1	\N	ENST00000372348:c.821A>T	\N	38	2	\N
501	c.904	G	1	241	1	302	110	1	\N	ENST00000372348:c.904T>G	\N	38	2	\N
504	c.1109	C	1	243	1	304	110	1	\N	ENST00000372348:c.1109T>C	\N	38	2	\N
456	c.38	A	-1	4	1	6	1	1	\N	ENST00000369535:c.38G>T	\N	1	2	\N
457	c.38	T	-1	4	1	8	1	1	\N	ENST00000369535:c.38G>A	\N	1	2	\N
476	c.818	T	-1	64	1	72	15	1	\N	ENST00000269305:c.818G>A	\N	15	2	\N
477	c.817	A	-1	65	1	73	15	1	\N	ENST00000269305:c.817C>T	\N	15	2	\N
478	c.746	G	-1	66	1	74	15	1	\N	ENST00000269305:c.746G>C	\N	15	2	\N
479	c.745	A	-1	67	1	75	15	1	\N	ENST00000269305:c.745A>T	\N	15	2	\N
480	c.743	T	-1	68	1	76	15	1	\N	ENST00000269305:c.743G>A	\N	15	2	\N
481	c.659	C	-1	69	1	77	15	1	\N	ENST00000269305:c.659A>G	\N	15	2	\N
482	c.518	C	-1	70	1	78	15	1	\N	ENST00000269305:c.518T>G	\N	15	2	\N
483	c.518	G	-1	70	1	79	15	1	\N	ENST00000269305:c.518T>C	\N	15	2	\N
458	c.601	A	-1	100	1	126	22	2	\N	ENST00000300305:c.601C>T	\N	22	2	\N
459	c.486	A	-1	101	1	127	22	1	\N	ENST00000300305:c.486G>T	\N	22	2	\N
460	c.486	G	-1	101	1	127	22	1	\N	ENST00000300305:c.486G>C	\N	22	2	\N
461	c.485	T	-1	102	1	128	22	1	\N	ENST00000300305:c.485G>A	\N	22	2	\N
462	c.484	C	-1	103	1	129	22	1	\N	ENST00000300305:c.484A>G	\N	22	2	\N
484	c.470	C	-1	104	1	130	23	1	\N	ENST00000291552:c.470A>G	\N	23	2	\N
485	c.470	G	-1	104	1	131	23	1	\N	ENST00000291552:c.470A>C	\N	23	2	\N
531	c.3335	G	1	255	1	319	68	1	\N	ENST00000318493:c.3335A>G	\N	44	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MET inhibitors","Status":"early trials","Evidence":"emerging","PMID":"23213094"}]}
532	c.3803	C	1	256	1	320	68	1	\N	ENST00000318493:c.3803T>C	\N	44	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MET inhibitors","Status":"case report","Evidence":"emerging","PMID":"23610116"}]}
404	c.1853	A	-1	9	1	18	3	1	\N	ENST00000373103:c.1853C>T	\N	3	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"ruxolitinib","Status":"case report","Evidence":"emerging","PMID":"23656643"}]}
517	c.1843	C	-1	253	1	317	3	1	\N	ENST00000373103:c.1843A>G	\N	3	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"23656643"}]}
533	c.7514	G	-1	257	1	321	118	1	\N	ENST00000361445:c.7514G>C	\N	45	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"rapamycin","Status":"preclinical","Evidence":"emerging","PMID":"24631838"}]}
534	c.6667	T	-1	258	1	322	118	1	\N	ENST00000361445:c.6667C>A	\N	45	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"everolimus","Status":"case report","Evidence":"emerging","PMID":"24622468"}]}
535	c.6644	T	-1	259	1	323	118	1	\N	ENST00000361445:c.6644C>A	\N	45	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"rapamycin","Status":"preclinical","Evidence":"emerging","PMID":"24631838"}]}
536	c.4379	G	-1	260	1	324	118	1	\N	ENST00000361445:c.4379T>C	\N	45	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"rapamycin","Status":"preclinical","Evidence":"emerging","PMID":"24631838"}]}
537	c.7255	T	-1	261	1	325	118	1	\N	ENST00000361445:c.7255G>A	\N	45	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"everolimus","Status":"case report","Evidence":"emerging","PMID":"24625776"}]}
538	c.6040	T	-1	262	1	326	118	1	\N	ENST00000361445:c.6040G>A	\N	45	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"everolimus","Status":"case report","Evidence":"emerging","PMID":"24625776"}]}
308	c.814	C	1	204	1	265	110	1	\N	ENST00000372348:c.814T>C	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
509	c.952	C	1	248	1	309	110	1	\N	ENST00000372348:c.952G>C	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
510	c.1000	G	1	249	1	310	110	1	\N	ENST00000372348:c.1000A>G	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
309	c.1001	T	1	205	1	266	110	1	\N	ENST00000372348:c.1001C>T	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
511	c.1006	A	1	250	1	311	110	1	\N	ENST00000372348:c.1006T>A	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
512	c.1006	G	1	250	1	312	110	1	\N	ENST00000372348:c.1006T>G	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
513	c.1007	G	1	251	1	313	110	1	\N	ENST00000372348:c.1007T>G	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
502	c.1008	A	1	242	1	303	110	1	\N	ENST00000372348:c.1008C>A	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
503	c.1008	G	1	242	1	303	110	1	\N	ENST00000372348:c.1008C>G	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
514	c.1132	A	1	245	1	314	110	1	\N	ENST00000372348:c.1132T>A	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
515	c.1132	C	1	245	1	315	110	1	\N	ENST00000372348:c.1132T>C	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
516	c.1133	G	1	252	1	316	110	1	\N	ENST00000372348:c.1133T>G	\N	38	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
548	c.1112	T	-1	270	1	335	73	1	\N	ENST00000392038:c.1112G>A	\N	48	2	\N
600	c.1614	A	-1	292	1	360	77	1	\N	ENST00000457416:c.1614G>T	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
601	c.1614	G	-1	292	1	360	77	1	\N	ENST00000457416:c.1614G>C	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
540	c.3617	T	-1	264	1	328	21	1	\N	ENST00000389048:c.3617C>A	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"},{"Association":"response","Therapeutic_context":"ceritinib","Status":"FDA-approved","Evidence":"consensus","PMID":"24670165"}]}
541	c.3604	T	-1	265	1	329	21	1	\N	ENST00000389048:c.3604G>A	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"}]}
542	c.3586	T	-1	266	1	330	21	1	\N	ENST00000389048:c.3586C>A	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"},{"Association":"response","Therapeutic_context":"ceritinib","Status":"FDA-approved","Evidence":"consensus","PMID":"24670165, 24327273"}]}
543	c.3522	C	-1	94	1	119	21	1	\N	ENST00000389048:c.3522C>G	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"},{"Association":"response","Therapeutic_context":"novel ALK inhibiors","Status":"preclinical","Evidence":"emerging","PMID":"24327273"}]}
545	c.641	G	1	268	1	332	124	1	\N	ENST00000377045:c.641C>G	\N	46	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"24569458"}]}
547	c.6094	T	-1	269	1	334	120	1	\N	ENST00000368508:c.6094G>A	\N	47	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"23724914"}]}
666	c.1924	G	1	144	1	193	28	1	\N	ENST00000288135:c.1924A>G	\N	28	2	\N
667	c.1961	A	1	145	1	194	28	1	\N	ENST00000288135:c.1961T>A	\N	28	2	\N
841	c.64_114	-	1	413	2	490	26	5	\N	ENST00000349496:c.64_114delGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGT	\N	26	2	\N
842	c.73_96	-	1	414	2	491	26	5	\N	ENST00000349496:c.73_96delTGGCAGCAACAGTCTTACCTGGAC	\N	26	2	\N
546	c.926	A	1	56	1	333	14	1	\N	ENST00000269571:c.926G>A	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ERBB2 TKIs, trastuzumab","Status":"preclinical","Evidence":"emerging","PMID":"22908275"}]}
550	c.2155	T	1	193	1	254	33	1	\N	ENST00000275493:c.2155G>T	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
609	c.1150	C	1	297	1	365	80	1	\N	ENST00000264033:c.1150T>C	\N	53	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors, dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"23696637"}]}
602	c.1614	T	-1	292	1	360	77	1	\N	ENST00000457416:c.1614G>A	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
647	c.1177	A	-1	312	1	381	85	1	\N	ENST00000342788:c.1177C>T	\N	56	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
563	c.716	G	1	272	1	337	2	1	\N	ENST00000367921:c.716T>G	\N	2	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
564	c.757	T	1	273	1	338	2	1	\N	ENST00000367921:c.757G>T	\N	2	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
565	c.1513	A	1	274	1	339	2	1	\N	ENST00000367921:c.1513G>A	\N	2	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
566	c.1912	T	1	275	1	340	2	1	\N	ENST00000367921:c.1912A>T	\N	2	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
567	c.2321	T	1	276	1	341	2	1	\N	ENST00000367921:c.2321G>T	\N	2	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
553	c.2573	G	1	196	1	257	33	1	\N	ENST00000275493:c.2573T>G	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
568	c.2156	A	1	194	1	342	33	1	\N	ENST00000275493:c.2156G>A	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
569	c.2240	C	1	277	1	343	33	1	\N	ENST00000275493:c.2240T>C	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
570	c.2303	T	1	278	1	344	33	1	\N	ENST00000275493:c.2303G>T	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
574	c.1171	T	-1	279	1	347	76	1	\N	ENST00000358432:c.1171G>A	\N	49	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"mTOR inhibitors, dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"20360610"}]}
575	c.959	C	-1	280	1	348	77	1	\N	ENST00000457416:c.959C>G	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23786770"}]}
576	c.870	G	-1	281	1	349	77	1	\N	ENST00000457416:c.870G>C	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23786770"}]}
588	c.1605	A	1	282	1	350	78	1	\N	ENST00000292408:c.1605C>A	\N	51	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24124571"}]}
589	c.1605	G	1	282	1	350	78	1	\N	ENST00000292408:c.1605C>G	\N	51	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24124571"}]}
590	c.1649	A	1	283	1	351	78	1	\N	ENST00000292408:c.1649T>A	\N	51	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24124571"}]}
592	c.1978	C	-1	285	1	353	77	1	\N	ENST00000457416:c.1978A>G	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
593	c.1852	T	-1	286	1	354	77	1	\N	ENST00000457416:c.1852T>A	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
598	c.1648	G	-1	290	1	358	77	1	\N	ENST00000457416:c.1648A>C	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
599	c.1642	C	-1	291	1	359	77	1	\N	ENST00000457416:c.1642A>G	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
633	c.1782	T	-1	185	1	240	32	1	\N	ENST00000288602:c.1782T>A	\N	32	2	\N
707	c.37	G	-1	18	1	10	7	1	\N	ENST00000311189:c.37G>C	\N	7	2	\N
578	c.1468	A	1	121	1	158	28	1	\N	ENST00000288135:c.1468G>A	\N	28	2	\N
579	c.1657	A	1	124	1	161	28	1	\N	ENST00000288135:c.1657T>A	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"imatinib","Status":"case report","Evidence":"emerging","PMID":"21969494"},{"Association":"response","Therapeutic_context":"sunitinib","Status":"case report","Evidence":"emerging","PMID":"23375402"}]}
580	c.1669	C	1	128	1	169	28	1	\N	ENST00000288135:c.1669T>C	\N	28	2	\N
581	c.1676	C	1	131	1	173	28	1	\N	ENST00000288135:c.1676T>C	\N	28	2	\N
582	c.1678	-	1	132	2	175	28	5	\N	ENST00000288135:c.1678delGTT	\N	28	2	{"Description":"deletion mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"imatinib","Status":"case report","Evidence":"emerging","PMID":"15201427"}]}
583	c.1727	C	1	140	1	189	28	1	\N	ENST00000288135:c.1727T>C	\N	28	2	\N
584	c.1730	-	1	141	2	190	28	5	\N	ENST00000288135:c.1730delCTTATGATC	\N	28	2	\N
585	c.2089	T	1	148	1	198	28	1	\N	ENST00000288135:c.2089C>T	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"sunitinib","Status":"preclinical","Evidence":"emerging","PMID":"19861435"}]}
586	c.2460	A	1	154	1	206	28	1	\N	ENST00000288135:c.2460T>A	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"19461405"}]}
668	c.1964	G	1	146	1	196	28	1	\N	ENST00000288135:c.1964A>G	\N	28	2	\N
669	c.1965	A	1	147	1	197	28	1	\N	ENST00000288135:c.1965T>A	\N	28	2	\N
591	c.2068	A	1	284	1	352	33	1	\N	ENST00000275493:c.2068G>A	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"lapatinib","Status":"case report","Evidence":"emerging","PMID":"22885469"}]}
603	c.1608	A	-1	293	1	361	77	1	\N	ENST00000457416:c.1608G>T	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
604	c.1608	G	-1	293	1	361	77	1	\N	ENST00000457416:c.1608G>C	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
605	c.1608	T	-1	293	1	361	77	1	\N	ENST00000457416:c.1608G>A	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
606	c.755	C	-1	294	1	362	77	1	\N	ENST00000457416:c.755C>G	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"sensitivity","list":[{"Association":"FGFR inhibitors","Therapeutic_context":"preclinical","Status":"emerging","Evidence":"18552176, 22238366, 23002168","PMID":"nan"}]}
607	c.1681	G	1	295	1	363	79	1	\N	ENST00000222254:c.1681A>G	\N	52	2	{"Description":"missense mutation","Effect":"loss-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"mTOR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21984976"}]}
608	c.1111	C	1	296	1	364	80	1	\N	ENST00000264033:c.1111T>C	\N	53	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors, dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"23696637"}]}
643	c.2614	T	-1	308	1	378	85	1	\N	ENST00000342788:c.2614G>A	\N	56	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
644	c.1630	A	-1	309	1	379	85	1	\N	ENST00000342788:c.1630C>T	\N	56	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
645	c.1624	T	-1	310	1	136	85	1	\N	ENST00000342788:c.1624G>A	\N	56	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
646	c.1354	T	-1	311	1	380	85	1	\N	ENST00000342788:c.1354G>A	\N	56	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
626	c.1799_1798	TT	-1	183	4	238	32	1	\N	ENST00000288602:c.1799_1798GT>AA	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"trametinib, dabrafenib + trametinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"vemurafenib","Status":"late trials","Evidence":"emerging","PMID":"22356324"}]}
628	c.1798	T	-1	305	1	374	32	1	\N	ENST00000288602:c.1798G>A	\N	32	2	\N
614	c.1790	C	-1	184	1	239	32	1	\N	ENST00000288602:c.1790T>G	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"trametinib, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"22805292, 22798288"},{"Association":"response","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23715574"}]}
629	c.1790	T	-1	184	1	375	32	1	\N	ENST00000288602:c.1790T>A	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"trametinib, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"22805292, 22798288"},{"Association":"response","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23715574"}]}
630	c.1790_1789	GA	-1	306	4	376	32	1	\N	ENST00000288602:c.1790_1789CT>TC	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"trametinib, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"22805292, 22798288"},{"Association":"response","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23715574"}]}
631	c.1789	C	-1	307	1	377	32	1	\N	ENST00000288602:c.1789C>G	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"trametinib, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"22805292, 22798288"},{"Association":"response","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23715574"}]}
632	c.1782	C	-1	185	1	240	32	1	\N	ENST00000288602:c.1782T>G	\N	32	2	\N
334	c.1406	T	-1	190	1	250	32	1	\N	ENST00000288602:c.1406G>A	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function (low activity)","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"sorafenib","Status":"preclinical","Evidence":"emerging","PMID":"18794803"}]}
708	c.35	A	-1	19	1	11	7	1	\N	ENST00000311189:c.35G>T	\N	7	2	\N
709	c.34	G	-1	20	1	15	7	1	\N	ENST00000311189:c.34G>C	\N	7	2	\N
638	c.110	A	1	115	1	150	26	1	\N	ENST00000349496:c.110C>A	\N	26	2	\N
639	c.110	T	1	115	1	151	26	1	\N	ENST00000349496:c.110C>T	\N	26	2	\N
640	c.133	C	1	116	1	152	26	1	\N	ENST00000349496:c.133T>C	\N	26	2	\N
641	c.134	A	1	117	1	153	26	1	\N	ENST00000349496:c.134C>A	\N	26	2	\N
642	c.134	T	1	117	1	154	26	1	\N	ENST00000349496:c.134C>T	\N	26	2	\N
648	c.949	T	-1	313	1	382	85	1	\N	ENST00000342788:c.949G>A	\N	56	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
650	c.626	T	1	77	1	89	17	1	\N	ENST00000078429:c.626A>T	\N	17	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"selumetinib","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)"},{"Association":"response","Therapeutic_context":"PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22733540, 22808163"}]}
674	c.169	G	1	314	1	383	12	1	\N	ENST00000307102:c.169A>G	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"vemurafenib","Status":"case report","Evidence":"emerging","PMID":"23569304"}]}
675	c.171	C	1	43	1	49	12	1	\N	ENST00000307102:c.171G>C	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"23444215"}]}
556	c.171	T	1	43	1	49	12	1	\N	ENST00000307102:c.171G>T	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"23444215"}]}
676	c.332	G	1	45	1	51	12	1	\N	ENST00000307102:c.332T>G	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"BRAF inhibitors in BRAF mutant tumor","Status":"case report","Evidence":"emerging","PMID":"22588879"}]}
677	c.362	C	1	46	1	52	12	1	\N	ENST00000307102:c.362G>C	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"21383288"},{"Association":"sensitivity","Therapeutic_context":"novel MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24448821"}]}
678	c.370	T	1	47	1	53	12	1	\N	ENST00000307102:c.370C>T	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"BRAF inhibitors in BRAF mutant tumor","Status":"case report","Evidence":"emerging","PMID":"22588879"}]}
679	c.371	T	1	48	1	54	12	1	\N	ENST00000307102:c.371C>T	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"19915144"}]}
680	c.383	A	1	315	1	384	12	1	\N	ENST00000307102:c.383G>A	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
681	c.385	C	1	316	1	385	12	1	\N	ENST00000307102:c.385T>C	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
654	c.1510	C	1	122	1	159	28	1	\N	ENST00000288135:c.1510T>C	\N	28	2	\N
655	c.1650	C	1	123	1	160	28	1	\N	ENST00000288135:c.1650A>C	\N	28	2	\N
656	c.1650	T	1	123	1	160	28	1	\N	ENST00000288135:c.1650A>T	\N	28	2	\N
657	c.1669	A	1	128	1	169	28	1	\N	ENST00000288135:c.1669T>A	\N	28	2	\N
658	c.1674	C	1	129	1	170	28	1	\N	ENST00000288135:c.1674G>C	\N	28	2	\N
659	c.1674	T	1	129	1	170	28	1	\N	ENST00000288135:c.1674G>T	\N	28	2	\N
660	c.1676	G	1	131	1	174	28	1	\N	ENST00000288135:c.1676T>G	\N	28	2	\N
661	c.1679	A	1	133	1	176	28	1	\N	ENST00000288135:c.1679T>A	\N	28	2	\N
662	c.1679	C	1	133	1	177	28	1	\N	ENST00000288135:c.1679T>C	\N	28	2	\N
663	c.1679	G	1	133	1	178	28	1	\N	ENST00000288135:c.1679T>G	\N	28	2	\N
664	c.1696	G	1	135	1	180	28	1	\N	ENST00000288135:c.1696A>G	\N	28	2	\N
665	c.1706	G	1	138	1	183	28	1	\N	ENST00000288135:c.1706T>G	\N	28	2	\N
652	c.626	C	-1	202	1	263	35	1	\N	ENST00000286548:c.626A>G	\N	36	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"selumetinib","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)"},{"Association":"response","Therapeutic_context":"PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22733540, 22808163"},{"Association":"sensitivity","Therapeutic_context":"PKC inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"22653968, 22253748"}]}
653	c.626	G	-1	202	1	88	35	1	\N	ENST00000286548:c.626A>C	\N	36	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"selumetinib","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)"},{"Association":"response","Therapeutic_context":"PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22733540, 22808163"},{"Association":"sensitivity","Therapeutic_context":"PKC inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"22653968, 22253748"}]}
685	c.376	C	-1	317	1	386	88	1	\N	ENST00000262948:c.376A>G	\N	57	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"}]}
686	c.373	T	-1	318	1	387	88	1	\N	ENST00000262948:c.373T>A	\N	57	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"}]}
687	c.179	G	-1	319	1	388	88	1	\N	ENST00000262948:c.179A>C	\N	57	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF + MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"24265154"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265154"}]}
688	c.136	A	-1	320	1	389	88	1	\N	ENST00000262948:c.136C>T	\N	57	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"}]}
825	c.416	A	-1	400	1	476	102	1	\N	ENST00000361570:c.416G>T	\N	69	2	\N
826	c.262	A	-1	401	1	477	102	2	\N	ENST00000446177:c.262G>T	\N	68	2	\N
689	c.103	T	-1	321	1	390	88	1	\N	ENST00000262948:c.103G>A	\N	57	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"}]}
827	c.488	A	-1	402	1	478	102	1	\N	ENST00000361570:c.488G>T	\N	69	2	\N
828	c.329	T	-1	403	1	479	102	2	\N	ENST00000446177:c.329G>A	\N	68	2	\N
752	c.1637	T	1	112	1	146	25	1	\N	ENST00000263967:c.1637A>T	\N	25	2	\N
684	c.1144	C	1	51	1	57	12	1	\N	ENST00000307102:c.1144A>C	\N	12	2	\N
710	c.182	G	-1	25	1	32	8	1	\N	ENST00000256078:c.182A>C	\N	8	2	\N
840	c.65	C	1	412	1	489	26	1	\N	ENST00000349496:c.65T>C	\N	26	2	\N
455	c.183	G	-1	1	1	1	1	1	\N	ENST00000369535:c.183A>C	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
690	c.183_182	CA	-1	322	4	2	1	1	\N	ENST00000369535:c.183_182AA>TG	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
691	c.183_182	CC	-1	322	4	27	1	1	\N	ENST00000369535:c.183_182AA>GG	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
701	c.1163	G	-1	328	1	396	89	1	\N	ENST00000442415:c.1163G>C	\N	58	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors in BRAF mutant tumors","Status":"preclinical","Evidence":"emerging","PMID":"23737487"}]}
702	c.769	G	-1	329	1	397	89	1	\N	ENST00000442415:c.769T>C	\N	58	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors in BRAF mutant tumors","Status":"preclinical","Evidence":"emerging","PMID":"23737487"}]}
703	c.582	A	1	330	1	398	90	1	\N	ENST00000326873:c.582C>A	\N	59	2	{"Description":"missense mutation","Effect":"loss-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"everolimus","Status":"case report","Evidence":"emerging","PMID":"21189378"}]}
704	c.582	G	1	330	1	398	90	1	\N	ENST00000326873:c.582C>G	\N	59	2	{"Description":"missense mutation","Effect":"loss-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"everolimus","Status":"case report","Evidence":"emerging","PMID":"21189378"}]}
696	c.1729	T	1	323	1	391	27	1	\N	ENST00000257290:c.1729C>T	\N	27	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"imatinib, crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"}]}
698	c.2522	A	1	325	1	393	27	1	\N	ENST00000257290:c.2522G>A	\N	27	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"imatinib, crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"}]}
699	c.2533	T	1	326	1	394	27	1	\N	ENST00000257290:c.2533C>T	\N	27	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"imatinib, crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"}]}
700	c.2558	A	1	327	1	395	27	1	\N	ENST00000257290:c.2558G>A	\N	27	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"imatinib, crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"}]}
359	c.182	C	-1	2	1	27	1	1	\N	ENST00000369535:c.182A>G	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
360	c.181	T	-1	3	1	5	1	1	\N	ENST00000369535:c.181C>A	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
364	c.34	A	-1	7	1	14	1	1	\N	ENST00000369535:c.34G>T	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
716	c.785	A	1	333	1	402	83	1	\N	ENST00000267101:c.785C>A	\N	55	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23680147"}]}
717	c.2426	G	1	334	1	403	83	1	\N	ENST00000267101:c.2426A>G	\N	55	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, lapatinib, PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23680147"}]}
718	c.604	T	1	335	1	404	93	1	\N	ENST00000354359:c.604C>T	\N	60	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21835143"}]}
719	c.605	A	1	336	1	405	93	1	\N	ENST00000354359:c.605G>A	\N	60	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21835143"}]}
720	c.605	T	1	336	1	406	93	1	\N	ENST00000354359:c.605G>T	\N	60	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21835143"}]}
821	c.181	A	-1	396	1	472	102	2	\N	ENST00000446177:c.181G>T	\N	68	2	\N
822	c.205	A	-1	397	1	473	102	2	\N	ENST00000446177:c.205G>T	\N	68	2	\N
823	c.238	A	-1	398	1	474	102	2	\N	ENST00000446177:c.238C>T	\N	68	2	\N
732	c.3743	G	1	346	1	417	68	1	\N	ENST00000318493:c.3743A>G	\N	44	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"reduced sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
733	c.3757	G	1	347	1	418	68	1	\N	ENST00000318493:c.3757T>G	\N	44	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"reduced sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
734	c.3804	A	1	348	1	419	68	1	\N	ENST00000318493:c.3804G>A	\N	44	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
735	c.3804	C	1	348	1	419	68	1	\N	ENST00000318493:c.3804G>C	\N	44	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
736	c.3804	T	1	348	1	419	68	1	\N	ENST00000318493:c.3804G>T	\N	44	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
318	c.49	T	-1	37	1	43	10	1	\N	ENST00000349310:c.49G>A	\N	10	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"allosteric AKT inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21464312, 17611497"}]}
737	c.1391	A	-1	349	1	420	32	1	\N	ENST00000288602:c.1391G>T	\N	32	2	\N
721	c.296	C	1	337	1	407	12	1	\N	ENST00000307102:c.296T>C	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
722	c.308	A	1	338	1	408	12	1	\N	ENST00000307102:c.308T>A	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
723	c.332	A	1	45	1	409	12	1	\N	ENST00000307102:c.332T>A	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
724	c.356	C	1	339	1	410	12	1	\N	ENST00000307102:c.356A>C	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
725	c.360	C	1	340	1	411	12	1	\N	ENST00000307102:c.360G>C	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
726	c.360	T	1	340	1	411	12	1	\N	ENST00000307102:c.360G>T	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
727	c.632	A	1	341	1	412	12	1	\N	ENST00000307102:c.632T>A	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
839	c.61	A	1	411	1	488	26	1	\N	ENST00000349496:c.61G>A	\N	26	2	\N
714	c.929	A	1	332	1	400	14	1	\N	ENST00000269571:c.929C>A	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ERBB2 TKIs, trastuzumab","Status":"preclinical","Evidence":"emerging","PMID":"22908275"}]}
715	c.929	T	1	332	1	401	14	1	\N	ENST00000269571:c.929C>T	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ERBB2 TKIs, trastuzumab","Status":"preclinical","Evidence":"emerging","PMID":"22908275"}]}
824	c.413	A	-1	399	1	475	102	1	\N	ENST00000361570:c.413C>T	\N	69	2	\N
764	c.758	C	-1	362	1	432	77	1	\N	ENST00000457416:c.758C>G	\N	50	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"pazopanib","Status":"case report","Evidence":"emerging","PMID":"23786770"}]}
766	c.1993	T	1	363	1	434	97	1	\N	ENST00000359376:c.1993C>T	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"ibrutinib","Status":"early trials","Evidence":"emerging","PMID":"24869598"}]}
767	c.2535	C	1	364	1	435	97	1	\N	ENST00000359376:c.2535A>C	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"ibrutinib","Status":"early trials","Evidence":"emerging","PMID":"24869598"}]}
768	c.2535	T	1	364	1	435	97	1	\N	ENST00000359376:c.2535A>T	\N	62	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"ibrutinib","Status":"early trials","Evidence":"emerging","PMID":"24869598"}]}
748	c.1138	C	1	352	1	422	30	1	\N	ENST00000206249:c.1138G>C	\N	30	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"anti-estrogens","Status":"early trials","Evidence":"emerging","PMID":"24185512, 24185510, 24398047"}]}
773	c.1604	A	1	165	1	217	30	1	\N	ENST00000206249:c.1604C>A	\N	30	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"anti-estrogens","Status":"early trials","Evidence":"emerging","PMID":"24185512"}]}
738	c.1442	G	-1	350	1	421	125	1	\N	ENST00000308731:c.1442G>C	\N	61	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"ibrutinib","Status":"early trials","Evidence":"emerging","PMID":"24869598"}]}
739	c.1441	T	-1	351	1	421	125	1	\N	ENST00000308731:c.1441T>A	\N	61	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"ibrutinib","Status":"early trials","Evidence":"emerging","PMID":"24869598"}]}
328	c.1799	T	-1	182	1	236	32	1	\N	ENST00000288602:c.1799T>A	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"vemurafenib","Status":"case report","Evidence":"emerging","PMID":"23612012"}]}
740	c.926	C	1	56	1	64	14	1	\N	ENST00000269571:c.926G>C	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}]}
741	c.2263	-	1	57	2	65	14	5	\N	ENST00000269571:c.2263delTTGAGGGAAAACACA	\N	14	2	\N
742	c.2305	C	1	59	1	66	14	1	\N	ENST00000269571:c.2305G>C	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}]}
743	c.2305	T	1	59	1	67	14	1	\N	ENST00000269571:c.2305G>T	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}]}
744	c.2329	T	1	60	1	68	14	1	\N	ENST00000269571:c.2329G>T	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}]}
745	c.2332_2333	GGCTCCCCA	1	61	3	69	14	6	\N	ENST00000269571:c.2332_2333insGGCTCCCCA	\N	14	2	\N
746	c.2524	A	1	62	1	70	14	1	\N	ENST00000269571:c.2524G>A	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}]}
747	c.2686	T	1	63	1	71	14	1	\N	ENST00000269571:c.2686C>T	\N	14	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}]}
758	c.787	C	1	356	1	426	33	1	\N	ENST00000275493:c.787A>C	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"erlotinib","Status":"preclinical","Evidence":"emerging","PMID":"17177598"}]}
759	c.866	T	1	357	1	427	33	1	\N	ENST00000275493:c.866C>T	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"erlotinib","Status":"preclinical","Evidence":"emerging","PMID":"17177598"}]}
760	c.1793	T	1	358	1	428	33	1	\N	ENST00000275493:c.1793G>T	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"erlotinib","Status":"preclinical","Evidence":"emerging","PMID":"17177598"}]}
761	c.1636	T	1	359	1	429	33	1	\N	ENST00000275493:c.1636C>T	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"cetuximab","Status":"case report","Evidence":"emerging","PMID":"23578570"}]}
762	c.2257	T	1	360	1	430	33	1	\N	ENST00000275493:c.2257C>T	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"cetuximab plus sirolimus","Status":"case report","Evidence":"emerging","PMID":"24934779"}]}
763	c.2527	A	1	361	1	431	33	1	\N	ENST00000275493:c.2527G>A	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"no response","Therapeutic_context":"gefitinib","Status":"case report","Evidence":"emerging","PMID":"21274259"}]}
779	c.1936	G	-1	367	1	438	99	1	\N	ENST00000320356:c.1936T>C	\N	64	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"EZH2 inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"23023262"}]}
780	c.1936	T	-1	367	1	439	99	1	\N	ENST00000320356:c.1936T>A	\N	64	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"EZH2 inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"23023262"}]}
782	c.1937	G	-1	368	1	441	99	1	\N	ENST00000320356:c.1937A>C	\N	64	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"EZH2 inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"23023262"}]}
783	c.2045	C	-1	369	1	442	99	1	\N	ENST00000320356:c.2045C>G	\N	64	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"EZH2 inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"23023262"}]}
781	c.1937	A	-1	368	1	440	99	1	\N	ENST00000320356:c.1937A>T	\N	64	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"EZH2 inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"24563539"}]}
784	c.818	C	1	370	1	443	100	1	\N	ENST00000417037:c.818T>C	\N	65	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21179087"}]}
785	c.904	C	-1	371	1	444	73	1	\N	ENST00000392038:c.904A>G	\N	48	2	\N
786	c.3928_3938	-	1	372	2	445	43	3	\N	ENST00000257430:c.3928_3938delAAGATTGGAAC	\N	41	2	\N
787	c.3928_3947	-	1	373	2	445	43	3	\N	ENST00000257430:c.3928_3947delAAGATTGGAACTAGGTCAGC	\N	41	2	\N
788	c.4396_4400	-	1	374	2	446	43	3	\N	ENST00000257430:c.4396_4400delGGACC	\N	41	2	\N
789	c.4669_4676	-	1	375	2	447	43	3	\N	ENST00000257430:c.4669_4676delATTGATTC	\N	41	2	\N
819	c.71	T	-1	394	1	470	101	1	\N	ENST00000257904:c.71G>A	\N	67	2	\N
829	c.330	T	-1	404	1	479	102	2	\N	ENST00000446177:c.330G>A	\N	68	2	\N
830	c.341	A	-1	405	1	480	102	1	\N	ENST00000446177:c.341C>T	\N	68	2	\N
831	c.902	G	-1	406	1	481	81	1	\N	ENST00000286301:c.902T>C	\N	54	2	\N
832	c.902	T	-1	406	1	482	81	2	\N	ENST00000286301:c.902T>A	\N	54	2	\N
833	c.2906	C	-1	407	1	483	81	1	\N	ENST00000286301:c.2906A>G	\N	54	2	\N
834	c.2906	A	-1	407	1	484	81	1	\N	ENST00000286301:c.2906A>T	\N	54	2	\N
835	c.2905	G	-1	408	1	485	81	1	\N	ENST00000286301:c.2905T>C	\N	54	2	\N
836	c.2907	T	-1	409	1	486	81	2	\N	ENST00000286301:c.2907T>A	\N	54	2	\N
837	c.2907	C	-1	409	1	486	81	2	\N	ENST00000286301:c.2907T>G	\N	54	2	\N
775	c.1609	A	1	167	1	219	30	1	\N	ENST00000206249:c.1609T>A	\N	30	2	\N
776	c.1610	C	1	168	1	220	30	1	\N	ENST00000206249:c.1610A>C	\N	30	2	\N
777	c.1610	G	1	168	1	221	30	1	\N	ENST00000206249:c.1610A>G	\N	30	2	\N
778	c.1613	G	1	169	1	222	30	1	\N	ENST00000206249:c.1613A>G	\N	30	2	\N
790	c.1330	A	-1	376	1	448	32	1	\N	ENST00000288602:c.1330C>T	\N	32	2	\N
791	c.1390	T	-1	377	1	449	32	1	\N	ENST00000288602:c.1390G>A	\N	32	2	\N
792	c.1397	G	-1	192	1	450	32	1	\N	ENST00000288602:c.1397G>C	\N	32	2	\N
793	c.1397	T	-1	192	1	451	32	1	\N	ENST00000288602:c.1397G>A	\N	32	2	\N
794	c.1405	T	-1	378	1	452	32	1	\N	ENST00000288602:c.1405G>A	\N	32	2	\N
795	c.1405	G	-1	378	1	452	32	1	\N	ENST00000288602:c.1405G>C	\N	32	2	\N
796	c.1406_1405	GA	-1	191	4	453	32	1	\N	ENST00000288602:c.1406_1405GG>TC	\N	32	2	\N
797	c.1411	A	-1	379	1	454	32	1	\N	ENST00000288602:c.1411G>T	\N	32	2	\N
798	c.1742	C	-1	380	1	455	32	1	\N	ENST00000288602:c.1742A>G	\N	32	2	\N
800	c.1756	T	-1	381	1	456	32	1	\N	ENST00000288602:c.1756G>A	\N	32	2	\N
801	c.1760	G	-1	382	1	457	32	1	\N	ENST00000288602:c.1760A>C	\N	32	2	\N
802	c.1761	T	-1	383	1	458	32	1	\N	ENST00000288602:c.1761C>A	\N	32	2	\N
803	c.1761	C	-1	383	1	458	32	1	\N	ENST00000288602:c.1761C>G	\N	32	2	\N
804	c.1776	C	-1	384	1	459	32	1	\N	ENST00000288602:c.1776A>G	\N	32	2	\N
805	c.1774	C	-1	385	1	460	32	1	\N	ENST00000288602:c.1774A>G	\N	32	2	\N
806	c.1783	G	-1	386	1	461	32	1	\N	ENST00000288602:c.1783T>C	\N	32	2	\N
807	c.608	T	-1	387	1	462	32	2	\N	ENST00000496384:c.608T>A	\N	33	2	\N
808	c.1785	C	-1	387	1	461	32	1	\N	ENST00000288602:c.1785T>G	\N	32	2	\N
809	c.1784	G	-1	388	1	463	32	1	\N	ENST00000288602:c.1784T>C	\N	32	2	\N
810	c.619	A	-1	389	1	464	32	2	\N	ENST00000496384:c.619C>T	\N	33	2	\N
811	c.1799	G	-1	182	1	465	32	1	\N	ENST00000288602:c.1799T>C	\N	32	2	\N
812	c.1800_1799	TT	-1	181	4	236	32	1	\N	ENST00000288602:c.1800_1799TG>AA	\N	32	2	\N
813	c.1798	G	-1	305	1	373	32	1	\N	ENST00000288602:c.1798G>C	\N	32	2	\N
814	c.1803_1801	-	-1	390	2	466	32	5	\N	ENST00000288602:c.1803_1801delAAA	\N	32	2	\N
815	c.1803	A	-1	391	1	467	32	1	\N	ENST00000288602:c.1803A>T	\N	32	2	\N
816	c.1803	G	-1	391	1	467	32	1	\N	ENST00000288602:c.1803A>C	\N	32	2	\N
817	c.1814_1813	AA	-1	392	4	468	32	1	\N	ENST00000288602:c.1814_1813AG>TT	\N	32	2	\N
818	c.1814	T	-1	393	1	469	32	1	\N	ENST00000288602:c.1814G>A	\N	32	2	\N
838	c.37	A	1	410	1	487	26	1	\N	ENST00000349496:c.37G>A	\N	26	2	\N
888	c.473	A	-1	442	1	531	103	1	\N	ENST00000425967:c.473C>T	\N	70	2	\N
889	c.847	T	-1	443	1	532	103	1	\N	ENST00000425967:c.847C>A	\N	70	2	\N
890	c.929	C	-1	444	1	533	77	1	\N	ENST00000457416:c.929A>G	\N	50	2	\N
891	c.1118	C	-1	445	1	534	77	1	\N	ENST00000457416:c.1118C>G	\N	50	2	\N
892	c.1127	C	-1	446	1	535	77	1	\N	ENST00000457416:c.1127A>G	\N	50	2	\N
893	c.1144	G	-1	447	1	536	77	1	\N	ENST00000457416:c.1144T>C	\N	50	2	\N
894	c.1917	T	-1	448	1	537	77	1	\N	ENST00000457416:c.1917T>A	\N	50	2	\N
905	c.683	T	1	459	1	546	93	1	\N	ENST00000354359:c.683A>T	\N	60	2	\N
917	c.394	T	-1	464	1	547	65	1	\N	ENST00000458235:c.394C>A	\N	42	2	\N
896	c.746	G	1	450	1	539	126	1	\N	ENST00000340107:c.746C>G	\N	63	2	\N
897	c.1114	T	1	451	1	540	126	1	\N	ENST00000340107:c.1114G>T	\N	63	2	\N
898	c.1117	T	1	452	1	534	126	1	\N	ENST00000340107:c.1117A>T	\N	63	2	\N
899	c.1954	C	1	453	1	541	126	1	\N	ENST00000340107:c.1954A>C	\N	63	2	\N
900	c.2095	T	1	454	1	542	126	1	\N	ENST00000340107:c.2095G>T	\N	63	2	\N
906	c.34	A	-1	20	1	14	7	1	\N	ENST00000311189:c.34G>T	\N	7	2	\N
907	c.35	T	-1	19	1	13	7	1	\N	ENST00000311189:c.35G>A	\N	7	2	\N
908	c.37	T	-1	18	1	33	7	1	\N	ENST00000311189:c.37G>A	\N	7	2	\N
909	c.38	A	-1	460	1	6	7	1	\N	ENST00000311189:c.38G>T	\N	7	2	\N
910	c.183	G	-1	461	1	1	7	1	\N	ENST00000311189:c.183G>C	\N	7	2	\N
911	c.183	A	-1	461	1	1	7	1	\N	ENST00000311189:c.183G>T	\N	7	2	\N
912	c.181	T	-1	462	1	5	7	1	\N	ENST00000311189:c.181C>A	\N	7	2	\N
913	c.182	A	-1	17	1	2	7	1	\N	ENST00000311189:c.182A>T	\N	7	2	\N
914	c.182	G	-1	17	1	32	7	1	\N	ENST00000311189:c.182A>C	\N	7	2	\N
915	c.183_182	TC	-1	463	4	27	7	1	\N	ENST00000311189:c.183_182AG>GA	\N	7	2	\N
916	c.183_182	AC	-1	463	4	27	7	1	\N	ENST00000311189:c.183_182AG>GT	\N	7	2	\N
844	c.95	G	1	415	1	493	26	1	\N	ENST00000349496:c.95A>G	\N	26	2	\N
845	c.94	C	1	416	1	494	26	1	\N	ENST00000349496:c.94G>C	\N	26	2	\N
846	c.94	A	1	416	1	495	26	1	\N	ENST00000349496:c.94G>A	\N	26	2	\N
847	c.95	T	1	415	1	496	26	1	\N	ENST00000349496:c.95A>T	\N	26	2	\N
848	c.94	T	1	416	1	497	26	1	\N	ENST00000349496:c.94G>T	\N	26	2	\N
849	c.98	G	1	417	1	498	26	1	\N	ENST00000349496:c.98C>G	\N	26	2	\N
850	c.98	A	1	417	1	499	26	1	\N	ENST00000349496:c.98C>A	\N	26	2	\N
851	c.101	A	1	418	1	500	26	1	\N	ENST00000349496:c.101G>A	\N	26	2	\N
852	c.100	A	1	419	1	501	26	1	\N	ENST00000349496:c.100G>A	\N	26	2	\N
853	c.100	C	1	419	1	501	26	1	\N	ENST00000349496:c.100G>C	\N	26	2	\N
854	c.101	T	1	418	1	502	26	1	\N	ENST00000349496:c.101G>T	\N	26	2	\N
855	c.109	G	1	420	1	503	26	1	\N	ENST00000349496:c.109T>G	\N	26	2	\N
856	c.110	G	1	115	1	504	26	1	\N	ENST00000349496:c.110C>G	\N	26	2	\N
857	c.109	C	1	420	1	505	26	1	\N	ENST00000349496:c.109T>C	\N	26	2	\N
858	c.118	G	1	421	1	506	26	1	\N	ENST00000349496:c.118A>G	\N	26	2	\N
859	c.119	T	1	422	1	507	26	1	\N	ENST00000349496:c.119C>T	\N	26	2	\N
860	c.118	C	1	421	1	508	26	1	\N	ENST00000349496:c.118A>C	\N	26	2	\N
861	c.118	T	1	421	1	509	26	1	\N	ENST00000349496:c.118A>T	\N	26	2	\N
862	c.119	G	1	422	1	509	26	1	\N	ENST00000349496:c.119C>G	\N	26	2	\N
863	c.133	G	1	116	1	510	26	1	\N	ENST00000349496:c.133T>G	\N	26	2	\N
864	c.134	G	1	117	1	511	26	1	\N	ENST00000349496:c.134C>G	\N	26	2	\N
883	c.2354	C	1	439	1	528	14	1	\N	ENST00000269571:c.2354T>C	\N	14	2	\N
884	c.2264	C	1	58	1	45	14	1	\N	ENST00000269571:c.2264T>C	\N	14	2	\N
885	c.2326	A	1	440	1	529	14	1	\N	ENST00000269571:c.2326G>A	\N	14	2	\N
886	c.2326_2327	TGT	1	441	3	530	14	6	\N	ENST00000269571:c.2326_2327insTGT	\N	14	2	\N
887	c.2329	C	1	60	1	68	14	1	\N	ENST00000269571:c.2329G>C	\N	14	2	\N
865	c.2193	A	1	423	1	512	33	2	\N	ENST00000275493:c.2193G>A	\N	34	2	\N
866	c.2198	T	1	424	1	513	33	1	\N	ENST00000275493:c.2198C>T	\N	34	2	\N
867	c.2200	A	1	425	1	514	33	1	\N	ENST00000275493:c.2200G>A	\N	34	2	\N
868	c.2203	A	1	426	1	515	33	1	\N	ENST00000275493:c.2203G>A	\N	34	2	\N
870	c.2234	G	1	428	1	517	33	1	\N	ENST00000275493:c.2234A>G	\N	34	2	\N
871	c.2236	A	1	429	1	518	33	1	\N	ENST00000275493:c.2236G>A	\N	34	2	\N
872	c.2248	C	1	430	1	519	33	1	\N	ENST00000275493:c.2248G>C	\N	34	2	\N
873	c.2255	A	1	431	1	520	33	1	\N	ENST00000275493:c.2255C>A	\N	34	2	\N
874	c.2281	A	1	432	1	521	33	1	\N	ENST00000275493:c.2281G>A	\N	34	2	\N
875	c.2281	T	1	432	1	522	33	1	\N	ENST00000275493:c.2281G>T	\N	34	2	\N
876	c.2318	G	1	433	1	523	33	1	\N	ENST00000275493:c.2318A>G	\N	34	2	\N
877	c.2429	A	1	434	1	524	33	1	\N	ENST00000275493:c.2429G>A	\N	34	2	\N
878	c.2428	A	1	435	1	525	33	1	\N	ENST00000275493:c.2428G>A	\N	34	2	\N
879	c.2572	A	1	436	1	526	33	1	\N	ENST00000275493:c.2572C>A	\N	34	2	\N
880	c.2573_2574	GT	1	437	4	257	33	1	\N	ENST00000275493:c.2573_2574TG>GT	\N	34	2	\N
881	c.2572_2573	AG	1	438	4	257	33	1	\N	ENST00000275493:c.2572_2573CT>AG	\N	34	2	\N
882	c.2573	A	1	196	1	527	33	1	\N	ENST00000275493:c.2573T>A	\N	34	2	\N
901	c.1715	C	-1	455	1	543	9	1	\N	ENST00000380982:c.1715A>G	\N	9	2	\N
902	c.2505_2503	-	-1	456	2	544	9	5	\N	ENST00000380982:c.2505_2503delGAT	\N	9	2	\N
903	c.2508_2506	-	-1	457	2	545	9	5	\N	ENST00000380982:c.2508_2506delATC	\N	9	2	\N
918	c.1715	A	-1	465	1	548	65	1	\N	ENST00000458235:c.1715C>T	\N	42	2	\N
919	c.2164	T	-1	466	1	549	65	1	\N	ENST00000458235:c.2164G>A	\N	42	2	\N
930	c.3334	T	1	474	1	556	68	1	\N	ENST00000318493:c.3334C>T	\N	44	2	\N
931	c.3742	C	1	475	1	557	68	1	\N	ENST00000318493:c.3742T>C	\N	44	2	\N
932	c.1151	A	1	476	1	558	104	1	\N	ENST00000231790:c.1151T>A	\N	71	2	\N
933	c.169	T	1	477	1	559	105	1	\N	ENST00000377970:c.169C>T	\N	72	2	\N
934	c.176	T	1	478	1	560	105	1	\N	ENST00000377970:c.176C>T	\N	72	2	\N
935	c.218	T	1	479	1	561	105	1	\N	ENST00000377970:c.218C>T	\N	72	2	\N
936	c.230	T	1	480	1	562	105	1	\N	ENST00000377970:c.230C>T	\N	72	2	\N
937	c.302	C	1	481	1	563	105	1	\N	ENST00000377970:c.302A>C	\N	72	2	\N
938	c.778	G	1	482	1	564	105	1	\N	ENST00000377970:c.778C>G	\N	72	2	\N
964	c.1126	A	1	502	1	584	106	1	\N	ENST00000396611:c.1126G>A	\N	73	2	\N
965	c.1126	C	1	502	1	584	106	1	\N	ENST00000396611:c.1126G>C	\N	73	2	\N
966	c.1315	-	1	503	2	585	106	5	\N	ENST00000396611:c.1315delGAA	\N	73	2	\N
967	c.1381	T	1	504	1	586	106	2	\N	ENST00000396611:c.1381C>T	\N	73	2	\N
968	c.1678	T	1	505	1	587	106	1	\N	ENST00000396611:c.1678G>T	\N	73	2	\N
969	c.1678_1695	-	1	506	2	588	106	5	\N	ENST00000396611:c.1678_1695delGACAAACGTATGAACAGC	\N	73	2	\N
970	c.1690	G	1	507	1	589	106	1	\N	ENST00000396611:c.1690A>G	\N	73	2	\N
971	c.1692	A	1	508	1	590	106	1	\N	ENST00000396611:c.1692C>A	\N	73	2	\N
972	c.1692	G	1	508	1	590	106	1	\N	ENST00000396611:c.1692C>G	\N	73	2	\N
973	c.1726_1728	-	1	509	2	591	106	5	\N	ENST00000396611:c.1726_1728delACG	\N	73	2	\N
974	c.1747	-	1	510	2	592	106	5	\N	ENST00000396611:c.1747delTGG	\N	73	2	\N
979	c.409	T	1	515	1	597	107	2	\N	ENST00000267163:c.409G>T	\N	74	2	\N
980	c.596	A	1	516	1	598	107	2	\N	ENST00000267163:c.596T>A	\N	74	2	\N
981	c.958	T	1	517	1	599	107	2	\N	ENST00000267163:c.958C>T	\N	74	2	\N
982	c.1072	T	1	518	1	600	107	2	\N	ENST00000267163:c.1072C>T	\N	74	2	\N
983	c.1363	T	1	519	1	601	107	2	\N	ENST00000267163:c.1363C>T	\N	74	2	\N
984	c.1654	T	1	520	1	602	107	2	\N	ENST00000267163:c.1654C>T	\N	74	2	\N
985	c.1666	T	1	521	1	603	107	2	\N	ENST00000267163:c.1666C>T	\N	74	2	\N
986	c.1735	T	1	522	1	604	107	2	\N	ENST00000267163:c.1735C>T	\N	74	2	\N
987	c.2117	T	1	523	1	605	107	1	\N	ENST00000267163:c.2117G>T	\N	74	2	\N
988	c.2242	T	1	524	1	606	107	2	\N	ENST00000267163:c.2242G>T	\N	74	2	\N
990	c.1892	G	1	526	1	608	4	1	\N	ENST00000355710:c.1892A>G	\N	4	2	\N
949	c.263	A	1	492	1	572	25	1	\N	ENST00000263967:c.263G>A	\N	25	2	\N
950	c.1035	A	1	493	1	573	25	1	\N	ENST00000263967:c.1035T>A	\N	25	2	\N
951	c.1035	G	1	493	1	573	25	1	\N	ENST00000263967:c.1035T>G	\N	25	2	\N
952	c.1258	C	1	494	1	574	25	1	\N	ENST00000263967:c.1258T>C	\N	25	2	\N
953	c.1616	G	1	495	1	575	25	1	\N	ENST00000263967:c.1616C>G	\N	25	2	\N
954	c.1624	C	1	108	1	576	25	1	\N	ENST00000263967:c.1624G>C	\N	25	2	\N
955	c.1635	T	1	496	1	577	25	1	\N	ENST00000263967:c.1635G>T	\N	25	2	\N
956	c.1635	C	1	496	1	577	25	1	\N	ENST00000263967:c.1635G>C	\N	25	2	\N
957	c.2102	C	1	497	1	578	25	1	\N	ENST00000263967:c.2102A>C	\N	25	2	\N
958	c.3062	G	1	498	1	579	25	1	\N	ENST00000263967:c.3062A>G	\N	25	2	\N
959	c.3129	T	1	499	1	580	25	1	\N	ENST00000263967:c.3129G>T	\N	25	2	\N
960	c.3129	A	1	499	1	580	25	1	\N	ENST00000263967:c.3129G>A	\N	25	2	\N
961	c.3139	T	1	500	1	581	25	1	\N	ENST00000263967:c.3139C>T	\N	25	2	\N
962	c.3145	A	1	501	1	582	25	1	\N	ENST00000263967:c.3145G>A	\N	25	2	\N
963	c.3145	C	1	501	1	583	25	1	\N	ENST00000263967:c.3145G>C	\N	25	2	\N
929	c.361	A	1	473	1	52	12	1	\N	ENST00000307102:c.361T>A	\N	12	2	\N
975	c.517	T	1	511	1	593	5	1	\N	ENST00000371953:c.517C>T	\N	5	2	\N
976	c.518	A	1	512	1	594	5	1	\N	ENST00000371953:c.518G>A	\N	5	2	\N
977	c.700	T	1	513	1	595	5	1	\N	ENST00000371953:c.700C>T	\N	5	2	\N
978	c.1003	T	1	514	1	596	5	2	\N	ENST00000371953:c.1003C>T	\N	5	2	\N
920	c.154	A	1	467	1	550	28	1	\N	ENST00000288135:c.154G>A	\N	28	2	\N
922	c.2474	C	1	468	1	551	28	1	\N	ENST00000288135:c.2474T>C	\N	28	2	\N
923	c.2515	A	1	469	1	552	28	1	\N	ENST00000288135:c.2515G>A	\N	28	2	\N
924	c.57	A	-1	470	1	553	8	1	\N	ENST00000256078:c.57G>T	\N	8	2	\N
925	c.57	G	-1	470	1	553	8	1	\N	ENST00000256078:c.57G>C	\N	8	2	\N
926	c.64	T	-1	471	1	554	8	1	\N	ENST00000256078:c.64C>A	\N	8	2	\N
927	c.175	T	-1	472	1	555	8	1	\N	ENST00000256078:c.175G>A	\N	8	2	\N
928	c.181	C	-1	26	1	4	8	1	\N	ENST00000256078:c.181C>G	\N	8	2	\N
942	c.2521_2526	-	1	485	2	566	27	5	\N	ENST00000257290:c.2521_2526delAGAGAC	\N	27	2	\N
943	c.2524_2525	AT	1	486	4	567	27	1	\N	ENST00000257290:c.2524_2525GA>AT	\N	27	2	\N
944	c.2524	T	1	487	1	568	27	1	\N	ENST00000257290:c.2524G>T	\N	27	2	\N
945	c.2524_2532	-	1	488	2	569	27	5	\N	ENST00000257290:c.2524_2532delGACATCATG	\N	27	2	\N
946	c.2524_2535	-	1	489	2	570	27	5	\N	ENST00000257290:c.2524_2535delGACATCATGCAT	\N	27	2	\N
947	c.2527_2538	-	1	490	2	570	27	5	\N	ENST00000257290:c.2527_2538delATCATGCATGAT	\N	27	2	\N
948	c.2536	T	1	491	1	571	27	1	\N	ENST00000257290:c.2536G>T	\N	27	2	\N
939	c.37	T	-1	5	1	33	1	1	\N	ENST00000369535:c.37G>A	\N	1	2	\N
940	c.52	T	-1	483	1	565	1	1	\N	ENST00000369535:c.52G>A	\N	1	2	\N
941	c.182_181	CT	-1	484	4	27	1	1	\N	ENST00000369535:c.182_181CA>AG	\N	1	2	\N
997	c.1609	T	1	533	1	615	108	2	\N	ENST00000360723:c.1609C>T	\N	75	2	\N
998	c.109	T	1	534	1	616	90	2	\N	ENST00000326873:c.109C>T	\N	59	2	\N
999	c.508	T	1	535	1	617	90	2	\N	ENST00000326873:c.508C>T	\N	59	2	\N
1000	c.580	A	1	536	1	618	90	1	\N	ENST00000326873:c.580G>A	\N	59	2	\N
1001	c.581	T	1	537	1	619	90	1	\N	ENST00000326873:c.581A>T	\N	59	2	\N
1002	c.587	T	1	538	1	620	90	1	\N	ENST00000326873:c.587G>T	\N	59	2	\N
1003	c.595	A	1	539	1	621	90	1	\N	ENST00000326873:c.595G>A	\N	59	2	\N
1004	c.595	T	1	539	1	622	90	2	\N	ENST00000326873:c.595G>T	\N	59	2	\N
1005	c.842	T	1	540	1	623	90	1	\N	ENST00000326873:c.842C>T	\N	59	2	\N
1006	c.996	A	1	541	1	624	90	2	\N	ENST00000326873:c.996G>A	\N	59	2	\N
1011	c.241	T	1	546	1	629	109	1	\N	ENST00000256474:c.241C>T	\N	76	2	\N
1012	c.254	C	1	547	1	630	109	1	\N	ENST00000256474:c.254T>C	\N	76	2	\N
1013	c.266	A	1	548	1	631	109	1	\N	ENST00000256474:c.266T>A	\N	76	2	\N
1014	c.473	A	1	549	1	632	109	1	\N	ENST00000256474:c.473T>A	\N	76	2	\N
1015	c.481	T	1	550	1	633	109	2	\N	ENST00000256474:c.481C>T	\N	76	2	\N
1016	c.499	T	1	551	1	634	109	1	\N	ENST00000256474:c.499C>T	\N	76	2	\N
310	c.695	C	-1	203	1	264	36	1	\N	ENST00000381567:c.695T>G	\N	37	2	\N
521	c.3734	C	-1	91	1	116	21	1	\N	ENST00000389048:c.3734T>G	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"22072639"}]}
523	c.3522	T	-1	94	1	119	21	1	\N	ENST00000389048:c.3522C>A	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"},{"Association":"response","Therapeutic_context":"novel ALK inhibiors","Status":"preclinical","Evidence":"emerging","PMID":"24327273"}]}
519	c.3824	T	-1	89	1	114	21	1	\N	ENST00000389048:c.3824G>A	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"22072639"}]}
539	c.3806	G	-1	263	1	327	21	1	\N	ENST00000389048:c.3806G>C	\N	21	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"},{"Association":"response","Therapeutic_context":"ceritinib","Status":"FDA-approved","Evidence":"consensus","PMID":"24670165"}]}
587	c.3673	T	-1	93	1	118	21	1	\N	ENST00000389048:c.3673G>A	\N	21	2	\N
711	c.1902	G	1	331	1	399	4	1	\N	ENST00000355710:c.1902C>G	\N	4	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"vandetanib","Status":"FDA-approved","Evidence":"consensus","PMID":"20065189, 22025146"},{"Association":"sensitivity","Therapeutic_context":"cabozantinib, sunitinib","Status":"preclinical","Evidence":"emerging","PMID":"21470995"},{"Association":"sensitivity","Therapeutic_context":"RET inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23056499"}]}
989	c.1834_1860	-	1	525	2	607	4	5	\N	ENST00000355710:c.1834_1860delTTCCCTGAGGAGGAGAAGTGCTTCTGC	\N	4	2	\N
991	c.1894_1899	-	1	527	2	609	4	5	\N	ENST00000355710:c.1894_1899delGAGCTG	\N	4	2	\N
992	c.1900	C	1	528	1	610	4	1	\N	ENST00000355710:c.1900T>C	\N	4	2	\N
993	c.1901	A	1	529	1	611	4	1	\N	ENST00000355710:c.1901G>A	\N	4	2	\N
994	c.2304	C	1	530	1	612	4	1	\N	ENST00000355710:c.2304G>C	\N	4	2	\N
995	c.2647_2648	TT	1	531	4	613	4	1	\N	ENST00000355710:c.2647_2648GC>TT	\N	4	2	\N
996	c.2692_2703	-	1	532	2	614	4	5	\N	ENST00000355710:c.2692_2703delGATGTTTATGAA	\N	4	2	\N
751	c.926	C	-1	40	1	46	11	1	\N	ENST00000261609:c.926C>G	\N	11	2	\N
750	c.2264	G	-1	39	1	45	11	1	\N	ENST00000261609:c.2264T>C	\N	11	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}]}
749	c.2277	-	-1	38	2	44	11	5	\N	ENST00000261609:c.2277delAACGGTCCTGACCTG	\N	11	2	\N
488	c.1143_1142	ACCGTACA	-1	16	3	26	6	4	\N	ENST00000332351:c.1143_1142insTGTACGGT	\N	6	2	\N
562	c.187	G	1	271	1	336	2	1	\N	ENST00000367921:c.187C>G	\N	2	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
713	c.2304	A	1	8	1	17	2	1	\N	ENST00000367921:c.2304T>A	\N	2	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib + erlotinib","Status":"case report","Evidence":"emerging","PMID":"22328973"},{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
434	c.395	A	-1	84	1	101	19	1	\N	ENST00000345146:c.395G>T	\N	19	2	\N
436	c.395	T	-1	84	1	103	19	1	\N	ENST00000345146:c.395G>A	\N	19	2	{"Description":"missense mutation","Effect":"switch-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"IDH inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23558169"}]}
649	c.626	C	1	77	1	88	17	1	\N	ENST00000078429:c.626A>C	\N	17	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"selumetinib","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)"},{"Association":"response","Therapeutic_context":"PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22733540, 22808163"}]}
1008	c.733	T	-1	543	1	626	15	1	\N	ENST00000269305:c.733G>A	\N	15	2	\N
1009	c.742	A	-1	544	1	627	15	1	\N	ENST00000269305:c.742C>T	\N	15	2	\N
1010	c.916	A	-1	545	1	628	15	2	\N	ENST00000269305:c.916C>T	\N	15	2	\N
450	c.862_863	CATG	1	162	3	214	29	4	\N	ENST00000296930:c.862_863insCATG	\N	29	2	\N
442	c.515	T	-1	53	1	60	13	1	\N	ENST00000330062:c.515G>A	\N	13	2	{"Description":"missense mutation","Effect":"switch-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"IDH inhibitor","Status":"early trials","Evidence":"emerging","PMID":"AACR 2014; abstr CT103"}]}
895	c.742	T	1	449	1	538	126	1	\N	ENST00000340107:c.742C>T	\N	63	2	\N
774	c.1607	G	1	166	1	218	30	1	\N	ENST00000206249:c.1607T>G	\N	30	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"anti-estrogens","Status":"early trials","Evidence":"emerging","PMID":"24185512, 24185510"}]}
314	c.2047	G	1	199	1	260	34	1	\N	ENST00000381652:c.2047A>G	\N	35	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"18805579, 22955920"}]}
446	c.1849	T	1	198	1	259	34	1	\N	ENST00000381652:c.1849G>T	\N	35	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"ruxolitinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"}]}
620	c.235	T	-1	303	1	371	10	1	\N	ENST00000349310:c.235C>A	\N	10	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265152"}]}
333	c.1406	G	-1	190	1	249	32	1	\N	ENST00000288602:c.1406G>C	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"EGFR TKIs","Status":"case report","Evidence":"emerging","PMID":"22773810"},{"Association":"sensitivity","Therapeutic_context":"EGFR TKIs + MEK inhibitors in EGFR mutant","Status":"preclinical","Evidence":"emerging","PMID":"22773810"}]}
625	c.1799_1798	CT	-1	183	4	237	32	1	\N	ENST00000288602:c.1799_1798GT>AG	\N	32	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"BRAF inhibitors","Status":"early trials","Evidence":"emerging","PMID":"23237741"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"23248257"}]}
555	c.167	C	1	42	1	48	12	1	\N	ENST00000307102:c.167A>C	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"vemurafenib","Status":"case report","Evidence":"emerging","PMID":"23569304"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
682	c.607	A	1	49	1	55	12	1	\N	ENST00000307102:c.607G>A	\N	12	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"vemurafenib","Status":"case report","Evidence":"emerging","PMID":"23569304"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
390	c.1675	A	1	220	1	281	28	1	\N	ENST00000288135:c.1675G>A	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
577	c.2459	T	1	153	1	205	28	1	\N	ENST00000288135:c.2459A>T	\N	28	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib","Status":"early trials","Evidence":"emerging","PMID":"18559612"}]}
921	c.1675_1677	-	1	130	2	171	28	5	\N	ENST00000288135:c.1675_1677delGTT	\N	28	2	\N
349	c.38	T	-1	27	1	8	8	1	\N	ENST00000256078:c.38G>A	\N	8	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"panitumumab","Status":"FDA-rejected","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"cetuximab","Status":"late trials","Evidence":"emerging","PMID":"22734028, 20978259"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors + PI3K pathway inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22392911"}]}
651	c.626	A	-1	202	1	89	35	1	\N	ENST00000286548:c.626A>T	\N	36	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"selumetinib","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)"},{"Association":"response","Therapeutic_context":"PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22733540, 22808163"},{"Association":"sensitivity","Therapeutic_context":"PKC inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"22653968, 22253748"}]}
904	c.626_625	AA	-1	458	4	89	35	1	\N	ENST00000286548:c.626_625CA>TT	\N	36	2	\N
612	c.1417	C	1	173	1	226	31	1	\N	ENST00000249373:c.1417G>C	\N	31	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"vismodegib","Status":"case report","Evidence":"emerging","PMID":"19726788"}]}
507	c.1244	G	1	246	1	307	110	1	\N	ENST00000372348:c.1244A>G	\N	38	2	\N
697	c.1973	C	1	324	1	392	27	1	\N	ENST00000257290:c.1973T>C	\N	27	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"},{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"}]}
692	c.181	C	-1	3	1	4	1	1	\N	ENST00000369535:c.181C>G	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
454	c.183	A	-1	1	1	1	1	1	\N	ENST00000369535:c.183A>T	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
558	c.182	A	-1	2	1	2	1	1	\N	ENST00000369535:c.182A>T	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
559	c.182	G	-1	2	1	32	1	1	\N	ENST00000369535:c.182A>C	\N	1	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
1007	c.524	T	-1	542	1	625	15	1	\N	ENST00000269305:c.524G>A	\N	15	2	\N
554	c.2582	A	1	197	1	258	33	1	\N	ENST00000275493:c.2582T>A	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
572	c.2582	G	1	197	1	346	33	1	\N	ENST00000275493:c.2582T>G	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
336	c.1474	G	1	219	1	280	33	1	\N	ENST00000275493:c.1474A>G	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"cetuximab","Status":"case report","Evidence":"emerging","PMID":"22270724"},{"Association":"response","Therapeutic_context":"panitumumab","Status":"case report","Evidence":"emerging","PMID":"22270724"}]}
549	c.2155	A	1	193	1	253	33	1	\N	ENST00000275493:c.2155G>A	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
551	c.2156	C	1	194	1	255	33	1	\N	ENST00000275493:c.2156G>C	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
3433	c.2047	G	1	199	1	260	34	1	\N	ENST00000381652:c.2047A>G	\N	35	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"18805579, 22955920"}]}
3497	c.3140	T	1	114	1	149	25	1	\N	ENST00000263967:c.3140A>T	\N	25	6	\N
552	c.2369	T	1	195	1	256	33	1	\N	ENST00000275493:c.2369C>T	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"erlotinib, afatinib","Status":"NCCN/ CAP guidelines","Evidence":"consensus","PMID":"NCCN"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"response","Therapeutic_context":"irreversible EGFR T790M inhibitors","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
571	c.2582	C	1	197	1	345	33	1	\N	ENST00000275493:c.2582T>C	\N	34	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
869	c.2225	C	1	427	1	516	33	1	\N	ENST00000275493:c.2225T>C	\N	34	2	\N
411	c.2525	C	-1	222	1	283	9	1	\N	ENST00000380982:c.2525A>G	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
416	c.2505	C	-1	34	1	37	9	1	\N	ENST00000380982:c.2505T>G	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
429	c.2026	C	-1	228	1	289	9	1	\N	ENST00000380982:c.2026A>G	\N	9	2	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
3427	c.814	C	1	204	1	265	110	1	\N	ENST00000372348:c.814T>C	\N	38	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
3428	c.1001	T	1	205	1	266	110	1	\N	ENST00000372348:c.1001C>T	\N	38	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
3429	c.695	C	-1	203	1	264	36	1	\N	ENST00000381567:c.695T>G	\N	37	6	\N
3430	c.553	T	1	206	1	267	39	1	\N	ENST00000303115:c.553A>T	\N	39	6	{"Description":"mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib (in SH2B3 deleted)","Status":"preclinical","Evidence":"emerging","PMID":"22897847, 22955920"},{"Association":"sensitivity","Therapeutic_context":"mTOR inhibitors  (in SH2B3 deleted)","Status":"preclinical","Evidence":"emerging","PMID":"22955920"}]}
3431	c.1937	A	-1	207	1	268	40	1	\N	ENST00000342505:c.1937C>T	\N	40	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"22955920"}]}
3432	c.1972	A	-1	208	1	269	40	1	\N	ENST00000342505:c.1972G>T	\N	40	6	\N
3434	c.2048	C	1	200	1	261	34	1	\N	ENST00000381652:c.2048G>C	\N	35	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"18805579, 22955920"}]}
3435	c.2049	C	1	201	1	262	34	1	\N	ENST00000381652:c.2049A>C	\N	35	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"18805579, 22955920"}]}
3436	c.2049	T	1	201	1	262	34	1	\N	ENST00000381652:c.2049A>T	\N	35	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"18805579, 22955920"}]}
3437	c.49	T	-1	37	1	43	10	1	\N	ENST00000349310:c.49G>A	\N	10	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"allosteric AKT inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21464312, 17611497"}]}
3438	c.2626	T	1	209	1	270	43	2	\N	ENST00000257430:c.2626C>T	\N	41	6	\N
3439	c.3340	T	1	210	1	271	43	2	\N	ENST00000257430:c.3340C>T	\N	41	6	\N
3440	c.3916	T	1	211	1	272	43	2	\N	ENST00000257430:c.3916G>T	\N	41	6	\N
3441	c.4012	T	1	212	1	273	43	2	\N	ENST00000257430:c.4012C>T	\N	41	6	\N
3442	c.4099	T	1	213	1	274	43	2	\N	ENST00000257430:c.4099C>T	\N	41	6	\N
3443	c.4132	T	1	214	1	275	43	2	\N	ENST00000257430:c.4132C>T	\N	41	6	\N
3444	c.4135	T	1	215	1	276	43	2	\N	ENST00000257430:c.4135G>T	\N	41	6	\N
3445	c.4285	T	1	216	1	277	43	2	\N	ENST00000257430:c.4285C>T	\N	41	6	\N
3446	c.4348	T	1	217	1	278	43	2	\N	ENST00000257430:c.4348C>T	\N	41	6	\N
3448	c.1786	G	-1	218	1	279	32	1	\N	ENST00000288602:c.1786G>C	\N	32	6	\N
3449	c.1781	A	-1	186	1	241	32	1	\N	ENST00000288602:c.1781A>T	\N	32	6	\N
3450	c.1781	C	-1	186	1	242	32	1	\N	ENST00000288602:c.1781A>G	\N	32	6	{"Description":"missense mutation","Effect":"gain-of-function (low activity)","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"sorafenib","Status":"preclinical","Evidence":"emerging","PMID":"18794803"}]}
3451	c.229	A	-1	190	1	248	32	2	\N	ENST00000496384:c.229G>T	\N	33	6	\N
3452	c.1406	G	-1	190	1	249	32	1	\N	ENST00000288602:c.1406G>C	\N	32	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"EGFR TKIs","Status":"case report","Evidence":"emerging","PMID":"22773810"},{"Association":"sensitivity","Therapeutic_context":"EGFR TKIs + MEK inhibitors in EGFR mutant","Status":"preclinical","Evidence":"emerging","PMID":"22773810"}]}
3453	c.1406	T	-1	190	1	250	32	1	\N	ENST00000288602:c.1406G>A	\N	32	6	{"Description":"missense mutation","Effect":"gain-of-function (low activity)","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"sorafenib","Status":"preclinical","Evidence":"emerging","PMID":"18794803"}]}
3454	c.1397	A	-1	192	1	252	32	1	\N	ENST00000288602:c.1397G>T	\N	32	6	{"Description":"missense mutation","Effect":"reduced kinase activity","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22649091"}]}
3455	c.1474	G	1	219	1	280	33	1	\N	ENST00000275493:c.1474A>G	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"cetuximab","Status":"case report","Evidence":"emerging","PMID":"22270724"},{"Association":"response","Therapeutic_context":"panitumumab","Status":"case report","Evidence":"emerging","PMID":"22270724"}]}
3457	c.436	G	-1	22	1	29	8	1	\N	ENST00000256078:c.436G>C	\N	8	6	\N
3458	c.436	T	-1	22	1	30	8	1	\N	ENST00000256078:c.436G>A	\N	8	6	\N
3459	c.351	A	-1	23	1	31	8	1	\N	ENST00000256078:c.351A>T	\N	8	6	\N
3460	c.351	G	-1	23	1	31	8	1	\N	ENST00000256078:c.351A>C	\N	8	6	\N
3461	c.183	A	-1	24	1	1	8	1	\N	ENST00000256078:c.183A>T	\N	8	6	\N
3462	c.183	G	-1	24	1	1	8	1	\N	ENST00000256078:c.183A>C	\N	8	6	\N
3463	c.182	A	-1	25	1	2	8	1	\N	ENST00000256078:c.182A>T	\N	8	6	\N
3464	c.182	C	-1	25	1	27	8	1	\N	ENST00000256078:c.182A>G	\N	8	6	\N
3465	c.181	T	-1	26	1	5	8	1	\N	ENST00000256078:c.181C>A	\N	8	6	\N
3466	c.38	A	-1	27	1	6	8	1	\N	ENST00000256078:c.38G>T	\N	8	6	\N
3467	c.38	G	-1	27	1	7	8	1	\N	ENST00000256078:c.38G>C	\N	8	6	\N
3469	c.37	A	-1	28	1	9	8	1	\N	ENST00000256078:c.37G>T	\N	8	6	\N
3470	c.37	G	-1	28	1	10	8	1	\N	ENST00000256078:c.37G>C	\N	8	6	\N
3471	c.37	T	-1	28	1	33	8	1	\N	ENST00000256078:c.37G>A	\N	8	6	\N
3476	c.34	G	-1	30	1	15	8	1	\N	ENST00000256078:c.34G>C	\N	8	6	\N
3477	c.34	T	-1	30	1	16	8	1	\N	ENST00000256078:c.34G>A	\N	8	6	\N
3480	c.35	A	-1	6	1	11	1	1	\N	ENST00000369535:c.35G>T	\N	1	6	\N
3481	c.35	G	-1	6	1	12	1	1	\N	ENST00000369535:c.35G>C	\N	1	6	\N
3482	c.35	T	-1	6	1	13	1	1	\N	ENST00000369535:c.35G>A	\N	1	6	\N
3483	c.34	A	-1	7	1	14	1	1	\N	ENST00000369535:c.34G>T	\N	1	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
3484	c.34	T	-1	7	1	16	1	1	\N	ENST00000369535:c.34G>A	\N	1	6	\N
3487	c.1633	C	1	109	1	138	25	1	\N	ENST00000263967:c.1633G>C	\N	25	6	\N
3488	c.1634	C	1	110	1	139	25	1	\N	ENST00000263967:c.1634A>C	\N	25	6	\N
3489	c.1634	G	1	110	1	140	25	1	\N	ENST00000263967:c.1634A>G	\N	25	6	\N
3490	c.1634	T	1	110	1	141	25	1	\N	ENST00000263967:c.1634A>T	\N	25	6	\N
3491	c.1636	A	1	111	1	142	25	1	\N	ENST00000263967:c.1636C>A	\N	25	6	\N
3492	c.1636	G	1	111	1	143	25	1	\N	ENST00000263967:c.1636C>G	\N	25	6	\N
3493	c.1637	C	1	112	1	144	25	1	\N	ENST00000263967:c.1637A>C	\N	25	6	\N
3494	c.1637	G	1	112	1	145	25	1	\N	ENST00000263967:c.1637A>G	\N	25	6	\N
3495	c.1645	A	1	113	1	147	25	1	\N	ENST00000263967:c.1645G>A	\N	25	6	\N
3498	c.477	T	1	13	1	23	5	1	\N	ENST00000371953:c.477G>T	\N	5	6	\N
3499	c.697	T	1	14	1	24	5	2	\N	ENST00000371953:c.697C>T	\N	5	6	\N
3500	c.800	-	1	15	2	25	5	3	\N	ENST00000371953:c.800delA	\N	5	6	\N
3501	c.989	C	1	71	1	80	16	1	\N	ENST00000342988:c.989A>C	\N	16	6	\N
3502	c.1051	A	1	72	1	81	16	1	\N	ENST00000342988:c.1051G>A	\N	16	6	\N
3503	c.1051	C	1	72	1	82	16	1	\N	ENST00000342988:c.1051G>C	\N	16	6	\N
3504	c.1065	A	1	73	1	83	16	1	\N	ENST00000342988:c.1065C>A	\N	16	6	\N
3505	c.1081	A	1	74	1	84	16	1	\N	ENST00000342988:c.1081C>A	\N	16	6	\N
3506	c.1081	T	1	74	1	85	16	1	\N	ENST00000342988:c.1081C>T	\N	16	6	\N
3507	c.1082	A	1	75	1	86	16	1	\N	ENST00000342988:c.1082G>A	\N	16	6	\N
3508	c.1609	T	1	76	1	87	16	1	\N	ENST00000342988:c.1609G>T	\N	16	6	\N
3509	c.1675	A	1	220	1	281	28	1	\N	ENST00000288135:c.1675G>A	\N	28	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
3510	c.1676	A	1	131	1	172	28	1	\N	ENST00000288135:c.1676T>A	\N	28	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
3512	c.2009	T	1	221	1	282	28	1	\N	ENST00000288135:c.2009C>T	\N	28	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
3513	c.2446	C	1	149	1	199	28	1	\N	ENST00000288135:c.2446G>C	\N	28	6	\N
3514	c.2446	T	1	149	1	200	28	1	\N	ENST00000288135:c.2446G>T	\N	28	6	\N
3516	c.2465	T	1	156	1	208	28	1	\N	ENST00000288135:c.2465A>T	\N	28	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
3517	c.2467	G	1	158	1	210	28	1	\N	ENST00000288135:c.2467T>G	\N	28	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
3585	c.2099	C	-1	79	1	92	18	1	\N	ENST00000335508:c.2099A>G	\N	18	6	\N
3518	c.2485	C	1	159	1	211	28	1	\N	ENST00000288135:c.2485G>C	\N	28	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"23582185, 21689725, 17259998"}]}
3519	c.1682	A	1	118	1	155	27	1	\N	ENST00000257290:c.1682T>A	\N	27	6	\N
3520	c.1977	A	1	119	1	156	27	1	\N	ENST00000257290:c.1977C>A	\N	27	6	\N
3521	c.1977	G	1	119	1	156	27	1	\N	ENST00000257290:c.1977C>G	\N	27	6	\N
3523	c.1853	A	-1	9	1	18	3	1	\N	ENST00000373103:c.1853C>T	\N	3	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"ruxolitinib","Status":"case report","Evidence":"emerging","PMID":"23656643"}]}
3524	c.2645	A	-1	86	1	107	20	1	\N	ENST00000264709:c.2645G>T	\N	20	6	\N
3525	c.2645	G	-1	86	1	108	20	1	\N	ENST00000264709:c.2645G>C	\N	20	6	\N
3526	c.2645	T	-1	86	1	109	20	1	\N	ENST00000264709:c.2645G>A	\N	20	6	\N
3527	c.2644	A	-1	87	1	110	20	1	\N	ENST00000264709:c.2644C>T	\N	20	6	\N
3528	c.2644	C	-1	87	1	111	20	1	\N	ENST00000264709:c.2644C>G	\N	20	6	\N
3529	c.2644	T	-1	87	1	112	20	1	\N	ENST00000264709:c.2644C>A	\N	20	6	\N
3530	c.2525	C	-1	222	1	283	9	1	\N	ENST00000380982:c.2525A>G	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
3531	c.2524	G	-1	223	1	284	9	1	\N	ENST00000380982:c.2524T>C	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
3532	c.2516	C	-1	31	1	34	9	1	\N	ENST00000380982:c.2516A>G	\N	9	6	\N
3533	c.2508	C	-1	32	1	35	9	1	\N	ENST00000380982:c.2508C>G	\N	9	6	\N
3534	c.2506	G	-1	33	1	36	9	1	\N	ENST00000380982:c.2506A>C	\N	9	6	\N
3548	c.2026	C	-1	228	1	289	9	1	\N	ENST00000380982:c.2026A>G	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
3535	c.2505	C	-1	34	1	37	9	1	\N	ENST00000380982:c.2505T>G	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
3536	c.2505	T	-1	34	1	37	9	1	\N	ENST00000380982:c.2505T>A	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
3537	c.2504	A	-1	35	1	38	9	1	\N	ENST00000380982:c.2504A>T	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"}]}
3538	c.2504	G	-1	35	1	39	9	1	\N	ENST00000380982:c.2504A>C	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
3539	c.2504_2503	AA	-1	224	4	285	9	1	\N	ENST00000380982:c.2504_2503GA>TT	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"}]}
3540	c.2503	A	-1	36	1	40	9	1	\N	ENST00000380982:c.2503G>T	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"}]}
3541	c.2503	G	-1	36	1	41	9	1	\N	ENST00000380982:c.2503G>C	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
3542	c.2503	T	-1	36	1	42	9	1	\N	ENST00000380982:c.2503G>A	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"resistance","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"22368270"},{"Association":"response","Therapeutic_context":"midostaurin","Status":"case report","Evidence":"emerging","PMID":"20733134"},{"Association":"response","Therapeutic_context":"lestaurtinib","Status":"case report","Evidence":"emerging","PMID":"16857985.0"}]}
3543	c.2073	C	-1	225	1	286	9	1	\N	ENST00000380982:c.2073T>G	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"}]}
3544	c.2073	T	-1	225	1	286	9	1	\N	ENST00000380982:c.2073T>A	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"}]}
3545	c.2059	A	-1	226	1	287	9	1	\N	ENST00000380982:c.2059A>T	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
3546	c.2028	C	-1	227	1	288	9	1	\N	ENST00000380982:c.2028C>G	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"23878140"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
3547	c.2028	T	-1	227	1	288	9	1	\N	ENST00000380982:c.2028C>A	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"23878140"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
3567	c.2466	A	1	157	1	209	28	1	\N	ENST00000288135:c.2466T>A	\N	28	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"23149070"}]}
3586	c.2099	G	-1	79	1	93	18	1	\N	ENST00000335508:c.2099A>C	\N	18	6	\N
3549	c.1952	C	-1	229	1	290	9	1	\N	ENST00000380982:c.1952A>G	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
3550	c.1855	A	-1	230	1	291	9	1	\N	ENST00000380982:c.1855G>T	\N	9	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"},{"Association":"resistance","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23430109"},{"Association":"sensitivity","Therapeutic_context":"crenolanib, PKC412","Status":"preclinical","Evidence":"emerging","PMID":"24619500"}]}
3551	c.1192	A	-1	106	1	134	24	1	\N	ENST00000341105:c.1192C>T	\N	24	6	\N
3552	c.1061	A	-1	107	1	135	24	1	\N	ENST00000341105:c.1061C>T	\N	24	6	\N
3553	c.395	A	-1	84	1	101	19	1	\N	ENST00000345146:c.395G>T	\N	19	6	\N
3554	c.395	G	-1	84	1	102	19	1	\N	ENST00000345146:c.395G>C	\N	19	6	\N
3555	c.395	T	-1	84	1	103	19	1	\N	ENST00000345146:c.395G>A	\N	19	6	{"Description":"missense mutation","Effect":"switch-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"IDH inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23558169"}]}
3556	c.394	A	-1	85	1	104	19	1	\N	ENST00000345146:c.394C>T	\N	19	6	\N
3557	c.394	C	-1	85	1	105	19	1	\N	ENST00000345146:c.394C>G	\N	19	6	\N
3558	c.394	T	-1	85	1	106	19	1	\N	ENST00000345146:c.394C>A	\N	19	6	\N
3559	c.516	G	-1	52	1	58	13	1	\N	ENST00000330062:c.516G>C	\N	13	6	\N
3560	c.515	A	-1	53	1	59	13	1	\N	ENST00000330062:c.515G>T	\N	13	6	\N
3562	c.419	A	-1	54	1	61	13	1	\N	ENST00000330062:c.419G>T	\N	13	6	\N
3563	c.419	T	-1	54	1	62	13	1	\N	ENST00000330062:c.419G>A	\N	13	6	{"Description":"missense mutation","Effect":"switch-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"IDH inhibitor","Status":"early trials","Evidence":"emerging","PMID":"AACR 2014; abstr CT103"}]}
3564	c.418	A	-1	55	1	63	13	1	\N	ENST00000330062:c.418C>T	\N	13	6	\N
3566	c.2446_2447	AT	1	150	4	201	28	1	\N	ENST00000288135:c.2446_2447GA>AT	\N	28	6	\N
3568	c.2466	G	1	157	1	209	28	1	\N	ENST00000288135:c.2466T>G	\N	28	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"23149070"}]}
3569	c.862_863	CATG	1	162	3	214	29	4	\N	ENST00000296930:c.862_863insCATG	\N	29	6	\N
3570	c.862_863	CCTG	1	162	3	214	29	4	\N	ENST00000296930:c.862_863insCCTG	\N	29	6	\N
3571	c.862_863	TCAG	1	162	3	214	29	4	\N	ENST00000296930:c.862_863insTCAG	\N	29	6	\N
3572	c.862_863	TCTG	1	162	3	214	29	4	\N	ENST00000296930:c.862_863insTCTG	\N	29	6	\N
3573	c.183	A	-1	1	1	1	1	1	\N	ENST00000369535:c.183A>T	\N	1	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
3574	c.183	G	-1	1	1	1	1	1	\N	ENST00000369535:c.183A>C	\N	1	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
3575	c.38	A	-1	4	1	6	1	1	\N	ENST00000369535:c.38G>T	\N	1	6	\N
3577	c.601	A	-1	100	1	126	22	2	\N	ENST00000300305:c.601C>T	\N	22	6	\N
3578	c.486	A	-1	101	1	127	22	1	\N	ENST00000300305:c.486G>T	\N	22	6	\N
3579	c.486	G	-1	101	1	127	22	1	\N	ENST00000300305:c.486G>C	\N	22	6	\N
3580	c.485	T	-1	102	1	128	22	1	\N	ENST00000300305:c.485G>A	\N	22	6	\N
3581	c.484	C	-1	103	1	129	22	1	\N	ENST00000300305:c.484A>G	\N	22	6	\N
3582	c.2100	A	-1	78	1	90	18	1	\N	ENST00000335508:c.2100A>T	\N	18	6	\N
3583	c.2100	G	-1	78	1	90	18	1	\N	ENST00000335508:c.2100A>C	\N	18	6	\N
3584	c.2099	A	-1	79	1	91	18	1	\N	ENST00000335508:c.2099A>T	\N	18	6	\N
3587	c.2098	A	-1	80	1	94	18	2	\N	ENST00000335508:c.2098A>T	\N	18	6	\N
3588	c.2098	C	-1	80	1	95	18	1	\N	ENST00000335508:c.2098A>G	\N	18	6	\N
3589	c.2098	G	-1	80	1	96	18	1	\N	ENST00000335508:c.2098A>C	\N	18	6	\N
3591	c.1998	G	-1	81	1	97	18	1	\N	ENST00000335508:c.1998G>C	\N	18	6	\N
3592	c.1997	C	-1	82	1	98	18	1	\N	ENST00000335508:c.1997A>G	\N	18	6	\N
3593	c.1997	G	-1	82	1	99	18	1	\N	ENST00000335508:c.1997A>C	\N	18	6	\N
3594	c.1996	C	-1	83	1	100	18	1	\N	ENST00000335508:c.1996A>G	\N	18	6	\N
3598	c.745	A	-1	67	1	75	15	1	\N	ENST00000269305:c.745A>T	\N	15	6	\N
3600	c.659	C	-1	69	1	77	15	1	\N	ENST00000269305:c.659A>G	\N	15	6	\N
3601	c.518	C	-1	70	1	78	15	1	\N	ENST00000269305:c.518T>G	\N	15	6	\N
3602	c.518	G	-1	70	1	79	15	1	\N	ENST00000269305:c.518T>C	\N	15	6	\N
3603	c.470	C	-1	104	1	130	23	1	\N	ENST00000291552:c.470A>G	\N	23	6	\N
3606	c.101	T	-1	105	1	133	23	1	\N	ENST00000291552:c.101C>A	\N	23	6	\N
3607	c.1143_1142	ACCGTACA	-1	16	3	26	6	4	\N	ENST00000332351:c.1143_1142insTGTACGGT	\N	6	6	\N
3608	c.1970	T	-1	231	1	292	65	1	\N	ENST00000458235:c.1970G>A	\N	42	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"18397343"}]}
3609	c.1503	A	-1	232	1	293	65	1	\N	ENST00000458235:c.1503G>T	\N	42	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"18397343"}]}
3610	c.1503	G	-1	232	1	293	65	1	\N	ENST00000458235:c.1503G>C	\N	42	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"18397343"}]}
3611	c.260	G	-1	233	1	294	65	1	\N	ENST00000458235:c.260T>C	\N	42	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"18397343"}]}
3612	c.787	G	1	234	1	295	110	1	\N	ENST00000372348:c.787A>G	\N	38	6	\N
3613	c.799	G	1	235	1	296	110	1	\N	ENST00000372348:c.799C>G	\N	38	6	\N
3614	c.806	A	1	236	1	297	110	1	\N	ENST00000372348:c.806G>A	\N	38	6	\N
3615	c.813	C	1	237	1	298	110	1	\N	ENST00000372348:c.813G>C	\N	38	6	\N
3616	c.813	T	1	237	1	298	110	1	\N	ENST00000372348:c.813G>T	\N	38	6	\N
3617	c.815	T	1	238	1	299	110	1	\N	ENST00000372348:c.815A>T	\N	38	6	\N
3618	c.820	A	1	239	1	300	110	1	\N	ENST00000372348:c.820G>A	\N	38	6	\N
3619	c.821	T	1	240	1	301	110	1	\N	ENST00000372348:c.821A>T	\N	38	6	\N
3620	c.904	G	1	241	1	302	110	1	\N	ENST00000372348:c.904T>G	\N	38	6	\N
3621	c.1008	A	1	242	1	303	110	1	\N	ENST00000372348:c.1008C>A	\N	38	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
3622	c.1008	G	1	242	1	303	110	1	\N	ENST00000372348:c.1008C>G	\N	38	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
3623	c.1109	C	1	243	1	304	110	1	\N	ENST00000372348:c.1109T>C	\N	38	6	\N
3624	c.1121	G	1	244	1	305	110	1	\N	ENST00000372348:c.1121A>G	\N	38	6	\N
3625	c.1132	G	1	245	1	306	110	1	\N	ENST00000372348:c.1132T>G	\N	38	6	\N
3626	c.1244	G	1	246	1	307	110	1	\N	ENST00000372348:c.1244A>G	\N	38	6	\N
3627	c.763	A	1	247	1	308	110	1	\N	ENST00000372348:c.763G>A	\N	38	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
3628	c.952	C	1	248	1	309	110	1	\N	ENST00000372348:c.952G>C	\N	38	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
3629	c.1000	G	1	249	1	310	110	1	\N	ENST00000372348:c.1000A>G	\N	38	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
3630	c.1006	A	1	250	1	311	110	1	\N	ENST00000372348:c.1006T>A	\N	38	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
3631	c.1006	G	1	250	1	312	110	1	\N	ENST00000372348:c.1006T>G	\N	38	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
3632	c.1007	G	1	251	1	313	110	1	\N	ENST00000372348:c.1007T>G	\N	38	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"nilotinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
3782	c.1679	G	1	133	1	178	28	1	\N	ENST00000288135:c.1679T>G	\N	28	6	\N
3633	c.1132	A	1	245	1	314	110	1	\N	ENST00000372348:c.1132T>A	\N	38	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
3634	c.1132	C	1	245	1	315	110	1	\N	ENST00000372348:c.1132T>C	\N	38	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
3635	c.1133	G	1	252	1	316	110	1	\N	ENST00000372348:c.1133T>G	\N	38	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib, bosutinib, ponatinib","Status":"NCCN guidelines","Evidence":"consensus","PMID":"21562040"}]}
3636	c.1843	C	-1	253	1	317	3	1	\N	ENST00000373103:c.1843A>G	\N	3	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ruxolitinib","Status":"preclinical","Evidence":"emerging","PMID":"23656643"}]}
3637	c.3833	G	-1	88	1	113	21	1	\N	ENST00000389048:c.3833A>C	\N	21	6	\N
3639	c.3735	C	-1	90	1	115	21	1	\N	ENST00000389048:c.3735C>G	\N	21	6	\N
3640	c.3734	C	-1	91	1	116	21	1	\N	ENST00000389048:c.3734T>G	\N	21	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"22072639"}]}
3641	c.3733	C	-1	92	1	117	21	1	\N	ENST00000389048:c.3733T>G	\N	21	6	\N
3643	c.3521	C	-1	95	1	120	21	1	\N	ENST00000389048:c.3521T>G	\N	21	6	\N
3644	c.3520	C	-1	96	1	121	21	1	\N	ENST00000389048:c.3520T>G	\N	21	6	\N
3645	c.3520	T	-1	96	1	122	21	1	\N	ENST00000389048:c.3520T>A	\N	21	6	\N
3646	c.3512	T	-1	97	1	123	21	1	\N	ENST00000389048:c.3512T>A	\N	21	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"22072639"}]}
3647	c.3452	A	-1	98	1	124	21	1	\N	ENST00000389048:c.3452C>T	\N	21	6	\N
3648	c.3271	T	-1	99	1	125	21	1	\N	ENST00000389048:c.3271G>A	\N	21	6	\N
3649	c.1514	A	1	254	1	318	67	1	\N	ENST00000372470:c.1514G>A	\N	43	6	\N
3650	c.3335	G	1	255	1	319	68	1	\N	ENST00000318493:c.3335A>G	\N	44	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MET inhibitors","Status":"early trials","Evidence":"emerging","PMID":"23213094"}]}
3651	c.3803	C	1	256	1	320	68	1	\N	ENST00000318493:c.3803T>C	\N	44	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MET inhibitors","Status":"case report","Evidence":"emerging","PMID":"23610116"}]}
3652	c.7514	G	-1	257	1	321	118	1	\N	ENST00000361445:c.7514G>C	\N	45	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"rapamycin","Status":"preclinical","Evidence":"emerging","PMID":"24631838"}]}
3653	c.6667	T	-1	258	1	322	118	1	\N	ENST00000361445:c.6667C>A	\N	45	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"everolimus","Status":"case report","Evidence":"emerging","PMID":"24622468"}]}
3654	c.6644	T	-1	259	1	323	118	1	\N	ENST00000361445:c.6644C>A	\N	45	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"rapamycin","Status":"preclinical","Evidence":"emerging","PMID":"24631838"}]}
3655	c.4379	G	-1	260	1	324	118	1	\N	ENST00000361445:c.4379T>C	\N	45	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"rapamycin","Status":"preclinical","Evidence":"emerging","PMID":"24631838"}]}
3656	c.7255	T	-1	261	1	325	118	1	\N	ENST00000361445:c.7255G>A	\N	45	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"everolimus","Status":"case report","Evidence":"emerging","PMID":"24625776"}]}
3657	c.6040	T	-1	262	1	326	118	1	\N	ENST00000361445:c.6040G>A	\N	45	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"everolimus","Status":"case report","Evidence":"emerging","PMID":"24625776"}]}
3662	c.3522	C	-1	94	1	119	21	1	\N	ENST00000389048:c.3522C>G	\N	21	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"},{"Association":"response","Therapeutic_context":"novel ALK inhibiors","Status":"preclinical","Evidence":"emerging","PMID":"24327273"}]}
3665	c.926	A	1	56	1	333	14	1	\N	ENST00000269571:c.926G>A	\N	14	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ERBB2 TKIs, trastuzumab","Status":"preclinical","Evidence":"emerging","PMID":"22908275"}]}
3667	c.1112	T	-1	270	1	335	73	1	\N	ENST00000392038:c.1112G>A	\N	48	6	\N
3682	c.716	G	1	272	1	337	2	1	\N	ENST00000367921:c.716T>G	\N	2	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
3783	c.1696	G	1	135	1	180	28	1	\N	ENST00000288135:c.1696A>G	\N	28	6	\N
3669	c.2155	T	1	193	1	254	33	1	\N	ENST00000275493:c.2155G>T	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
3670	c.2156	C	1	194	1	255	33	1	\N	ENST00000275493:c.2156G>C	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
3672	c.2573	G	1	196	1	257	33	1	\N	ENST00000275493:c.2573T>G	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
3683	c.757	T	1	273	1	338	2	1	\N	ENST00000367921:c.757G>T	\N	2	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
3673	c.2582	A	1	197	1	258	33	1	\N	ENST00000275493:c.2582T>A	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
3675	c.171	T	1	43	1	49	12	1	\N	ENST00000307102:c.171G>T	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"23444215"}]}
3676	c.199	A	1	44	1	50	12	1	\N	ENST00000307102:c.199G>A	\N	12	6	\N
3678	c.182	G	-1	2	1	32	1	1	\N	ENST00000369535:c.182A>C	\N	1	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
3679	c.181	A	-1	3	1	3	1	2	\N	ENST00000369535:c.181C>T	\N	1	6	\N
3680	c.34	G	-1	7	1	15	1	1	\N	ENST00000369535:c.34G>C	\N	1	6	\N
3681	c.187	G	1	271	1	336	2	1	\N	ENST00000367921:c.187C>G	\N	2	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
3684	c.1513	A	1	274	1	339	2	1	\N	ENST00000367921:c.1513G>A	\N	2	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
3685	c.1912	T	1	275	1	340	2	1	\N	ENST00000367921:c.1912A>T	\N	2	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
3686	c.2321	T	1	276	1	341	2	1	\N	ENST00000367921:c.2321G>T	\N	2	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
3687	c.2156	A	1	194	1	342	33	1	\N	ENST00000275493:c.2156G>A	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
3688	c.2240	C	1	277	1	343	33	1	\N	ENST00000275493:c.2240T>C	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
3689	c.2303	T	1	278	1	344	33	1	\N	ENST00000275493:c.2303G>T	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
3732	c.1396	T	-1	300	1	368	32	1	\N	ENST00000288602:c.1396G>A	\N	32	6	\N
3690	c.2582	C	1	197	1	345	33	1	\N	ENST00000275493:c.2582T>C	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
3691	c.2582	G	1	197	1	346	33	1	\N	ENST00000275493:c.2582T>G	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}]}
3692	c.1171	G	-1	279	1	347	76	1	\N	ENST00000358432:c.1171G>C	\N	49	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"mTOR inhibitors, dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"20360610"}]}
3693	c.1171	T	-1	279	1	347	76	1	\N	ENST00000358432:c.1171G>A	\N	49	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"mTOR inhibitors, dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"20360610"}]}
3694	c.959	C	-1	280	1	348	77	1	\N	ENST00000457416:c.959C>G	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23786770"}]}
3695	c.870	G	-1	281	1	349	77	1	\N	ENST00000457416:c.870G>C	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23786770"}]}
3696	c.2459	T	1	153	1	205	28	1	\N	ENST00000288135:c.2459A>T	\N	28	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib","Status":"early trials","Evidence":"emerging","PMID":"18559612"}]}
3697	c.1468	A	1	121	1	158	28	1	\N	ENST00000288135:c.1468G>A	\N	28	6	\N
3780	c.1679	A	1	133	1	176	28	1	\N	ENST00000288135:c.1679T>A	\N	28	6	\N
3698	c.1657	A	1	124	1	161	28	1	\N	ENST00000288135:c.1657T>A	\N	28	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"imatinib","Status":"case report","Evidence":"emerging","PMID":"21969494"},{"Association":"response","Therapeutic_context":"sunitinib","Status":"case report","Evidence":"emerging","PMID":"23375402"}]}
3699	c.1669	C	1	128	1	169	28	1	\N	ENST00000288135:c.1669T>C	\N	28	6	\N
3700	c.1676	C	1	131	1	173	28	1	\N	ENST00000288135:c.1676T>C	\N	28	6	\N
3701	c.1678	-	1	132	2	175	28	5	\N	ENST00000288135:c.1678delGTT	\N	28	6	{"Description":"deletion mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"imatinib","Status":"case report","Evidence":"emerging","PMID":"15201427"}]}
3703	c.1730	-	1	141	2	190	28	5	\N	ENST00000288135:c.1730delCTTATGATC	\N	28	6	\N
3704	c.2089	T	1	148	1	198	28	1	\N	ENST00000288135:c.2089C>T	\N	28	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"sunitinib","Status":"preclinical","Evidence":"emerging","PMID":"19861435"}]}
3705	c.2460	A	1	154	1	206	28	1	\N	ENST00000288135:c.2460T>A	\N	28	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"19461405"}]}
3706	c.3673	T	-1	93	1	118	21	1	\N	ENST00000389048:c.3673G>A	\N	21	6	\N
3707	c.1605	A	1	282	1	350	78	1	\N	ENST00000292408:c.1605C>A	\N	51	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24124571"}]}
3708	c.1605	G	1	282	1	350	78	1	\N	ENST00000292408:c.1605C>G	\N	51	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24124571"}]}
3709	c.1649	A	1	283	1	351	78	1	\N	ENST00000292408:c.1649T>A	\N	51	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24124571"}]}
3710	c.2068	A	1	284	1	352	33	1	\N	ENST00000275493:c.2068G>A	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"lapatinib","Status":"case report","Evidence":"emerging","PMID":"22885469"}]}
3711	c.1978	C	-1	285	1	353	77	1	\N	ENST00000457416:c.1978A>G	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
3712	c.1852	T	-1	286	1	354	77	1	\N	ENST00000457416:c.1852T>A	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
3713	c.1697	C	-1	287	1	355	77	1	\N	ENST00000457416:c.1697A>G	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
3714	c.1693	T	-1	288	1	356	77	1	\N	ENST00000457416:c.1693G>A	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
3715	c.1650	C	-1	289	1	357	77	1	\N	ENST00000457416:c.1650T>G	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
3716	c.1650	T	-1	289	1	357	77	1	\N	ENST00000457416:c.1650T>A	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
3717	c.1648	G	-1	290	1	358	77	1	\N	ENST00000457416:c.1648A>C	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
3718	c.1642	C	-1	291	1	359	77	1	\N	ENST00000457416:c.1642A>G	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
3719	c.1614	A	-1	292	1	360	77	1	\N	ENST00000457416:c.1614G>T	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
3720	c.1614	G	-1	292	1	360	77	1	\N	ENST00000457416:c.1614G>C	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
3781	c.1679	C	1	133	1	177	28	1	\N	ENST00000288135:c.1679T>C	\N	28	6	\N
3721	c.1614	T	-1	292	1	360	77	1	\N	ENST00000457416:c.1614G>A	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
3722	c.1608	A	-1	293	1	361	77	1	\N	ENST00000457416:c.1608G>T	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
3723	c.1608	G	-1	293	1	361	77	1	\N	ENST00000457416:c.1608G>C	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
3724	c.1608	T	-1	293	1	361	77	1	\N	ENST00000457416:c.1608G>A	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"dovitinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"},{"Association":"sensitivity","Therapeutic_context":"ponatinib","Status":"preclinical","Evidence":"emerging","PMID":"23908597"}]}
3725	c.755	C	-1	294	1	362	77	1	\N	ENST00000457416:c.755C>G	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"sensitivity","list":[{"Association":"FGFR inhibitors","Therapeutic_context":"preclinical","Status":"emerging","Evidence":"18552176, 22238366, 23002168","PMID":"nan"}]}
3726	c.1681	G	1	295	1	363	79	1	\N	ENST00000222254:c.1681A>G	\N	52	6	{"Description":"missense mutation","Effect":"loss-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"mTOR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21984976"}]}
3727	c.1111	C	1	296	1	364	80	1	\N	ENST00000264033:c.1111T>C	\N	53	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors, dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"23696637"}]}
3728	c.1150	C	1	297	1	365	80	1	\N	ENST00000264033:c.1150T>C	\N	53	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors, dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"23696637"}]}
3729	c.1711	C	-1	298	1	366	81	1	\N	ENST00000286301:c.1711T>G	\N	54	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"18971950"}]}
3730	c.1544	T	1	299	1	367	67	1	\N	ENST00000372470:c.1544G>T	\N	43	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"16834459"}]}
3734	c.388	G	1	11	1	20	5	1	\N	ENST00000371953:c.388C>G	\N	5	6	\N
3735	c.388	T	1	11	1	21	5	2	\N	ENST00000371953:c.388C>T	\N	5	6	\N
3736	c.389	A	1	12	1	22	5	1	\N	ENST00000371953:c.389G>A	\N	5	6	\N
3737	c.1513	T	1	301	1	369	67	1	\N	ENST00000372470:c.1513A>T	\N	43	6	\N
3738	c.850	A	1	302	1	370	83	1	\N	ENST00000267101:c.850G>A	\N	55	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23680147"}]}
3739	c.235	T	-1	303	1	371	10	1	\N	ENST00000349310:c.235C>A	\N	10	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265152"}]}
3740	c.1802	C	-1	304	1	372	32	1	\N	ENST00000288602:c.1802A>G	\N	32	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"23248257"}]}
3741	c.1801	C	-1	180	1	233	32	1	\N	ENST00000288602:c.1801A>G	\N	32	6	\N
3742	c.1800_1799	AT	-1	181	4	234	32	1	\N	ENST00000288602:c.1800_1799TG>AT	\N	32	6	\N
3743	c.1799	C	-1	182	1	235	32	1	\N	ENST00000288602:c.1799T>G	\N	32	6	\N
3744	c.1799_1798	CT	-1	183	4	237	32	1	\N	ENST00000288602:c.1799_1798GT>AG	\N	32	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"BRAF inhibitors","Status":"early trials","Evidence":"emerging","PMID":"23237741"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"23248257"}]}
3745	c.1799_1798	TT	-1	183	4	238	32	1	\N	ENST00000288602:c.1799_1798GT>AA	\N	32	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"trametinib, dabrafenib + trametinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"vemurafenib","Status":"late trials","Evidence":"emerging","PMID":"22356324"}]}
3746	c.1798	A	-1	305	1	373	32	1	\N	ENST00000288602:c.1798G>T	\N	32	6	\N
3747	c.1798	T	-1	305	1	374	32	1	\N	ENST00000288602:c.1798G>A	\N	32	6	\N
3748	c.1790	T	-1	184	1	375	32	1	\N	ENST00000288602:c.1790T>A	\N	32	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"trametinib, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"22805292, 22798288"},{"Association":"response","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23715574"}]}
3749	c.1790_1789	GA	-1	306	4	376	32	1	\N	ENST00000288602:c.1790_1789CT>TC	\N	32	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"trametinib, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"22805292, 22798288"},{"Association":"response","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23715574"}]}
3750	c.1789	C	-1	307	1	377	32	1	\N	ENST00000288602:c.1789C>G	\N	32	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"trametinib, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"22805292, 22798288"},{"Association":"response","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23715574"}]}
3751	c.1782	C	-1	185	1	240	32	1	\N	ENST00000288602:c.1782T>G	\N	32	6	\N
3752	c.1782	T	-1	185	1	240	32	1	\N	ENST00000288602:c.1782T>A	\N	32	6	\N
3753	c.1781	G	-1	186	1	243	32	1	\N	ENST00000288602:c.1781A>C	\N	32	6	\N
3754	c.1780	G	-1	187	1	245	32	1	\N	ENST00000288602:c.1780G>C	\N	32	6	\N
3755	c.1780	T	-1	187	1	246	32	1	\N	ENST00000288602:c.1780G>A	\N	32	6	\N
3756	c.1780_1779	TC	-1	188	4	246	32	1	\N	ENST00000288602:c.1780_1779TG>GA	\N	32	6	\N
3757	c.110	A	1	115	1	150	26	1	\N	ENST00000349496:c.110C>A	\N	26	6	\N
3758	c.110	T	1	115	1	151	26	1	\N	ENST00000349496:c.110C>T	\N	26	6	\N
3759	c.133	C	1	116	1	152	26	1	\N	ENST00000349496:c.133T>C	\N	26	6	\N
3760	c.134	A	1	117	1	153	26	1	\N	ENST00000349496:c.134C>A	\N	26	6	\N
3761	c.134	T	1	117	1	154	26	1	\N	ENST00000349496:c.134C>T	\N	26	6	\N
3762	c.2614	T	-1	308	1	378	85	1	\N	ENST00000342788:c.2614G>A	\N	56	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
3763	c.1630	A	-1	309	1	379	85	1	\N	ENST00000342788:c.1630C>T	\N	56	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
3764	c.1624	T	-1	310	1	136	85	1	\N	ENST00000342788:c.1624G>A	\N	56	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
3765	c.1354	T	-1	311	1	380	85	1	\N	ENST00000342788:c.1354G>A	\N	56	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
3766	c.1177	A	-1	312	1	381	85	1	\N	ENST00000342788:c.1177C>T	\N	56	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
3767	c.949	T	-1	313	1	382	85	1	\N	ENST00000342788:c.949G>A	\N	56	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib","Status":"preclinical","Evidence":"emerging","PMID":"19718025"}]}
3768	c.626	C	1	77	1	88	17	1	\N	ENST00000078429:c.626A>C	\N	17	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"selumetinib","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)"},{"Association":"response","Therapeutic_context":"PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22733540, 22808163"}]}
3769	c.626	T	1	77	1	89	17	1	\N	ENST00000078429:c.626A>T	\N	17	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"selumetinib","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)"},{"Association":"response","Therapeutic_context":"PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22733540, 22808163"}]}
3770	c.626	A	-1	202	1	89	35	1	\N	ENST00000286548:c.626A>T	\N	36	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"selumetinib","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)"},{"Association":"response","Therapeutic_context":"PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22733540, 22808163"},{"Association":"sensitivity","Therapeutic_context":"PKC inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"22653968, 22253748"}]}
3771	c.626	C	-1	202	1	263	35	1	\N	ENST00000286548:c.626A>G	\N	36	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"selumetinib","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)"},{"Association":"response","Therapeutic_context":"PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22733540, 22808163"},{"Association":"sensitivity","Therapeutic_context":"PKC inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"22653968, 22253748"}]}
3772	c.626	G	-1	202	1	88	35	1	\N	ENST00000286548:c.626A>C	\N	36	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"selumetinib","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr CRA9003)"},{"Association":"response","Therapeutic_context":"PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22733540, 22808163"},{"Association":"sensitivity","Therapeutic_context":"PKC inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"22653968, 22253748"}]}
3773	c.1510	C	1	122	1	159	28	1	\N	ENST00000288135:c.1510T>C	\N	28	6	\N
3774	c.1650	C	1	123	1	160	28	1	\N	ENST00000288135:c.1650A>C	\N	28	6	\N
3775	c.1650	T	1	123	1	160	28	1	\N	ENST00000288135:c.1650A>T	\N	28	6	\N
3776	c.1669	A	1	128	1	169	28	1	\N	ENST00000288135:c.1669T>A	\N	28	6	\N
3777	c.1674	C	1	129	1	170	28	1	\N	ENST00000288135:c.1674G>C	\N	28	6	\N
3778	c.1674	T	1	129	1	170	28	1	\N	ENST00000288135:c.1674G>T	\N	28	6	\N
3779	c.1676	G	1	131	1	174	28	1	\N	ENST00000288135:c.1676T>G	\N	28	6	\N
3784	c.1706	G	1	138	1	183	28	1	\N	ENST00000288135:c.1706T>G	\N	28	6	\N
3785	c.1924	G	1	144	1	193	28	1	\N	ENST00000288135:c.1924A>G	\N	28	6	\N
3786	c.1961	A	1	145	1	194	28	1	\N	ENST00000288135:c.1961T>A	\N	28	6	\N
3787	c.1964	G	1	146	1	196	28	1	\N	ENST00000288135:c.1964A>G	\N	28	6	\N
3788	c.1965	A	1	147	1	197	28	1	\N	ENST00000288135:c.1965T>A	\N	28	6	\N
3789	c.1965	G	1	147	1	197	28	1	\N	ENST00000288135:c.1965T>G	\N	28	6	\N
3790	c.2458	C	1	152	1	203	28	1	\N	ENST00000288135:c.2458G>C	\N	28	6	\N
3791	c.2458	T	1	152	1	204	28	1	\N	ENST00000288135:c.2458G>T	\N	28	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"imatinib","Status":"case report","Evidence":"emerging","PMID":"23775962"}]}
3792	c.157	C	1	41	1	47	12	1	\N	ENST00000307102:c.157T>C	\N	12	6	\N
3793	c.169	G	1	314	1	383	12	1	\N	ENST00000307102:c.169A>G	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"vemurafenib","Status":"case report","Evidence":"emerging","PMID":"23569304"}]}
3794	c.171	C	1	43	1	49	12	1	\N	ENST00000307102:c.171G>C	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"23444215"}]}
3795	c.332	G	1	45	1	51	12	1	\N	ENST00000307102:c.332T>G	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"BRAF inhibitors in BRAF mutant tumor","Status":"case report","Evidence":"emerging","PMID":"22588879"}]}
3796	c.362	C	1	46	1	52	12	1	\N	ENST00000307102:c.362G>C	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"21383288"},{"Association":"sensitivity","Therapeutic_context":"novel MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24448821"}]}
3798	c.371	T	1	48	1	54	12	1	\N	ENST00000307102:c.371C>T	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"19915144"}]}
3799	c.383	A	1	315	1	384	12	1	\N	ENST00000307102:c.383G>A	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
3922	c.1776	C	-1	384	1	459	32	1	\N	ENST00000288602:c.1776A>G	\N	32	6	\N
3800	c.385	C	1	316	1	385	12	1	\N	ENST00000307102:c.385T>C	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
3801	c.607	A	1	49	1	55	12	1	\N	ENST00000307102:c.607G>A	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"vemurafenib","Status":"case report","Evidence":"emerging","PMID":"23569304"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
3802	c.790	T	1	50	1	56	12	1	\N	ENST00000307102:c.790C>T	\N	12	6	\N
3803	c.1144	C	1	51	1	57	12	1	\N	ENST00000307102:c.1144A>C	\N	12	6	\N
3804	c.376	C	-1	317	1	386	88	1	\N	ENST00000262948:c.376A>G	\N	57	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"}]}
3805	c.373	T	-1	318	1	387	88	1	\N	ENST00000262948:c.373T>A	\N	57	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"}]}
3806	c.179	G	-1	319	1	388	88	1	\N	ENST00000262948:c.179A>C	\N	57	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF + MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"24265154"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265154"}]}
3807	c.136	A	-1	320	1	389	88	1	\N	ENST00000262948:c.136C>T	\N	57	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"}]}
3808	c.103	T	-1	321	1	390	88	1	\N	ENST00000262948:c.103G>A	\N	57	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"24265153"}]}
3923	c.1774	C	-1	385	1	460	32	1	\N	ENST00000288602:c.1774A>G	\N	32	6	\N
3809	c.183_182	CA	-1	322	4	2	1	1	\N	ENST00000369535:c.183_182AA>TG	\N	1	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
3810	c.183_182	CC	-1	322	4	27	1	1	\N	ENST00000369535:c.183_182AA>GG	\N	1	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
3811	c.181	C	-1	3	1	4	1	1	\N	ENST00000369535:c.181C>G	\N	1	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
3812	c.38	G	-1	4	1	7	1	1	\N	ENST00000369535:c.38G>C	\N	1	6	\N
3813	c.37	A	-1	5	1	9	1	1	\N	ENST00000369535:c.37G>T	\N	1	6	\N
3814	c.37	G	-1	5	1	10	1	1	\N	ENST00000369535:c.37G>C	\N	1	6	\N
3815	c.1729	T	1	323	1	391	27	1	\N	ENST00000257290:c.1729C>T	\N	27	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"imatinib, crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"}]}
3816	c.1973	C	1	324	1	392	27	1	\N	ENST00000257290:c.1973T>C	\N	27	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"},{"Association":"resistance","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"}]}
3924	c.1783	G	-1	386	1	461	32	1	\N	ENST00000288602:c.1783T>C	\N	32	6	\N
3817	c.2522	A	1	325	1	393	27	1	\N	ENST00000257290:c.2522G>A	\N	27	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"imatinib, crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"}]}
3818	c.2533	T	1	326	1	394	27	1	\N	ENST00000257290:c.2533C>T	\N	27	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"imatinib, crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"}]}
3819	c.2558	A	1	327	1	395	27	1	\N	ENST00000257290:c.2558G>A	\N	27	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"imatinib, crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"24132921"}]}
3820	c.1163	G	-1	328	1	396	89	1	\N	ENST00000442415:c.1163G>C	\N	58	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors in BRAF mutant tumors","Status":"preclinical","Evidence":"emerging","PMID":"23737487"}]}
3821	c.769	G	-1	329	1	397	89	1	\N	ENST00000442415:c.769T>C	\N	58	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"BRAF inhibitors in BRAF mutant tumors","Status":"preclinical","Evidence":"emerging","PMID":"23737487"}]}
3822	c.582	A	1	330	1	398	90	1	\N	ENST00000326873:c.582C>A	\N	59	6	{"Description":"missense mutation","Effect":"loss-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"everolimus","Status":"case report","Evidence":"emerging","PMID":"21189378"}]}
3823	c.582	G	1	330	1	398	90	1	\N	ENST00000326873:c.582C>G	\N	59	6	{"Description":"missense mutation","Effect":"loss-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"everolimus","Status":"case report","Evidence":"emerging","PMID":"21189378"}]}
3824	c.182	C	-1	17	1	27	7	1	\N	ENST00000311189:c.182A>G	\N	7	6	\N
3825	c.37	A	-1	18	1	9	7	1	\N	ENST00000311189:c.37G>T	\N	7	6	\N
3826	c.37	G	-1	18	1	10	7	1	\N	ENST00000311189:c.37G>C	\N	7	6	\N
3827	c.35	A	-1	19	1	11	7	1	\N	ENST00000311189:c.35G>T	\N	7	6	\N
3828	c.34	G	-1	20	1	15	7	1	\N	ENST00000311189:c.34G>C	\N	7	6	\N
3829	c.182	G	-1	25	1	32	8	1	\N	ENST00000256078:c.182A>C	\N	8	6	\N
3841	c.308	A	1	338	1	408	12	1	\N	ENST00000307102:c.308T>A	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
3832	c.2304	A	1	8	1	17	2	1	\N	ENST00000367921:c.2304T>A	\N	2	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib + erlotinib","Status":"case report","Evidence":"emerging","PMID":"22328973"},{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"22328973"}]}
3833	c.929	A	1	332	1	400	14	1	\N	ENST00000269571:c.929C>A	\N	14	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ERBB2 TKIs, trastuzumab","Status":"preclinical","Evidence":"emerging","PMID":"22908275"}]}
3834	c.929	T	1	332	1	401	14	1	\N	ENST00000269571:c.929C>T	\N	14	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"ERBB2 TKIs, trastuzumab","Status":"preclinical","Evidence":"emerging","PMID":"22908275"}]}
3835	c.785	A	1	333	1	402	83	1	\N	ENST00000267101:c.785C>A	\N	55	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23680147"}]}
3836	c.2426	G	1	334	1	403	83	1	\N	ENST00000267101:c.2426A>G	\N	55	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, lapatinib, PI3K pathway inhibitors + MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23680147"}]}
3837	c.604	T	1	335	1	404	93	1	\N	ENST00000354359:c.604C>T	\N	60	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21835143"}]}
3838	c.605	A	1	336	1	405	93	1	\N	ENST00000354359:c.605G>A	\N	60	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21835143"}]}
3839	c.605	T	1	336	1	406	93	1	\N	ENST00000354359:c.605G>T	\N	60	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21835143"}]}
3840	c.296	C	1	337	1	407	12	1	\N	ENST00000307102:c.296T>C	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
3842	c.332	A	1	45	1	409	12	1	\N	ENST00000307102:c.332T>A	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
3843	c.356	C	1	339	1	410	12	1	\N	ENST00000307102:c.356A>C	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
3844	c.360	C	1	340	1	411	12	1	\N	ENST00000307102:c.360G>C	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
3845	c.360	T	1	340	1	411	12	1	\N	ENST00000307102:c.360G>T	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
3846	c.632	A	1	341	1	412	12	1	\N	ENST00000307102:c.632T>A	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}]}
3847	c.644	C	1	342	1	413	12	1	\N	ENST00000307102:c.644T>C	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"},{"Association":"sensitivity","Therapeutic_context":"ERK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}]}
3848	c.2962	T	1	343	1	414	68	1	\N	ENST00000318493:c.2962C>T	\N	44	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
3849	c.3029	T	1	344	1	415	68	1	\N	ENST00000318493:c.3029C>T	\N	44	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
3850	c.3328	A	1	345	1	416	68	1	\N	ENST00000318493:c.3328G>A	\N	44	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
3851	c.3743	G	1	346	1	417	68	1	\N	ENST00000318493:c.3743A>G	\N	44	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"reduced sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
3852	c.3757	G	1	347	1	418	68	1	\N	ENST00000318493:c.3757T>G	\N	44	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"reduced sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
3853	c.3804	A	1	348	1	419	68	1	\N	ENST00000318493:c.3804G>A	\N	44	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
3854	c.3804	C	1	348	1	419	68	1	\N	ENST00000318493:c.3804G>C	\N	44	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
3855	c.3804	T	1	348	1	419	68	1	\N	ENST00000318493:c.3804G>T	\N	44	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"17483355"}]}
3856	c.1391	A	-1	349	1	420	32	1	\N	ENST00000288602:c.1391G>T	\N	32	6	\N
3857	c.1442	G	-1	350	1	421	125	1	\N	ENST00000308731:c.1442G>C	\N	61	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"ibrutinib","Status":"early trials","Evidence":"emerging","PMID":"24869598"}]}
3860	c.2263	-	1	57	2	65	14	5	\N	ENST00000269571:c.2263delTTGAGGGAAAACACA	\N	14	6	\N
3864	c.2332_2333	GGCTCCCCA	1	61	3	69	14	6	\N	ENST00000269571:c.2332_2333insGGCTCCCCA	\N	14	6	\N
3867	c.1138	C	1	352	1	422	30	1	\N	ENST00000206249:c.1138G>C	\N	30	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"anti-estrogens","Status":"early trials","Evidence":"emerging","PMID":"24185512, 24185510, 24398047"}]}
3868	c.2277	-	-1	38	2	44	11	5	\N	ENST00000261609:c.2277delAACGGTCCTGACCTG	\N	11	6	\N
3869	c.2264	G	-1	39	1	45	11	1	\N	ENST00000261609:c.2264T>C	\N	11	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}]}
3870	c.926	C	-1	40	1	46	11	1	\N	ENST00000261609:c.926C>G	\N	11	6	\N
3871	c.1637	T	1	112	1	146	25	1	\N	ENST00000263967:c.1637A>T	\N	25	6	\N
3872	c.1415	C	-1	189	1	247	32	1	\N	ENST00000288602:c.1415A>G	\N	32	6	{"Description":"missense mutation","Effect":"reduced kinase activity","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"dasatinib","Status":"case report","Evidence":"emerging","PMID":"22649091"}]}
3873	c.229_228	AA	-1	191	4	251	32	2	\N	ENST00000496384:c.229_228GG>TT	\N	33	6	\N
3874	c.3575	G	-1	353	1	423	21	1	\N	ENST00000389048:c.3575G>C	\N	21	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"22072639"}]}
3875	c.3383	G	-1	354	1	424	21	1	\N	ENST00000389048:c.3383G>C	\N	21	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"22072639"}]}
3876	c.323	A	1	355	1	425	33	1	\N	ENST00000275493:c.323G>A	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"erlotinib","Status":"preclinical","Evidence":"emerging","PMID":"17177598"}]}
3877	c.787	C	1	356	1	426	33	1	\N	ENST00000275493:c.787A>C	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"erlotinib","Status":"preclinical","Evidence":"emerging","PMID":"17177598"}]}
3878	c.866	T	1	357	1	427	33	1	\N	ENST00000275493:c.866C>T	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"erlotinib","Status":"preclinical","Evidence":"emerging","PMID":"17177598"}]}
3879	c.1793	T	1	358	1	428	33	1	\N	ENST00000275493:c.1793G>T	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"erlotinib","Status":"preclinical","Evidence":"emerging","PMID":"17177598"}]}
3880	c.1636	T	1	359	1	429	33	1	\N	ENST00000275493:c.1636C>T	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"cetuximab","Status":"case report","Evidence":"emerging","PMID":"23578570"}]}
3881	c.2257	T	1	360	1	430	33	1	\N	ENST00000275493:c.2257C>T	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"cetuximab plus sirolimus","Status":"case report","Evidence":"emerging","PMID":"24934779"}]}
3882	c.2527	A	1	361	1	431	33	1	\N	ENST00000275493:c.2527G>A	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"no response","Therapeutic_context":"gefitinib","Status":"case report","Evidence":"emerging","PMID":"21274259"}]}
3883	c.758	C	-1	362	1	432	77	1	\N	ENST00000457416:c.758C>G	\N	50	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"pazopanib","Status":"case report","Evidence":"emerging","PMID":"23786770"}]}
3884	c.1391	T	-1	349	1	433	32	1	\N	ENST00000288602:c.1391G>A	\N	32	6	\N
3885	c.1993	T	1	363	1	434	97	1	\N	ENST00000359376:c.1993C>T	\N	62	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"ibrutinib","Status":"early trials","Evidence":"emerging","PMID":"24869598"}]}
3886	c.2535	C	1	364	1	435	97	1	\N	ENST00000359376:c.2535A>C	\N	62	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"ibrutinib","Status":"early trials","Evidence":"emerging","PMID":"24869598"}]}
3887	c.2535	T	1	364	1	435	97	1	\N	ENST00000359376:c.2535A>T	\N	62	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"ibrutinib","Status":"early trials","Evidence":"emerging","PMID":"24869598"}]}
3889	c.1663	A	1	366	1	437	126	1	\N	ENST00000340107:c.1663G>A	\N	63	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22869148"}]}
3890	c.1387	C	1	163	1	215	30	1	\N	ENST00000206249:c.1387T>C	\N	30	6	\N
3891	c.1601	A	1	164	1	216	30	1	\N	ENST00000206249:c.1601T>A	\N	30	6	\N
3892	c.1604	A	1	165	1	217	30	1	\N	ENST00000206249:c.1604C>A	\N	30	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"anti-estrogens","Status":"early trials","Evidence":"emerging","PMID":"24185512"}]}
3893	c.1607	G	1	166	1	218	30	1	\N	ENST00000206249:c.1607T>G	\N	30	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"anti-estrogens","Status":"early trials","Evidence":"emerging","PMID":"24185512, 24185510"}]}
3921	c.1761	C	-1	383	1	458	32	1	\N	ENST00000288602:c.1761C>G	\N	32	6	\N
3898	c.1936	G	-1	367	1	438	99	1	\N	ENST00000320356:c.1936T>C	\N	64	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"EZH2 inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"23023262"}]}
3899	c.1936	T	-1	367	1	439	99	1	\N	ENST00000320356:c.1936T>A	\N	64	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"EZH2 inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"23023262"}]}
3900	c.1937	A	-1	368	1	440	99	1	\N	ENST00000320356:c.1937A>T	\N	64	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"EZH2 inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"24563539"}]}
3901	c.1937	G	-1	368	1	441	99	1	\N	ENST00000320356:c.1937A>C	\N	64	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"EZH2 inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"23023262"}]}
3902	c.2045	C	-1	369	1	442	99	1	\N	ENST00000320356:c.2045C>G	\N	64	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"EZH2 inhibitor","Status":"preclinical","Evidence":"emerging","PMID":"23023262"}]}
3903	c.818	C	1	370	1	443	100	1	\N	ENST00000417037:c.818T>C	\N	65	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"JAK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"21179087"}]}
3904	c.904	C	-1	371	1	444	73	1	\N	ENST00000392038:c.904A>G	\N	48	6	\N
3905	c.3928_3938	-	1	372	2	445	43	3	\N	ENST00000257430:c.3928_3938delAAGATTGGAAC	\N	41	6	\N
3906	c.3928_3947	-	1	373	2	445	43	3	\N	ENST00000257430:c.3928_3947delAAGATTGGAACTAGGTCAGC	\N	41	6	\N
3907	c.4396_4400	-	1	374	2	446	43	3	\N	ENST00000257430:c.4396_4400delGGACC	\N	41	6	\N
3908	c.4669_4676	-	1	375	2	447	43	3	\N	ENST00000257430:c.4669_4676delATTGATTC	\N	41	6	\N
3909	c.1330	A	-1	376	1	448	32	1	\N	ENST00000288602:c.1330C>T	\N	32	6	\N
3910	c.1390	T	-1	377	1	449	32	1	\N	ENST00000288602:c.1390G>A	\N	32	6	\N
3911	c.1397	G	-1	192	1	450	32	1	\N	ENST00000288602:c.1397G>C	\N	32	6	\N
3912	c.1397	T	-1	192	1	451	32	1	\N	ENST00000288602:c.1397G>A	\N	32	6	\N
3913	c.1405	T	-1	378	1	452	32	1	\N	ENST00000288602:c.1405G>A	\N	32	6	\N
3914	c.1405	G	-1	378	1	452	32	1	\N	ENST00000288602:c.1405G>C	\N	32	6	\N
3915	c.1406_1405	GA	-1	191	4	453	32	1	\N	ENST00000288602:c.1406_1405GG>TC	\N	32	6	\N
3916	c.1411	A	-1	379	1	454	32	1	\N	ENST00000288602:c.1411G>T	\N	32	6	\N
3917	c.1742	C	-1	380	1	455	32	1	\N	ENST00000288602:c.1742A>G	\N	32	6	\N
3918	c.1756	T	-1	381	1	456	32	1	\N	ENST00000288602:c.1756G>A	\N	32	6	\N
3919	c.1760	G	-1	382	1	457	32	1	\N	ENST00000288602:c.1760A>C	\N	32	6	\N
3920	c.1761	T	-1	383	1	458	32	1	\N	ENST00000288602:c.1761C>A	\N	32	6	\N
3925	c.608	T	-1	387	1	462	32	2	\N	ENST00000496384:c.608T>A	\N	33	6	\N
3926	c.1785	C	-1	387	1	461	32	1	\N	ENST00000288602:c.1785T>G	\N	32	6	\N
3927	c.1784	G	-1	388	1	463	32	1	\N	ENST00000288602:c.1784T>C	\N	32	6	\N
3928	c.619	A	-1	389	1	464	32	2	\N	ENST00000496384:c.619C>T	\N	33	6	\N
3929	c.1799	G	-1	182	1	465	32	1	\N	ENST00000288602:c.1799T>C	\N	32	6	\N
3930	c.1800_1799	TT	-1	181	4	236	32	1	\N	ENST00000288602:c.1800_1799TG>AA	\N	32	6	\N
3931	c.1798	G	-1	305	1	373	32	1	\N	ENST00000288602:c.1798G>C	\N	32	6	\N
3932	c.1803_1801	-	-1	390	2	466	32	5	\N	ENST00000288602:c.1803_1801delAAA	\N	32	6	\N
3933	c.1803	A	-1	391	1	467	32	1	\N	ENST00000288602:c.1803A>T	\N	32	6	\N
3934	c.1803	G	-1	391	1	467	32	1	\N	ENST00000288602:c.1803A>C	\N	32	6	\N
3935	c.1814_1813	AA	-1	392	4	468	32	1	\N	ENST00000288602:c.1814_1813AG>TT	\N	32	6	\N
3936	c.1814	T	-1	393	1	469	32	1	\N	ENST00000288602:c.1814G>A	\N	32	6	\N
3937	c.71	T	-1	394	1	470	101	1	\N	ENST00000257904:c.71G>A	\N	67	6	\N
3938	c.172	A	-1	395	1	471	102	2	\N	ENST00000446177:c.172C>T	\N	68	6	\N
3939	c.181	A	-1	396	1	472	102	2	\N	ENST00000446177:c.181G>T	\N	68	6	\N
3940	c.205	A	-1	397	1	473	102	2	\N	ENST00000446177:c.205G>T	\N	68	6	\N
3941	c.238	A	-1	398	1	474	102	2	\N	ENST00000446177:c.238C>T	\N	68	6	\N
3942	c.413	A	-1	399	1	475	102	1	\N	ENST00000361570:c.413C>T	\N	69	6	\N
3943	c.416	A	-1	400	1	476	102	1	\N	ENST00000361570:c.416G>T	\N	69	6	\N
3944	c.262	A	-1	401	1	477	102	2	\N	ENST00000446177:c.262G>T	\N	68	6	\N
3945	c.488	A	-1	402	1	478	102	1	\N	ENST00000361570:c.488G>T	\N	69	6	\N
3946	c.329	T	-1	403	1	479	102	2	\N	ENST00000446177:c.329G>A	\N	68	6	\N
3947	c.330	T	-1	404	1	479	102	2	\N	ENST00000446177:c.330G>A	\N	68	6	\N
3948	c.341	A	-1	405	1	480	102	1	\N	ENST00000446177:c.341C>T	\N	68	6	\N
3949	c.902	G	-1	406	1	481	81	1	\N	ENST00000286301:c.902T>C	\N	54	6	\N
3950	c.902	T	-1	406	1	482	81	2	\N	ENST00000286301:c.902T>A	\N	54	6	\N
3951	c.2906	C	-1	407	1	483	81	1	\N	ENST00000286301:c.2906A>G	\N	54	6	\N
3952	c.2906	A	-1	407	1	484	81	1	\N	ENST00000286301:c.2906A>T	\N	54	6	\N
3953	c.2905	G	-1	408	1	485	81	1	\N	ENST00000286301:c.2905T>C	\N	54	6	\N
3954	c.2907	T	-1	409	1	486	81	2	\N	ENST00000286301:c.2907T>A	\N	54	6	\N
3955	c.2907	C	-1	409	1	486	81	2	\N	ENST00000286301:c.2907T>G	\N	54	6	\N
3956	c.37	A	1	410	1	487	26	1	\N	ENST00000349496:c.37G>A	\N	26	6	\N
3957	c.61	A	1	411	1	488	26	1	\N	ENST00000349496:c.61G>A	\N	26	6	\N
3958	c.65	C	1	412	1	489	26	1	\N	ENST00000349496:c.65T>C	\N	26	6	\N
3959	c.64_114	-	1	413	2	490	26	5	\N	ENST00000349496:c.64_114delGTTAGTCACTGGCAGCAACAGTCTTACCTGGACTCTGGAATCCATTCTGGT	\N	26	6	\N
3960	c.73_96	-	1	414	2	491	26	5	\N	ENST00000349496:c.73_96delTGGCAGCAACAGTCTTACCTGGAC	\N	26	6	\N
3961	c.95	C	1	415	1	492	26	1	\N	ENST00000349496:c.95A>C	\N	26	6	\N
3962	c.95	G	1	415	1	493	26	1	\N	ENST00000349496:c.95A>G	\N	26	6	\N
3963	c.94	C	1	416	1	494	26	1	\N	ENST00000349496:c.94G>C	\N	26	6	\N
3964	c.94	A	1	416	1	495	26	1	\N	ENST00000349496:c.94G>A	\N	26	6	\N
3965	c.95	T	1	415	1	496	26	1	\N	ENST00000349496:c.95A>T	\N	26	6	\N
3966	c.94	T	1	416	1	497	26	1	\N	ENST00000349496:c.94G>T	\N	26	6	\N
3967	c.98	G	1	417	1	498	26	1	\N	ENST00000349496:c.98C>G	\N	26	6	\N
3968	c.98	A	1	417	1	499	26	1	\N	ENST00000349496:c.98C>A	\N	26	6	\N
3969	c.101	A	1	418	1	500	26	1	\N	ENST00000349496:c.101G>A	\N	26	6	\N
3970	c.100	A	1	419	1	501	26	1	\N	ENST00000349496:c.100G>A	\N	26	6	\N
3971	c.100	C	1	419	1	501	26	1	\N	ENST00000349496:c.100G>C	\N	26	6	\N
3972	c.101	T	1	418	1	502	26	1	\N	ENST00000349496:c.101G>T	\N	26	6	\N
3973	c.109	G	1	420	1	503	26	1	\N	ENST00000349496:c.109T>G	\N	26	6	\N
3974	c.110	G	1	115	1	504	26	1	\N	ENST00000349496:c.110C>G	\N	26	6	\N
3975	c.109	C	1	420	1	505	26	1	\N	ENST00000349496:c.109T>C	\N	26	6	\N
3976	c.118	G	1	421	1	506	26	1	\N	ENST00000349496:c.118A>G	\N	26	6	\N
3977	c.119	T	1	422	1	507	26	1	\N	ENST00000349496:c.119C>T	\N	26	6	\N
3978	c.118	C	1	421	1	508	26	1	\N	ENST00000349496:c.118A>C	\N	26	6	\N
3979	c.118	T	1	421	1	509	26	1	\N	ENST00000349496:c.118A>T	\N	26	6	\N
3980	c.119	G	1	422	1	509	26	1	\N	ENST00000349496:c.119C>G	\N	26	6	\N
3981	c.133	G	1	116	1	510	26	1	\N	ENST00000349496:c.133T>G	\N	26	6	\N
3982	c.134	G	1	117	1	511	26	1	\N	ENST00000349496:c.134C>G	\N	26	6	\N
3983	c.2193	A	1	423	1	512	33	2	\N	ENST00000275493:c.2193G>A	\N	34	6	\N
3984	c.2198	T	1	424	1	513	33	1	\N	ENST00000275493:c.2198C>T	\N	34	6	\N
3985	c.2200	A	1	425	1	514	33	1	\N	ENST00000275493:c.2200G>A	\N	34	6	\N
3986	c.2203	A	1	426	1	515	33	1	\N	ENST00000275493:c.2203G>A	\N	34	6	\N
3987	c.2225	C	1	427	1	516	33	1	\N	ENST00000275493:c.2225T>C	\N	34	6	\N
3988	c.2234	G	1	428	1	517	33	1	\N	ENST00000275493:c.2234A>G	\N	34	6	\N
3989	c.2236	A	1	429	1	518	33	1	\N	ENST00000275493:c.2236G>A	\N	34	6	\N
3990	c.2248	C	1	430	1	519	33	1	\N	ENST00000275493:c.2248G>C	\N	34	6	\N
3991	c.2255	A	1	431	1	520	33	1	\N	ENST00000275493:c.2255C>A	\N	34	6	\N
3992	c.2281	A	1	432	1	521	33	1	\N	ENST00000275493:c.2281G>A	\N	34	6	\N
3993	c.2281	T	1	432	1	522	33	1	\N	ENST00000275493:c.2281G>T	\N	34	6	\N
3994	c.2318	G	1	433	1	523	33	1	\N	ENST00000275493:c.2318A>G	\N	34	6	\N
3995	c.2429	A	1	434	1	524	33	1	\N	ENST00000275493:c.2429G>A	\N	34	6	\N
3996	c.2428	A	1	435	1	525	33	1	\N	ENST00000275493:c.2428G>A	\N	34	6	\N
3997	c.2572	A	1	436	1	526	33	1	\N	ENST00000275493:c.2572C>A	\N	34	6	\N
3998	c.2573_2574	GT	1	437	4	257	33	1	\N	ENST00000275493:c.2573_2574TG>GT	\N	34	6	\N
3999	c.2572_2573	AG	1	438	4	257	33	1	\N	ENST00000275493:c.2572_2573CT>AG	\N	34	6	\N
4000	c.2573	A	1	196	1	527	33	1	\N	ENST00000275493:c.2573T>A	\N	34	6	\N
4001	c.2354	C	1	439	1	528	14	1	\N	ENST00000269571:c.2354T>C	\N	14	6	\N
4003	c.2326	A	1	440	1	529	14	1	\N	ENST00000269571:c.2326G>A	\N	14	6	\N
4004	c.2326_2327	TGT	1	441	3	530	14	6	\N	ENST00000269571:c.2326_2327insTGT	\N	14	6	\N
4005	c.2329	C	1	60	1	68	14	1	\N	ENST00000269571:c.2329G>C	\N	14	6	\N
4006	c.473	A	-1	442	1	531	103	1	\N	ENST00000425967:c.473C>T	\N	70	6	\N
4007	c.847	T	-1	443	1	532	103	1	\N	ENST00000425967:c.847C>A	\N	70	6	\N
4008	c.929	C	-1	444	1	533	77	1	\N	ENST00000457416:c.929A>G	\N	50	6	\N
4009	c.1118	C	-1	445	1	534	77	1	\N	ENST00000457416:c.1118C>G	\N	50	6	\N
4010	c.1127	C	-1	446	1	535	77	1	\N	ENST00000457416:c.1127A>G	\N	50	6	\N
4011	c.1144	G	-1	447	1	536	77	1	\N	ENST00000457416:c.1144T>C	\N	50	6	\N
4012	c.1917	T	-1	448	1	537	77	1	\N	ENST00000457416:c.1917T>A	\N	50	6	\N
4013	c.742	T	1	449	1	538	126	1	\N	ENST00000340107:c.742C>T	\N	63	6	\N
4014	c.746	G	1	450	1	539	126	1	\N	ENST00000340107:c.746C>G	\N	63	6	\N
4015	c.1114	T	1	451	1	540	126	1	\N	ENST00000340107:c.1114G>T	\N	63	6	\N
4016	c.1117	T	1	452	1	534	126	1	\N	ENST00000340107:c.1117A>T	\N	63	6	\N
4017	c.1954	C	1	453	1	541	126	1	\N	ENST00000340107:c.1954A>C	\N	63	6	\N
4018	c.2095	T	1	454	1	542	126	1	\N	ENST00000340107:c.2095G>T	\N	63	6	\N
4019	c.1715	C	-1	455	1	543	9	1	\N	ENST00000380982:c.1715A>G	\N	9	6	\N
4020	c.2505_2503	-	-1	456	2	544	9	5	\N	ENST00000380982:c.2505_2503delGAT	\N	9	6	\N
4021	c.2508_2506	-	-1	457	2	545	9	5	\N	ENST00000380982:c.2508_2506delATC	\N	9	6	\N
4022	c.626_625	AA	-1	458	4	89	35	1	\N	ENST00000286548:c.626_625CA>TT	\N	36	6	\N
4023	c.683	T	1	459	1	546	93	1	\N	ENST00000354359:c.683A>T	\N	60	6	\N
4024	c.34	A	-1	20	1	14	7	1	\N	ENST00000311189:c.34G>T	\N	7	6	\N
4025	c.35	T	-1	19	1	13	7	1	\N	ENST00000311189:c.35G>A	\N	7	6	\N
4026	c.37	T	-1	18	1	33	7	1	\N	ENST00000311189:c.37G>A	\N	7	6	\N
4027	c.38	A	-1	460	1	6	7	1	\N	ENST00000311189:c.38G>T	\N	7	6	\N
4028	c.183	G	-1	461	1	1	7	1	\N	ENST00000311189:c.183G>C	\N	7	6	\N
4029	c.183	A	-1	461	1	1	7	1	\N	ENST00000311189:c.183G>T	\N	7	6	\N
4030	c.181	T	-1	462	1	5	7	1	\N	ENST00000311189:c.181C>A	\N	7	6	\N
4031	c.182	A	-1	17	1	2	7	1	\N	ENST00000311189:c.182A>T	\N	7	6	\N
4032	c.182	G	-1	17	1	32	7	1	\N	ENST00000311189:c.182A>C	\N	7	6	\N
4033	c.183_182	TC	-1	463	4	27	7	1	\N	ENST00000311189:c.183_182AG>GA	\N	7	6	\N
4034	c.183_182	AC	-1	463	4	27	7	1	\N	ENST00000311189:c.183_182AG>GT	\N	7	6	\N
4035	c.394	T	-1	464	1	547	65	1	\N	ENST00000458235:c.394C>A	\N	42	6	\N
4036	c.1715	A	-1	465	1	548	65	1	\N	ENST00000458235:c.1715C>T	\N	42	6	\N
4037	c.2164	T	-1	466	1	549	65	1	\N	ENST00000458235:c.2164G>A	\N	42	6	\N
4038	c.154	A	1	467	1	550	28	1	\N	ENST00000288135:c.154G>A	\N	28	6	\N
4039	c.1675_1677	-	1	130	2	171	28	5	\N	ENST00000288135:c.1675_1677delGTT	\N	28	6	\N
4040	c.2474	C	1	468	1	551	28	1	\N	ENST00000288135:c.2474T>C	\N	28	6	\N
4041	c.2515	A	1	469	1	552	28	1	\N	ENST00000288135:c.2515G>A	\N	28	6	\N
4042	c.57	A	-1	470	1	553	8	1	\N	ENST00000256078:c.57G>T	\N	8	6	\N
4043	c.57	G	-1	470	1	553	8	1	\N	ENST00000256078:c.57G>C	\N	8	6	\N
4044	c.64	T	-1	471	1	554	8	1	\N	ENST00000256078:c.64C>A	\N	8	6	\N
4045	c.175	T	-1	472	1	555	8	1	\N	ENST00000256078:c.175G>A	\N	8	6	\N
4046	c.181	C	-1	26	1	4	8	1	\N	ENST00000256078:c.181C>G	\N	8	6	\N
4047	c.361	A	1	473	1	52	12	1	\N	ENST00000307102:c.361T>A	\N	12	6	\N
4048	c.3334	T	1	474	1	556	68	1	\N	ENST00000318493:c.3334C>T	\N	44	6	\N
4049	c.3742	C	1	475	1	557	68	1	\N	ENST00000318493:c.3742T>C	\N	44	6	\N
4050	c.1151	A	1	476	1	558	104	1	\N	ENST00000231790:c.1151T>A	\N	71	6	\N
4051	c.169	T	1	477	1	559	105	1	\N	ENST00000377970:c.169C>T	\N	72	6	\N
4052	c.176	T	1	478	1	560	105	1	\N	ENST00000377970:c.176C>T	\N	72	6	\N
4053	c.218	T	1	479	1	561	105	1	\N	ENST00000377970:c.218C>T	\N	72	6	\N
4054	c.230	T	1	480	1	562	105	1	\N	ENST00000377970:c.230C>T	\N	72	6	\N
4055	c.302	C	1	481	1	563	105	1	\N	ENST00000377970:c.302A>C	\N	72	6	\N
4056	c.778	G	1	482	1	564	105	1	\N	ENST00000377970:c.778C>G	\N	72	6	\N
4057	c.37	T	-1	5	1	33	1	1	\N	ENST00000369535:c.37G>A	\N	1	6	\N
4058	c.52	T	-1	483	1	565	1	1	\N	ENST00000369535:c.52G>A	\N	1	6	\N
4059	c.182_181	CT	-1	484	4	27	1	1	\N	ENST00000369535:c.182_181CA>AG	\N	1	6	\N
4060	c.2521_2526	-	1	485	2	566	27	5	\N	ENST00000257290:c.2521_2526delAGAGAC	\N	27	6	\N
4061	c.2524_2525	AT	1	486	4	567	27	1	\N	ENST00000257290:c.2524_2525GA>AT	\N	27	6	\N
4063	c.2524_2532	-	1	488	2	569	27	5	\N	ENST00000257290:c.2524_2532delGACATCATG	\N	27	6	\N
4064	c.2524_2535	-	1	489	2	570	27	5	\N	ENST00000257290:c.2524_2535delGACATCATGCAT	\N	27	6	\N
4065	c.2527_2538	-	1	490	2	570	27	5	\N	ENST00000257290:c.2527_2538delATCATGCATGAT	\N	27	6	\N
4066	c.2536	T	1	491	1	571	27	1	\N	ENST00000257290:c.2536G>T	\N	27	6	\N
4067	c.263	A	1	492	1	572	25	1	\N	ENST00000263967:c.263G>A	\N	25	6	\N
4068	c.1035	A	1	493	1	573	25	1	\N	ENST00000263967:c.1035T>A	\N	25	6	\N
4069	c.1035	G	1	493	1	573	25	1	\N	ENST00000263967:c.1035T>G	\N	25	6	\N
4070	c.1258	C	1	494	1	574	25	1	\N	ENST00000263967:c.1258T>C	\N	25	6	\N
4071	c.1616	G	1	495	1	575	25	1	\N	ENST00000263967:c.1616C>G	\N	25	6	\N
4072	c.1624	C	1	108	1	576	25	1	\N	ENST00000263967:c.1624G>C	\N	25	6	\N
4073	c.1635	T	1	496	1	577	25	1	\N	ENST00000263967:c.1635G>T	\N	25	6	\N
4074	c.1635	C	1	496	1	577	25	1	\N	ENST00000263967:c.1635G>C	\N	25	6	\N
4075	c.2102	C	1	497	1	578	25	1	\N	ENST00000263967:c.2102A>C	\N	25	6	\N
4076	c.3062	G	1	498	1	579	25	1	\N	ENST00000263967:c.3062A>G	\N	25	6	\N
4077	c.3129	T	1	499	1	580	25	1	\N	ENST00000263967:c.3129G>T	\N	25	6	\N
4078	c.3129	A	1	499	1	580	25	1	\N	ENST00000263967:c.3129G>A	\N	25	6	\N
4079	c.3139	T	1	500	1	581	25	1	\N	ENST00000263967:c.3139C>T	\N	25	6	\N
4080	c.3145	A	1	501	1	582	25	1	\N	ENST00000263967:c.3145G>A	\N	25	6	\N
4081	c.3145	C	1	501	1	583	25	1	\N	ENST00000263967:c.3145G>C	\N	25	6	\N
4082	c.1126	A	1	502	1	584	106	1	\N	ENST00000396611:c.1126G>A	\N	73	6	\N
4083	c.1126	C	1	502	1	584	106	1	\N	ENST00000396611:c.1126G>C	\N	73	6	\N
4084	c.1315	-	1	503	2	585	106	5	\N	ENST00000396611:c.1315delGAA	\N	73	6	\N
4085	c.1381	T	1	504	1	586	106	2	\N	ENST00000396611:c.1381C>T	\N	73	6	\N
4086	c.1678	T	1	505	1	587	106	1	\N	ENST00000396611:c.1678G>T	\N	73	6	\N
4087	c.1678_1695	-	1	506	2	588	106	5	\N	ENST00000396611:c.1678_1695delGACAAACGTATGAACAGC	\N	73	6	\N
4088	c.1690	G	1	507	1	589	106	1	\N	ENST00000396611:c.1690A>G	\N	73	6	\N
4089	c.1692	A	1	508	1	590	106	1	\N	ENST00000396611:c.1692C>A	\N	73	6	\N
4090	c.1692	G	1	508	1	590	106	1	\N	ENST00000396611:c.1692C>G	\N	73	6	\N
4091	c.1726_1728	-	1	509	2	591	106	5	\N	ENST00000396611:c.1726_1728delACG	\N	73	6	\N
4092	c.1747	-	1	510	2	592	106	5	\N	ENST00000396611:c.1747delTGG	\N	73	6	\N
4093	c.517	T	1	511	1	593	5	1	\N	ENST00000371953:c.517C>T	\N	5	6	\N
4094	c.518	A	1	512	1	594	5	1	\N	ENST00000371953:c.518G>A	\N	5	6	\N
4095	c.700	T	1	513	1	595	5	1	\N	ENST00000371953:c.700C>T	\N	5	6	\N
4096	c.1003	T	1	514	1	596	5	2	\N	ENST00000371953:c.1003C>T	\N	5	6	\N
4097	c.409	T	1	515	1	597	107	2	\N	ENST00000267163:c.409G>T	\N	74	6	\N
4098	c.596	A	1	516	1	598	107	2	\N	ENST00000267163:c.596T>A	\N	74	6	\N
4099	c.958	T	1	517	1	599	107	2	\N	ENST00000267163:c.958C>T	\N	74	6	\N
4100	c.1072	T	1	518	1	600	107	2	\N	ENST00000267163:c.1072C>T	\N	74	6	\N
4101	c.1363	T	1	519	1	601	107	2	\N	ENST00000267163:c.1363C>T	\N	74	6	\N
4102	c.1654	T	1	520	1	602	107	2	\N	ENST00000267163:c.1654C>T	\N	74	6	\N
4103	c.1666	T	1	521	1	603	107	2	\N	ENST00000267163:c.1666C>T	\N	74	6	\N
4104	c.1735	T	1	522	1	604	107	2	\N	ENST00000267163:c.1735C>T	\N	74	6	\N
4105	c.2117	T	1	523	1	605	107	1	\N	ENST00000267163:c.2117G>T	\N	74	6	\N
4106	c.2242	T	1	524	1	606	107	2	\N	ENST00000267163:c.2242G>T	\N	74	6	\N
4107	c.1834_1860	-	1	525	2	607	4	5	\N	ENST00000355710:c.1834_1860delTTCCCTGAGGAGGAGAAGTGCTTCTGC	\N	4	6	\N
4108	c.1892	G	1	526	1	608	4	1	\N	ENST00000355710:c.1892A>G	\N	4	6	\N
4109	c.1894_1899	-	1	527	2	609	4	5	\N	ENST00000355710:c.1894_1899delGAGCTG	\N	4	6	\N
4110	c.1900	C	1	528	1	610	4	1	\N	ENST00000355710:c.1900T>C	\N	4	6	\N
4111	c.1901	A	1	529	1	611	4	1	\N	ENST00000355710:c.1901G>A	\N	4	6	\N
4112	c.2304	C	1	530	1	612	4	1	\N	ENST00000355710:c.2304G>C	\N	4	6	\N
4113	c.2647_2648	TT	1	531	4	613	4	1	\N	ENST00000355710:c.2647_2648GC>TT	\N	4	6	\N
4114	c.2692_2703	-	1	532	2	614	4	5	\N	ENST00000355710:c.2692_2703delGATGTTTATGAA	\N	4	6	\N
4115	c.1609	T	1	533	1	615	108	2	\N	ENST00000360723:c.1609C>T	\N	75	6	\N
4116	c.109	T	1	534	1	616	90	2	\N	ENST00000326873:c.109C>T	\N	59	6	\N
4117	c.508	T	1	535	1	617	90	2	\N	ENST00000326873:c.508C>T	\N	59	6	\N
4118	c.580	A	1	536	1	618	90	1	\N	ENST00000326873:c.580G>A	\N	59	6	\N
4119	c.581	T	1	537	1	619	90	1	\N	ENST00000326873:c.581A>T	\N	59	6	\N
4120	c.587	T	1	538	1	620	90	1	\N	ENST00000326873:c.587G>T	\N	59	6	\N
4121	c.595	A	1	539	1	621	90	1	\N	ENST00000326873:c.595G>A	\N	59	6	\N
4122	c.595	T	1	539	1	622	90	2	\N	ENST00000326873:c.595G>T	\N	59	6	\N
4123	c.842	T	1	540	1	623	90	1	\N	ENST00000326873:c.842C>T	\N	59	6	\N
4124	c.996	A	1	541	1	624	90	2	\N	ENST00000326873:c.996G>A	\N	59	6	\N
4135	c.763	A	1	239	1	308	110	1	\N	ENST00000318560:c.763G>A	\N	77	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/4/summary/variants/3/summary#variant"}
4126	c.733	T	-1	543	1	626	15	1	\N	ENST00000269305:c.733G>A	\N	15	6	\N
4136	c.85	T	1	552	1	635	111	1	\N	ENST00000356142:c.85C>T	\N	78	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/4753/summary/variants/367/summary#variant"}
4128	c.916	A	-1	545	1	628	15	2	\N	ENST00000269305:c.916C>T	\N	15	6	\N
4129	c.241	T	1	546	1	629	109	1	\N	ENST00000256474:c.241C>T	\N	76	6	\N
4130	c.254	C	1	547	1	630	109	1	\N	ENST00000256474:c.254T>C	\N	76	6	\N
4131	c.266	A	1	548	1	631	109	1	\N	ENST00000256474:c.266T>A	\N	76	6	\N
4132	c.473	A	1	549	1	632	109	1	\N	ENST00000256474:c.473T>A	\N	76	6	\N
4133	c.481	T	1	550	1	633	109	2	\N	ENST00000256474:c.481C>T	\N	76	6	\N
4134	c.499	T	1	551	1	634	109	1	\N	ENST00000256474:c.499C>T	\N	76	6	\N
3897	c.1613	G	1	169	1	222	30	1	\N	ENST00000206249:c.1613A>G	\N	30	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/21/summary/variants/47/summary#variant"}
3473	c.35	G	-1	29	1	12	8	1	\N	ENST00000256078:c.35G>C	\N	8	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/148/summary#variant"}
3642	c.3522	T	-1	94	1	119	21	1	\N	ENST00000389048:c.3522C>A	\N	21	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"},{"Association":"response","Therapeutic_context":"novel ALK inhibiors","Status":"preclinical","Evidence":"emerging","PMID":"24327273"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/8/summary#variant"}
4002	c.2264	C	1	58	1	45	14	1	\N	ENST00000269571:c.2264T>C	\N	14	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/39/summary#variant"}
3866	c.2686	T	1	63	1	71	14	1	\N	ENST00000269571:c.2686C>T	\N	14	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/43/summary#variant"}
4137	c.4924	G	-1	553	1	636	112	1	\N	ENST00000277541:c.4924G>C	\N	79	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/50/summary/variants/135/summary#variant"}
3478	c.182	C	-1	2	1	27	1	1	\N	ENST00000369535:c.182A>G	\N	1	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/36/summary/variants/96/summary#variant"}
3830	c.1902	G	1	331	1	399	4	1	\N	ENST00000355710:c.1902C>G	\N	4	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"vandetanib","Status":"FDA-approved","Evidence":"consensus","PMID":"20065189, 22025146"},{"Association":"sensitivity","Therapeutic_context":"cabozantinib, sunitinib","Status":"preclinical","Evidence":"emerging","PMID":"21470995"},{"Association":"sensitivity","Therapeutic_context":"RET inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23056499"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/42/summary/variants/112/summary#variant"}
3485	c.1624	A	1	108	1	136	25	1	\N	ENST00000263967:c.1624G>A	\N	25	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/37/summary/variants/103/summary#variant"}
3660	c.3604	T	-1	265	1	329	21	1	\N	ENST00000389048:c.3604G>A	\N	21	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/171/summary#variant"}
3677	c.182	A	-1	2	1	2	1	1	\N	ENST00000369535:c.182A>T	\N	1	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/36/summary/variants/95/summary#variant"}
3456	c.437	A	-1	21	1	28	8	1	\N	ENST00000256078:c.437C>T	\N	8	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/322/summary#variant"}
4138	c.2629	C	1	554	1	637	113	1	\N	ENST00000374690:c.2629T>C	\N	80	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/67/summary/variants/175/summary#variant"}
4139	c.697	T	1	14	1	24	5	7	\N	ENST00000371953:c.697C>T	\N	5	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/41/summary/variants/110/summary#variant"}
4140	c.2608	A	1	555	1	638	114	1	\N	ENST00000282030:c.2608G>A	\N	81	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/10024/summary/variants/351/summary#variant"}
4141	c.1621	C	1	556	1	639	28	1	\N	ENST00000288135:c.1621A>C	\N	28	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/29/summary/variants/201/summary#variant"}
4142	c.1682	C	1	118	1	640	27	1	\N	ENST00000257290:c.1682T>C	\N	27	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/38/summary/variants/247/summary#variant"}
4143	c.580	A	-1	557	1	641	115	1	\N	ENST00000262887:c.580C>T	\N	82	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/6144/summary/variants/249/summary#variant"}
3862	c.2305	T	1	59	1	67	14	1	\N	ENST00000269571:c.2305G>T	\N	14	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/36/summary#variant"}
3896	c.1610	G	1	168	1	221	30	1	\N	ENST00000206249:c.1610A>G	\N	30	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/21/summary/variants/48/summary#variant"}
3895	c.1610	C	1	168	1	220	30	1	\N	ENST00000206249:c.1610A>C	\N	30	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/21/summary/variants/50/summary#variant"}
3511	c.1961	C	1	145	1	195	28	1	\N	ENST00000288135:c.1961T>C	\N	28	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"decreased sensitivity","Therapeutic_context":"imatinib","Status":"preclinical","Evidence":"emerging","PMID":"16751810"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/29/summary/variants/73/summary#variant"}
3674	c.167	C	1	42	1	48	12	1	\N	ENST00000307102:c.167A>C	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"vemurafenib","Status":"case report","Evidence":"emerging","PMID":"23569304"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors, MEK inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"19915144"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/31/summary/variants/83/summary#variant"}
3731	c.1417	C	1	173	1	226	31	1	\N	ENST00000249373:c.1417G>C	\N	31	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"vismodegib","Status":"case report","Evidence":"emerging","PMID":"19726788"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/5365/summary/variants/299/summary#variant"}
3496	c.3140	G	1	114	1	148	25	1	\N	ENST00000263967:c.3140A>G	\N	25	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/37/summary/variants/107/summary#variant"}
3597	c.746	G	-1	66	1	74	15	1	\N	ENST00000269305:c.746G>C	\N	15	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/45/summary/variants/119/summary#variant"}
3596	c.817	A	-1	65	1	73	15	1	\N	ENST00000269305:c.817C>T	\N	15	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/45/summary/variants/121/summary#variant"}
3666	c.6094	T	-1	269	1	334	120	1	\N	ENST00000368508:c.6094G>A	\N	47	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"23724914"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/4941/summary/variants/465/summary#variant"}
3522	c.2525	T	1	120	1	157	27	1	\N	ENST00000257290:c.2525A>T	\N	27	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"imatinib, sunitinib","Status":"late trials, preclinical","Evidence":"emerging","PMID":"22718859, 16638875"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"18794084"},{"Association":"sensitivity","Therapeutic_context":"crenolanib","Status":"preclinical","Evidence":"emerging","PMID":"22745105"},{"Association":"sensitivity","Therapeutic_context":"dasatinib","Status":"preclinical","Evidence":"emerging","PMID":"18794084"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/38/summary/variants/99/summary#variant"}
3595	c.818	T	-1	64	1	72	15	1	\N	ENST00000269305:c.818G>A	\N	15	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/45/summary/variants/122/summary#variant"}
3661	c.3586	T	-1	266	1	330	21	1	\N	ENST00000389048:c.3586C>A	\N	21	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"},{"Association":"response","Therapeutic_context":"ceritinib","Status":"FDA-approved","Evidence":"consensus","PMID":"24670165, 24327273"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/7/summary#variant"}
3702	c.1727	C	1	140	1	189	28	1	\N	ENST00000288135:c.1727T>C	\N	28	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/29/summary/variants/72/summary#variant"}
4152	c.49	T	-1	37	1	43	10	1	\N	ENST00000407796:c.49G>A	\N	89	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/2/summary/variants/4/summary#variant"}
4153	c.235	T	-1	303	1	371	10	1	\N	ENST00000407796:c.235C>A	\N	89	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/2/summary/variants/169/summary#variant"}
4154	c.949	C	1	250	1	647	110	1	\N	ENST00000318560:c.949T>C	\N	77	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/4/summary/variants/241/summary#variant"}
4155	c.2677	T	-1	561	1	648	119	1	\N	ENST00000265724:c.2677T>A	\N	86	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/4244/summary/variants/262/summary#variant"}
3515	c.2447	T	1	151	1	202	28	1	\N	ENST00000288135:c.2447A>T	\N	28	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"quizartinib","Status":"preclinical","Evidence":"emerging","PMID":"22504184"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/29/summary/variants/65/summary#variant"}
3797	c.370	T	1	47	1	53	12	1	\N	ENST00000307102:c.370C>T	\N	12	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"BRAF inhibitors in BRAF mutant tumor","Status":"case report","Evidence":"emerging","PMID":"22588879"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/31/summary/variants/82/summary#variant"}
3590	c.1998	A	-1	81	1	97	18	1	\N	ENST00000335508:c.1998G>T	\N	18	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/44/summary/variants/114/summary#variant"}
3861	c.2305	C	1	59	1	66	14	1	\N	ENST00000269571:c.2305G>C	\N	14	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"trastuzumab, lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/35/summary#variant"}
3604	c.470	G	-1	104	1	131	23	1	\N	ENST00000291552:c.470A>C	\N	23	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/48/summary/variants/127/summary#variant"}
3863	c.2329	T	1	60	1	68	14	1	\N	ENST00000269571:c.2329G>T	\N	14	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/44/summary#variant"}
3733	c.1790	C	-1	184	1	239	32	1	\N	ENST00000288602:c.1790T>G	\N	32	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"trametinib, MEK inhibitors","Status":"case report","Evidence":"emerging","PMID":"22805292, 22798288"},{"Association":"response","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23715574"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/288/summary#variant"}
3663	c.3455	C	-1	267	1	331	21	1	\N	ENST00000389048:c.3455T>G	\N	21	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/307/summary#variant"}
3671	c.2369	T	1	195	1	256	33	1	\N	ENST00000275493:c.2369C>T	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"erlotinib, afatinib","Status":"NCCN/ CAP guidelines","Evidence":"consensus","PMID":"NCCN"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"response","Therapeutic_context":"irreversible EGFR T790M inhibitors","Status":"early trials","Evidence":"emerging","PMID":"J Clin Oncol 2013;31: (suppl; abstr 2524), ASCO 2014; abstr 8009"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/34/summary#variant"}
3472	c.35	A	-1	29	1	11	8	1	\N	ENST00000256078:c.35G>T	\N	8	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/425/summary#variant"}
3668	c.2155	A	1	193	1	253	33	1	\N	ENST00000275493:c.2155G>A	\N	34	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"erlotinib, afatinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"irreversible EGFR TKIs","Status":"late trials","Evidence":"emerging","PMID":"22753918"},{"Association":"response","Therapeutic_context":"afatinib + cetuximab","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):1289"},{"Association":"response","Therapeutic_context":"HSP90 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"Annals Oncol 2012;23(Suppl 9):4380"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors (alone or in combination)","Status":"preclinical","Evidence":"emerging","PMID":"23102728.0"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/134/summary#variant"}
4162	c.647	T	1	565	1	652	121	1	\N	ENST00000268058:c.647C>T	\N	90	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/39/summary/variants/462/summary#variant"}
4163	c.2170	A	1	566	1	653	33	1	\N	ENST00000275493:c.2170G>A	\N	34	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/317/summary#variant"}
3664	c.641	G	1	268	1	332	124	1	\N	ENST00000377045:c.641C>G	\N	46	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"sorafenib","Status":"case report","Evidence":"emerging","PMID":"24569458"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/3/summary/variants/10/summary#variant"}
3894	c.1609	A	1	167	1	219	30	1	\N	ENST00000206249:c.1609T>A	\N	30	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/21/summary/variants/49/summary#variant"}
3475	c.34	A	-1	30	1	14	8	1	\N	ENST00000256078:c.34G>T	\N	8	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/78/summary#variant"}
3474	c.35	T	-1	29	1	13	8	1	\N	ENST00000256078:c.35G>A	\N	8	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/79/summary#variant"}
3468	c.38	T	-1	27	1	8	8	1	\N	ENST00000256078:c.38G>A	\N	8	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"panitumumab","Status":"FDA-rejected","Evidence":"consensus","PMID":"FDA"},{"Association":"response","Therapeutic_context":"cetuximab","Status":"late trials","Evidence":"emerging","PMID":"22734028, 20978259"},{"Association":"sensitivity","Therapeutic_context":"MEK inhibitors + PI3K pathway inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22392911"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/81/summary#variant"}
3831	c.2753	C	1	10	1	19	4	1	\N	ENST00000355710:c.2753T>C	\N	4	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"vandetanib","Status":"FDA-approved","Evidence":"consensus","PMID":"20065189, 22025146"},{"Association":"sensitivity","Therapeutic_context":"cabozantinib, sunitinib","Status":"preclinical","Evidence":"emerging","PMID":"21470995"},{"Association":"sensitivity","Therapeutic_context":"RET inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23056499"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/42/summary/variants/113/summary#variant"}
4125	c.524	T	-1	542	1	625	15	1	\N	ENST00000269305:c.524G>A	\N	15	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/45/summary/variants/116/summary#variant"}
3599	c.743	T	-1	68	1	76	15	1	\N	ENST00000269305:c.743G>A	\N	15	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/45/summary/variants/117/summary#variant"}
3858	c.1441	T	-1	351	1	421	125	1	\N	ENST00000308731:c.1441T>A	\N	61	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"ibrutinib","Status":"early trials","Evidence":"emerging","PMID":"24869598"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/65/summary/variants/168/summary#variant"}
3659	c.3617	T	-1	264	1	328	21	1	\N	ENST00000389048:c.3617C>A	\N	21	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"},{"Association":"response","Therapeutic_context":"ceritinib","Status":"FDA-approved","Evidence":"consensus","PMID":"24670165"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/172/summary#variant"}
3888	c.1124	G	1	365	1	436	126	1	\N	ENST00000340107:c.1124A>G	\N	63	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"bortezomib","Status":"preclinical","Evidence":"emerging","PMID":"19331127, 21273588"},{"Association":"sensitivity","Therapeutic_context":"FGFR inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"22869148"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/23/summary/variants/196/summary#variant"}
3447	c.1799	T	-1	182	1	236	32	1	\N	ENST00000288602:c.1799T>A	\N	32	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"vemurafenib","Status":"case report","Evidence":"emerging","PMID":"23612012"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary#variant"}
3561	c.515	T	-1	53	1	60	13	1	\N	ENST00000330062:c.515G>A	\N	13	6	{"Description":"missense mutation","Effect":"switch-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"IDH inhibitor","Status":"early trials","Evidence":"emerging","PMID":"AACR 2014; abstr CT103"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/27/summary/variants/63/summary#variant"}
4062	c.2524	T	1	487	1	568	27	1	\N	ENST00000257290:c.2524G>T	\N	27	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/38/summary/variants/100/summary#variant"}
3658	c.3806	G	-1	263	1	327	21	1	\N	ENST00000389048:c.3806G>C	\N	21	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"resistance","Therapeutic_context":"crizotinib","Status":"case report","Evidence":"emerging","PMID":"22277784"},{"Association":"response","Therapeutic_context":"ceritinib","Status":"FDA-approved","Evidence":"consensus","PMID":"24670165"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/308/summary#variant"}
4161	c.2321	T	1	276	1	341	2	1	\N	ENST00000367922:c.2321G>T	\N	88	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/51/summary/variants/144/summary#variant"}
4156	c.6637	A	-1	562	1	649	118	1	\N	ENST00000361445:c.6637C>T	\N	45	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/2073/summary/variants/284/summary#variant"}
4157	c.1412	T	1	563	1	650	25	1	\N	ENST00000263967:c.1412C>T	\N	25	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/37/summary/variants/294/summary#variant"}
3479	c.181	T	-1	3	1	5	1	1	\N	ENST00000369535:c.181C>A	\N	1	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"late trials","Evidence":"emerging","PMID":"23414587"},{"Association":"response","Therapeutic_context":"MEK inhibitors","Status":"early trials","Evidence":"emerging","PMID":"18390968, 22761467"},{"Association":"response","Therapeutic_context":"MEK inhibitors + CDK4/6 inhibitors","Status":"early trials","Evidence":"emerging","PMID":"ASCO 2014; abstr 9009"},{"Association":"sensitivity","Therapeutic_context":"HSP90 inhibitors","Status":"preclinical","Evidence":"emerging","PMID":"23538902"},{"Association":"resistance","Therapeutic_context":"BRAF inhibitors","Status":"case report","Evidence":"emerging","PMID":"23569304.0"},{"Association":"ERK inhibitors","Therapeutic_context":"preclinical","Status":"preclinical","Evidence":"emerging","PMID":"23614898"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/36/summary/variants/427/summary#variant"}
3859	c.926	C	1	56	1	64	14	1	\N	ENST00000269571:c.926G>C	\N	14	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/38/summary#variant"}
3576	c.38	T	-1	4	1	8	1	1	\N	ENST00000369535:c.38G>A	\N	1	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/36/summary/variants/93/summary#variant"}
4127	c.742	A	-1	544	1	627	15	1	\N	ENST00000269305:c.742C>T	\N	15	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/45/summary/variants/118/summary#variant"}
3605	c.101	A	-1	105	1	132	23	1	\N	ENST00000291552:c.101C>T	\N	23	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/48/summary/variants/128/summary#variant"}
3638	c.3824	T	-1	89	1	114	21	1	\N	ENST00000389048:c.3824G>A	\N	21	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"crizotinib","Status":"preclinical","Evidence":"emerging","PMID":"22072639"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/9/summary#variant"}
3865	c.2524	A	1	62	1	70	14	1	\N	ENST00000269571:c.2524G>A	\N	14	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"sensitivity","Therapeutic_context":"lapatinib, neratinib","Status":"preclinical","Evidence":"emerging","PMID":"23220880"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/45/summary#variant"}
3565	c.1849	T	1	198	1	259	34	1	\N	ENST00000381652:c.1849G>T	\N	35	6	{"Description":"missense mutation","Effect":"gain-of-function","Pathway":"activation","list":[{"Association":"response","Therapeutic_context":"ruxolitinib","Status":"FDA-approved","Evidence":"consensus","PMID":"FDA"}],"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/28/summary/variants/64/summary#variant"}
3486	c.1633	A	1	109	1	137	25	1	\N	ENST00000263967:c.1633G>A	\N	25	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/37/summary/variants/104/summary#variant"}
4144	c.313	G	1	558	1	642	116	1	\N	ENST00000398606:c.313A>G	\N	83	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/2473/summary/variants/259/summary#variant"}
4145	c.2251	G	-1	559	1	643	117	1	\N	ENST00000391945:c.2251A>C	\N	84	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/1736/summary/variants/264/summary#variant"}
4146	c.38	T	-1	460	1	8	7	1	\N	ENST00000451590:c.38G>A	\N	85	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/2747/summary/variants/274/summary#variant"}
4147	c.6324	T	-1	560	1	644	118	1	\N	ENST00000361445:c.6324C>A	\N	45	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/2073/summary/variants/470/summary#variant"}
4148	c.2677	C	-1	561	1	645	119	1	\N	ENST00000265724:c.2677T>G	\N	86	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/4244/summary/variants/451/summary#variant"}
4149	c.2264	G	1	58	1	646	14	1	\N	ENST00000269571:c.2264T>G	\N	14	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/40/summary#variant"}
4151	c.1513	A	1	274	1	339	2	1	\N	ENST00000367922:c.1513G>A	\N	88	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/51/summary/variants/142/summary#variant"}
4175	c.394	A	-1	85	1	104	19	1	\N	ENST00000415913:c.394C>T	\N	94	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/26/summary/variants/59/summary#variant"}
4176	c.3467	T	-1	574	1	662	21	1	\N	ENST00000389048:c.3467G>A	\N	21	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/6/summary#variant"}
4177	c.653	C	1	575	1	663	121	1	\N	ENST00000268058:c.653T>C	\N	90	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/39/summary/variants/463/summary#variant"}
4158	c.1351	T	1	564	1	651	33	1	\N	ENST00000275493:c.1351C>T	\N	34	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/454/summary#variant"}
4159	c.1476	A	1	583	1	671	33	1	\N	ENST00000275493:c.1476C>A	\N	34	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/453/summary#variant"}
4160	c.757	T	1	273	1	338	2	1	\N	ENST00000367922:c.757G>T	\N	88	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/51/summary/variants/141/summary#variant"}
4164	c.3435	G	-1	567	1	654	119	8	\N	ENST00000265724:c.3435T>C	\N	86	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/4244/summary/variants/263/summary#variant"}
4165	c.1075	G	-1	568	1	655	122	1	\N	ENST00000343289:c.1075A>C	\N	91	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/9189/summary/variants/239/summary#variant"}
4166	c.944	T	1	205	1	656	110	1	\N	ENST00000318560:c.944C>T	\N	77	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/4/summary/variants/2/summary#variant"}
4167	c.2389	A	1	569	1	657	33	1	\N	ENST00000275493:c.2389T>A	\N	34	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/415/summary#variant"}
4168	c.3532	T	1	570	1	658	123	7	\N	ENST00000219476:c.3532C>T	\N	92	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/47/summary/variants/469/summary#variant"}
4150	c.2503	A	-1	36	1	40	9	1	\N	ENST00000241453:c.2503G>T	\N	87	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/24/summary/variants/437/summary#variant"}
4169	c.2033	A	1	571	1	659	14	1	\N	ENST00000269571:c.2033G>A	\N	14	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/42/summary#variant"}
4170	c.6979	A	-1	572	1	660	112	1	\N	ENST00000277541:c.6979C>T	\N	79	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/50/summary/variants/136/summary#variant"}
4171	c.187	G	1	271	1	336	2	1	\N	ENST00000367922:c.187C>G	\N	88	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/51/summary/variants/139/summary#variant"}
4172	c.1912	T	1	275	1	340	2	1	\N	ENST00000367922:c.1912A>T	\N	88	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/51/summary/variants/143/summary#variant"}
4173	c.2320	-	-1	573	2	661	127	9	\N	ENST00000350721:c.2320delT	\N	93	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/524/summary/variants/271/summary#variant"}
4174	c.395	T	-1	84	1	103	19	1	\N	ENST00000415913:c.395G>A	\N	94	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/26/summary/variants/420/summary#variant"}
4178	c.1100	T	-1	576	1	664	122	1	\N	ENST00000343289:c.1100G>A	\N	91	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/9189/summary/variants/238/summary#variant"}
4179	c.1220	G	-1	577	1	665	122	1	\N	ENST00000343289:c.1220A>C	\N	91	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/9189/summary/variants/240/summary#variant"}
4180	c.402	C	-1	578	1	666	128	1	\N	ENST00000330315:c.402C>G	\N	95	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/72/summary/variants/198/summary#variant"}
4181	c.8623	C	1	579	1	667	129	1	\N	ENST00000278616:c.8623A>C	\N	96	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/69/summary/variants/244/summary#variant"}
4182	c.5902	A	-1	580	1	668	118	1	\N	ENST00000361445:c.5902C>T	\N	45	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/2073/summary/variants/283/summary#variant"}
4183	c.2304	A	1	8	1	17	2	1	\N	ENST00000367922:c.2304T>A	\N	88	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/51/summary/variants/145/summary#variant"}
4184	c.421	T	-1	581	1	669	130	1	\N	ENST00000237612:c.421C>A	\N	97	6	{"civic_variant_url":"https://civic.genome.wustl.edu/#/events/genes/7451/summary/variants/260/summary#variant"}
\.


--
-- Data for Name: disease_source_variants; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY disease_source_variants (id, disease_id, source_id, variant_id, my_cancer_genome_url, civic_url) FROM stdin;
1	1	1	1	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
2	1	2	1	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
3	1	3	1	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
4	2	4	1	\N	\N
5	2	3	1	\N	\N
6	1	5	2	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
7	3	6	3	\N	\N
8	3	7	3	\N	\N
9	3	8	3	\N	\N
10	3	9	3	\N	\N
11	1	10	4	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
12	1	11	4	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
13	4	11	5	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75	\N
14	1	12	5	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
16	1	13	5	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
17	1	14	5	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
18	1	15	5	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
19	3	13	5	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75	\N
20	3	16	5	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75	\N
21	3	17	5	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75	\N
22	3	11	5	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75	\N
23	2	13	5	\N	\N
24	2	16	5	\N	\N
25	2	17	5	\N	\N
26	2	11	5	\N	\N
27	5	13	5	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
28	5	16	5	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
29	5	17	5	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
30	5	11	5	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
31	1	13	6	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
32	1	16	6	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
33	1	17	6	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
34	1	11	6	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
35	2	18	6	\N	\N
36	2	19	6	\N	\N
37	2	20	6	\N	\N
38	2	3	6	\N	\N
39	1	21	7	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
40	1	22	7	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
41	1	23	7	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
42	1	3	7	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
43	1	18	8	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
44	1	24	8	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
45	1	25	8	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
46	1	22	8	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
47	1	3	8	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
48	2	22	8	\N	\N
49	2	23	8	\N	\N
50	2	26	8	\N	\N
51	2	3	8	\N	\N
52	1	22	9	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
53	1	23	9	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
54	1	26	9	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
55	1	27	9	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
56	1	28	9	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
57	1	29	9	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
58	1	30	9	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
59	1	3	9	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
60	1	23	10	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
61	1	26	10	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
62	1	31	10	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
63	1	29	10	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
64	1	30	10	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
65	1	27	10	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
66	1	3	10	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
67	1	22	11	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
68	1	18	11	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
69	1	32	11	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
70	1	33	11	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
71	1	3	11	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
72	2	22	11	\N	\N
73	2	23	11	\N	\N
74	2	26	11	\N	\N
75	2	27	11	\N	\N
76	2	3	11	\N	\N
77	5	22	11	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
78	5	23	11	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
79	5	27	11	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
80	5	34	11	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
81	5	35	11	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
82	5	30	11	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
83	5	3	11	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
84	1	22	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
85	1	23	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
86	1	26	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
87	1	27	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
88	1	28	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
89	1	25	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
90	1	29	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
91	1	30	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
92	1	33	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
93	1	35	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
94	1	18	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
95	1	3	12	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
96	3	20	12	http://www.mycancergenome.org/content/disease/lung-cancer/nras/85	\N
97	3	36	12	http://www.mycancergenome.org/content/disease/lung-cancer/nras/85	\N
98	3	37	12	http://www.mycancergenome.org/content/disease/lung-cancer/nras/85	\N
99	5	38	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
100	5	39	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
101	5	40	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
102	5	41	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
103	5	42	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
104	5	43	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
105	5	44	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
106	5	45	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
107	5	46	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
108	5	47	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
109	5	48	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
110	5	49	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
111	5	50	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
112	5	51	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
113	5	52	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
114	5	53	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
115	5	54	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
116	5	55	12	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
117	1	38	13	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
118	1	39	13	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
119	1	40	13	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
120	1	41	13	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
121	1	56	13	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
122	3	38	13	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87	\N
123	3	39	13	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87	\N
124	3	40	13	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87	\N
125	3	41	13	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87	\N
126	3	57	13	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87	\N
127	3	58	13	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87	\N
128	3	59	13	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87	\N
129	3	56	13	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87	\N
130	2	38	13	\N	\N
131	2	39	13	\N	\N
132	2	40	13	\N	\N
133	2	41	13	\N	\N
134	2	56	13	\N	\N
135	2	49	13	\N	\N
136	5	38	13	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
137	5	39	13	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
138	5	40	13	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
139	5	60	13	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
140	5	41	13	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
141	5	56	13	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
142	1	38	14	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
143	1	39	14	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
144	1	40	14	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
145	1	60	14	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
146	1	41	14	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
147	1	56	14	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
148	3	38	14	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86	\N
149	3	39	14	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86	\N
150	3	40	14	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86	\N
151	3	60	14	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86	\N
152	3	41	14	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86	\N
153	3	56	14	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86	\N
154	2	38	14	\N	\N
155	2	39	14	\N	\N
156	2	40	14	\N	\N
157	2	60	14	\N	\N
158	2	41	14	\N	\N
159	2	56	14	\N	\N
160	5	61	14	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86	\N
161	1	62	15	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
162	1	63	15	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
163	1	64	15	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
164	1	65	15	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
165	1	66	15	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
166	1	67	15	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
167	1	68	15	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
322	2	68	26	\N	\N
168	1	69	15	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
169	3	62	15	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88	\N
170	3	63	15	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88	\N
171	3	64	15	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88	\N
172	3	65	15	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88	\N
173	3	66	15	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88	\N
174	3	67	15	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88	\N
175	3	68	15	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88	\N
176	3	69	15	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88	\N
177	1	62	16	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
178	1	63	16	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
179	1	64	16	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
180	1	65	16	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
181	1	66	16	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
182	1	67	16	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
183	1	68	16	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
184	1	69	16	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
185	3	62	16	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
186	3	63	16	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
187	3	64	16	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
188	3	65	16	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
189	3	66	16	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
190	3	67	16	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
191	3	68	16	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
192	3	69	16	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
193	2	62	16	\N	\N
194	2	63	16	\N	\N
195	2	64	16	\N	\N
196	2	65	16	\N	\N
197	2	66	16	\N	\N
198	2	67	16	\N	\N
199	2	68	16	\N	\N
200	2	69	16	\N	\N
201	5	62	16	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
202	5	63	16	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
203	5	64	16	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
204	5	65	16	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
205	5	66	16	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
206	5	67	16	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
207	5	68	16	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
208	5	69	16	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
209	6	62	17	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78	\N
210	6	63	17	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78	\N
211	6	64	17	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78	\N
212	6	65	17	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78	\N
213	6	66	17	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78	\N
214	6	67	17	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78	\N
215	6	68	17	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78	\N
216	6	69	17	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78	\N
217	2	62	18	\N	\N
218	2	63	18	\N	\N
219	2	64	18	\N	\N
220	2	65	18	\N	\N
221	2	66	18	\N	\N
222	2	67	18	\N	\N
223	2	68	18	\N	\N
224	2	69	18	\N	\N
225	4	62	19	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
226	4	63	19	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
227	4	64	19	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
228	4	65	19	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
229	4	66	19	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
230	4	67	19	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
231	4	68	19	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
232	4	69	19	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
233	7	62	20	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145	\N
234	7	63	20	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145	\N
235	7	64	20	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145	\N
236	7	65	20	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145	\N
237	7	66	20	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145	\N
238	7	67	20	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145	\N
239	7	68	20	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145	\N
240	7	69	20	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145	\N
241	7	62	21	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137	\N
242	7	63	21	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137	\N
243	7	64	21	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137	\N
244	7	65	21	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137	\N
245	7	66	21	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137	\N
246	7	67	21	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137	\N
247	7	68	21	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137	\N
323	2	69	26	\N	\N
911	2	162	96	\N	\N
248	7	69	21	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137	\N
249	7	62	22	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144	\N
250	7	63	22	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144	\N
251	7	64	22	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144	\N
252	7	65	22	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144	\N
253	7	66	22	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144	\N
254	7	67	22	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144	\N
255	7	68	22	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144	\N
256	7	69	22	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144	\N
257	8	62	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
258	8	63	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
259	8	64	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
260	8	65	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
261	8	66	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
262	8	67	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
263	8	68	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
264	8	69	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
265	8	70	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
266	8	71	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
267	8	72	23	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
268	5	62	23	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
269	5	63	23	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
270	5	64	23	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
271	5	65	23	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
272	5	66	23	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
273	5	67	23	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
274	5	68	23	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
275	5	69	23	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
276	8	62	24	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25	\N
277	8	63	24	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25	\N
278	8	64	24	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25	\N
279	8	65	24	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25	\N
280	8	66	24	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25	\N
281	8	67	24	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25	\N
282	8	68	24	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25	\N
283	8	69	24	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25	\N
284	3	62	24	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
285	3	63	24	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
286	3	64	24	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
287	3	65	24	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
288	3	66	24	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
289	3	67	24	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
290	3	68	24	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
291	3	69	24	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
292	5	62	24	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
293	5	63	24	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
294	5	64	24	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
295	5	65	24	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
296	5	66	24	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
297	5	67	24	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
298	5	68	24	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
299	5	69	24	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
300	8	62	25	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26	\N
301	8	63	25	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26	\N
302	8	64	25	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26	\N
303	8	65	25	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26	\N
304	8	66	25	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26	\N
305	8	67	25	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26	\N
306	8	68	25	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26	\N
307	8	69	25	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26	\N
308	5	62	25	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
309	5	63	25	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
310	5	64	25	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
311	5	65	25	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
312	5	66	25	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
313	5	67	25	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
314	5	68	25	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
315	5	69	25	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
316	2	62	26	\N	\N
317	2	63	26	\N	\N
318	2	64	26	\N	\N
319	2	65	26	\N	\N
320	2	66	26	\N	\N
321	2	67	26	\N	\N
324	4	62	27	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307	\N
325	4	63	27	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307	\N
326	4	64	27	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307	\N
327	4	65	27	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307	\N
328	4	66	27	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307	\N
329	4	67	27	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307	\N
330	4	68	27	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307	\N
331	4	69	27	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307	\N
332	4	62	28	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305	\N
333	4	63	28	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305	\N
334	4	64	28	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305	\N
335	4	65	28	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305	\N
336	4	66	28	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305	\N
337	4	67	28	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305	\N
338	4	68	28	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305	\N
339	4	69	28	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305	\N
340	4	49	29	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306	\N
341	4	73	29	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306	\N
342	4	74	29	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306	\N
343	4	75	29	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306	\N
344	4	76	29	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306	\N
345	4	77	29	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306	\N
346	4	78	29	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306	\N
347	4	49	30	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304	\N
348	4	73	30	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304	\N
349	4	74	30	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304	\N
350	4	75	30	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304	\N
351	4	76	30	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304	\N
352	4	77	30	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304	\N
353	4	78	30	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304	\N
354	4	49	31	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303	\N
355	4	73	31	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303	\N
356	4	74	31	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303	\N
357	4	75	31	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303	\N
358	4	76	31	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303	\N
359	4	77	31	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303	\N
360	4	78	31	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303	\N
361	4	49	32	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29	\N
362	4	73	32	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29	\N
363	4	74	32	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29	\N
364	4	75	32	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29	\N
365	4	76	32	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29	\N
366	4	77	32	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29	\N
367	4	78	32	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29	\N
368	5	49	32	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
369	5	73	32	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
370	5	74	32	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
371	5	75	32	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
372	5	76	32	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
373	5	77	32	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
374	5	78	32	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
375	5	49	33	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
376	5	73	33	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
377	5	74	33	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
378	5	75	33	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
379	5	76	33	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
380	5	77	33	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
381	5	78	33	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
382	5	49	34	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
383	5	73	34	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
384	5	74	34	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
385	5	75	34	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
386	5	76	34	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
387	5	77	34	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
388	5	78	34	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
389	5	79	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
390	5	80	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
391	5	81	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
392	5	82	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
393	5	83	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
394	5	84	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
395	5	85	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
396	5	86	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
397	5	49	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
398	5	87	35	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
399	5	79	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
400	5	80	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
401	5	81	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
402	5	82	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
403	5	83	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
404	5	84	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
405	5	85	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
406	5	86	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
407	5	49	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
408	5	87	36	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
409	3	79	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31	\N
410	3	80	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31	\N
411	3	81	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31	\N
412	3	82	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31	\N
413	3	83	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31	\N
414	3	84	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31	\N
415	3	85	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31	\N
416	3	86	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31	\N
417	3	49	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31	\N
418	3	87	37	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31	\N
419	2	79	37	\N	\N
420	2	80	37	\N	\N
421	2	81	37	\N	\N
422	2	82	37	\N	\N
423	2	83	37	\N	\N
424	2	84	37	\N	\N
425	2	85	37	\N	\N
426	2	86	37	\N	\N
427	2	49	37	\N	\N
428	2	87	37	\N	\N
429	5	79	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
430	5	80	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
431	5	81	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
432	5	82	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
433	5	83	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
434	5	84	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
435	5	85	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
436	5	86	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
437	5	49	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
438	5	87	37	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
439	3	79	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30	\N
440	3	80	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30	\N
441	3	81	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30	\N
442	3	82	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30	\N
443	3	83	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30	\N
444	3	84	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30	\N
445	3	85	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30	\N
446	3	86	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30	\N
447	3	49	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30	\N
448	3	87	38	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30	\N
449	2	79	38	\N	\N
450	2	80	38	\N	\N
451	2	81	38	\N	\N
452	2	82	38	\N	\N
453	2	83	38	\N	\N
454	2	84	38	\N	\N
455	2	85	38	\N	\N
456	2	86	38	\N	\N
457	2	49	38	\N	\N
458	2	87	38	\N	\N
459	5	79	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
460	5	80	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
461	5	81	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
462	5	82	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
463	5	83	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
464	5	84	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
465	5	85	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
466	5	86	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
467	5	49	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
468	5	87	38	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
469	4	79	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
470	4	80	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
471	4	81	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
472	4	82	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
473	4	83	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
474	4	84	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
904	2	160	95	\N	\N
905	2	161	95	\N	\N
475	4	85	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
476	4	86	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
477	4	49	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
478	4	87	39	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
479	3	79	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42	\N
480	3	80	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42	\N
481	3	81	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42	\N
482	3	82	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42	\N
483	3	83	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42	\N
484	3	84	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42	\N
485	3	85	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42	\N
486	3	86	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42	\N
487	3	49	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42	\N
488	3	87	39	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42	\N
489	5	79	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
490	5	80	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
491	5	81	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
492	5	82	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
493	5	83	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
494	5	84	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
495	5	85	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
496	5	86	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
497	5	49	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
498	5	87	39	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
499	4	79	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
500	4	80	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
501	4	81	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
502	4	82	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
503	4	83	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
504	4	84	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
505	4	85	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
506	4	86	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
507	4	49	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
508	4	87	40	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
509	3	79	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43	\N
510	3	80	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43	\N
511	3	81	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43	\N
512	3	82	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43	\N
513	3	83	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43	\N
514	3	84	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43	\N
515	3	85	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43	\N
516	3	86	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43	\N
517	3	49	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43	\N
518	3	87	40	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43	\N
519	5	79	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
520	5	80	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
521	5	81	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
522	5	82	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
523	5	83	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
524	5	84	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
525	5	85	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
526	5	86	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
527	5	49	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
528	5	87	40	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
529	4	79	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
530	4	80	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
531	4	81	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
532	4	82	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
533	4	83	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
534	4	84	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
535	4	85	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
536	4	86	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
537	4	49	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
538	4	87	41	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
539	4	79	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
540	4	80	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
541	4	81	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
542	4	82	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
543	4	83	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
544	4	84	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
545	4	85	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
546	4	86	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
547	4	49	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
548	4	87	42	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
549	3	88	42	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
550	3	89	42	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
551	3	90	42	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
552	3	91	42	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
553	3	92	42	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
554	3	93	42	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
555	3	94	42	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
556	5	88	42	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
557	5	89	42	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
558	5	90	42	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
559	5	91	42	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
560	5	92	42	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
561	5	93	42	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
562	5	94	42	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
563	5	88	43	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
564	5	89	43	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
565	5	90	43	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
566	5	91	43	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
567	5	92	43	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
568	5	93	43	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
569	5	94	43	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
570	3	88	44	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68	\N
571	3	89	44	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68	\N
572	3	90	44	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68	\N
573	3	91	44	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68	\N
574	3	92	44	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68	\N
575	3	93	44	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68	\N
576	3	94	44	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68	\N
577	5	88	44	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
578	5	89	44	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
579	5	90	44	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
580	5	91	44	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
581	5	92	44	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
582	5	93	44	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
583	5	94	44	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
584	4	88	45	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39	\N
585	4	89	45	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39	\N
586	4	90	45	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39	\N
587	4	91	45	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39	\N
588	4	92	45	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39	\N
589	4	93	45	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39	\N
590	4	94	45	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39	\N
591	7	88	45	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39	\N
592	7	89	45	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39	\N
593	7	90	45	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39	\N
594	7	91	45	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39	\N
595	7	92	45	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39	\N
596	7	93	45	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39	\N
597	7	94	45	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39	\N
598	3	88	45	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39	\N
599	3	89	45	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39	\N
600	3	90	45	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39	\N
601	3	91	45	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39	\N
602	3	92	45	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39	\N
603	3	93	45	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39	\N
604	3	94	45	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39	\N
605	2	95	45	\N	\N
606	2	41	45	\N	\N
607	2	96	45	\N	\N
608	2	97	45	\N	\N
609	2	98	45	\N	\N
610	2	51	45	\N	\N
611	5	99	45	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
612	5	100	45	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
613	5	101	45	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
614	3	99	46	http://www.mycancergenome.org/content/disease/lung-cancer/kras/38	\N
615	3	100	46	http://www.mycancergenome.org/content/disease/lung-cancer/kras/38	\N
616	3	101	46	http://www.mycancergenome.org/content/disease/lung-cancer/kras/38	\N
617	5	99	46	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
906	2	162	95	\N	\N
618	5	100	46	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
619	5	101	46	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
620	4	99	47	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40	\N
621	4	100	47	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40	\N
622	4	101	47	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40	\N
623	3	102	47	http://www.mycancergenome.org/content/disease/lung-cancer/kras/40	\N
624	5	103	47	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
625	4	99	48	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69	\N
626	4	100	48	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69	\N
627	4	101	48	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69	\N
628	3	104	48	http://www.mycancergenome.org/content/disease/lung-cancer/kras/69	\N
629	5	104	48	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
630	4	104	49	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37	\N
631	7	99	49	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37	\N
632	7	100	49	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37	\N
633	7	101	49	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37	\N
634	2	99	49	\N	\N
635	2	100	49	\N	\N
636	2	101	49	\N	\N
637	5	99	49	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
638	5	100	49	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
639	5	101	49	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
640	7	99	50	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32	\N
641	7	100	50	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32	\N
642	7	101	50	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32	\N
643	3	99	50	http://www.mycancergenome.org/content/disease/lung-cancer/kras/32	\N
644	3	100	50	http://www.mycancergenome.org/content/disease/lung-cancer/kras/32	\N
645	3	101	50	http://www.mycancergenome.org/content/disease/lung-cancer/kras/32	\N
646	5	105	50	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
647	5	106	50	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
648	4	105	51	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34	\N
649	4	106	51	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34	\N
650	7	105	51	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/34	\N
651	7	106	51	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/34	\N
652	3	105	51	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34	\N
653	3	106	51	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34	\N
654	3	107	51	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34	\N
655	3	108	51	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34	\N
656	3	109	51	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34	\N
657	3	110	51	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34	\N
658	2	111	51	\N	\N
659	5	112	51	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
660	5	113	51	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
661	4	114	52	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33	\N
662	4	112	52	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33	\N
663	4	115	52	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33	\N
664	7	114	52	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33	\N
665	7	112	52	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33	\N
666	7	116	52	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33	\N
667	7	117	52	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33	\N
668	7	118	52	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33	\N
669	7	119	52	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33	\N
670	7	120	52	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33	\N
671	3	114	52	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33	\N
672	3	112	52	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33	\N
673	3	116	52	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33	\N
674	3	118	52	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33	\N
675	3	119	52	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33	\N
676	3	120	52	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33	\N
677	5	112	52	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
678	5	116	52	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
679	4	114	53	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35	\N
680	4	112	53	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35	\N
681	4	113	53	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35	\N
682	4	119	53	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35	\N
683	4	120	53	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35	\N
684	7	121	53	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35	\N
685	7	122	53	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35	\N
686	7	123	53	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35	\N
687	3	121	53	http://www.mycancergenome.org/content/disease/lung-cancer/kras/35	\N
688	3	122	53	http://www.mycancergenome.org/content/disease/lung-cancer/kras/35	\N
689	3	123	53	http://www.mycancergenome.org/content/disease/lung-cancer/kras/35	\N
907	2	163	95	\N	\N
908	2	164	95	\N	\N
690	5	124	53	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
691	4	125	54	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36	\N
692	4	126	54	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36	\N
693	4	127	54	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36	\N
694	4	16	54	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36	\N
695	4	128	54	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36	\N
696	4	129	54	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36	\N
697	3	125	54	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36	\N
698	3	126	54	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36	\N
699	3	127	54	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36	\N
700	3	16	54	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36	\N
701	3	128	54	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36	\N
702	3	129	54	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36	\N
703	5	125	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
704	5	126	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
705	5	127	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
706	5	16	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
707	5	128	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
708	5	130	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
709	5	131	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
710	5	132	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
711	5	133	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
712	5	121	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
713	5	122	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
714	5	134	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
715	5	135	54	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
716	2	125	55	\N	\N
717	2	126	55	\N	\N
718	2	127	55	\N	\N
719	2	16	55	\N	\N
720	2	128	55	\N	\N
721	2	130	55	\N	\N
722	2	131	55	\N	\N
723	2	132	55	\N	\N
724	2	133	55	\N	\N
725	2	121	55	\N	\N
726	2	122	55	\N	\N
727	2	134	55	\N	\N
728	2	135	55	\N	\N
729	2	125	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
730	2	126	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
731	2	127	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
732	2	16	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
733	2	128	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
734	2	130	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
735	2	131	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
736	2	132	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
737	2	133	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
738	2	121	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
739	2	122	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
740	2	134	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
741	2	135	56	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
742	2	121	57	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284	\N
743	2	125	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
744	2	126	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
745	2	127	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
746	2	16	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
747	2	128	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
748	2	130	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
749	2	121	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
750	2	122	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
751	2	134	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
752	2	135	58	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
753	2	121	59	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
754	2	125	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
755	2	126	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
756	2	127	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
757	2	16	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
758	2	128	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
759	2	130	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
760	2	131	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
761	2	132	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
762	2	133	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
763	2	121	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
764	2	122	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
909	2	160	96	\N	\N
910	2	161	96	\N	\N
765	2	134	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
766	2	135	60	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
767	2	121	61	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
768	2	125	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
769	2	126	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
770	2	127	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
771	2	16	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
772	2	128	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
773	2	121	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
774	2	131	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
775	2	132	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
776	2	122	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
777	2	134	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
778	2	135	62	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
779	2	125	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
780	2	126	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
781	2	127	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
782	2	16	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
783	2	128	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
784	2	136	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
785	2	131	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
786	2	132	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
787	2	121	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
788	2	122	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
789	2	134	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
790	2	135	63	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
791	2	121	64	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
792	8	121	65	http://www.mycancergenome.org/content/disease/breast-cancer/akt1/23	\N
793	3	121	65	http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23	\N
794	3	122	65	http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23	\N
795	3	123	65	http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23	\N
796	5	137	65	http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23	\N
797	5	123	65	http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23	\N
798	8	137	66	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242	\N
799	8	123	66	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242	\N
800	8	121	67	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246	\N
801	8	122	67	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246	\N
802	8	123	67	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246	\N
803	8	121	68	http://www.mycancergenome.org/content/disease/breast-cancer/her2/239	\N
804	8	122	68	http://www.mycancergenome.org/content/disease/breast-cancer/her2/239	\N
805	8	123	68	http://www.mycancergenome.org/content/disease/breast-cancer/her2/239	\N
806	1	121	69	http://www.mycancergenome.org/content/disease/melanoma/mek1/210	\N
807	1	122	69	http://www.mycancergenome.org/content/disease/melanoma/mek1/210	\N
808	1	123	69	http://www.mycancergenome.org/content/disease/melanoma/mek1/210	\N
809	3	138	70	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/74	\N
810	3	139	70	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/74	\N
811	3	138	71	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/72	\N
812	3	139	71	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/72	\N
813	3	112	72	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60	\N
814	3	116	72	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60	\N
815	3	140	72	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60	\N
816	3	141	72	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60	\N
817	1	112	73	http://www.mycancergenome.org/content/disease/melanoma/mek1/211	\N
818	1	116	73	http://www.mycancergenome.org/content/disease/melanoma/mek1/211	\N
819	1	140	73	http://www.mycancergenome.org/content/disease/melanoma/mek1/211	\N
820	1	133	74	http://www.mycancergenome.org/content/disease/melanoma/mek1/212	\N
821	1	112	74	http://www.mycancergenome.org/content/disease/melanoma/mek1/212	\N
822	1	116	74	http://www.mycancergenome.org/content/disease/melanoma/mek1/212	\N
823	1	140	74	http://www.mycancergenome.org/content/disease/melanoma/mek1/212	\N
824	1	118	74	http://www.mycancergenome.org/content/disease/melanoma/mek1/212	\N
825	1	141	74	http://www.mycancergenome.org/content/disease/melanoma/mek1/212	\N
826	1	133	75	http://www.mycancergenome.org/content/disease/melanoma/mek1/214	\N
827	1	112	75	http://www.mycancergenome.org/content/disease/melanoma/mek1/214	\N
828	1	116	75	http://www.mycancergenome.org/content/disease/melanoma/mek1/214	\N
829	1	140	75	http://www.mycancergenome.org/content/disease/melanoma/mek1/214	\N
830	1	141	75	http://www.mycancergenome.org/content/disease/melanoma/mek1/214	\N
831	1	142	75	http://www.mycancergenome.org/content/disease/melanoma/mek1/214	\N
832	1	112	76	http://www.mycancergenome.org/content/disease/melanoma/mek1/213	\N
833	1	116	76	http://www.mycancergenome.org/content/disease/melanoma/mek1/213	\N
834	1	140	76	http://www.mycancergenome.org/content/disease/melanoma/mek1/213	\N
835	1	141	76	http://www.mycancergenome.org/content/disease/melanoma/mek1/213	\N
836	1	142	76	http://www.mycancergenome.org/content/disease/melanoma/mek1/213	\N
837	1	133	77	http://www.mycancergenome.org/content/disease/melanoma/mek1/215	\N
838	1	112	77	http://www.mycancergenome.org/content/disease/melanoma/mek1/215	\N
839	1	116	77	http://www.mycancergenome.org/content/disease/melanoma/mek1/215	\N
840	1	140	77	http://www.mycancergenome.org/content/disease/melanoma/mek1/215	\N
841	1	112	78	http://www.mycancergenome.org/content/disease/melanoma/mek1/216	\N
842	1	116	78	http://www.mycancergenome.org/content/disease/melanoma/mek1/216	\N
843	1	140	78	http://www.mycancergenome.org/content/disease/melanoma/mek1/216	\N
844	1	118	78	http://www.mycancergenome.org/content/disease/melanoma/mek1/216	\N
845	1	112	79	http://www.mycancergenome.org/content/disease/melanoma/mek1/217	\N
846	1	116	79	http://www.mycancergenome.org/content/disease/melanoma/mek1/217	\N
847	1	140	79	http://www.mycancergenome.org/content/disease/melanoma/mek1/217	\N
848	2	112	80	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272	\N
849	2	140	80	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272	\N
850	2	118	80	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272	\N
851	2	143	80	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272	\N
852	2	141	80	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272	\N
853	2	142	80	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272	\N
854	2	112	81	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271	\N
855	2	140	81	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271	\N
856	2	112	82	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
857	2	118	82	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
858	2	143	82	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
859	2	144	82	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
860	2	141	82	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
861	2	142	82	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
862	2	112	83	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268	\N
863	2	116	83	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268	\N
864	2	140	83	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268	\N
865	2	12	84	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266	\N
866	2	145	84	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266	\N
867	2	146	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
868	2	147	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
869	2	148	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
870	2	149	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
871	2	150	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
872	2	151	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
873	2	152	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
874	2	153	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
875	2	154	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
876	2	155	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
877	2	156	85	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
878	8	104	86	http://www.mycancergenome.org/content/disease/breast-cancer/her2/239/	\N
879	8	128	86	http://www.mycancergenome.org/content/disease/breast-cancer/her2/239/	\N
880	8	128	87	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242/	\N
881	8	104	87	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242/	\N
882	8	104	88	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/	\N
883	8	128	88	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/	\N
884	8	157	88	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/	\N
885	8	158	88	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246/	\N
886	8	121	89	http://www.mycancergenome.org/content/disease/breast-cancer/her2/240	\N
887	8	159	90	http://www.mycancergenome.org/content/disease/breast-cancer/her2/241	\N
888	8	159	91	http://www.mycancergenome.org/content/disease/breast-cancer/her2/247	\N
889	8	160	92	http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/	\N
890	8	161	92	http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/	\N
891	8	162	92	http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/	\N
892	8	163	92	http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/	\N
893	8	164	92	http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/	\N
894	8	160	93	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244	\N
895	8	161	93	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244	\N
896	8	162	93	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244	\N
897	8	163	93	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244	\N
898	8	164	93	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244	\N
899	8	160	94	http://www.mycancergenome.org/content/disease/breast-cancer/her2/245	\N
900	8	161	94	http://www.mycancergenome.org/content/disease/breast-cancer/her2/245	\N
901	8	162	94	http://www.mycancergenome.org/content/disease/breast-cancer/her2/245	\N
902	8	163	94	http://www.mycancergenome.org/content/disease/breast-cancer/her2/245	\N
903	8	164	94	http://www.mycancergenome.org/content/disease/breast-cancer/her2/245	\N
912	2	163	96	\N	\N
913	2	164	96	\N	\N
914	2	133	97	\N	\N
915	2	133	98	\N	\N
916	2	133	99	\N	\N
917	2	133	100	\N	\N
918	2	133	101	\N	\N
919	2	133	102	\N	\N
920	5	160	103	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
921	5	161	103	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
922	5	162	103	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
923	5	163	103	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
924	5	164	103	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
925	5	133	104	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154	\N
926	5	133	105	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152	\N
927	5	133	106	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155	\N
928	5	133	107	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156	\N
929	5	133	108	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
930	5	160	108	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
931	5	161	108	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
932	5	162	108	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
933	5	163	108	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
934	5	164	108	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
935	5	133	109	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
936	5	160	109	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
937	5	161	109	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
938	5	162	109	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
939	5	163	109	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
940	5	164	109	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
941	5	133	110	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153	\N
942	1	165	111	http://www.mycancergenome.org/content/disease/melanoma/gna11/101	\N
943	1	166	112	http://www.mycancergenome.org/content/disease/melanoma/gna11/99	\N
944	1	167	112	http://www.mycancergenome.org/content/disease/melanoma/gna11/99	\N
945	1	168	112	http://www.mycancergenome.org/content/disease/melanoma/gna11/99	\N
946	2	166	113	\N	\N
947	2	167	113	\N	\N
948	2	168	113	\N	\N
949	2	166	114	\N	\N
950	2	169	114	\N	\N
951	2	166	115	\N	\N
952	2	169	115	\N	\N
953	2	170	116	\N	\N
954	2	170	117	\N	\N
955	2	170	118	\N	\N
956	2	170	119	\N	\N
957	2	170	120	\N	\N
958	2	170	121	\N	\N
959	2	170	122	\N	\N
960	2	170	123	\N	\N
961	2	170	124	\N	\N
962	2	170	125	\N	\N
963	2	111	126	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264	\N
964	2	111	127	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/265	\N
965	2	111	128	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263	\N
966	2	171	129	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260	\N
967	2	172	129	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260	\N
968	2	173	129	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260	\N
969	2	171	130	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261	\N
970	2	172	130	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261	\N
971	2	173	130	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261	\N
972	2	171	131	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262	\N
973	2	172	131	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262	\N
974	2	173	131	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262	\N
975	2	171	132	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296	\N
976	2	172	132	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296	\N
977	2	173	132	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296	\N
978	2	171	133	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294	\N
979	2	172	133	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294	\N
980	2	173	133	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294	\N
981	2	171	134	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
982	2	172	134	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
983	2	173	134	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
984	2	171	135	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291	\N
985	2	172	135	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291	\N
986	2	173	135	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291	\N
987	2	171	136	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295	\N
988	2	172	136	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295	\N
989	2	173	136	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295	\N
990	2	174	137	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292	\N
991	9	174	138	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/184	\N
992	9	174	139	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/183	\N
993	9	175	139	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/183	\N
1110	2	184	158	\N	\N
994	9	174	140	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/181	\N
995	9	175	140	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/181	\N
996	9	166	141	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180	\N
997	9	176	141	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180	\N
998	9	177	141	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180	\N
999	9	178	141	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180	\N
1000	9	179	141	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180	\N
1001	9	180	141	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180	\N
1002	9	181	142	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/182	\N
1003	10	182	143	http://www.mycancergenome.org/content/disease/rhabdomyosarcoma/alk/187	\N
1004	9	182	144	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/178	\N
1005	9	182	145	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/176	\N
1006	9	182	146	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/179	\N
1007	9	183	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177	\N
1008	9	184	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177	\N
1009	9	185	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177	\N
1010	9	186	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177	\N
1011	9	187	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177	\N
1012	9	188	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177	\N
1013	9	189	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177	\N
1014	9	190	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177	\N
1015	9	3	147	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177	\N
1016	9	191	148	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175	\N
1017	9	192	148	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175	\N
1018	9	193	148	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175	\N
1019	9	188	148	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175	\N
1020	9	186	148	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175	\N
1021	9	3	148	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175	\N
1022	9	194	149	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174	\N
1023	9	195	149	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174	\N
1024	9	188	149	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174	\N
1025	9	186	149	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174	\N
1026	9	184	149	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174	\N
1027	9	196	149	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174	\N
1028	9	183	149	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174	\N
1029	9	3	149	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174	\N
1030	9	197	150	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173	\N
1031	9	198	150	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173	\N
1032	9	186	150	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173	\N
1033	9	188	150	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173	\N
1034	9	190	150	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173	\N
1035	9	3	150	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173	\N
1036	2	188	151	\N	\N
1037	2	197	151	\N	\N
1038	2	3	151	\N	\N
1039	2	186	152	\N	\N
1040	2	188	152	\N	\N
1041	2	190	152	\N	\N
1042	2	3	152	\N	\N
1043	2	183	153	\N	\N
1044	2	184	153	\N	\N
1045	2	194	153	\N	\N
1046	2	186	153	\N	\N
1047	2	199	153	\N	\N
1048	2	200	153	\N	\N
1049	2	201	153	\N	\N
1050	2	197	153	\N	\N
1051	2	202	153	\N	\N
1052	2	203	153	\N	\N
1053	2	190	153	\N	\N
1054	2	195	153	\N	\N
1055	2	204	153	\N	\N
1056	2	205	153	\N	\N
1057	2	3	153	\N	\N
1058	2	206	154	\N	\N
1059	2	207	154	\N	\N
1060	2	208	154	\N	\N
1061	2	209	154	\N	\N
1062	2	210	154	\N	\N
1063	2	211	154	\N	\N
1064	2	202	154	\N	\N
1065	2	188	154	\N	\N
1066	2	195	154	\N	\N
1067	2	190	154	\N	\N
1068	2	4	154	\N	\N
1069	2	2	154	\N	\N
1070	2	183	154	\N	\N
1071	2	212	154	\N	\N
1072	2	213	154	\N	\N
1073	2	214	154	\N	\N
1074	2	3	154	\N	\N
1075	2	183	155	\N	\N
1076	2	202	155	\N	\N
1077	2	188	155	\N	\N
1078	2	190	155	\N	\N
1079	2	2	155	\N	\N
1080	2	215	155	\N	\N
1081	2	207	155	\N	\N
1082	2	216	155	\N	\N
1083	2	217	155	\N	\N
1084	2	3	155	\N	\N
1085	2	184	156	\N	\N
1086	2	202	156	\N	\N
1087	2	204	156	\N	\N
1088	2	218	156	\N	\N
1089	2	3	156	\N	\N
1090	2	219	157	\N	\N
1091	2	220	157	\N	\N
1092	2	196	157	\N	\N
1093	2	221	157	\N	\N
1094	2	222	157	\N	\N
1095	2	184	157	\N	\N
1096	2	223	157	\N	\N
1097	2	224	157	\N	\N
1098	2	186	157	\N	\N
1099	2	183	157	\N	\N
1100	2	202	157	\N	\N
1101	2	188	157	\N	\N
1102	2	190	157	\N	\N
1103	2	2	157	\N	\N
1104	2	207	157	\N	\N
1105	2	195	157	\N	\N
1106	2	225	157	\N	\N
1107	2	211	157	\N	\N
1108	2	226	157	\N	\N
1109	2	3	157	\N	\N
1111	2	227	158	\N	\N
1112	2	228	158	\N	\N
1113	2	229	158	\N	\N
1114	2	188	158	\N	\N
1115	2	186	158	\N	\N
1116	2	3	158	\N	\N
1117	2	183	159	\N	\N
1118	2	230	159	\N	\N
1119	2	227	159	\N	\N
1120	2	186	159	\N	\N
1121	2	188	159	\N	\N
1122	2	195	159	\N	\N
1123	2	3	159	\N	\N
1124	2	183	160	\N	\N
1125	2	220	160	\N	\N
1126	2	202	160	\N	\N
1127	2	188	160	\N	\N
1128	2	195	160	\N	\N
1129	2	190	160	\N	\N
1130	2	225	160	\N	\N
1131	2	231	160	\N	\N
1132	2	232	160	\N	\N
1133	2	233	160	\N	\N
1134	2	234	160	\N	\N
1135	2	235	160	\N	\N
1136	2	201	160	\N	\N
1137	2	236	160	\N	\N
1138	2	3	160	\N	\N
1139	2	183	161	\N	\N
1140	2	188	161	\N	\N
1141	2	190	161	\N	\N
1142	2	204	161	\N	\N
1143	2	237	161	\N	\N
1144	2	238	161	\N	\N
1145	2	235	161	\N	\N
1146	2	3	161	\N	\N
1147	8	183	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
1148	8	188	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
1149	8	184	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
1150	8	186	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
1151	8	202	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
1152	8	210	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
1153	8	239	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
1154	8	231	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
1155	8	240	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
1156	8	3	162	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
1157	7	227	162	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7	\N
1158	7	183	162	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7	\N
1159	7	241	162	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7	\N
1160	7	202	162	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7	\N
1161	7	188	162	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7	\N
1162	7	190	162	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7	\N
1163	7	3	162	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7	\N
1164	3	210	162	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
1165	5	210	162	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
1166	8	210	163	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
1167	7	210	163	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/8	\N
1168	3	210	163	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
1169	5	210	163	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
1170	8	210	164	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
1171	3	210	164	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
1172	5	210	164	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
1173	8	210	165	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
1174	7	210	165	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/12	\N
1175	5	210	165	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
1176	8	210	166	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
1177	5	242	166	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
1178	8	242	167	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
1179	5	243	167	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
1180	5	244	167	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
1181	8	243	168	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
1182	8	244	168	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
1183	7	243	168	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/16	\N
1184	7	244	168	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/16	\N
1185	5	244	168	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
1186	5	243	168	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
1187	8	243	169	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
1188	8	244	169	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
1189	5	243	169	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
1190	5	244	169	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
1191	8	243	170	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
1192	8	244	170	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
1193	5	243	170	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
1194	5	244	170	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
1195	8	243	171	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
1196	8	244	171	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
1197	5	244	171	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
1198	5	243	171	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
1199	8	243	172	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
1200	8	244	172	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
1201	8	243	173	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
2569	2	164	343	\N	\N
1202	8	244	173	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
1203	5	245	173	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
1204	5	3	173	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
1205	8	246	174	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
1206	7	247	174	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/11	\N
1207	7	248	174	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/11	\N
1208	3	249	174	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
1209	5	250	174	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
1210	8	251	175	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
1211	7	252	175	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/10	\N
1212	3	251	175	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
1213	5	251	175	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
1214	1	253	176	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105	\N
1215	1	253	177	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104	\N
1216	1	254	178	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107	\N
1217	1	3	178	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107	\N
1218	1	255	179	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108	\N
1219	1	3	179	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108	\N
1220	1	256	180	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106	\N
1221	1	257	180	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106	\N
1222	11	256	181	http://www.mycancergenome.org/content/disease/gist/pdgfra/48	\N
1223	11	257	181	http://www.mycancergenome.org/content/disease/gist/pdgfra/48	\N
1224	11	256	182	http://www.mycancergenome.org/content/disease/gist/pdgfra/51	\N
1225	11	256	183	http://www.mycancergenome.org/content/disease/gist/pdgfra/51	\N
1226	11	257	183	http://www.mycancergenome.org/content/disease/gist/pdgfra/51	\N
1227	11	258	183	http://www.mycancergenome.org/content/disease/gist/pdgfra/51	\N
1228	11	256	184	http://www.mycancergenome.org/content/disease/gist/pdgfra/45	\N
1229	11	258	184	http://www.mycancergenome.org/content/disease/gist/pdgfra/45	\N
1230	12	256	185	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/218	\N
1231	12	258	185	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/218	\N
1232	1	256	186	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1233	1	259	187	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1234	1	260	188	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1235	1	261	189	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1236	12	262	189	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/124	\N
1237	1	20	190	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1238	1	3	190	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1239	1	263	191	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1240	1	3	191	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1241	1	264	192	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1242	1	3	192	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1243	1	265	193	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1244	1	266	193	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1245	1	267	193	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1246	1	20	193	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1247	1	268	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1248	1	269	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1249	1	270	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1250	1	271	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1251	1	272	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1252	1	273	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1253	1	274	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1254	1	275	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1255	1	276	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1256	1	277	194	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1257	1	268	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1258	1	269	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1259	1	270	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1260	1	271	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1261	1	272	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1262	1	273	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1263	1	274	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1264	1	275	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1265	1	276	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1266	1	277	195	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1267	1	268	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1268	1	269	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1269	1	270	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1270	1	271	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1271	1	272	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1272	1	273	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1273	1	274	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1274	1	275	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
2570	2	160	349	\N	\N
1275	1	276	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1276	1	277	196	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1277	1	268	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1278	1	269	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1279	1	270	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1280	1	278	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1281	1	279	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1282	1	280	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1283	1	281	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1284	1	282	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1285	1	283	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1286	1	284	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1287	1	285	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1288	1	286	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1289	1	287	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1290	1	288	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1291	1	289	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1292	1	277	197	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1293	1	268	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1294	1	269	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1295	1	270	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1296	1	271	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1297	1	290	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1298	1	291	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1299	1	292	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1300	1	293	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1301	1	294	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1302	1	295	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1303	1	296	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1304	1	297	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1305	1	298	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1306	1	299	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1307	1	300	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1308	1	301	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1309	1	276	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1310	1	275	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1311	1	277	198	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1312	1	268	199	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1313	1	269	199	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1314	1	270	199	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1315	1	271	199	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1316	1	276	199	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1317	1	277	199	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1318	12	302	199	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/110	\N
1319	12	303	199	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/110	\N
1320	1	302	200	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1321	1	303	200	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1322	1	302	201	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1323	1	303	201	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1324	1	302	202	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1325	1	303	202	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1326	1	302	203	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1327	1	303	203	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1328	1	302	204	\N	\N
1329	1	303	204	\N	\N
1330	12	302	204	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112	\N
1331	12	303	204	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112	\N
1332	1	302	205	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1333	1	303	205	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1334	12	302	206	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123	\N
1335	12	303	206	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123	\N
1336	1	302	207	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1337	1	303	207	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1338	1	302	208	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1339	1	303	208	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1340	1	302	209	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1341	1	303	209	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1342	1	302	210	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1343	1	303	210	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1344	1	302	211	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1345	1	303	211	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1346	1	302	212	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1347	1	303	212	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1348	1	304	213	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1349	1	305	213	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1350	1	304	214	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1351	1	306	215	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1352	1	304	215	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1353	1	302	216	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1354	1	255	216	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1355	1	307	216	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1356	1	302	217	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1357	1	255	217	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1358	1	307	217	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1359	1	302	218	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1360	1	255	218	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1361	1	307	218	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1362	1	308	219	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1363	1	307	219	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1364	1	307	220	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1365	1	302	221	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1366	1	255	221	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1367	1	307	221	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1368	1	302	222	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1369	1	255	222	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1370	1	307	222	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1371	1	302	223	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
1372	1	255	223	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
1373	1	307	223	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
1374	12	302	223	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96	\N
1375	12	255	223	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96	\N
1376	12	307	223	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96	\N
1377	12	302	224	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122	\N
1378	12	255	224	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122	\N
1379	12	307	224	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122	\N
1380	1	302	225	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1381	1	303	225	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1382	1	309	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1383	1	79	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1384	1	80	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1385	1	81	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1386	1	82	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1387	1	83	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1388	1	84	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1389	1	310	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1390	1	311	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1391	1	312	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1392	1	281	226	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1393	1	309	227	\N	\N
1394	1	79	227	\N	\N
1395	1	80	227	\N	\N
1396	1	81	227	\N	\N
1397	1	82	227	\N	\N
1398	1	83	227	\N	\N
1399	1	84	227	\N	\N
1400	1	310	227	\N	\N
1401	1	311	227	\N	\N
1402	1	312	227	\N	\N
1403	1	281	227	\N	\N
1404	1	309	228	\N	\N
1405	1	79	228	\N	\N
1406	1	80	228	\N	\N
1407	1	81	228	\N	\N
1408	1	82	228	\N	\N
1409	1	83	228	\N	\N
1410	1	84	228	\N	\N
1411	1	310	228	\N	\N
1412	1	311	228	\N	\N
1413	1	312	228	\N	\N
1414	1	281	228	\N	\N
1415	1	309	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1416	1	79	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1417	1	80	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1418	1	81	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1419	1	82	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1420	1	83	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1421	1	84	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1422	1	310	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1423	1	311	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1424	1	312	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1425	1	281	229	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1426	1	309	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1427	1	79	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1428	1	80	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1429	1	81	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1430	1	82	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1431	1	83	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1432	1	84	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1433	1	310	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1434	1	311	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1435	1	312	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1436	1	281	230	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1437	1	313	231	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1438	1	314	231	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1439	1	315	231	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1440	1	316	231	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1441	1	317	231	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1442	1	318	231	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1443	1	319	231	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1444	1	320	232	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1445	12	320	233	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/121	\N
1446	1	320	234	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
1447	2	320	234	\N	\N
1448	1	320	235	\N	\N
1449	2	320	235	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/274	\N
1450	11	276	235	\N	\N
1451	11	277	235	\N	\N
1452	2	276	236	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/276	\N
1453	2	277	236	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/276	\N
1454	1	276	237	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1455	1	277	237	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1456	2	276	237	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275	\N
1457	2	277	237	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275	\N
1458	11	276	237	\N	\N
1459	11	277	237	\N	\N
1460	1	321	238	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
1461	1	321	239	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1462	1	322	240	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1463	12	322	241	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/120	\N
1464	1	323	242	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1465	1	3	242	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1466	1	324	243	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1467	1	325	244	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1468	1	3	244	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1469	1	326	245	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1470	1	327	245	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1471	1	328	246	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1472	1	326	246	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1473	1	329	246	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1474	1	330	247	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1475	1	326	247	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1476	1	331	248	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1477	1	330	248	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1478	1	326	248	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1479	1	332	249	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1480	1	333	249	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1481	1	334	249	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1482	1	335	249	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
1483	2	326	250	\N	\N
1484	2	334	250	\N	\N
1485	2	336	250	\N	\N
1486	2	337	251	\N	\N
1487	2	332	252	\N	\N
1488	2	338	253	\N	\N
1489	2	326	253	\N	\N
1490	2	339	253	\N	\N
1491	13	340	254	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
1492	13	341	255	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
1493	13	341	256	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
1494	13	341	257	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
1495	13	342	258	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
1496	13	3	258	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
1497	13	343	259	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
1498	13	344	260	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
1499	13	344	261	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
1500	14	344	262	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/164	\N
1501	14	344	263	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/165	\N
1502	14	345	264	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/166	\N
1503	14	346	264	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/166	\N
1504	14	347	264	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/166	\N
1505	14	344	265	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/163	\N
1506	15	345	265	http://www.mycancergenome.org/content/disease/medulloblastoma/smo/163	\N
1507	15	346	265	http://www.mycancergenome.org/content/disease/medulloblastoma/smo/163	\N
1508	15	347	265	http://www.mycancergenome.org/content/disease/medulloblastoma/smo/163	\N
1509	14	344	266	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/167	\N
1510	14	344	267	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/168	\N
1511	14	344	268	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/169	\N
1512	14	344	269	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/170	\N
1513	14	344	270	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/171	\N
1514	14	344	271	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/172	\N
1515	1	344	272	\N	\N
1516	1	344	273	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
1517	1	344	274	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
1518	16	344	275	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
2571	2	161	349	\N	\N
2572	2	162	349	\N	\N
1519	4	345	275	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
1520	4	346	275	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
1521	4	347	275	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
1522	7	348	275	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54	\N
1523	11	349	275	http://www.mycancergenome.org/content/disease/gist/braf/54	\N
1524	5	349	275	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1525	1	350	276	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
1526	1	351	277	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
1527	7	352	278	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138	\N
1528	7	353	278	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138	\N
1529	1	3	279	http://www.mycancergenome.org/content/disease/melanoma/braf/301	\N
1530	5	354	280	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
1531	5	355	280	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
1532	5	41	280	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
1533	5	96	280	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
1534	5	97	280	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
1535	5	51	280	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
1536	5	356	280	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
1537	1	354	281	http://www.mycancergenome.org/content/disease/melanoma/braf/148	\N
1538	1	355	281	http://www.mycancergenome.org/content/disease/melanoma/braf/148	\N
1539	1	41	281	http://www.mycancergenome.org/content/disease/melanoma/braf/148	\N
1540	1	96	281	http://www.mycancergenome.org/content/disease/melanoma/braf/148	\N
1541	1	97	281	http://www.mycancergenome.org/content/disease/melanoma/braf/148	\N
1542	1	51	281	http://www.mycancergenome.org/content/disease/melanoma/braf/148	\N
1543	5	354	281	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148	\N
1544	5	355	281	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148	\N
1545	5	41	281	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148	\N
1546	5	357	281	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148	\N
1547	1	355	282	\N	\N
1548	1	356	282	\N	\N
1549	1	355	283	\N	\N
1550	1	356	283	\N	\N
1551	1	355	284	http://www.mycancergenome.org/content/disease/melanoma/braf/300	\N
1552	1	356	284	http://www.mycancergenome.org/content/disease/melanoma/braf/300	\N
1553	1	355	285	http://www.mycancergenome.org/content/disease/melanoma/braf/298	\N
1554	1	356	285	http://www.mycancergenome.org/content/disease/melanoma/braf/298	\N
1555	1	355	286	http://www.mycancergenome.org/content/disease/melanoma/braf/299	\N
1556	1	356	286	http://www.mycancergenome.org/content/disease/melanoma/braf/299	\N
1557	16	355	287	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
1558	16	356	287	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
1559	5	80	288	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147	\N
1560	5	358	288	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147	\N
1561	16	80	289	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
1562	16	358	289	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
1563	5	80	289	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71	\N
1564	5	358	289	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71	\N
1565	5	80	290	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146	\N
1566	5	358	290	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146	\N
1567	16	80	291	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
1568	16	358	291	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
1569	16	80	292	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
1570	16	358	292	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
1571	5	359	292	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70	\N
1572	5	317	292	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70	\N
1573	5	318	292	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70	\N
1574	3	359	293	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
1575	3	317	293	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
1576	3	318	293	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
1577	3	359	294	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
1578	3	317	294	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
1579	3	318	294	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
1580	3	248	295	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
1581	3	360	295	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
1582	3	361	295	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
1583	3	362	296	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
1584	3	247	297	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
1585	3	360	297	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
1586	3	248	297	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
1587	3	363	298	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6	\N
1588	2	364	299	\N	\N
1589	17	365	300	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200	\N
1590	17	366	301	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203	\N
1591	17	367	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
1592	17	41	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
1593	17	357	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
1594	17	96	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
1595	17	97	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
1596	17	368	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
1597	17	369	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
1598	17	370	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
1599	17	371	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
1600	17	372	302	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
1601	17	41	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1602	17	367	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1603	17	371	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1604	17	372	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1605	17	369	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1606	17	370	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1607	17	373	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1608	17	97	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1609	17	51	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1610	17	374	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1611	17	96	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1612	17	375	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1613	17	368	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1614	17	376	303	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1615	1	41	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
1616	1	367	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
1617	1	97	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
1618	1	51	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
1619	1	374	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
1620	1	96	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
1621	1	375	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
1622	1	368	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
1623	1	369	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
1624	1	370	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
1625	1	371	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
1626	1	372	304	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
1627	1	41	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1628	1	367	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1629	1	377	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1630	1	373	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1631	1	97	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1632	1	51	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1633	1	374	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1634	1	96	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1635	1	375	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1636	1	368	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1637	1	369	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1638	1	370	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1639	1	371	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1640	1	372	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1641	1	378	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1642	1	379	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1643	1	380	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1644	1	381	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1645	1	382	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1646	1	383	305	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
1647	1	41	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
1648	1	367	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
1649	1	384	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
1650	1	376	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
1651	1	97	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
1652	1	51	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
1653	1	374	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
1654	1	96	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
1655	1	375	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
1656	1	368	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
1657	1	369	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
1658	1	370	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
1659	1	371	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
1660	1	372	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
1661	1	366	306	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
1662	17	41	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1663	17	367	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1664	17	377	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1665	17	373	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1667	17	51	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1668	17	96	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1669	17	375	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1670	17	368	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1671	17	97	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1672	17	369	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1673	17	370	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1674	17	372	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1675	17	371	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1676	17	385	307	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1678	18	1	308	\N	\N
1679	18	2	308	\N	\N
1680	18	3	308	\N	\N
1681	18	4	309	\N	\N
1682	18	3	309	\N	\N
1683	18	5	309	\N	\N
1684	18	6	310	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1685	18	7	310	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1686	18	8	310	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1687	18	9	310	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
1688	18	10	311	\N	\N
1689	18	11	311	\N	\N
1690	18	11	312	\N	\N
1691	18	12	313	\N	\N
1693	18	13	313	\N	\N
1694	18	14	313	\N	\N
1695	18	15	313	\N	\N
1696	18	13	314	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200	\N
1697	18	16	314	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200	\N
1698	18	17	314	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200	\N
1699	18	11	314	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200	\N
1700	18	13	315	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203	\N
1701	18	16	315	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203	\N
1702	18	17	315	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203	\N
1703	18	11	315	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203	\N
1704	18	13	316	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
1705	18	16	316	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
1706	18	17	316	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
1707	18	11	316	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
1708	18	13	317	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1709	18	16	317	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1710	18	17	317	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1711	18	11	317	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
1712	5	18	318	\N	\N
1713	5	19	318	\N	\N
1714	5	20	318	\N	\N
1715	5	3	318	\N	\N
1716	5	21	319	\N	\N
1717	5	22	319	\N	\N
1718	5	23	319	\N	\N
1719	5	3	319	\N	\N
1720	5	18	320	\N	\N
1721	5	24	320	\N	\N
1722	5	25	320	\N	\N
1723	5	22	320	\N	\N
1724	5	3	320	\N	\N
1725	5	22	321	\N	\N
1726	5	23	321	\N	\N
1727	5	26	321	\N	\N
1728	5	3	321	\N	\N
1729	5	22	322	\N	\N
1730	5	23	322	\N	\N
1731	5	26	322	\N	\N
1732	5	27	322	\N	\N
1733	5	28	322	\N	\N
1734	5	29	322	\N	\N
1735	5	30	322	\N	\N
1736	5	3	322	\N	\N
1737	5	23	323	\N	\N
1738	5	26	323	\N	\N
1739	5	31	323	\N	\N
1740	5	29	323	\N	\N
1741	5	30	323	\N	\N
1742	5	27	323	\N	\N
1743	5	3	323	\N	\N
1744	5	22	324	\N	\N
1745	5	18	324	\N	\N
1746	5	32	324	\N	\N
1747	5	33	324	\N	\N
1748	5	3	324	\N	\N
1749	5	22	325	\N	\N
1750	5	23	325	\N	\N
1751	5	26	325	\N	\N
1752	5	27	325	\N	\N
1753	5	3	325	\N	\N
1754	5	22	326	\N	\N
1755	5	23	326	\N	\N
1756	5	27	326	\N	\N
1757	5	34	326	\N	\N
1758	5	35	326	\N	\N
1759	5	30	326	\N	\N
1760	5	3	326	\N	\N
1761	5	22	327	\N	\N
1762	5	23	327	\N	\N
1763	5	26	327	\N	\N
1764	5	27	327	\N	\N
1765	5	28	327	\N	\N
1766	5	25	327	\N	\N
1767	5	29	327	\N	\N
1768	5	30	327	\N	\N
1769	5	33	327	\N	\N
1770	5	35	327	\N	\N
1771	5	18	327	\N	\N
1772	5	3	327	\N	\N
1774	5	36	318	http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23	\N
1775	5	37	318	http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23	\N
1776	5	38	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1777	5	39	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
2592	2	161	359	\N	\N
2593	2	162	359	\N	\N
1778	5	40	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1779	5	41	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1780	5	42	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1781	5	43	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1782	5	44	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1783	5	45	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1784	5	46	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1785	5	47	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1786	5	48	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1787	5	49	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1788	5	50	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1789	5	51	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1790	5	52	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1791	5	53	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1792	5	54	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1793	5	55	328	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
1794	5	38	329	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/150	\N
1795	5	39	329	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/150	\N
1796	5	40	329	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/150	\N
1797	5	41	329	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/150	\N
1798	5	56	329	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/150	\N
1799	5	38	330	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
1800	5	39	330	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
1801	5	40	330	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
1802	5	41	330	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
1803	5	57	330	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
1804	5	58	330	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
1805	5	59	330	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
1806	5	56	330	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
1807	5	38	331	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148	\N
1808	5	39	331	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148	\N
1809	5	40	331	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148	\N
1810	5	41	331	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148	\N
1811	5	56	331	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148	\N
1812	5	49	331	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148	\N
1813	5	38	332	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147	\N
1814	5	39	332	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147	\N
1815	5	40	332	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147	\N
1816	5	60	332	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147	\N
1817	5	41	332	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147	\N
1818	5	56	332	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147	\N
1819	5	38	333	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71	\N
1820	5	39	333	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71	\N
1821	5	40	333	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71	\N
1822	5	60	333	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71	\N
1823	5	41	333	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71	\N
1824	5	56	333	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71	\N
1825	5	38	334	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146	\N
1826	5	39	334	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146	\N
1827	5	40	334	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146	\N
1828	5	60	334	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146	\N
1829	5	41	334	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146	\N
1830	5	56	334	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146	\N
1831	5	38	335	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70	\N
1832	5	39	335	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70	\N
1833	5	40	335	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70	\N
1834	5	60	335	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70	\N
1835	5	41	335	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70	\N
1836	5	56	335	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70	\N
1837	5	61	336	\N	\N
1838	5	62	337	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
1839	5	63	337	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
1840	5	64	337	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
1841	5	65	337	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
2573	2	163	349	\N	\N
2574	2	164	349	\N	\N
1842	5	66	337	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
1843	5	67	337	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
1844	5	68	337	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
1845	5	69	337	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
1846	5	62	338	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
1847	5	63	338	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
1848	5	64	338	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
1849	5	65	338	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
1850	5	66	338	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
1851	5	67	338	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
1852	5	68	338	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
1853	5	69	338	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
1854	5	62	339	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
1855	5	63	339	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
1856	5	64	339	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
1857	5	65	339	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
1858	5	66	339	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
1859	5	67	339	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
1860	5	68	339	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
1861	5	69	339	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
1862	5	62	340	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
1863	5	63	340	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
1864	5	64	340	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
1865	5	65	340	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
1866	5	66	340	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
1867	5	67	340	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
1868	5	68	340	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
1869	5	69	340	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
1870	5	62	341	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
1871	5	63	341	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
1872	5	64	341	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
1873	5	65	341	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
1874	5	66	341	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
1875	5	67	341	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
1876	5	68	341	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
1877	5	69	341	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
1878	5	62	342	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
1879	5	63	342	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
1880	5	64	342	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
1881	5	65	342	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
1882	5	66	342	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
1883	5	67	342	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
1884	5	68	342	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
1885	5	69	342	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
1886	5	62	343	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
1887	5	63	343	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
1888	5	64	343	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
1889	5	65	343	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
1890	5	66	343	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
1891	5	67	343	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
1892	5	68	343	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
1893	5	69	343	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
1894	5	62	344	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
1895	5	63	344	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
1896	5	64	344	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
1897	5	65	344	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
1898	5	66	344	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
1899	5	67	344	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
1900	5	68	344	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
1901	5	69	344	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
1902	5	62	345	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
1903	5	63	345	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
1904	5	64	345	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
1905	5	65	345	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
1906	5	66	345	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
1907	5	67	345	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
1908	5	68	345	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
1909	5	69	345	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
1910	5	62	346	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
1911	5	63	346	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
1912	5	64	346	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
1913	5	65	346	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
1914	5	66	346	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
1915	5	67	346	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
1916	5	68	346	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
1917	5	69	346	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
1918	5	62	347	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
1919	5	63	347	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
1920	5	64	347	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
1921	5	65	347	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
1922	5	66	347	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
1923	5	67	347	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
1924	5	68	347	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
1925	5	69	347	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
1926	5	62	348	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
1927	5	63	348	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
1928	5	64	348	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
1929	5	65	348	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
1930	5	66	348	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
1931	5	67	348	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
1932	5	68	348	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
1933	5	69	348	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
1934	5	62	349	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
1935	5	63	349	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
1936	5	64	349	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
1937	5	65	349	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
1938	5	66	349	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
1939	5	67	349	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
1940	5	68	349	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
1941	5	69	349	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
1942	5	70	349	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
1943	5	71	349	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
1944	5	72	349	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
1945	5	62	350	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
1946	5	63	350	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
1947	5	64	350	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
1948	5	65	350	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
1949	5	66	350	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
1950	5	67	350	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
1951	5	68	350	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
1952	5	69	350	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
1953	5	62	351	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
1954	5	63	351	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
1955	5	64	351	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
1956	5	65	351	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
1957	5	66	351	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
1958	5	67	351	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
1959	5	68	351	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
1960	5	69	351	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
1961	5	62	352	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
1962	5	63	352	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
1963	5	64	352	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
1964	5	65	352	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
1965	5	66	352	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
1966	5	67	352	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
1967	5	68	352	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
1968	5	69	352	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
1969	5	62	353	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
1970	5	63	353	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
1971	5	64	353	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
1972	5	65	353	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
1973	5	66	353	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
1974	5	67	353	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
1975	5	68	353	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
1976	5	69	353	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
1977	5	62	354	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
1978	5	63	354	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
1979	5	64	354	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
2575	2	160	353	\N	\N
2576	2	161	353	\N	\N
1980	5	65	354	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
1981	5	66	354	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
1982	5	67	354	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
1983	5	68	354	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
1984	5	69	354	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
1985	5	62	355	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
1986	5	63	355	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
1987	5	64	355	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
1988	5	65	355	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
1989	5	66	355	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
1990	5	67	355	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
1991	5	68	355	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
1992	5	69	355	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
1993	5	62	356	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
1994	5	63	356	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
1995	5	64	356	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
1996	5	65	356	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
1997	5	66	356	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
1998	5	67	356	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
1999	5	68	356	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
2000	5	69	356	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
2001	5	62	357	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
2002	5	63	357	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
2003	5	64	357	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
2004	5	65	357	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
2005	5	66	357	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
2006	5	67	357	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
2007	5	68	357	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
2008	5	69	357	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
2009	5	62	358	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
2010	5	63	358	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
2011	5	64	358	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
2012	5	65	358	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
2013	5	66	358	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
2014	5	67	358	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
2015	5	68	358	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
2016	5	69	358	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
2017	5	49	359	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77	\N
2018	5	73	359	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77	\N
2019	5	74	359	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77	\N
2020	5	75	359	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77	\N
2021	5	76	359	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77	\N
2022	5	77	359	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77	\N
2023	5	78	359	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77	\N
2024	5	49	360	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
2025	5	73	360	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
2026	5	74	360	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
2027	5	75	360	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
2028	5	76	360	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
2029	5	77	360	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
2030	5	78	360	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
2031	5	49	361	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
2032	5	73	361	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
2033	5	74	361	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
2034	5	75	361	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
2035	5	76	361	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
2036	5	77	361	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
2037	5	78	361	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
2038	5	49	362	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
2039	5	73	362	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
2040	5	74	362	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
2041	5	75	362	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
2042	5	76	362	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
2043	5	77	362	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
2044	5	78	362	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
2045	5	49	363	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
2046	5	73	363	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
2047	5	74	363	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
2048	5	75	363	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
2049	5	76	363	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
2050	5	77	363	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
2051	5	78	363	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
2052	5	49	364	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86	\N
2053	5	73	364	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86	\N
2054	5	74	364	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86	\N
2055	5	75	364	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86	\N
2056	5	76	364	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86	\N
2057	5	77	364	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86	\N
2058	5	78	364	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86	\N
2059	5	49	365	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
2060	5	73	365	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
2061	5	74	365	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
2062	5	75	365	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
2063	5	76	365	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
2064	5	77	365	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
2065	5	78	365	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
2066	5	79	366	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
2067	5	80	366	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
2068	5	81	366	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
2069	5	82	366	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
2070	5	83	366	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
2071	5	84	366	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
2072	5	85	366	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
2073	5	86	366	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
2074	5	49	366	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
2075	5	87	366	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
2076	5	79	367	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
2077	5	80	367	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
2078	5	81	367	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
2079	5	82	367	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
2080	5	83	367	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
2081	5	84	367	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
2082	5	85	367	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
2083	5	86	367	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
2084	5	49	367	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
2085	5	87	367	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
2086	5	79	368	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
2087	5	80	368	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
2088	5	81	368	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
2089	5	82	368	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
2090	5	83	368	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
2091	5	84	368	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
2092	5	85	368	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
2093	5	86	368	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
2094	5	49	368	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
2095	5	87	368	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
2096	5	79	369	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
2097	5	80	369	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
2098	5	81	369	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
2099	5	82	369	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
2100	5	83	369	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
2101	5	84	369	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
2102	5	85	369	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
2103	5	86	369	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
2104	5	49	369	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
2105	5	87	369	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
2106	5	79	370	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
2107	5	80	370	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
2108	5	81	370	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
2109	5	82	370	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
2110	5	83	370	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
2111	5	84	370	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
2112	5	85	370	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
2113	5	86	370	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
2114	5	49	370	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
2115	5	87	370	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
2577	2	162	353	\N	\N
2578	2	163	353	\N	\N
2116	5	79	371	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
2117	5	80	371	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
2118	5	81	371	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
2594	2	163	359	\N	\N
2595	2	164	359	\N	\N
2119	5	82	371	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
2120	5	83	371	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
2121	5	84	371	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
2122	5	85	371	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
2123	5	86	371	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
2124	5	49	371	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
2125	5	87	371	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
2126	5	79	372	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
2127	5	80	372	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
2128	5	81	372	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
2129	5	82	372	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
2130	5	83	372	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
2131	5	84	372	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
2132	5	85	372	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
2133	5	86	372	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
2134	5	49	372	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
2135	5	87	372	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
2136	5	79	373	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
2137	5	80	373	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
2138	5	81	373	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
2139	5	82	373	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
2140	5	83	373	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
2141	5	84	373	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
2142	5	85	373	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
2143	5	86	373	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
2144	5	49	373	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
2145	5	87	373	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
2146	5	79	374	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
2147	5	80	374	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
2148	5	81	374	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
2149	5	82	374	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
2150	5	83	374	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
2151	5	84	374	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
2152	5	85	374	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
2153	5	86	374	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
2154	5	49	374	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
2155	5	87	374	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
2156	5	79	375	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
2157	5	80	375	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
2158	5	81	375	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
2159	5	82	375	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
2160	5	83	375	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
2161	5	84	375	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
2162	5	85	375	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
2163	5	86	375	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
2164	5	49	375	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
2165	5	87	375	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
2166	5	79	376	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
2167	5	80	376	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
2168	5	81	376	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
2169	5	82	376	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
2170	5	83	376	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
2171	5	84	376	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
2172	5	85	376	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
2173	5	86	376	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
2174	5	49	376	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
2175	5	87	376	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
2176	5	79	377	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2177	5	80	377	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2178	5	81	377	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2179	5	82	377	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2180	5	83	377	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2579	2	164	353	\N	\N
2580	2	160	355	\N	\N
2181	5	84	377	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2182	5	85	377	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2183	5	86	377	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2184	5	49	377	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2185	5	87	377	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2186	5	79	378	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2187	5	80	378	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2188	5	81	378	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2189	5	82	378	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2190	5	83	378	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2191	5	84	378	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2192	5	85	378	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2193	5	86	378	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2194	5	49	378	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2195	5	87	378	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
2196	5	79	379	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
2197	5	80	379	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
2198	5	81	379	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
2199	5	82	379	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
2200	5	83	379	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
2201	5	84	379	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
2202	5	85	379	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
2203	5	86	379	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
2204	5	49	379	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
2205	5	87	379	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
2206	5	79	380	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
2207	5	80	380	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
2208	5	81	380	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
2209	5	82	380	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
2210	5	83	380	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
2211	5	84	380	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
2212	5	85	380	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
2213	5	86	380	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
2214	5	49	380	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
2215	5	87	380	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
2216	5	79	381	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
2217	5	80	381	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
2218	5	81	381	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
2219	5	82	381	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
2220	5	83	381	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
2221	5	84	381	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
2222	5	85	381	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
2223	5	86	381	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
2224	5	49	381	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
2225	5	87	381	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
2226	5	88	382	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
2227	5	89	382	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
2228	5	90	382	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
2229	5	91	382	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
2230	5	92	382	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
2231	5	93	382	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
2232	5	94	382	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
2233	5	88	383	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154	\N
2234	5	89	383	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154	\N
2235	5	90	383	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154	\N
2236	5	91	383	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154	\N
2237	5	92	383	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154	\N
2238	5	93	383	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154	\N
2239	5	94	383	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154	\N
2240	5	88	384	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152	\N
2241	5	89	384	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152	\N
2242	5	90	384	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152	\N
2243	5	91	384	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152	\N
2244	5	92	384	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152	\N
2245	5	93	384	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152	\N
2246	5	94	384	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152	\N
2247	5	88	385	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155	\N
2581	2	161	355	\N	\N
2582	2	162	355	\N	\N
2248	5	89	385	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155	\N
2249	5	90	385	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155	\N
2250	5	91	385	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155	\N
2251	5	92	385	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155	\N
2252	5	93	385	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155	\N
2253	5	94	385	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155	\N
2254	5	88	386	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156	\N
2255	5	89	386	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156	\N
2256	5	90	386	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156	\N
2257	5	91	386	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156	\N
2258	5	92	386	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156	\N
2259	5	93	386	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156	\N
2260	5	94	386	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156	\N
2261	5	88	387	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
2262	5	89	387	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
2263	5	90	387	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
2264	5	91	387	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
2265	5	92	387	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
2266	5	93	387	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
2267	5	94	387	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
2268	5	88	388	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
2269	5	89	388	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
2270	5	90	388	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
2271	5	91	388	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
2272	5	92	388	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
2273	5	93	388	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
2274	5	94	388	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
2275	5	88	389	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153	\N
2276	5	89	389	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153	\N
2277	5	90	389	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153	\N
2278	5	91	389	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153	\N
2279	5	92	389	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153	\N
2280	5	93	389	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153	\N
2281	5	94	389	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153	\N
2282	11	95	328	http://www.mycancergenome.org/content/disease/gist/braf/54	\N
2283	11	41	328	http://www.mycancergenome.org/content/disease/gist/braf/54	\N
2284	11	96	328	http://www.mycancergenome.org/content/disease/gist/braf/54	\N
2285	11	97	328	http://www.mycancergenome.org/content/disease/gist/braf/54	\N
2286	11	98	328	http://www.mycancergenome.org/content/disease/gist/braf/54	\N
2287	11	51	328	http://www.mycancergenome.org/content/disease/gist/braf/54	\N
2288	11	99	390	\N	\N
2289	11	100	390	\N	\N
2290	11	101	390	\N	\N
2291	11	99	391	\N	\N
2292	11	100	391	\N	\N
2293	11	101	391	\N	\N
2294	11	99	392	\N	\N
2295	11	100	392	\N	\N
2296	11	101	392	\N	\N
2297	11	102	392	\N	\N
2298	11	103	393	\N	\N
2299	11	99	393	\N	\N
2300	11	100	393	\N	\N
2301	11	101	393	\N	\N
2302	11	104	394	\N	\N
2303	11	104	395	\N	\N
2304	11	104	396	\N	\N
2305	11	99	396	\N	\N
2306	11	100	396	\N	\N
2307	11	101	396	\N	\N
2308	11	99	397	\N	\N
2309	11	100	397	\N	\N
2310	11	101	397	\N	\N
2311	11	99	398	\N	\N
2312	11	100	398	\N	\N
2313	11	101	398	\N	\N
2314	11	99	399	\N	\N
2315	11	100	399	\N	\N
2316	11	101	399	\N	\N
2317	11	105	400	http://www.mycancergenome.org/content/disease/gist/pdgfra/48	\N
2318	11	106	400	http://www.mycancergenome.org/content/disease/gist/pdgfra/48	\N
2319	11	105	401	http://www.mycancergenome.org/content/disease/gist/pdgfra/51	\N
2320	11	106	401	http://www.mycancergenome.org/content/disease/gist/pdgfra/51	\N
2321	11	105	402	http://www.mycancergenome.org/content/disease/gist/pdgfra/51	\N
2322	11	106	402	http://www.mycancergenome.org/content/disease/gist/pdgfra/51	\N
2323	11	105	403	http://www.mycancergenome.org/content/disease/gist/pdgfra/45	\N
2324	11	106	403	http://www.mycancergenome.org/content/disease/gist/pdgfra/45	\N
2325	11	107	403	http://www.mycancergenome.org/content/disease/gist/pdgfra/45	\N
2326	11	108	403	http://www.mycancergenome.org/content/disease/gist/pdgfra/45	\N
2327	11	109	403	http://www.mycancergenome.org/content/disease/gist/pdgfra/45	\N
2328	11	110	403	http://www.mycancergenome.org/content/disease/gist/pdgfra/45	\N
2329	2	111	404	\N	\N
2330	2	112	405	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296	\N
2331	2	113	405	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296	\N
2332	2	114	406	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294	\N
2333	2	112	406	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294	\N
2334	2	115	406	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294	\N
2583	2	163	355	\N	\N
2335	2	114	407	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
2336	2	112	407	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
2337	2	116	407	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
2338	2	117	407	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
2339	2	118	407	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
2340	2	119	407	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
2341	2	120	407	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
2342	2	114	408	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291	\N
2343	2	112	408	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291	\N
2344	2	116	408	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291	\N
2345	2	118	408	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291	\N
2346	2	119	408	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291	\N
2347	2	120	408	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291	\N
2348	2	112	409	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295	\N
2349	2	116	409	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295	\N
2350	2	114	410	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292	\N
2351	2	112	410	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292	\N
2352	2	113	410	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292	\N
2353	2	119	410	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292	\N
2354	2	120	410	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292	\N
2355	2	121	411	\N	\N
2356	2	122	411	\N	\N
2357	2	123	411	\N	\N
2358	2	121	412	\N	\N
2359	2	122	412	\N	\N
2360	2	123	412	\N	\N
2361	2	124	413	\N	\N
2362	2	125	414	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
2363	2	126	414	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
2364	2	127	414	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
2365	2	16	414	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
2366	2	128	414	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
2367	2	129	414	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
2368	2	125	415	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284	\N
2369	2	126	415	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284	\N
2370	2	127	415	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284	\N
2371	2	16	415	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284	\N
2372	2	128	415	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284	\N
2373	2	129	415	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284	\N
2374	2	125	416	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
2375	2	126	416	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
2376	2	127	416	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
2377	2	16	416	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
2378	2	128	416	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
2379	2	130	416	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
2380	2	131	416	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
2381	2	132	416	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
2382	2	133	416	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
2383	2	121	416	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
2384	2	122	416	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
2385	2	134	416	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
2386	2	135	416	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
2387	2	125	417	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
2388	2	126	417	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
2389	2	127	417	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
2390	2	16	417	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
2391	2	128	417	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
2392	2	130	417	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
2393	2	131	417	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
2394	2	132	417	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
2395	2	133	417	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
2396	2	121	417	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
2397	2	122	417	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
2398	2	134	417	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
2399	2	135	417	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
2400	2	125	418	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
2401	2	126	418	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
2402	2	127	418	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
2403	2	16	418	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
2404	2	128	418	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
2405	2	130	418	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
2406	2	131	418	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
2407	2	132	418	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
2408	2	133	418	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
2409	2	121	418	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
2410	2	122	418	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
2411	2	134	418	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
2412	2	135	418	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
2414	2	125	419	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
2415	2	126	419	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
2416	2	127	419	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
2417	2	16	419	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
2418	2	128	419	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
2419	2	130	419	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
2420	2	121	419	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
2421	2	122	419	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
2422	2	134	419	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
2423	2	135	419	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
2424	2	121	420	\N	\N
2425	2	125	421	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
2426	2	126	421	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
2427	2	127	421	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
2428	2	16	421	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
2429	2	128	421	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
2430	2	130	421	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
2431	2	131	421	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
2432	2	132	421	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
2433	2	133	421	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
2434	2	121	421	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
2435	2	122	421	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
2436	2	134	421	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
2437	2	135	421	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
2439	2	125	422	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
2440	2	126	422	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
2441	2	127	422	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
2442	2	16	422	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
2443	2	128	422	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
2444	2	121	422	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
2445	2	131	422	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
2446	2	132	422	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
2447	2	122	422	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
2448	2	134	422	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
2449	2	135	422	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
2450	2	125	423	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
2451	2	126	423	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
2452	2	127	423	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
2453	2	16	423	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
2454	2	128	423	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
2455	2	136	423	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
2456	2	131	423	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
2457	2	132	423	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
2458	2	121	423	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
2459	2	122	423	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
2460	2	134	423	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
2461	2	135	423	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
2462	2	121	424	\N	\N
2463	2	121	425	\N	\N
2464	2	121	426	\N	\N
2465	2	122	426	\N	\N
2466	2	123	426	\N	\N
2467	2	137	427	\N	\N
2468	2	123	427	\N	\N
2469	2	137	428	\N	\N
2470	2	123	428	\N	\N
2471	2	121	429	\N	\N
2472	2	122	429	\N	\N
2473	2	123	429	\N	\N
2474	2	121	430	\N	\N
2475	2	122	430	\N	\N
2476	2	123	430	\N	\N
2477	2	121	431	\N	\N
2478	2	122	431	\N	\N
2479	2	123	431	\N	\N
2480	2	138	432	\N	\N
2481	2	139	432	\N	\N
2482	2	138	433	\N	\N
2483	2	139	433	\N	\N
2484	2	112	434	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264	\N
2485	2	116	434	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264	\N
2486	2	140	434	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264	\N
2487	2	141	434	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264	\N
2488	2	112	435	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/265	\N
2489	2	116	435	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/265	\N
2596	2	133	360	\N	\N
2597	2	133	456	\N	\N
2490	2	140	435	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/265	\N
2491	2	133	436	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263	\N
2492	2	112	436	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263	\N
2493	2	116	436	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263	\N
2494	2	140	436	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263	\N
2495	2	118	436	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263	\N
2496	2	141	436	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263	\N
2497	2	133	437	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260	\N
2498	2	112	437	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260	\N
2499	2	116	437	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260	\N
2500	2	140	437	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260	\N
2501	2	141	437	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260	\N
2502	2	142	437	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260	\N
2503	2	112	438	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261	\N
2504	2	116	438	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261	\N
2505	2	140	438	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261	\N
2506	2	141	438	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261	\N
2507	2	142	438	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261	\N
2508	2	133	439	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262	\N
2509	2	112	439	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262	\N
2510	2	116	439	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262	\N
2511	2	140	439	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262	\N
2512	2	112	440	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272	\N
2513	2	116	440	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272	\N
2514	2	140	440	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272	\N
2515	2	118	440	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272	\N
2516	2	112	441	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271	\N
2517	2	116	441	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271	\N
2518	2	140	441	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271	\N
2519	2	112	442	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
2520	2	140	442	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
2521	2	118	442	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
2522	2	143	442	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
2523	2	141	442	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
2524	2	142	442	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
2525	2	112	443	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268	\N
2526	2	140	443	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268	\N
2527	2	112	444	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266	\N
2528	2	118	444	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266	\N
2529	2	143	444	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266	\N
2530	2	144	444	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266	\N
2531	2	141	444	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266	\N
2532	2	142	444	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266	\N
2533	2	112	445	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
2534	2	116	445	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
2535	2	140	445	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
2536	2	12	313	\N	\N
2537	2	145	313	\N	\N
2538	2	146	446	\N	\N
2539	2	147	446	\N	\N
2540	2	148	446	\N	\N
2541	2	149	446	\N	\N
2542	2	150	446	\N	\N
2543	2	151	446	\N	\N
2544	2	152	446	\N	\N
2545	2	153	446	\N	\N
2546	2	154	446	\N	\N
2547	2	155	446	\N	\N
2548	2	156	446	\N	\N
2549	2	104	395	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/274	\N
2550	2	128	395	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/274	\N
2551	2	128	447	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/276	\N
2552	2	104	447	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/276	\N
2553	2	104	396	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275	\N
2554	2	128	396	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275	\N
2555	2	157	396	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275	\N
2556	2	158	396	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275	\N
2557	2	121	396	\N	\N
2558	2	159	448	\N	\N
2559	2	159	449	\N	\N
2560	2	160	342	\N	\N
2561	2	161	342	\N	\N
2562	2	162	342	\N	\N
2563	2	163	342	\N	\N
2564	2	164	342	\N	\N
2565	2	160	343	\N	\N
2566	2	161	343	\N	\N
2567	2	162	343	\N	\N
2568	2	163	343	\N	\N
2584	2	164	355	\N	\N
2585	2	133	450	\N	\N
2586	2	133	451	\N	\N
2587	2	133	452	\N	\N
2588	2	133	453	\N	\N
2589	2	133	454	\N	\N
2590	2	133	455	\N	\N
2591	2	160	359	\N	\N
2598	2	133	457	\N	\N
2599	2	133	361	\N	\N
2600	2	133	363	\N	\N
2601	2	160	363	\N	\N
2602	2	161	363	\N	\N
2603	2	162	363	\N	\N
2604	2	163	363	\N	\N
2605	2	164	363	\N	\N
2606	2	133	364	\N	\N
2607	2	160	364	\N	\N
2608	2	161	364	\N	\N
2609	2	162	364	\N	\N
2610	2	163	364	\N	\N
2611	2	164	364	\N	\N
2612	2	133	365	\N	\N
2613	2	165	458	\N	\N
2614	2	166	459	\N	\N
2615	2	167	459	\N	\N
2616	2	168	459	\N	\N
2617	2	166	460	\N	\N
2618	2	167	460	\N	\N
2619	2	168	460	\N	\N
2620	2	166	461	\N	\N
2621	2	169	461	\N	\N
2622	2	166	462	\N	\N
2623	2	169	462	\N	\N
2624	2	170	463	\N	\N
2625	2	170	464	\N	\N
2626	2	170	465	\N	\N
2627	2	170	466	\N	\N
2628	2	170	467	\N	\N
2629	2	170	468	\N	\N
2630	2	170	469	\N	\N
2631	2	170	470	\N	\N
2632	2	170	471	\N	\N
2633	2	170	472	\N	\N
2634	2	111	473	\N	\N
2635	2	111	474	\N	\N
2636	2	111	475	\N	\N
2637	2	171	476	\N	\N
2638	2	172	476	\N	\N
2639	2	173	476	\N	\N
2640	2	171	477	\N	\N
2641	2	172	477	\N	\N
2642	2	173	477	\N	\N
2643	2	171	478	\N	\N
2644	2	172	478	\N	\N
2645	2	173	478	\N	\N
2646	2	171	479	\N	\N
2647	2	172	479	\N	\N
2648	2	173	479	\N	\N
2649	2	171	480	\N	\N
2650	2	172	480	\N	\N
2651	2	173	480	\N	\N
2652	2	171	481	\N	\N
2653	2	172	481	\N	\N
2654	2	173	481	\N	\N
2655	2	171	482	\N	\N
2656	2	172	482	\N	\N
2657	2	173	482	\N	\N
2658	2	171	483	\N	\N
2659	2	172	483	\N	\N
2660	2	173	483	\N	\N
2661	2	174	484	\N	\N
2662	2	174	485	\N	\N
2663	2	174	486	\N	\N
2664	2	175	486	\N	\N
2665	2	174	487	\N	\N
2666	2	175	487	\N	\N
2667	2	166	488	\N	\N
2668	2	176	488	\N	\N
2669	2	177	488	\N	\N
2670	2	178	488	\N	\N
2671	2	179	488	\N	\N
2672	2	180	488	\N	\N
2673	19	181	313	\N	\N
2674	20	182	489	\N	\N
2675	20	182	490	\N	\N
2676	20	182	491	\N	\N
2677	20	182	492	\N	\N
2678	21	183	493	\N	\N
2679	21	184	493	\N	\N
2680	21	185	493	\N	\N
2681	21	186	493	\N	\N
2682	21	187	493	\N	\N
2683	21	188	493	\N	\N
2684	21	189	493	\N	\N
2685	21	190	493	\N	\N
2686	21	3	493	\N	\N
2687	21	191	494	\N	\N
2688	21	192	494	\N	\N
2689	21	193	494	\N	\N
2690	21	188	494	\N	\N
2691	21	186	494	\N	\N
2692	21	3	494	\N	\N
2693	21	194	495	\N	\N
2694	21	195	495	\N	\N
2695	21	188	495	\N	\N
2696	21	186	495	\N	\N
2697	21	184	495	\N	\N
2698	21	196	495	\N	\N
2699	21	183	495	\N	\N
2700	21	3	495	\N	\N
2701	21	197	496	\N	\N
2702	21	198	496	\N	\N
2703	21	186	496	\N	\N
2704	21	188	496	\N	\N
2705	21	190	496	\N	\N
2706	21	3	496	\N	\N
2707	21	188	497	\N	\N
2708	21	197	497	\N	\N
2709	21	3	497	\N	\N
2710	21	186	498	\N	\N
2711	21	188	498	\N	\N
2712	21	190	498	\N	\N
2713	21	3	498	\N	\N
2714	21	183	308	\N	\N
2715	21	184	308	\N	\N
2716	21	194	308	\N	\N
2717	21	186	308	\N	\N
2718	21	199	308	\N	\N
2719	21	200	308	\N	\N
2720	21	201	308	\N	\N
2721	21	197	308	\N	\N
2722	21	202	308	\N	\N
2723	21	203	308	\N	\N
2724	21	190	308	\N	\N
2725	21	195	308	\N	\N
2726	21	204	308	\N	\N
2727	21	205	308	\N	\N
2728	21	3	308	\N	\N
2729	21	206	499	\N	\N
2730	21	207	499	\N	\N
2731	21	208	499	\N	\N
2732	21	209	499	\N	\N
2733	21	210	499	\N	\N
2734	21	211	499	\N	\N
2735	21	202	499	\N	\N
2736	21	188	499	\N	\N
2737	21	195	499	\N	\N
2738	21	190	499	\N	\N
2739	21	4	499	\N	\N
2740	21	2	499	\N	\N
2741	21	183	499	\N	\N
2742	21	212	499	\N	\N
2743	21	213	499	\N	\N
2744	21	214	499	\N	\N
2745	21	3	499	\N	\N
2746	21	183	500	\N	\N
2747	21	202	500	\N	\N
2748	21	188	500	\N	\N
2749	21	190	500	\N	\N
2750	21	2	500	\N	\N
2751	21	215	500	\N	\N
2752	21	207	500	\N	\N
2753	21	216	500	\N	\N
2754	21	217	500	\N	\N
2755	21	3	500	\N	\N
2756	21	184	501	\N	\N
2757	21	202	501	\N	\N
2758	21	204	501	\N	\N
2759	21	218	501	\N	\N
2760	21	3	501	\N	\N
2761	21	219	309	\N	\N
2762	21	220	309	\N	\N
2763	21	196	309	\N	\N
2764	21	221	309	\N	\N
2765	21	222	309	\N	\N
2766	21	184	309	\N	\N
2767	21	223	309	\N	\N
2768	21	224	309	\N	\N
2769	21	186	309	\N	\N
2770	21	183	309	\N	\N
2771	21	202	309	\N	\N
2772	21	188	309	\N	\N
2773	21	190	309	\N	\N
2774	21	2	309	\N	\N
2775	21	207	309	\N	\N
2776	21	195	309	\N	\N
2777	21	225	309	\N	\N
2778	21	211	309	\N	\N
2779	21	226	309	\N	\N
2780	21	3	309	\N	\N
2781	21	184	502	\N	\N
2782	21	227	502	\N	\N
2783	21	228	502	\N	\N
2784	21	229	502	\N	\N
2785	21	188	502	\N	\N
2786	21	186	502	\N	\N
2787	21	3	502	\N	\N
2788	21	183	503	\N	\N
2789	21	230	503	\N	\N
2790	21	227	503	\N	\N
2791	21	186	503	\N	\N
2792	21	188	503	\N	\N
2793	21	195	503	\N	\N
2794	21	3	503	\N	\N
2795	21	183	504	\N	\N
2796	21	220	504	\N	\N
2797	21	202	504	\N	\N
2798	21	188	504	\N	\N
2799	21	195	504	\N	\N
2800	21	190	504	\N	\N
2801	21	225	504	\N	\N
2802	21	231	504	\N	\N
2803	21	232	504	\N	\N
2804	21	233	504	\N	\N
2805	21	234	504	\N	\N
2806	21	235	504	\N	\N
2807	21	201	504	\N	\N
2808	21	236	504	\N	\N
2809	21	3	504	\N	\N
2810	21	183	505	\N	\N
2811	21	188	505	\N	\N
2812	21	190	505	\N	\N
2813	21	204	505	\N	\N
2814	21	237	505	\N	\N
2815	21	238	505	\N	\N
2816	21	235	505	\N	\N
2817	21	3	505	\N	\N
2818	21	183	506	\N	\N
2819	21	188	506	\N	\N
2820	21	184	506	\N	\N
2821	21	186	506	\N	\N
2822	21	202	506	\N	\N
2823	21	210	506	\N	\N
2824	21	239	506	\N	\N
2825	21	231	506	\N	\N
2826	21	240	506	\N	\N
2827	21	3	506	\N	\N
2828	21	227	507	\N	\N
2829	21	183	507	\N	\N
2830	21	241	507	\N	\N
2831	21	202	507	\N	\N
2832	21	188	507	\N	\N
2833	21	190	507	\N	\N
2834	21	3	507	\N	\N
2835	21	210	508	\N	\N
2836	21	210	308	\N	\N
2837	21	210	509	\N	\N
2838	21	210	510	\N	\N
2839	21	210	309	\N	\N
2840	21	210	511	\N	\N
2841	21	210	512	\N	\N
2842	21	210	513	\N	\N
2843	21	210	502	\N	\N
2844	21	210	503	\N	\N
2845	21	210	514	\N	\N
2846	21	210	515	\N	\N
2847	21	210	516	\N	\N
2848	21	242	404	\N	\N
2849	21	242	517	\N	\N
2850	9	243	518	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/184	\N
2851	9	244	518	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/184	\N
2852	9	243	519	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/183	\N
2853	9	244	519	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/183	\N
2854	9	243	520	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/181	\N
2855	9	244	520	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/181	\N
2856	9	244	521	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180	\N
2857	9	243	521	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180	\N
2858	9	243	522	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/182	\N
2859	9	244	522	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/182	\N
2860	9	243	523	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/178	\N
2861	9	244	523	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/178	\N
2862	9	243	524	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/176	\N
2863	9	244	524	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/176	\N
2864	9	243	525	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/179	\N
2865	9	244	525	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/179	\N
2866	9	243	526	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177	\N
2867	9	244	526	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177	\N
2868	9	244	527	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175	\N
2869	9	243	527	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175	\N
2870	9	243	528	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174	\N
2871	9	244	528	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174	\N
2872	9	243	529	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173	\N
2873	9	244	529	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173	\N
2874	22	245	318	\N	\N
2875	22	3	318	\N	\N
2876	23	246	446	\N	\N
2877	23	247	530	\N	\N
2878	23	248	530	\N	\N
2879	24	249	531	\N	\N
2880	24	250	532	\N	\N
2881	24	251	533	\N	\N
2882	24	252	534	\N	\N
2883	24	251	535	\N	\N
2884	24	251	536	\N	\N
2885	25	253	537	\N	\N
2886	25	253	538	\N	\N
2887	26	254	318	\N	\N
2888	26	3	318	\N	\N
2889	26	255	320	\N	\N
2890	26	3	320	\N	\N
2891	26	256	539	\N	\N
2892	26	257	539	\N	\N
2893	26	256	540	\N	\N
2894	26	257	540	\N	\N
2895	26	256	541	\N	\N
2896	26	256	542	\N	\N
2897	26	257	542	\N	\N
2898	26	258	542	\N	\N
2899	26	256	543	\N	\N
2900	26	258	543	\N	\N
2901	26	256	523	\N	\N
2902	26	258	523	\N	\N
2903	26	256	544	\N	\N
2904	26	259	545	\N	\N
2905	26	260	333	\N	\N
2906	26	261	546	\N	\N
2907	26	262	547	\N	\N
2908	3	20	318	\N	\N
2909	3	3	318	\N	\N
2910	3	263	318	\N	\N
2911	3	264	548	\N	\N
2912	3	3	548	\N	\N
4316	1	531	328	\N	\N
4317	1	532	328	\N	\N
2913	3	265	318	http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23	\N
2914	3	266	318	http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23	\N
2915	3	267	318	http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23	\N
2917	3	268	549	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
2918	3	269	549	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
2919	3	270	549	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
2920	3	271	549	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
2921	3	272	549	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
2922	3	273	549	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
2923	3	274	549	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
2924	3	275	549	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
2925	3	276	549	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
2926	3	277	549	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
2927	3	268	550	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
2928	3	269	550	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
2929	3	270	550	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
2930	3	271	550	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
2931	3	272	550	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
2932	3	273	550	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
2933	3	274	550	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
2934	3	275	550	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
2935	3	276	550	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
2936	3	277	550	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
2937	3	268	551	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
2938	3	269	551	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
2939	3	270	551	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
2940	3	271	551	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
2941	3	272	551	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
2942	3	273	551	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
2943	3	274	551	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
2944	3	275	551	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
2945	3	276	551	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
2946	3	277	551	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
2947	3	268	552	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
2948	3	269	552	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
2949	3	270	552	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
2950	3	278	552	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
2951	3	279	552	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
2952	3	280	552	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
2953	3	281	552	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
2954	3	282	552	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
2955	3	283	552	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
2956	3	284	552	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
2957	3	285	552	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
2958	3	286	552	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
2959	3	287	552	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
2960	3	288	552	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
2961	3	289	552	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
2962	3	277	552	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
2963	3	268	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2964	3	269	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2965	3	270	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2966	3	271	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2967	3	290	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2968	3	291	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2969	3	292	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2970	3	293	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2971	3	294	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2972	3	295	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2973	3	296	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2974	3	297	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2975	3	298	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2976	3	299	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2977	3	300	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2978	3	301	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2979	3	276	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2980	3	275	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2981	3	277	553	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
2982	3	268	554	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6	\N
2983	3	269	554	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6	\N
2984	3	270	554	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6	\N
2985	3	271	554	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6	\N
2986	3	276	554	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6	\N
2987	3	277	554	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6	\N
2988	3	302	342	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31	\N
2989	3	303	342	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31	\N
2990	3	302	343	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30	\N
2991	3	303	343	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30	\N
2992	3	302	344	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42	\N
2993	3	303	344	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42	\N
2994	3	302	345	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43	\N
2995	3	303	345	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43	\N
2996	3	302	346	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
2997	3	303	346	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
2998	3	302	348	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68	\N
2999	3	303	348	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68	\N
3000	3	302	349	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39	\N
3001	3	303	349	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39	\N
3002	3	302	350	http://www.mycancergenome.org/content/disease/lung-cancer/kras/38	\N
3003	3	303	350	http://www.mycancergenome.org/content/disease/lung-cancer/kras/38	\N
3004	3	302	351	http://www.mycancergenome.org/content/disease/lung-cancer/kras/40	\N
3005	3	303	351	http://www.mycancergenome.org/content/disease/lung-cancer/kras/40	\N
3006	3	302	352	http://www.mycancergenome.org/content/disease/lung-cancer/kras/69	\N
3007	3	303	352	http://www.mycancergenome.org/content/disease/lung-cancer/kras/69	\N
3008	3	302	354	http://www.mycancergenome.org/content/disease/lung-cancer/kras/32	\N
3009	3	303	354	http://www.mycancergenome.org/content/disease/lung-cancer/kras/32	\N
3010	3	302	355	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34	\N
3011	3	303	355	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34	\N
3012	3	302	356	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33	\N
3013	3	303	356	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33	\N
3014	3	302	357	http://www.mycancergenome.org/content/disease/lung-cancer/kras/35	\N
3015	3	303	357	http://www.mycancergenome.org/content/disease/lung-cancer/kras/35	\N
3016	3	302	358	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36	\N
3017	3	303	358	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36	\N
3018	3	304	555	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/74	\N
3019	3	305	555	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/74	\N
3020	3	304	556	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/72	\N
3021	3	306	557	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60	\N
3022	3	304	557	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60	\N
3023	3	302	455	http://www.mycancergenome.org/content/disease/lung-cancer/nras/80	\N
3024	3	255	455	http://www.mycancergenome.org/content/disease/lung-cancer/nras/80	\N
3025	3	307	455	http://www.mycancergenome.org/content/disease/lung-cancer/nras/80	\N
3026	3	302	558	http://www.mycancergenome.org/content/disease/lung-cancer/nras/76	\N
3027	3	255	558	http://www.mycancergenome.org/content/disease/lung-cancer/nras/76	\N
3028	3	307	558	http://www.mycancergenome.org/content/disease/lung-cancer/nras/76	\N
3029	3	302	359	http://www.mycancergenome.org/content/disease/lung-cancer/nras/77	\N
3030	3	255	359	http://www.mycancergenome.org/content/disease/lung-cancer/nras/77	\N
3031	3	307	359	http://www.mycancergenome.org/content/disease/lung-cancer/nras/77	\N
3032	3	308	559	\N	\N
3033	3	307	559	\N	\N
3034	3	307	560	\N	\N
3035	3	302	360	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75	\N
3036	3	255	360	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75	\N
3037	3	307	360	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75	\N
3038	3	302	362	http://www.mycancergenome.org/content/disease/lung-cancer/nras/85	\N
3039	3	255	362	http://www.mycancergenome.org/content/disease/lung-cancer/nras/85	\N
3040	3	307	362	http://www.mycancergenome.org/content/disease/lung-cancer/nras/85	\N
3041	3	302	363	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87	\N
3042	3	255	363	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87	\N
3043	3	307	363	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87	\N
3044	3	302	364	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86	\N
3045	3	255	364	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86	\N
3046	3	307	364	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86	\N
3047	3	302	561	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88	\N
3048	3	255	561	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88	\N
3049	3	307	561	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88	\N
3050	3	302	365	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
3051	3	303	365	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
3052	3	309	366	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
3053	3	79	366	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
3054	3	80	366	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
3055	3	81	366	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
3056	3	82	366	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
3057	3	83	366	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
3058	3	84	366	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
3059	3	310	366	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
3060	3	311	366	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
3061	3	312	366	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
3062	3	281	366	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
3063	3	309	367	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
3064	3	79	367	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
3065	3	80	367	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
3066	3	81	367	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
3067	3	82	367	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
3068	3	83	367	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
3069	3	84	367	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
3070	3	310	367	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
3071	3	311	367	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
3072	3	312	367	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
3073	3	281	367	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
3074	3	309	368	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
3075	3	79	368	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
3076	3	80	368	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
3077	3	81	368	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
3078	3	82	368	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
3079	3	83	368	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
3080	3	84	368	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
3081	3	310	368	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
3082	3	311	368	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
3083	3	312	368	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
3084	3	281	368	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
3085	3	309	377	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
3086	3	79	377	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
3087	3	80	377	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
3088	3	81	377	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
3089	3	82	377	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
3090	3	83	377	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
3091	3	84	377	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
3092	3	310	377	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
3093	3	311	377	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
3094	3	312	377	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
3095	3	281	377	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
3096	3	309	378	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
3097	3	79	378	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
3098	3	80	378	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
3099	3	81	378	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
3100	3	82	378	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
3101	3	83	378	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
3102	3	84	378	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
3103	3	310	378	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
3104	3	311	378	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
3105	3	312	378	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
3106	3	281	378	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
3107	3	313	380	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
3108	3	314	380	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
3109	3	315	380	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
3110	3	316	380	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
3111	3	317	380	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
3112	3	318	380	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
3113	3	319	380	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
3114	27	320	562	\N	\N
3115	27	320	563	\N	\N
3116	27	320	564	\N	\N
3117	27	320	565	\N	\N
3118	27	320	566	\N	\N
3119	27	320	567	\N	\N
3120	27	276	568	\N	\N
3121	27	277	568	\N	\N
3122	27	276	569	\N	\N
3123	27	277	569	\N	\N
3124	27	276	570	\N	\N
3125	27	277	570	\N	\N
3126	27	276	571	\N	\N
3127	27	277	571	\N	\N
3128	27	276	572	\N	\N
3129	27	277	572	\N	\N
3130	27	321	573	\N	\N
3131	27	321	574	\N	\N
3132	27	322	575	\N	\N
3133	27	322	576	\N	\N
3134	28	323	318	\N	\N
3135	28	3	318	\N	\N
3136	29	324	577	\N	\N
3137	30	325	318	\N	\N
3138	30	3	318	\N	\N
3139	12	326	578	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/218	\N
4318	1	533	328	\N	\N
4319	35	3	328	\N	\N
3140	12	327	578	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/218	\N
3141	12	328	579	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/124	\N
3142	12	326	579	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/124	\N
3143	12	329	579	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/124	\N
3144	12	330	580	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/110	\N
3145	12	326	580	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/110	\N
3146	12	331	581	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112	\N
3147	12	330	581	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112	\N
3148	12	326	581	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112	\N
3149	12	332	582	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123	\N
3150	12	333	582	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123	\N
3151	12	334	582	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123	\N
3152	12	335	582	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123	\N
3153	12	326	583	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96	\N
3154	12	334	583	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96	\N
3155	12	336	583	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96	\N
3156	12	337	584	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122	\N
3157	12	332	585	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/121	\N
3158	12	338	586	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/120	\N
3159	12	326	586	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/120	\N
3160	12	339	586	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/120	\N
3161	10	340	587	http://www.mycancergenome.org/content/disease/rhabdomyosarcoma/alk/187	\N
3162	10	341	588	\N	\N
3163	10	341	589	\N	\N
3164	10	341	590	\N	\N
3165	31	342	318	\N	\N
3166	31	3	318	\N	\N
3167	31	343	591	\N	\N
3168	31	344	592	\N	\N
3169	31	344	593	\N	\N
3170	31	344	594	\N	\N
3171	31	344	595	\N	\N
3172	31	345	596	\N	\N
3173	31	346	596	\N	\N
3174	31	347	596	\N	\N
3175	31	344	596	\N	\N
3176	31	345	597	\N	\N
3177	31	346	597	\N	\N
3178	31	347	597	\N	\N
3179	31	344	597	\N	\N
3180	31	344	598	\N	\N
3181	31	344	599	\N	\N
3182	31	344	600	\N	\N
3183	31	344	601	\N	\N
3184	31	344	602	\N	\N
3185	31	344	603	\N	\N
3186	31	344	604	\N	\N
3187	31	344	605	\N	\N
3188	31	345	606	\N	\N
3189	31	346	606	\N	\N
3190	31	347	606	\N	\N
3191	31	348	607	\N	\N
3192	32	349	608	\N	\N
3193	32	349	609	\N	\N
3194	32	350	610	\N	\N
3195	32	351	611	\N	\N
3196	14	352	612	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/163	\N
3197	14	353	612	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/163	\N
3198	7	3	613	\N	\N
3199	7	354	328	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54	\N
3200	7	355	328	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54	\N
3201	7	41	328	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54	\N
3202	7	96	328	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54	\N
3203	7	97	328	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54	\N
3204	7	51	328	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54	\N
3205	7	356	328	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54	\N
3212	7	354	614	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138	\N
3213	7	355	614	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138	\N
3214	7	41	614	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138	\N
3215	7	357	614	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138	\N
3216	7	355	349	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39	\N
3217	7	356	349	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39	\N
3218	7	355	353	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37	\N
3219	7	356	353	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37	\N
3220	7	355	354	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32	\N
3221	7	356	354	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32	\N
3222	7	355	355	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/34	\N
3223	7	356	355	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/34	\N
3224	7	355	356	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33	\N
3225	7	356	356	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33	\N
3226	7	355	357	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35	\N
3227	7	356	357	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35	\N
3228	7	80	366	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7	\N
3229	7	358	366	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7	\N
3230	7	80	367	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/8	\N
3231	7	358	367	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/8	\N
3232	7	80	369	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/12	\N
3233	7	358	369	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/12	\N
3234	7	80	372	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/16	\N
3235	7	358	372	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/16	\N
3236	7	80	377	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/11	\N
3237	7	358	377	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/11	\N
3238	7	80	378	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/10	\N
3239	7	358	378	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/10	\N
3240	7	359	615	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145	\N
3241	7	317	615	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145	\N
3242	7	318	615	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145	\N
3243	7	359	616	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137	\N
3244	7	317	616	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137	\N
3245	7	318	616	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137	\N
3246	7	359	617	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144	\N
3247	7	317	617	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144	\N
3248	7	318	617	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144	\N
3249	33	248	530	\N	\N
3250	33	360	530	\N	\N
3251	33	361	530	\N	\N
3252	33	362	618	\N	\N
3253	34	247	530	\N	\N
3254	34	360	530	\N	\N
3255	34	248	530	\N	\N
3256	34	363	530	\N	\N
3257	35	364	619	\N	\N
3258	1	365	620	\N	\N
3259	1	366	621	\N	\N
3260	1	367	622	\N	\N
3261	1	41	622	\N	\N
3262	1	357	622	\N	\N
3263	1	96	622	\N	\N
3264	1	97	622	\N	\N
3265	1	368	622	\N	\N
3266	1	369	622	\N	\N
3267	1	370	622	\N	\N
3268	1	371	622	\N	\N
3269	1	372	622	\N	\N
3270	1	41	623	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
3271	1	367	623	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
3272	1	371	623	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
3273	1	372	623	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
3274	1	369	623	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
3275	1	370	623	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
3276	1	373	623	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
3277	1	97	623	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
3278	1	51	623	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
3279	1	374	623	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
3280	1	96	623	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
3281	1	375	623	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
3282	1	368	623	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
3283	1	376	623	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
3284	1	41	624	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
3285	1	367	624	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
3286	1	97	624	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
3287	1	51	624	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
3288	1	374	624	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
3289	1	96	624	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
3290	1	375	624	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
3291	1	368	624	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
3292	1	369	624	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
3293	1	370	624	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
3294	1	371	624	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
3295	1	372	624	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
3296	1	41	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3297	1	367	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3298	1	377	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3299	1	373	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3300	1	97	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3301	1	51	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3302	1	374	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3303	1	96	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3304	1	375	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3305	1	368	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3306	1	369	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3307	1	370	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3308	1	371	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3309	1	372	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3310	1	378	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3311	1	379	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3312	1	380	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3313	1	381	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3314	1	382	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3315	1	383	328	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
3316	1	41	625	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
3317	1	367	625	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
4320	35	46	328	\N	\N
4321	1	3	812	\N	\N
3318	1	384	625	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
3319	1	376	625	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
3320	1	97	625	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
3321	1	51	625	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
3322	1	374	625	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
3323	1	96	625	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
3324	1	375	625	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
3325	1	368	625	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
3326	1	369	625	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
3327	1	370	625	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
3328	1	371	625	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
3329	1	372	625	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
3973	37	487	733	\N	\N
3974	37	487	734	\N	\N
3330	1	366	625	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
3331	1	41	626	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
3332	1	367	626	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
3333	1	377	626	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
3334	1	373	626	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
3336	1	51	626	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
3337	1	96	626	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
3338	1	375	626	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
3339	1	368	626	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
3340	1	97	626	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
3341	1	369	626	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
3342	1	370	626	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
3343	1	372	626	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
3344	1	371	626	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
3345	1	385	626	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
3347	1	386	627	\N	\N
3348	1	378	627	\N	\N
3349	1	302	628	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
3350	1	387	628	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
3351	1	41	628	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
3352	1	388	628	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
3353	1	389	628	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
3354	1	390	628	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
3355	1	391	628	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
3356	1	392	628	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
3357	1	393	628	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
3358	1	394	628	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
3359	1	302	614	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
3360	1	387	614	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
3361	1	41	614	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
3362	1	388	614	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
3363	1	389	614	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
3364	1	390	614	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
3365	1	391	614	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
3366	1	392	614	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
3367	1	357	614	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
3368	1	370	614	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
3369	1	395	614	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
3370	1	302	629	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
3371	1	387	629	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
3372	1	41	629	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
3373	1	388	629	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
3374	1	389	629	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
3375	1	390	629	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
3376	1	391	629	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
3377	1	392	629	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
3378	1	357	629	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
3379	1	370	629	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
3380	1	395	629	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
3381	1	302	630	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
3382	1	387	630	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
3383	1	41	630	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
3384	1	388	630	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
3385	1	389	630	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
3386	1	390	630	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
3387	1	391	630	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
3388	1	392	630	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
3389	1	357	630	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
3390	1	370	630	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
3391	1	395	630	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
3392	1	302	631	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
3393	1	387	631	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
4322	1	97	812	\N	\N
4323	1	531	812	\N	\N
3394	1	41	631	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
3395	1	388	631	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
3396	1	389	631	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
3397	1	390	631	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
3398	1	391	631	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
3399	1	392	631	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
3400	1	357	631	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
3401	1	370	631	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
3402	1	395	631	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
3403	1	41	632	http://www.mycancergenome.org/content/disease/melanoma/braf/302	\N
3404	1	367	632	http://www.mycancergenome.org/content/disease/melanoma/braf/302	\N
3405	1	41	633	http://www.mycancergenome.org/content/disease/melanoma/braf/301	\N
3406	1	367	633	http://www.mycancergenome.org/content/disease/melanoma/braf/301	\N
3407	1	41	330	http://www.mycancergenome.org/content/disease/melanoma/braf/149	\N
3408	1	367	330	http://www.mycancergenome.org/content/disease/melanoma/braf/149	\N
3409	1	41	331	http://www.mycancergenome.org/content/disease/melanoma/braf/148	\N
3410	1	367	331	http://www.mycancergenome.org/content/disease/melanoma/braf/148	\N
3411	1	396	331	http://www.mycancergenome.org/content/disease/melanoma/braf/148	\N
3412	1	397	634	\N	\N
3413	1	41	635	http://www.mycancergenome.org/content/disease/melanoma/braf/300	\N
3414	1	367	635	http://www.mycancergenome.org/content/disease/melanoma/braf/300	\N
3415	1	41	636	http://www.mycancergenome.org/content/disease/melanoma/braf/298	\N
3416	1	367	636	http://www.mycancergenome.org/content/disease/melanoma/braf/298	\N
3417	1	41	637	http://www.mycancergenome.org/content/disease/melanoma/braf/299	\N
3418	1	367	637	http://www.mycancergenome.org/content/disease/melanoma/braf/299	\N
3419	1	398	637	http://www.mycancergenome.org/content/disease/melanoma/braf/299	\N
3420	1	396	334	\N	\N
3421	1	399	638	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105	\N
3422	1	400	638	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105	\N
3423	1	401	638	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105	\N
3424	1	402	638	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105	\N
3425	1	403	638	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105	\N
3426	1	404	638	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105	\N
3427	1	405	638	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105	\N
3428	1	399	639	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104	\N
3429	1	400	639	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104	\N
3430	1	401	639	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104	\N
3431	1	402	639	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104	\N
3432	1	403	639	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104	\N
3433	1	404	639	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104	\N
3434	1	405	639	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104	\N
3435	1	399	640	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107	\N
3436	1	400	640	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107	\N
3437	1	401	640	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107	\N
3438	1	402	640	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107	\N
3439	1	403	640	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107	\N
3440	1	404	640	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107	\N
3441	1	405	640	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107	\N
3442	1	399	641	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108	\N
3443	1	400	641	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108	\N
3444	1	401	641	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108	\N
3445	1	402	641	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108	\N
3446	1	403	641	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108	\N
3447	1	404	641	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108	\N
3448	1	405	641	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108	\N
3449	1	399	642	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106	\N
3450	1	400	642	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106	\N
3451	1	401	642	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106	\N
3452	1	402	642	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106	\N
3453	1	403	642	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106	\N
3454	1	404	642	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106	\N
3455	1	405	642	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106	\N
3456	1	406	643	\N	\N
3457	1	406	644	\N	\N
3458	1	406	645	\N	\N
3459	1	406	646	\N	\N
3460	1	406	647	\N	\N
3461	1	406	648	\N	\N
3462	1	407	649	http://www.mycancergenome.org/content/disease/melanoma/gna11/101	\N
3463	1	410	649	http://www.mycancergenome.org/content/disease/melanoma/gna11/101	\N
3464	1	411	649	http://www.mycancergenome.org/content/disease/melanoma/gna11/101	\N
3465	1	408	649	http://www.mycancergenome.org/content/disease/melanoma/gna11/101	\N
3466	1	409	649	http://www.mycancergenome.org/content/disease/melanoma/gna11/101	\N
3467	1	407	650	http://www.mycancergenome.org/content/disease/melanoma/gna11/99	\N
3468	1	410	650	http://www.mycancergenome.org/content/disease/melanoma/gna11/99	\N
3469	1	411	650	http://www.mycancergenome.org/content/disease/melanoma/gna11/99	\N
3470	1	408	650	http://www.mycancergenome.org/content/disease/melanoma/gna11/99	\N
3471	1	409	650	http://www.mycancergenome.org/content/disease/melanoma/gna11/99	\N
3472	1	412	651	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
3473	1	415	651	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
3474	1	407	651	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
3475	1	411	651	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
3476	1	410	651	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
3477	1	408	651	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
3478	1	409	651	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
3479	1	413	651	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
3480	1	414	651	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
3481	1	412	652	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
3482	1	415	652	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
3483	1	407	652	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
3484	1	411	652	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
3485	1	410	652	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
3486	1	408	652	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
3487	1	409	652	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
3488	1	413	652	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
3489	1	414	652	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
3490	1	412	653	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
3491	1	415	653	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
3492	1	407	653	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
3493	1	411	653	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
3494	1	410	653	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
3495	1	408	653	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
3496	1	409	653	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
3497	1	413	653	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
3498	1	414	653	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
3499	1	416	654	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3500	1	417	655	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3501	1	418	655	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3502	1	417	656	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3503	1	418	656	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3504	1	328	579	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3505	1	326	579	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3506	1	419	657	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3507	1	420	657	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3508	1	421	657	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3509	1	422	657	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3510	1	334	657	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3511	1	423	657	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3512	1	424	657	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3513	1	425	657	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3514	1	426	657	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3515	1	427	657	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3516	1	428	657	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3517	1	429	657	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3518	1	430	657	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3519	1	431	657	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3520	1	419	580	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3521	1	420	580	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3522	1	421	580	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3523	1	422	580	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3524	1	334	580	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3525	1	423	580	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3526	1	424	580	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3527	1	425	580	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3528	1	426	580	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3529	1	427	580	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3530	1	428	580	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3531	1	429	580	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3532	1	430	580	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3533	1	431	580	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3534	1	432	658	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3535	1	432	659	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3536	1	419	391	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3537	1	420	391	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3538	1	421	391	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3539	1	422	391	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3540	1	334	391	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3541	1	423	391	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3542	1	433	391	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3543	1	427	391	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3544	1	429	391	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3545	1	430	391	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
4324	1	532	812	\N	\N
3546	1	431	391	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3547	1	424	391	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3548	1	419	581	\N	\N
3549	1	420	581	\N	\N
3550	1	421	581	\N	\N
3551	1	422	581	\N	\N
3552	1	334	581	\N	\N
3553	1	423	581	\N	\N
3554	1	433	581	\N	\N
3555	1	427	581	\N	\N
3556	1	429	581	\N	\N
3557	1	430	581	\N	\N
3558	1	431	581	\N	\N
3559	1	424	581	\N	\N
3560	1	434	581	\N	\N
3561	1	417	660	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3562	1	418	660	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3563	1	430	661	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3564	1	430	662	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3565	1	430	663	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3566	1	417	664	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3975	37	487	735	\N	\N
3976	37	487	736	\N	\N
3567	1	418	664	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3568	1	417	665	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3569	1	418	665	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3570	1	419	583	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
3571	1	420	583	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
3572	1	421	583	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
3573	1	422	583	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
3574	1	334	583	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
3575	1	423	583	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
3576	1	433	583	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
3577	1	424	583	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
3578	1	435	583	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
3579	1	429	583	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
3580	1	428	583	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
3581	1	431	583	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
3582	1	419	666	\N	\N
3583	1	420	666	\N	\N
3584	1	421	666	\N	\N
3585	1	422	666	\N	\N
3586	1	334	666	\N	\N
3587	1	423	666	\N	\N
3588	1	433	666	\N	\N
3589	1	424	666	\N	\N
3590	1	426	666	\N	\N
3591	1	436	666	\N	\N
3592	1	437	667	\N	\N
3593	1	437	392	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3594	1	438	392	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3595	1	417	668	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3596	1	418	668	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3597	1	417	669	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3598	1	418	669	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3599	1	439	670	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3600	1	419	394	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
3601	1	420	394	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
3602	1	421	394	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
3603	1	422	394	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
3605	1	440	394	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
3606	1	431	394	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
3607	1	424	394	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
3608	1	441	395	\N	\N
3609	1	419	671	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
3610	1	420	671	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
3611	1	421	671	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
3612	1	422	671	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
3614	1	440	671	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
3615	1	431	671	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
3616	1	424	671	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
3617	1	442	672	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3618	1	424	672	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3619	1	443	672	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3620	1	444	397	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3621	1	424	448	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3622	1	437	448	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3623	1	424	449	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3624	1	437	449	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3625	1	99	399	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
3626	1	445	673	http://www.mycancergenome.org/content/disease/melanoma/mek1/210	\N
3627	1	446	555	\N	\N
3628	1	447	555	\N	\N
3629	1	446	674	\N	\N
3630	1	448	675	\N	\N
3631	1	448	556	\N	\N
3632	1	445	676	http://www.mycancergenome.org/content/disease/melanoma/mek1/211	\N
3633	1	449	676	http://www.mycancergenome.org/content/disease/melanoma/mek1/211	\N
3634	1	445	677	http://www.mycancergenome.org/content/disease/melanoma/mek1/212	\N
3635	1	450	677	http://www.mycancergenome.org/content/disease/melanoma/mek1/212	\N
3636	1	449	677	http://www.mycancergenome.org/content/disease/melanoma/mek1/212	\N
3637	1	451	677	http://www.mycancergenome.org/content/disease/melanoma/mek1/212	\N
3638	1	445	678	http://www.mycancergenome.org/content/disease/melanoma/mek1/214	\N
3639	1	449	678	http://www.mycancergenome.org/content/disease/melanoma/mek1/214	\N
3640	1	445	679	http://www.mycancergenome.org/content/disease/melanoma/mek1/213	\N
3641	1	447	679	http://www.mycancergenome.org/content/disease/melanoma/mek1/213	\N
3642	1	452	679	http://www.mycancergenome.org/content/disease/melanoma/mek1/213	\N
3643	1	447	680	\N	\N
3644	1	447	681	\N	\N
3645	1	383	681	\N	\N
3646	1	445	682	http://www.mycancergenome.org/content/disease/melanoma/mek1/215	\N
3647	1	446	682	http://www.mycancergenome.org/content/disease/melanoma/mek1/215	\N
3648	1	447	682	http://www.mycancergenome.org/content/disease/melanoma/mek1/215	\N
3649	1	445	683	http://www.mycancergenome.org/content/disease/melanoma/mek1/216	\N
3650	1	453	683	http://www.mycancergenome.org/content/disease/melanoma/mek1/216	\N
3651	1	445	684	http://www.mycancergenome.org/content/disease/melanoma/mek1/217	\N
3652	1	454	685	\N	\N
3653	1	454	686	\N	\N
3654	1	455	687	\N	\N
3655	1	454	688	\N	\N
3656	1	454	689	\N	\N
3657	1	456	454	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
3658	1	461	454	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
3659	1	462	454	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
3660	1	463	454	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
3661	1	464	454	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
3662	1	457	454	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
3663	1	458	454	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
3664	1	459	454	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
3665	1	460	454	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
3666	1	446	454	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
3667	1	383	454	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
3668	1	456	455	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
3669	1	461	455	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
3670	1	462	455	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
3671	1	463	455	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
3672	1	464	455	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
3673	1	457	455	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
3674	1	458	455	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
3675	1	459	455	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
3676	1	460	455	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
3677	1	446	455	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
3678	1	383	455	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
3679	1	456	690	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
3680	1	461	690	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
3681	1	462	690	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
3682	1	463	690	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
3683	1	464	690	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
3684	1	457	690	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
3685	1	458	690	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
3686	1	459	690	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
3687	1	460	690	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
3688	1	446	690	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
3689	1	383	690	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
3690	1	456	691	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
3691	1	461	691	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
3692	1	462	691	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
3693	1	463	691	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
3694	1	464	691	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
3695	1	457	691	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
3696	1	458	691	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
3697	1	459	691	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
3698	1	460	691	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
3699	1	446	691	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
3700	1	383	691	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
3701	1	456	558	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
3702	1	461	558	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
3703	1	462	558	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
3704	1	463	558	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
3705	1	464	558	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
3706	1	457	558	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
3707	1	458	558	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
3708	1	459	558	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
3709	1	460	558	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
3710	1	446	558	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
3711	1	383	558	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
3712	1	465	359	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
3713	1	456	359	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
3714	1	461	359	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
3715	1	462	359	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
3716	1	463	359	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
3717	1	464	359	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
3718	1	457	359	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
3719	1	458	359	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
3720	1	459	359	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
3721	1	460	359	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
3722	1	446	359	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
3723	1	383	359	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
3724	1	456	559	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
3725	1	461	559	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
3726	1	462	559	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
3727	1	463	559	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
3728	1	464	559	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
3729	1	457	559	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
3730	1	458	559	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
3731	1	459	559	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
3732	1	460	559	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
3733	1	446	559	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
3977	8	20	318	\N	\N
3734	1	383	559	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
3735	1	456	692	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
3736	1	461	692	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
3737	1	462	692	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
3738	1	463	692	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
3739	1	464	692	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
3740	1	457	692	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
3741	1	458	692	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
3742	1	459	692	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
3743	1	460	692	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
3744	1	446	692	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
3745	1	383	692	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
3746	1	465	360	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
3747	1	456	360	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
3748	1	461	360	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
3749	1	462	360	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
3750	1	463	360	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
3751	1	464	360	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
3752	1	457	360	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
3753	1	458	360	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
3754	1	459	360	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
3755	1	460	360	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
3756	1	446	360	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
3757	1	383	360	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
3758	1	456	456	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
3759	1	461	456	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
3760	1	462	456	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
3761	1	463	456	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
3762	1	464	456	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
3763	1	457	456	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
3764	1	458	456	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
3765	1	456	693	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
3766	1	461	693	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
3767	1	462	693	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
3768	1	463	693	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
3769	1	464	693	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
3770	1	457	693	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
3771	1	458	693	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
3772	1	456	457	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
3773	1	461	457	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
3774	1	462	457	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
3775	1	463	457	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
3776	1	464	457	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
3777	1	457	457	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
3778	1	458	457	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
3779	1	456	694	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
3780	1	461	694	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
3781	1	462	694	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
3782	1	463	694	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
3783	1	464	694	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
3784	1	457	694	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
3785	1	458	694	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
3786	1	456	695	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
3787	1	461	695	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
3788	1	462	695	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
3789	1	463	695	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
3790	1	464	695	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
3791	1	457	695	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
3792	1	458	695	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
3793	1	456	361	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
4325	1	533	812	\N	\N
3794	1	461	361	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
3795	1	462	361	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
3796	1	463	361	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
3797	1	464	361	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
3798	1	457	361	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
3799	1	458	361	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
3800	1	456	362	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
3801	1	461	362	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
3802	1	462	362	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
3803	1	463	362	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
3804	1	464	362	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
3805	1	457	362	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
3806	1	458	362	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
3807	1	456	363	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
3808	1	461	363	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
3809	1	462	363	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
3810	1	463	363	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
3811	1	464	363	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
3812	1	457	363	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
3813	1	458	363	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
3814	1	456	364	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
3815	1	461	364	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
3816	1	462	364	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
3817	1	463	364	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
3818	1	464	364	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
3819	1	457	364	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
3820	1	458	364	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
3821	1	383	364	\N	\N
3822	1	456	561	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
3823	1	461	561	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
3824	1	462	561	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
3825	1	463	561	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
3826	1	464	561	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
3827	1	457	561	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
3828	1	458	561	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
3829	1	456	365	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
3830	1	461	365	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
3831	1	462	365	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
3832	1	463	365	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
3833	1	464	365	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
3834	1	457	365	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
3835	1	458	365	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
3836	1	466	696	\N	\N
3837	1	466	697	\N	\N
3838	1	466	698	\N	\N
3839	1	466	699	\N	\N
3840	1	466	700	\N	\N
3841	1	467	701	\N	\N
3842	1	467	702	\N	\N
3843	36	468	703	\N	\N
3844	36	468	704	\N	\N
3845	4	96	328	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
3846	4	472	328	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
3847	4	473	328	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
3848	4	41	328	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
3849	4	474	328	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
3850	4	475	328	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
3851	4	51	328	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
3853	4	469	328	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
3854	4	470	328	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
3855	4	471	328	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
3856	4	476	705	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307	\N
3857	4	471	705	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307	\N
3858	4	473	705	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307	\N
3859	4	472	705	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307	\N
3860	4	476	706	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305	\N
3861	4	471	706	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305	\N
3862	4	473	706	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305	\N
3863	4	472	706	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305	\N
3864	4	476	707	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306	\N
3865	4	471	707	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306	\N
3866	4	473	707	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306	\N
3867	4	472	707	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306	\N
3868	4	476	708	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304	\N
3869	4	471	708	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304	\N
3870	4	473	708	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304	\N
3871	4	472	708	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304	\N
3872	4	476	709	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303	\N
3873	4	471	709	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303	\N
3874	4	473	709	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303	\N
3875	4	472	709	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303	\N
3876	4	471	337	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29	\N
3877	4	473	337	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29	\N
3878	4	472	337	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29	\N
3879	4	476	344	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
3880	4	471	344	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
3881	4	473	344	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
3882	4	472	344	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
3883	4	476	345	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
3884	4	471	345	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
3885	4	473	345	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
3886	4	472	345	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
3887	4	476	710	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
3888	4	471	710	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
3889	4	473	710	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
3890	4	472	710	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
3891	4	476	346	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
3892	4	471	346	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
3893	4	473	346	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
3894	4	472	346	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
3895	4	476	349	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39	\N
3896	4	471	349	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39	\N
3897	4	473	349	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39	\N
3898	4	472	349	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39	\N
3899	4	476	351	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40	\N
3900	4	471	351	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40	\N
3901	4	473	351	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40	\N
3902	4	472	351	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40	\N
3903	4	476	352	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69	\N
3904	4	471	352	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69	\N
3905	4	473	352	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69	\N
3906	4	472	352	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69	\N
3907	4	476	353	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37	\N
3908	4	471	353	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37	\N
3909	4	473	353	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37	\N
3910	4	472	353	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37	\N
3911	4	476	355	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34	\N
3912	4	471	355	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34	\N
3913	4	473	355	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34	\N
3914	4	472	355	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34	\N
3915	4	476	356	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33	\N
3916	4	471	356	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33	\N
3917	4	473	356	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33	\N
3918	4	472	356	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33	\N
3919	4	476	357	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35	\N
3920	4	471	357	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35	\N
3921	4	473	357	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35	\N
3922	4	472	357	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35	\N
3923	4	476	358	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36	\N
3924	4	471	358	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36	\N
3925	4	473	358	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36	\N
3926	4	472	358	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36	\N
3927	4	476	359	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/77	\N
3928	4	471	359	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/77	\N
3929	4	473	359	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/77	\N
3930	4	472	359	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/77	\N
3931	4	476	360	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75	\N
3932	4	471	360	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75	\N
3933	4	473	360	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75	\N
3934	4	472	360	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75	\N
3935	4	477	711	\N	\N
3936	4	478	711	\N	\N
3937	4	479	711	\N	\N
3938	4	480	711	\N	\N
3939	4	481	712	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
3940	4	474	712	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
3941	4	472	712	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
3942	4	475	712	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
3943	4	482	712	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
3944	4	477	712	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
4326	35	3	812	\N	\N
4327	35	46	812	\N	\N
3945	4	478	712	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
3946	4	483	712	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
3947	4	479	712	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
3948	4	480	712	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
3949	6	484	713	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78	\N
3950	6	485	713	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78	\N
3951	6	320	713	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78	\N
3952	37	261	714	\N	\N
3953	37	261	715	\N	\N
3954	37	364	716	\N	\N
3955	37	364	717	\N	\N
3956	37	486	718	\N	\N
3957	37	486	719	\N	\N
3958	37	486	720	\N	\N
3959	37	447	721	\N	\N
3960	37	447	722	\N	\N
3961	37	383	722	\N	\N
3962	37	447	723	\N	\N
3963	37	447	724	\N	\N
3964	37	447	725	\N	\N
3965	37	447	726	\N	\N
3966	37	447	727	\N	\N
3967	37	447	728	\N	\N
3968	37	383	728	\N	\N
3969	37	487	729	\N	\N
3970	37	487	730	\N	\N
3971	37	487	731	\N	\N
3972	37	487	732	\N	\N
3978	8	488	318	\N	\N
3979	8	489	318	\N	\N
3980	8	490	318	\N	\N
3981	8	491	318	\N	\N
3982	8	492	318	\N	\N
3983	8	493	318	\N	\N
3984	8	3	318	\N	\N
3985	8	488	737	\N	\N
3986	8	41	737	\N	\N
3987	8	3	737	\N	\N
3988	8	82	318	http://www.mycancergenome.org/content/disease/breast-cancer/akt1/23	\N
3990	8	494	318	http://www.mycancergenome.org/content/disease/breast-cancer/akt1/23	\N
3991	8	495	738	\N	\N
3992	8	495	739	\N	\N
3993	8	496	740	\N	\N
3994	8	496	741	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242/	\N
3995	8	496	742	http://www.mycancergenome.org/content/disease/breast-cancer/her2/240	\N
3996	8	497	742	http://www.mycancergenome.org/content/disease/breast-cancer/her2/240	\N
3998	8	496	743	http://www.mycancergenome.org/content/disease/breast-cancer/her2/241	\N
3999	8	497	743	http://www.mycancergenome.org/content/disease/breast-cancer/her2/241	\N
4001	8	496	744	http://www.mycancergenome.org/content/disease/breast-cancer/her2/247	\N
4002	8	497	744	http://www.mycancergenome.org/content/disease/breast-cancer/her2/247	\N
4003	8	496	745	http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/	\N
4004	8	496	746	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244	\N
4005	8	497	746	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244	\N
4008	8	496	747	http://www.mycancergenome.org/content/disease/breast-cancer/her2/245	\N
4009	8	497	747	http://www.mycancergenome.org/content/disease/breast-cancer/her2/245	\N
4010	8	498	748	\N	\N
4011	8	499	748	\N	\N
4012	8	500	748	\N	\N
4013	8	496	749	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242	\N
4014	8	497	749	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242	\N
4015	8	496	750	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246	\N
4016	8	496	751	http://www.mycancergenome.org/content/disease/breast-cancer/her2/239	\N
4017	8	82	366	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
4018	8	501	366	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
4019	8	502	366	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
4020	8	80	366	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
4021	8	81	366	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
4022	8	83	366	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
4023	8	84	366	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
4024	8	85	366	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
4025	8	82	367	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
4026	8	501	367	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
4027	8	502	367	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
4028	8	80	367	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
4029	8	81	367	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
4030	8	83	367	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
4031	8	84	367	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
4032	8	85	367	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
4033	8	82	368	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
4034	8	501	368	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
4035	8	502	368	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
4036	8	80	368	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
4037	8	81	368	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
4038	8	83	368	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
4039	8	84	368	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
4040	8	85	368	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
4041	8	82	369	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
4328	1	3	626	\N	\N
4042	8	501	369	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
4043	8	502	369	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
4044	8	80	369	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
4045	8	81	369	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
4046	8	83	369	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
4047	8	84	369	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
4048	8	85	369	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
4049	8	82	370	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
4050	8	501	370	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
4051	8	502	370	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
4052	8	80	370	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
4053	8	81	370	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
4054	8	83	370	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
4055	8	84	370	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
4056	8	85	370	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
4057	8	82	371	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
4058	8	501	371	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
4059	8	502	371	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
4060	8	80	371	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
4061	8	81	371	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
4214	41	495	768	\N	\N
4215	42	511	318	\N	\N
4062	8	83	371	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
4063	8	84	371	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
4064	8	85	371	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
4065	8	82	372	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
4066	8	501	372	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
4067	8	502	372	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
4068	8	80	372	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
4069	8	81	372	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
4070	8	83	372	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
4071	8	84	372	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
4072	8	85	372	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
4073	8	82	373	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
4074	8	501	373	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
4075	8	502	373	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
4076	8	80	373	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
4077	8	81	373	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
4078	8	83	373	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
4079	8	84	373	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
4080	8	85	373	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
4081	8	82	374	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
4082	8	501	374	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
4083	8	502	374	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
4084	8	80	374	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
4085	8	81	374	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
4086	8	83	374	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
4087	8	84	374	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
4088	8	85	374	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
4089	8	82	375	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
4090	8	501	375	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
4091	8	502	375	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
4092	8	80	375	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
4093	8	81	375	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
4094	8	83	375	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
4095	8	84	375	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
4096	8	85	375	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
4097	8	82	752	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
4098	8	501	752	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
4099	8	502	752	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
4100	8	80	752	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
4101	8	81	752	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
4102	8	83	752	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
4103	8	84	752	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
4104	8	85	752	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
4105	8	82	376	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
4106	8	501	376	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
4107	8	502	376	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
4108	8	80	376	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
4109	8	81	376	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
4110	8	83	376	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
4111	8	84	376	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
4112	8	85	376	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
4113	8	82	377	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
4114	8	501	377	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
4115	8	502	377	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
4116	8	80	377	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
4117	8	81	377	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
4118	8	83	377	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
4119	8	84	377	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
4120	8	85	377	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
4121	8	82	378	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
4122	8	501	378	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
4123	8	502	378	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
4124	8	80	378	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
4125	8	81	378	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
4126	8	83	378	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
4127	8	84	378	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
4128	8	85	378	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
4129	8	82	379	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
4130	8	316	379	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
4131	8	317	379	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
4132	8	318	379	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
4133	8	82	380	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25	\N
4134	8	316	380	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25	\N
4135	8	317	380	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25	\N
4136	8	318	380	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25	\N
4137	8	82	381	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26	\N
4138	8	316	381	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26	\N
4139	8	317	381	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26	\N
4140	8	318	381	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26	\N
4141	16	302	328	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
4142	16	387	328	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
4143	16	41	328	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
4144	16	388	328	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
4145	16	389	328	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
4146	16	390	328	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
4147	16	391	328	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
4148	16	392	328	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
4149	16	393	328	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
4150	16	394	328	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
4151	16	260	328	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
4152	16	51	328	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
4153	16	302	631	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
4154	16	387	631	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
4155	16	41	631	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
4156	16	388	631	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
4157	16	389	631	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
4158	16	390	631	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
4159	16	391	631	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
4160	16	392	631	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
4161	16	357	631	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
4162	16	302	753	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
4163	16	387	753	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
4164	16	41	753	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
4165	16	388	753	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
4166	16	389	753	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
4167	16	390	753	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
4168	16	391	753	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
4169	16	392	753	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
4170	16	302	333	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
4171	16	387	333	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
4172	16	41	333	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
4173	16	388	333	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
4174	16	389	333	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
4175	16	390	333	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
4176	16	391	333	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
4177	16	392	333	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
4178	16	302	754	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
4179	16	387	754	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
4180	16	41	754	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
4181	16	388	754	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
4182	16	389	754	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
4183	16	390	754	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
4184	16	503	754	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
4185	16	391	754	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
4186	16	392	754	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
4187	16	302	335	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
4188	16	387	335	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
4189	16	41	335	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
4190	16	388	335	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
4191	16	389	335	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
4192	16	390	335	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
4193	16	391	335	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
4194	16	392	335	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
4195	38	243	519	\N	\N
4196	38	243	755	\N	\N
4197	38	243	756	\N	\N
4198	38	504	328	\N	\N
4199	38	505	328	\N	\N
4200	38	506	757	\N	\N
4201	38	506	758	\N	\N
4202	38	506	759	\N	\N
4203	38	506	760	\N	\N
4204	38	507	436	\N	\N
4205	39	508	761	\N	\N
4206	39	509	762	\N	\N
4207	39	510	763	\N	\N
4208	39	322	764	\N	\N
4209	40	364	619	\N	\N
4210	41	306	765	\N	\N
4211	41	3	765	\N	\N
4212	41	495	766	\N	\N
4213	41	495	767	\N	\N
4216	42	512	318	\N	\N
4217	42	3	318	\N	\N
4218	43	513	328	\N	\N
4219	43	514	769	\N	\N
4220	43	515	769	\N	\N
4221	43	516	769	\N	\N
4222	43	516	770	\N	\N
4223	13	498	771	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
4224	13	498	772	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
4225	13	498	773	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
4226	13	498	774	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
4227	13	499	774	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
4228	13	498	775	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
4229	13	500	775	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
4230	13	498	776	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
4231	13	500	776	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
4232	13	499	776	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
4233	13	498	777	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
4234	13	500	777	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
4235	13	498	778	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
4236	13	500	778	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
4237	13	499	778	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
4238	13	517	778	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
4239	44	518	779	\N	\N
4240	44	518	780	\N	\N
4241	44	518	781	\N	\N
4242	44	518	782	\N	\N
4243	44	518	783	\N	\N
4244	44	519	781	\N	\N
4245	44	520	784	\N	\N
4246	15	352	612	http://www.mycancergenome.org/content/disease/medulloblastoma/smo/163	\N
4247	15	353	612	http://www.mycancergenome.org/content/disease/medulloblastoma/smo/163	\N
4248	5	3	785	\N	\N
4249	5	521	785	\N	\N
4250	37	3	786	\N	\N
4251	37	3	787	\N	\N
4252	37	3	788	\N	\N
4253	37	3	789	\N	\N
4254	1	306	790	\N	\N
4255	1	3	790	\N	\N
4256	1	3	791	\N	\N
4257	1	522	791	\N	\N
4258	1	3	792	\N	\N
4259	1	3	793	\N	\N
4260	1	523	793	\N	\N
4261	3	3	335	\N	\N
4262	3	391	335	\N	\N
4263	26	3	333	\N	\N
4265	1	3	334	\N	\N
4267	1	3	794	\N	\N
4268	1	3	795	\N	\N
4269	1	3	796	\N	\N
4270	1	524	796	\N	\N
4271	37	3	332	\N	\N
4272	1	3	797	\N	\N
4273	21	3	798	\N	\N
4274	21	525	798	\N	\N
4276	1	3	800	\N	\N
4277	1	463	800	\N	\N
4278	1	526	800	\N	\N
4279	37	3	801	\N	\N
4280	37	3	802	\N	\N
4281	37	3	803	\N	\N
4282	37	3	804	\N	\N
4283	1	3	805	\N	\N
4284	1	527	805	\N	\N
4285	1	3	633	\N	\N
4286	1	528	633	\N	\N
4287	1	3	331	\N	\N
4289	5	3	331	\N	\N
4291	1	3	330	\N	\N
4292	1	3	806	\N	\N
4293	1	446	806	\N	\N
4294	1	3	807	\N	\N
4295	1	3	808	\N	\N
4296	1	446	808	\N	\N
4297	1	3	809	\N	\N
4298	1	3	329	\N	\N
4299	5	3	329	\N	\N
4300	5	48	329	\N	\N
4301	1	3	629	\N	\N
4302	1	529	629	\N	\N
4304	1	3	614	\N	\N
4307	1	3	630	\N	\N
4309	1	3	631	\N	\N
4310	1	3	810	\N	\N
4311	1	3	811	\N	\N
4312	1	3	623	\N	\N
4313	1	530	623	\N	\N
4314	1	3	328	\N	\N
4330	1	531	626	\N	\N
4331	1	532	626	\N	\N
4332	1	3	813	\N	\N
4333	1	446	813	\N	\N
4334	1	3	627	\N	\N
4335	1	446	627	\N	\N
4336	1	3	628	\N	\N
4337	1	533	628	\N	\N
4338	1	3	625	\N	\N
4339	1	530	625	\N	\N
4340	1	3	814	\N	\N
4341	1	3	622	\N	\N
4342	1	3	815	\N	\N
4343	1	3	816	\N	\N
4344	1	3	817	\N	\N
4345	1	3	818	\N	\N
4346	1	3	819	\N	\N
4347	37	3	820	\N	\N
4348	37	3	821	\N	\N
4349	37	3	822	\N	\N
4350	1	3	823	\N	\N
4351	1	534	823	\N	\N
4352	37	3	824	\N	\N
4353	37	3	825	\N	\N
4354	37	3	826	\N	\N
4355	37	3	827	\N	\N
4356	37	3	828	\N	\N
4357	37	3	829	\N	\N
4358	1	3	830	\N	\N
4359	37	3	831	\N	\N
4360	37	3	832	\N	\N
4361	37	3	833	\N	\N
4362	37	3	834	\N	\N
4363	37	3	835	\N	\N
4364	37	3	836	\N	\N
4365	37	3	837	\N	\N
4366	1	3	838	\N	\N
4367	1	3	839	\N	\N
4368	1	3	840	\N	\N
4369	1	3	841	\N	\N
4370	1	3	842	\N	\N
4371	1	3	843	\N	\N
4372	1	3	844	\N	\N
4373	1	3	845	\N	\N
4374	1	535	845	\N	\N
4375	45	3	846	\N	\N
4376	46	3	846	\N	\N
4377	46	3	847	\N	\N
4378	15	3	848	\N	\N
4379	47	3	848	\N	\N
4380	7	3	849	\N	\N
4381	38	3	849	\N	\N
4382	48	3	849	\N	\N
4383	15	3	850	\N	\N
4384	46	3	850	\N	\N
4385	49	3	851	\N	\N
4386	7	3	851	\N	\N
4387	47	3	852	\N	\N
4388	50	3	852	\N	\N
4389	47	3	853	\N	\N
4390	50	3	853	\N	\N
4391	1	3	854	\N	\N
4392	47	3	854	\N	\N
4393	48	3	855	\N	\N
4394	7	3	856	\N	\N
4395	26	3	856	\N	\N
4396	7	3	639	\N	\N
4397	40	3	857	\N	\N
4398	40	3	638	\N	\N
4399	40	3	858	\N	\N
4400	1	3	859	\N	\N
4401	37	3	860	\N	\N
4402	37	3	861	\N	\N
4403	37	3	862	\N	\N
4404	38	3	863	\N	\N
4405	51	3	863	\N	\N
4406	51	3	864	\N	\N
4407	51	3	642	\N	\N
4408	51	536	642	\N	\N
4409	51	3	640	\N	\N
4410	51	536	640	\N	\N
4411	1	3	641	\N	\N
4412	1	446	641	\N	\N
4413	3	3	551	\N	\N
4414	3	537	551	\N	\N
4415	3	538	551	\N	\N
4416	3	539	551	\N	\N
4417	3	3	550	\N	\N
4418	3	540	550	\N	\N
4419	3	541	550	\N	\N
4420	3	3	568	\N	\N
4421	3	542	568	\N	\N
4422	3	3	549	\N	\N
4423	3	543	549	\N	\N
4424	3	544	549	\N	\N
4425	3	3	865	\N	\N
4426	45	3	866	\N	\N
4427	3	3	866	\N	\N
4428	3	545	866	\N	\N
4429	3	3	867	\N	\N
4430	3	546	867	\N	\N
4431	42	3	868	\N	\N
4432	3	3	868	\N	\N
4433	3	545	868	\N	\N
4434	3	3	869	\N	\N
4435	3	547	869	\N	\N
4436	52	3	870	\N	\N
4437	52	548	870	\N	\N
4438	52	549	870	\N	\N
4439	3	3	871	\N	\N
4440	26	3	872	\N	\N
4441	26	280	872	\N	\N
4442	3	3	872	\N	\N
4443	3	550	872	\N	\N
4444	3	3	873	\N	\N
4445	3	3	762	\N	\N
4446	3	551	762	\N	\N
4447	3	3	874	\N	\N
4448	3	547	874	\N	\N
4449	3	552	874	\N	\N
4450	3	3	875	\N	\N
4451	3	553	875	\N	\N
4452	3	554	875	\N	\N
4453	53	3	570	\N	\N
4454	53	555	570	\N	\N
4455	3	3	570	\N	\N
4456	3	556	570	\N	\N
4457	3	547	570	\N	\N
4458	3	3	876	\N	\N
4459	3	557	876	\N	\N
4460	3	3	552	\N	\N
4462	3	558	552	\N	\N
4463	3	559	552	\N	\N
4464	3	560	552	\N	\N
4465	54	3	877	\N	\N
4466	54	3	878	\N	\N
4467	3	3	879	\N	\N
4468	3	561	879	\N	\N
4469	3	546	879	\N	\N
4470	3	3	553	\N	\N
4471	3	543	553	\N	\N
4472	3	546	553	\N	\N
4473	3	3	880	\N	\N
4474	3	3	881	\N	\N
4475	3	3	882	\N	\N
4476	8	3	883	\N	\N
4477	8	3	884	\N	\N
4478	8	562	884	\N	\N
4479	8	563	884	\N	\N
4480	8	3	742	\N	\N
4481	37	3	885	\N	\N
4482	8	3	886	\N	\N
4483	8	3	744	\N	\N
4484	8	562	744	\N	\N
4485	8	564	744	\N	\N
4486	8	3	887	\N	\N
4487	8	562	887	\N	\N
4488	8	564	887	\N	\N
4489	37	3	888	\N	\N
4490	37	3	889	\N	\N
4491	46	3	606	\N	\N
4492	46	345	606	\N	\N
4493	46	565	606	\N	\N
4494	46	3	890	\N	\N
4495	46	345	890	\N	\N
4496	46	3	891	\N	\N
4497	46	565	891	\N	\N
4498	46	3	892	\N	\N
4499	46	565	892	\N	\N
4500	46	3	893	\N	\N
4501	46	3	894	\N	\N
4502	26	3	895	\N	\N
4503	26	322	895	\N	\N
4504	55	3	896	\N	\N
4505	55	566	896	\N	\N
4506	55	3	897	\N	\N
4507	55	566	897	\N	\N
4508	55	3	898	\N	\N
4509	55	3	769	\N	\N
4510	55	566	769	\N	\N
4511	55	3	899	\N	\N
4512	55	3	900	\N	\N
4513	2	3	901	\N	\N
4514	2	3	902	\N	\N
4515	2	3	417	\N	\N
4517	2	567	417	\N	\N
4518	2	3	416	\N	\N
4520	2	567	416	\N	\N
4521	2	3	422	\N	\N
4522	2	568	422	\N	\N
4523	2	569	422	\N	\N
4524	2	570	422	\N	\N
4525	2	3	418	\N	\N
4526	2	570	418	\N	\N
4527	2	568	418	\N	\N
4528	2	571	418	\N	\N
4529	2	3	421	\N	\N
4530	2	572	421	\N	\N
4531	2	3	903	\N	\N
4532	2	3	414	\N	\N
4533	56	3	650	\N	\N
4534	56	408	650	\N	\N
4535	56	573	650	\N	\N
4536	56	574	650	\N	\N
4537	56	3	649	\N	\N
4538	56	408	649	\N	\N
4539	56	3	651	\N	\N
4540	56	408	651	\N	\N
4541	56	3	904	\N	\N
4542	56	3	653	\N	\N
4543	56	408	653	\N	\N
4544	37	3	718	\N	\N
4545	37	3	719	\N	\N
4546	37	3	905	\N	\N
4547	55	3	906	\N	\N
4548	8	3	907	\N	\N
4549	5	3	709	\N	\N
4550	5	575	709	\N	\N
4551	1	3	708	\N	\N
4552	37	3	706	\N	\N
4553	4	3	707	\N	\N
4554	37	3	908	\N	\N
4555	12	3	909	\N	\N
4556	12	576	909	\N	\N
4557	37	3	910	\N	\N
4558	37	3	911	\N	\N
4559	8	3	912	\N	\N
4560	57	3	913	\N	\N
4561	57	577	913	\N	\N
4562	57	578	913	\N	\N
4563	37	3	914	\N	\N
4564	37	3	705	\N	\N
4565	37	3	915	\N	\N
4566	37	3	916	\N	\N
4567	58	3	437	\N	\N
4568	58	3	436	\N	\N
4569	58	579	436	\N	\N
4570	58	580	436	\N	\N
4571	58	3	439	\N	\N
4572	58	581	439	\N	\N
4573	2	3	444	\N	\N
4574	2	582	444	\N	\N
4575	2	3	442	\N	\N
4576	2	583	442	\N	\N
4577	23	3	446	\N	\N
4578	23	584	446	\N	\N
4579	18	3	917	\N	\N
4580	18	585	917	\N	\N
4581	33	3	918	\N	\N
4582	33	586	918	\N	\N
4583	33	585	918	\N	\N
4584	33	587	918	\N	\N
4585	18	3	919	\N	\N
4586	37	3	920	\N	\N
4587	11	3	657	\N	\N
4588	11	3	580	\N	\N
4589	1	3	581	\N	\N
4590	1	444	581	\N	\N
4591	1	3	391	\N	\N
4592	1	588	391	\N	\N
4594	1	3	921	\N	\N
4595	11	3	660	\N	\N
4596	11	589	660	\N	\N
4597	33	3	390	\N	\N
4598	33	590	390	\N	\N
4599	1	3	661	\N	\N
4600	1	429	661	\N	\N
4601	11	3	661	\N	\N
4602	11	104	661	\N	\N
4603	11	3	663	\N	\N
4604	11	591	663	\N	\N
4605	11	592	663	\N	\N
4606	1	3	583	\N	\N
4609	11	3	666	\N	\N
4610	11	593	666	\N	\N
4611	11	594	666	\N	\N
4612	11	3	392	\N	\N
4613	11	108	392	\N	\N
4614	11	595	392	\N	\N
4615	11	596	392	\N	\N
4616	11	3	393	\N	\N
4617	11	108	393	\N	\N
4618	11	595	393	\N	\N
4619	11	597	393	\N	\N
4620	11	3	394	\N	\N
4622	11	598	394	\N	\N
4623	59	3	396	\N	\N
4624	59	599	396	\N	\N
4625	59	600	396	\N	\N
4626	59	601	396	\N	\N
4627	11	3	395	\N	\N
4628	11	591	395	\N	\N
4629	11	419	395	\N	\N
4630	11	3	448	\N	\N
4631	11	339	448	\N	\N
4632	11	595	448	\N	\N
4633	11	3	449	\N	\N
4634	11	339	449	\N	\N
4635	11	595	449	\N	\N
4636	1	3	922	\N	\N
4637	1	429	922	\N	\N
4638	1	446	922	\N	\N
4639	11	3	923	\N	\N
4640	11	419	923	\N	\N
4641	11	3	354	\N	\N
4642	11	602	354	\N	\N
4643	5	3	354	\N	\N
4644	5	603	354	\N	\N
4645	5	3	356	\N	\N
4646	5	603	356	\N	\N
4647	26	3	356	\N	\N
4648	26	604	356	\N	\N
4649	16	3	355	\N	\N
4650	16	311	355	\N	\N
4651	16	604	355	\N	\N
4652	5	3	357	\N	\N
4653	5	605	357	\N	\N
4654	5	603	357	\N	\N
4655	3	3	358	\N	\N
4656	3	606	358	\N	\N
4657	3	3	353	\N	\N
4658	3	607	353	\N	\N
4659	3	608	353	\N	\N
4660	3	609	353	\N	\N
4661	5	3	353	\N	\N
4662	5	610	353	\N	\N
4663	5	70	353	\N	\N
4664	5	609	353	\N	\N
4665	5	3	348	\N	\N
4666	5	3	350	\N	\N
4667	5	3	349	\N	\N
4669	5	603	349	\N	\N
4670	5	611	349	\N	\N
4671	5	609	349	\N	\N
4672	5	3	351	\N	\N
4673	5	3	352	\N	\N
4674	5	3	347	\N	\N
4675	4	3	347	\N	\N
4676	4	612	347	\N	\N
4677	60	3	924	\N	\N
4678	60	613	924	\N	\N
4679	60	3	925	\N	\N
4680	60	613	925	\N	\N
4681	5	3	926	\N	\N
4682	5	3	927	\N	\N
4683	5	609	927	\N	\N
4684	5	3	928	\N	\N
4685	5	3	342	\N	\N
4686	5	605	342	\N	\N
4687	5	50	342	\N	\N
4688	5	3	343	\N	\N
4689	5	605	343	\N	\N
4690	5	50	343	\N	\N
4691	5	3	346	\N	\N
4692	5	3	344	\N	\N
4693	5	49	344	\N	\N
4694	5	3	710	\N	\N
4695	5	3	345	\N	\N
4696	5	3	339	\N	\N
4697	5	609	339	\N	\N
4698	3	3	555	\N	\N
4699	26	3	675	\N	\N
4700	26	3	556	\N	\N
4701	1	3	557	\N	\N
4702	1	446	557	\N	\N
4703	26	3	929	\N	\N
4704	26	3	677	\N	\N
4705	1	3	679	\N	\N
4706	24	3	531	\N	\N
4707	24	3	930	\N	\N
4708	24	614	930	\N	\N
4709	24	3	732	\N	\N
4710	24	615	732	\N	\N
4711	24	3	931	\N	\N
4712	24	615	931	\N	\N
4713	24	616	931	\N	\N
4714	24	3	532	\N	\N
4715	61	3	932	\N	\N
4716	26	3	932	\N	\N
4717	26	617	932	\N	\N
4718	37	3	933	\N	\N
4719	37	3	934	\N	\N
4720	37	3	935	\N	\N
4721	37	3	936	\N	\N
4722	37	3	937	\N	\N
4723	37	3	938	\N	\N
4724	5	3	362	\N	\N
4725	5	3	364	\N	\N
4726	5	618	364	\N	\N
4727	2	3	363	\N	\N
4728	2	619	363	\N	\N
4729	21	3	561	\N	\N
4730	21	620	561	\N	\N
4731	5	3	561	\N	\N
4732	5	3	365	\N	\N
4734	2	3	361	\N	\N
4735	1	3	693	\N	\N
4736	1	3	694	\N	\N
4737	1	3	457	\N	\N
4738	1	621	457	\N	\N
4739	1	3	695	\N	\N
4740	1	622	695	\N	\N
4741	40	3	939	\N	\N
4742	37	3	456	\N	\N
4743	1	3	940	\N	\N
4744	1	522	940	\N	\N
4745	1	3	692	\N	\N
4747	1	3	454	\N	\N
4748	1	623	454	\N	\N
4749	1	3	455	\N	\N
4750	1	623	455	\N	\N
4751	1	3	560	\N	\N
4752	1	623	560	\N	\N
4753	1	3	558	\N	\N
4754	1	624	558	\N	\N
4755	1	625	558	\N	\N
4756	1	3	690	\N	\N
4757	1	624	690	\N	\N
4758	1	625	690	\N	\N
4759	1	3	559	\N	\N
4760	1	3	359	\N	\N
4761	1	3	941	\N	\N
4762	11	3	400	\N	\N
4763	11	626	400	\N	\N
4764	11	627	400	\N	\N
4765	11	3	942	\N	\N
4766	11	3	943	\N	\N
4767	11	626	943	\N	\N
4768	11	627	943	\N	\N
4769	11	110	943	\N	\N
4770	11	3	403	\N	\N
4772	11	626	403	\N	\N
4774	11	595	403	\N	\N
4775	11	3	944	\N	\N
4776	11	110	944	\N	\N
4777	11	3	945	\N	\N
4778	11	3	946	\N	\N
4779	11	3	947	\N	\N
4780	11	3	948	\N	\N
4781	11	106	948	\N	\N
4782	8	3	949	\N	\N
4783	5	3	949	\N	\N
4784	5	87	949	\N	\N
4785	8	3	950	\N	\N
4786	5	3	950	\N	\N
4787	5	87	950	\N	\N
4788	8	3	951	\N	\N
4789	5	3	951	\N	\N
4790	5	87	951	\N	\N
4791	8	3	952	\N	\N
4792	5	3	952	\N	\N
4793	8	3	953	\N	\N
4794	8	3	366	\N	\N
4795	8	628	366	\N	\N
4796	3	3	954	\N	\N
4797	8	3	369	\N	\N
4798	8	3	955	\N	\N
4799	8	3	956	\N	\N
4800	5	3	370	\N	\N
4801	1	3	370	\N	\N
4802	1	629	370	\N	\N
4803	8	3	367	\N	\N
4804	8	628	367	\N	\N
4805	39	3	368	\N	\N
4806	39	630	368	\N	\N
4807	16	3	372	\N	\N
4808	8	3	957	\N	\N
4809	8	502	957	\N	\N
4810	8	3	958	\N	\N
4811	5	3	959	\N	\N
4812	5	631	959	\N	\N
4813	5	3	960	\N	\N
4814	5	631	960	\N	\N
4815	5	3	378	\N	\N
4817	37	3	377	\N	\N
4818	62	3	961	\N	\N
4819	62	632	961	\N	\N
4820	5	3	962	\N	\N
4821	5	49	962	\N	\N
4822	62	3	963	\N	\N
4823	62	632	963	\N	\N
4824	37	3	964	\N	\N
4825	37	633	964	\N	\N
4826	37	3	965	\N	\N
4827	37	633	965	\N	\N
4828	37	3	966	\N	\N
4829	37	3	967	\N	\N
4830	37	3	968	\N	\N
4831	37	3	969	\N	\N
4832	37	3	970	\N	\N
4833	37	3	971	\N	\N
4834	37	634	971	\N	\N
4835	37	3	972	\N	\N
4836	37	634	972	\N	\N
4837	37	3	973	\N	\N
4838	37	3	974	\N	\N
4839	62	3	615	\N	\N
4840	62	632	615	\N	\N
4841	37	3	617	\N	\N
4842	38	3	616	\N	\N
4843	38	635	616	\N	\N
4844	38	3	975	\N	\N
4845	38	3	976	\N	\N
4846	38	636	976	\N	\N
4847	37	3	977	\N	\N
4848	38	3	978	\N	\N
4849	37	3	979	\N	\N
4850	63	3	980	\N	\N
4851	63	3	981	\N	\N
4852	63	637	981	\N	\N
4853	63	3	982	\N	\N
4854	63	637	982	\N	\N
4855	63	3	983	\N	\N
4856	63	3	984	\N	\N
4857	63	637	984	\N	\N
4858	37	3	985	\N	\N
4859	63	3	986	\N	\N
4860	22	3	987	\N	\N
4861	37	3	988	\N	\N
4862	64	3	989	\N	\N
4863	64	3	990	\N	\N
4864	64	3	991	\N	\N
4865	64	3	992	\N	\N
4866	64	638	992	\N	\N
4867	64	3	711	\N	\N
4868	64	639	711	\N	\N
4869	37	3	993	\N	\N
4870	37	3	994	\N	\N
4871	64	3	995	\N	\N
4872	64	638	995	\N	\N
4873	64	3	996	\N	\N
4874	64	3	712	\N	\N
4875	64	640	712	\N	\N
4876	37	3	997	\N	\N
4877	37	3	998	\N	\N
4878	37	3	999	\N	\N
4879	37	3	1000	\N	\N
4880	37	3	1001	\N	\N
4881	3	3	1002	\N	\N
4882	37	3	1003	\N	\N
4883	37	3	1004	\N	\N
4884	37	3	1005	\N	\N
4885	37	3	1006	\N	\N
4886	37	3	1007	\N	\N
4887	37	641	1007	\N	\N
4888	37	642	1007	\N	\N
4889	37	3	1008	\N	\N
4890	37	643	1008	\N	\N
4891	37	3	480	\N	\N
4892	37	644	480	\N	\N
4893	49	3	480	\N	\N
4894	49	645	480	\N	\N
4895	2	3	1009	\N	\N
4896	2	646	1009	\N	\N
4897	37	3	1009	\N	\N
4898	49	3	477	\N	\N
4899	49	645	477	\N	\N
4900	37	3	477	\N	\N
4901	37	3	476	\N	\N
4902	5	3	1010	\N	\N
4903	39	3	1010	\N	\N
4904	37	3	1011	\N	\N
4905	37	3	1012	\N	\N
4906	65	3	1013	\N	\N
4907	65	647	1013	\N	\N
4908	65	3	1014	\N	\N
4909	65	647	1014	\N	\N
4910	65	3	1015	\N	\N
4911	65	3	1016	\N	\N
4912	65	648	1016	\N	\N
15028	18	1	3427	\N	\N
15029	18	2	3427	\N	\N
15030	18	3	3427	\N	\N
15031	21	183	3427	\N	\N
15032	21	184	3427	\N	\N
15033	21	194	3427	\N	\N
15034	21	186	3427	\N	\N
15035	21	199	3427	\N	\N
15036	21	200	3427	\N	\N
15037	21	201	3427	\N	\N
15038	21	197	3427	\N	\N
15039	21	202	3427	\N	\N
15040	21	203	3427	\N	\N
15041	21	190	3427	\N	\N
15042	21	195	3427	\N	\N
15043	21	204	3427	\N	\N
15044	21	205	3427	\N	\N
15045	21	3	3427	\N	\N
15046	21	210	3427	\N	\N
15047	18	4	3428	\N	\N
15048	18	3	3428	\N	\N
15049	18	5	3428	\N	\N
15050	21	219	3428	\N	\N
15051	21	220	3428	\N	\N
15052	21	196	3428	\N	\N
15053	21	221	3428	\N	\N
15054	21	222	3428	\N	\N
15055	21	184	3428	\N	\N
15056	21	223	3428	\N	\N
15057	21	224	3428	\N	\N
15058	21	186	3428	\N	\N
15059	21	183	3428	\N	\N
15060	21	202	3428	\N	\N
15061	21	188	3428	\N	\N
15062	21	190	3428	\N	\N
15063	21	2	3428	\N	\N
15064	21	207	3428	\N	\N
15065	21	195	3428	\N	\N
15066	21	225	3428	\N	\N
15067	21	211	3428	\N	\N
15068	21	226	3428	\N	\N
15069	21	3	3428	\N	\N
15070	21	210	3428	\N	\N
15071	18	6	3429	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
15072	18	7	3429	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
15073	18	8	3429	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
15074	18	9	3429	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/crlf2/199	\N
15075	18	10	3430	\N	\N
15076	18	11	3430	\N	\N
15077	18	11	3431	\N	\N
15078	18	12	3432	\N	\N
15079	18	13	3432	\N	\N
15080	18	14	3432	\N	\N
15081	18	15	3432	\N	\N
15082	2	12	3432	\N	\N
15083	2	145	3432	\N	\N
15084	19	181	3432	\N	\N
15085	18	13	3433	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200	\N
15086	18	16	3433	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200	\N
15087	18	17	3433	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200	\N
15088	18	11	3433	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/200	\N
15089	18	13	3434	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203	\N
15090	18	16	3434	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203	\N
15091	18	17	3434	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203	\N
15092	18	11	3434	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/203	\N
15093	18	13	3435	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
15094	18	16	3435	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
15095	18	17	3435	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
15096	18	11	3435	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/202	\N
15097	18	13	3436	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
15098	18	16	3436	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
15099	18	17	3436	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
15100	18	11	3436	http://www.mycancergenome.org/content/disease/acute-lymphoblastic-leukemia/jak2/201	\N
15101	5	18	3437	\N	\N
15102	5	19	3437	\N	\N
15103	5	20	3437	\N	\N
15104	5	3	3437	\N	\N
15105	5	36	3437	http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23	\N
15106	5	37	3437	http://www.mycancergenome.org/content/disease/colorectal-cancer/akt1/23	\N
15107	22	245	3437	\N	\N
15108	22	3	3437	\N	\N
15109	26	254	3437	\N	\N
15110	26	3	3437	\N	\N
15111	3	20	3437	\N	\N
15112	3	3	3437	\N	\N
15113	3	263	3437	\N	\N
15114	3	265	3437	http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23	\N
15115	3	266	3437	http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23	\N
15116	3	267	3437	http://www.mycancergenome.org/content/disease/lung-cancer/akt1/23	\N
15117	28	323	3437	\N	\N
15118	28	3	3437	\N	\N
15119	30	325	3437	\N	\N
15120	30	3	3437	\N	\N
15121	31	342	3437	\N	\N
15122	31	3	3437	\N	\N
15123	8	20	3437	\N	\N
15124	8	488	3437	\N	\N
15125	8	489	3437	\N	\N
15126	8	490	3437	\N	\N
15127	8	491	3437	\N	\N
15128	8	492	3437	\N	\N
15129	8	493	3437	\N	\N
15130	8	3	3437	\N	\N
15131	8	82	3437	http://www.mycancergenome.org/content/disease/breast-cancer/akt1/23	\N
15132	8	494	3437	http://www.mycancergenome.org/content/disease/breast-cancer/akt1/23	\N
15133	42	511	3437	\N	\N
15134	42	512	3437	\N	\N
15135	42	3	3437	\N	\N
15136	5	21	3438	\N	\N
15137	5	22	3438	\N	\N
15138	5	23	3438	\N	\N
15139	5	3	3438	\N	\N
15140	5	18	3439	\N	\N
15141	5	24	3439	\N	\N
15142	5	25	3439	\N	\N
15143	5	22	3439	\N	\N
15144	5	3	3439	\N	\N
15145	26	255	3439	\N	\N
15146	26	3	3439	\N	\N
15147	5	22	3440	\N	\N
15148	5	23	3440	\N	\N
15149	5	26	3440	\N	\N
15150	5	3	3440	\N	\N
15151	5	22	3441	\N	\N
15152	5	23	3441	\N	\N
15153	5	26	3441	\N	\N
15154	5	27	3441	\N	\N
15155	5	28	3441	\N	\N
15156	5	29	3441	\N	\N
15157	5	30	3441	\N	\N
15158	5	3	3441	\N	\N
15159	5	23	3442	\N	\N
15160	5	26	3442	\N	\N
15161	5	31	3442	\N	\N
15162	5	29	3442	\N	\N
15163	5	30	3442	\N	\N
15164	5	27	3442	\N	\N
15165	5	3	3442	\N	\N
15166	5	22	3443	\N	\N
15167	5	18	3443	\N	\N
15168	5	32	3443	\N	\N
15169	5	33	3443	\N	\N
15170	5	3	3443	\N	\N
15171	5	22	3444	\N	\N
15172	5	23	3444	\N	\N
15173	5	26	3444	\N	\N
15174	5	27	3444	\N	\N
15175	5	3	3444	\N	\N
15176	5	22	3445	\N	\N
15177	5	23	3445	\N	\N
15178	5	27	3445	\N	\N
15179	5	34	3445	\N	\N
15180	5	35	3445	\N	\N
15181	5	30	3445	\N	\N
15182	5	3	3445	\N	\N
15183	5	22	3446	\N	\N
15184	5	23	3446	\N	\N
15185	5	26	3446	\N	\N
15186	5	27	3446	\N	\N
15187	5	28	3446	\N	\N
15188	5	25	3446	\N	\N
15189	5	29	3446	\N	\N
15190	5	30	3446	\N	\N
15191	5	33	3446	\N	\N
15192	5	35	3446	\N	\N
15193	5	18	3446	\N	\N
15194	5	3	3446	\N	\N
15195	5	38	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
15196	5	39	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
15197	5	40	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
15198	5	41	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
15199	5	42	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
15200	5	43	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
15201	5	44	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
15202	5	45	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
15203	5	46	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
15204	5	47	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
15207	5	50	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
15208	5	51	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
15209	5	52	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
15210	5	53	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
15211	5	54	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
15212	5	55	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	\N
15213	11	95	3447	http://www.mycancergenome.org/content/disease/gist/braf/54	\N
15214	11	41	3447	http://www.mycancergenome.org/content/disease/gist/braf/54	\N
15215	11	96	3447	http://www.mycancergenome.org/content/disease/gist/braf/54	\N
15216	11	97	3447	http://www.mycancergenome.org/content/disease/gist/braf/54	\N
15217	11	98	3447	http://www.mycancergenome.org/content/disease/gist/braf/54	\N
15218	11	51	3447	http://www.mycancergenome.org/content/disease/gist/braf/54	\N
15219	1	531	3447	\N	\N
15220	1	532	3447	\N	\N
15221	1	533	3447	\N	\N
15222	35	3	3447	\N	\N
15223	7	354	3447	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54	\N
15224	7	355	3447	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54	\N
15225	7	41	3447	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54	\N
15226	7	96	3447	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54	\N
15227	7	97	3447	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54	\N
15228	7	51	3447	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54	\N
15229	7	356	3447	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/54	\N
15230	1	41	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15231	1	367	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15232	1	377	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15233	1	373	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15234	1	97	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15235	1	51	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15236	1	374	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15237	1	96	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15238	1	375	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15239	1	368	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15240	1	369	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15241	1	370	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15242	1	371	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15243	1	372	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15244	1	378	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15245	1	379	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15246	1	380	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15247	1	381	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15248	1	382	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15249	1	383	3447	http://www.mycancergenome.org/content/disease/melanoma/braf/54	\N
15250	35	46	3447	\N	\N
15251	4	96	3447	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
15252	4	472	3447	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
15253	4	473	3447	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
15254	4	41	3447	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
15255	4	474	3447	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
15256	4	475	3447	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
15257	4	51	3447	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
15258	4	469	3447	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
15259	4	470	3447	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
15260	4	471	3447	http://www.mycancergenome.org/content/disease/thyroid-cancer/braf/54	\N
15261	16	302	3447	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
15262	16	387	3447	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
15263	16	41	3447	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
15264	16	388	3447	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
15265	16	389	3447	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
15266	16	390	3447	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
15267	16	391	3447	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
15268	16	392	3447	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
15269	16	393	3447	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
15270	16	394	3447	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
15271	16	260	3447	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
15272	16	51	3447	http://www.mycancergenome.org/content/disease/lung-cancer/braf/54	\N
15273	38	504	3447	\N	\N
15274	38	505	3447	\N	\N
15275	43	513	3447	\N	\N
15276	1	3	3447	\N	\N
15277	5	38	3448	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/150	\N
15278	5	39	3448	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/150	\N
15279	5	40	3448	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/150	\N
15280	5	41	3448	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/150	\N
15281	5	56	3448	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/150	\N
15282	1	3	3448	\N	\N
15283	5	3	3448	\N	\N
15284	5	48	3448	\N	\N
15285	5	38	3449	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
15286	5	39	3449	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
15287	5	40	3449	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
15288	5	41	3449	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
15289	5	57	3449	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
15290	5	58	3449	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
15291	5	59	3449	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
15292	5	56	3449	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/149	\N
15293	1	41	3449	http://www.mycancergenome.org/content/disease/melanoma/braf/149	\N
15294	1	367	3449	http://www.mycancergenome.org/content/disease/melanoma/braf/149	\N
15295	1	3	3449	\N	\N
15296	5	38	3450	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148	\N
15297	5	39	3450	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148	\N
15298	5	40	3450	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148	\N
15299	5	41	3450	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148	\N
15300	5	56	3450	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148	\N
15301	5	49	3450	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/148	\N
15302	1	41	3450	http://www.mycancergenome.org/content/disease/melanoma/braf/148	\N
15303	1	367	3450	http://www.mycancergenome.org/content/disease/melanoma/braf/148	\N
15304	1	396	3450	http://www.mycancergenome.org/content/disease/melanoma/braf/148	\N
15305	1	3	3450	\N	\N
15306	5	3	3450	\N	\N
15307	5	38	3451	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147	\N
15308	5	39	3451	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147	\N
15309	5	40	3451	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147	\N
15310	5	60	3451	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147	\N
15311	5	41	3451	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147	\N
15312	5	56	3451	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/147	\N
15313	37	3	3451	\N	\N
15314	5	38	3452	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71	\N
15315	5	39	3452	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71	\N
15316	5	40	3452	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71	\N
15317	5	60	3452	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71	\N
15318	5	41	3452	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71	\N
15319	5	56	3452	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/71	\N
15320	26	260	3452	\N	\N
15321	16	302	3452	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
15322	16	387	3452	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
15323	16	41	3452	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
15324	16	388	3452	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
15325	16	389	3452	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
15326	16	390	3452	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
15327	16	391	3452	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
15328	16	392	3452	http://www.mycancergenome.org/content/disease/lung-cancer/braf/71	\N
15329	26	3	3452	\N	\N
15330	5	38	3453	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146	\N
15331	5	39	3453	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146	\N
15332	5	40	3453	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146	\N
15333	5	60	3453	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146	\N
15334	5	41	3453	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146	\N
15335	5	56	3453	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/146	\N
15336	1	396	3453	\N	\N
15337	1	3	3453	\N	\N
15338	5	38	3454	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70	\N
15339	5	39	3454	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70	\N
15340	5	40	3454	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70	\N
15341	5	60	3454	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70	\N
15342	5	41	3454	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70	\N
15343	5	56	3454	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/70	\N
15344	16	302	3454	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
15345	16	387	3454	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
15346	16	41	3454	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
15347	16	388	3454	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
15348	16	389	3454	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
15349	16	390	3454	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
15350	16	391	3454	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
15351	16	392	3454	http://www.mycancergenome.org/content/disease/lung-cancer/braf/70	\N
15352	3	3	3454	\N	\N
15353	3	391	3454	\N	\N
15354	5	61	3455	\N	\N
15355	5	62	3456	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
15356	5	63	3456	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
15357	5	64	3456	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
15358	5	65	3456	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
15359	5	66	3456	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
15360	5	67	3456	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
15361	5	68	3456	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
15362	5	69	3456	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/29	\N
15363	4	471	3456	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29	\N
15364	4	473	3456	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29	\N
15365	4	472	3456	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/29	\N
15366	5	62	3457	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
15367	5	63	3457	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
15368	5	64	3457	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
15369	5	65	3457	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
15370	5	66	3457	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
15371	5	67	3457	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
15372	5	68	3457	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
15373	5	69	3457	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/27	\N
15374	5	62	3458	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
15375	5	63	3458	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
15376	5	64	3458	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
15377	5	65	3458	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
15378	5	66	3458	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
15379	5	67	3458	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
15380	5	68	3458	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
15381	5	69	3458	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/28	\N
15382	5	3	3458	\N	\N
15383	5	609	3458	\N	\N
15384	5	62	3459	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
15385	5	63	3459	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
15386	5	64	3459	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
15387	5	65	3459	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
15388	5	66	3459	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
15389	5	67	3459	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
15390	5	68	3459	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
15391	5	69	3459	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/161	\N
15392	5	62	3460	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
15393	5	63	3460	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
15394	5	64	3460	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
15395	5	65	3460	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
15396	5	66	3460	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
15397	5	67	3460	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
15398	5	68	3460	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
15399	5	69	3460	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/160	\N
15400	5	62	3461	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
15401	5	63	3461	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
15402	5	64	3461	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
15403	5	65	3461	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
15404	5	66	3461	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
15405	5	67	3461	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
15406	5	68	3461	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
15407	5	69	3461	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/31	\N
15408	2	160	3461	\N	\N
15409	2	161	3461	\N	\N
15410	2	162	3461	\N	\N
15411	2	163	3461	\N	\N
15412	2	164	3461	\N	\N
15413	3	302	3461	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31	\N
15414	3	303	3461	http://www.mycancergenome.org/content/disease/lung-cancer/kras/31	\N
15415	5	3	3461	\N	\N
15416	5	605	3461	\N	\N
15417	5	50	3461	\N	\N
15418	2	164	3462	\N	\N
15419	5	62	3462	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
15420	5	63	3462	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
15421	5	64	3462	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
15422	5	65	3462	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
15423	5	66	3462	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
15424	5	67	3462	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
15425	5	68	3462	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
15426	5	69	3462	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/30	\N
15427	2	160	3462	\N	\N
15428	2	161	3462	\N	\N
15429	2	162	3462	\N	\N
15430	2	163	3462	\N	\N
15431	3	302	3462	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30	\N
15432	3	303	3462	http://www.mycancergenome.org/content/disease/lung-cancer/kras/30	\N
15433	5	3	3462	\N	\N
15434	5	605	3462	\N	\N
15435	5	50	3462	\N	\N
15436	5	62	3463	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
15437	5	63	3463	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
15438	5	64	3463	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
15439	5	65	3463	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
15440	5	66	3463	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
15441	5	67	3463	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
15442	5	68	3463	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
15443	5	69	3463	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/42	\N
15444	3	302	3463	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42	\N
15445	3	303	3463	http://www.mycancergenome.org/content/disease/lung-cancer/kras/42	\N
15446	4	476	3463	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
15447	4	471	3463	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
15448	4	473	3463	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
15449	4	472	3463	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/42	\N
15450	5	3	3463	\N	\N
15451	5	49	3463	\N	\N
15452	5	62	3464	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
15453	5	63	3464	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
15454	5	64	3464	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
15455	5	65	3464	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
15456	5	66	3464	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
15457	5	67	3464	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
15458	5	68	3464	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
15459	5	69	3464	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/43	\N
15460	3	302	3464	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43	\N
15461	3	303	3464	http://www.mycancergenome.org/content/disease/lung-cancer/kras/43	\N
15462	4	476	3464	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
15463	4	471	3464	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
15464	4	473	3464	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
15465	4	472	3464	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/43	\N
15466	5	3	3464	\N	\N
15467	5	62	3465	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
15468	5	63	3465	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
15469	5	64	3465	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
15470	5	65	3465	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
15471	5	66	3465	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
15472	5	67	3465	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
15473	5	68	3465	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
15474	5	69	3465	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/41	\N
15475	3	302	3465	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
15476	3	303	3465	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
15477	4	476	3465	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
15478	4	471	3465	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
15479	4	473	3465	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
15480	4	472	3465	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/41	\N
15481	5	3	3465	\N	\N
15482	5	62	3466	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
15483	5	63	3466	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
15484	5	64	3466	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
15485	5	65	3466	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
15486	5	66	3466	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
15487	5	67	3466	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
15488	5	68	3466	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
15489	5	69	3466	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/159	\N
15490	5	3	3466	\N	\N
15491	4	3	3466	\N	\N
15492	4	612	3466	\N	\N
15493	5	62	3467	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
15494	5	63	3467	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
15495	5	64	3467	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
15496	5	65	3467	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
15497	5	66	3467	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
15498	5	67	3467	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
15499	5	68	3467	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
15500	5	69	3467	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/68	\N
15501	3	302	3467	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68	\N
15502	3	303	3467	http://www.mycancergenome.org/content/disease/lung-cancer/kras/68	\N
15503	5	3	3467	\N	\N
15504	2	160	3468	\N	\N
15505	2	161	3468	\N	\N
15506	2	162	3468	\N	\N
15507	2	163	3468	\N	\N
15508	2	164	3468	\N	\N
15509	5	62	3468	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
15510	5	63	3468	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
15511	5	64	3468	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
15512	5	65	3468	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
15513	5	66	3468	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
15514	5	67	3468	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
15515	5	68	3468	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
15516	5	69	3468	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
15517	5	70	3468	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
15519	5	72	3468	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	\N
15520	3	302	3468	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39	\N
15521	3	303	3468	http://www.mycancergenome.org/content/disease/lung-cancer/kras/39	\N
15522	7	355	3468	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39	\N
15523	7	356	3468	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/39	\N
15524	4	476	3468	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39	\N
15525	4	471	3468	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39	\N
15526	4	473	3468	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39	\N
15527	4	472	3468	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/39	\N
15528	5	3	3468	\N	\N
15529	5	603	3468	\N	\N
15530	5	611	3468	\N	\N
15531	5	609	3468	\N	\N
15532	5	62	3469	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
15533	5	63	3469	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
15534	5	64	3469	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
15535	5	65	3469	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
15536	5	66	3469	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
15537	5	67	3469	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
15538	5	68	3469	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
15539	5	69	3469	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/38	\N
15540	3	302	3469	http://www.mycancergenome.org/content/disease/lung-cancer/kras/38	\N
15541	3	303	3469	http://www.mycancergenome.org/content/disease/lung-cancer/kras/38	\N
15542	5	3	3469	\N	\N
15543	5	62	3470	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
15544	5	63	3470	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
15545	5	64	3470	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
15546	5	65	3470	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
15547	5	66	3470	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
15548	5	67	3470	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
15549	5	68	3470	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
15550	5	69	3470	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/40	\N
15551	3	302	3470	http://www.mycancergenome.org/content/disease/lung-cancer/kras/40	\N
15552	3	303	3470	http://www.mycancergenome.org/content/disease/lung-cancer/kras/40	\N
15553	4	476	3470	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40	\N
15554	4	471	3470	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40	\N
15555	4	473	3470	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40	\N
15556	4	472	3470	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/40	\N
15557	5	3	3470	\N	\N
15558	5	62	3471	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
15559	5	63	3471	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
15560	5	64	3471	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
15561	5	65	3471	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
15562	5	66	3471	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
15563	5	67	3471	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
15564	5	68	3471	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
15565	5	69	3471	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/69	\N
15566	3	302	3471	http://www.mycancergenome.org/content/disease/lung-cancer/kras/69	\N
15567	3	303	3471	http://www.mycancergenome.org/content/disease/lung-cancer/kras/69	\N
15568	4	476	3471	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69	\N
15569	4	471	3471	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69	\N
15570	4	473	3471	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69	\N
15571	4	472	3471	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/69	\N
15572	5	3	3471	\N	\N
15573	5	62	3472	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
15574	5	63	3472	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
15575	5	64	3472	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
15576	5	65	3472	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
15577	5	66	3472	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
15578	5	67	3472	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
15579	5	68	3472	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
15580	5	69	3472	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/37	\N
15581	2	160	3472	\N	\N
15582	2	161	3472	\N	\N
15583	2	162	3472	\N	\N
15584	2	163	3472	\N	\N
15585	2	164	3472	\N	\N
15586	7	355	3472	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37	\N
15587	7	356	3472	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/37	\N
15588	4	476	3472	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37	\N
15589	4	471	3472	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37	\N
15590	4	473	3472	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37	\N
15591	4	472	3472	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/37	\N
15592	3	3	3472	\N	\N
15593	3	607	3472	\N	\N
15594	3	608	3472	\N	\N
15595	3	609	3472	\N	\N
15596	5	3	3472	\N	\N
15597	5	610	3472	\N	\N
15598	5	70	3472	\N	\N
15599	5	609	3472	\N	\N
15600	5	62	3473	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
15601	5	63	3473	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
15602	5	64	3473	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
15603	5	65	3473	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
15604	5	66	3473	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
15605	5	67	3473	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
15606	5	68	3473	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
15607	5	69	3473	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/32	\N
15608	3	302	3473	http://www.mycancergenome.org/content/disease/lung-cancer/kras/32	\N
15609	3	303	3473	http://www.mycancergenome.org/content/disease/lung-cancer/kras/32	\N
15610	7	355	3473	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32	\N
15611	7	356	3473	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/32	\N
15612	11	3	3473	\N	\N
15613	11	602	3473	\N	\N
15614	5	3	3473	\N	\N
15615	5	603	3473	\N	\N
15616	5	62	3474	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
15617	5	63	3474	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
15618	5	64	3474	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
15619	5	65	3474	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
15620	5	66	3474	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
15621	5	67	3474	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
15622	5	68	3474	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
15623	5	69	3474	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/34	\N
15624	2	160	3474	\N	\N
15625	2	161	3474	\N	\N
15626	2	162	3474	\N	\N
15627	2	163	3474	\N	\N
15628	2	164	3474	\N	\N
15629	3	302	3474	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34	\N
15630	3	303	3474	http://www.mycancergenome.org/content/disease/lung-cancer/kras/34	\N
15631	7	355	3474	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/34	\N
15632	7	356	3474	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/34	\N
15633	4	476	3474	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34	\N
15634	4	471	3474	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34	\N
15635	4	473	3474	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34	\N
15636	4	472	3474	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/34	\N
15637	16	3	3474	\N	\N
15638	16	311	3474	\N	\N
15639	16	604	3474	\N	\N
15640	5	62	3475	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
15641	5	63	3475	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
15642	5	64	3475	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
15643	5	65	3475	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
15644	5	66	3475	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
15645	5	67	3475	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
15646	5	68	3475	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
15647	5	69	3475	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/33	\N
15648	3	302	3475	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33	\N
15649	3	303	3475	http://www.mycancergenome.org/content/disease/lung-cancer/kras/33	\N
15650	7	355	3475	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33	\N
15651	7	356	3475	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/33	\N
15652	4	476	3475	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33	\N
15653	4	471	3475	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33	\N
15654	4	473	3475	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33	\N
15655	4	472	3475	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/33	\N
15656	5	3	3475	\N	\N
15657	5	603	3475	\N	\N
15658	26	3	3475	\N	\N
15659	26	604	3475	\N	\N
15660	5	62	3476	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
15661	5	63	3476	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
15662	5	64	3476	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
15663	5	65	3476	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
15664	5	66	3476	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
15665	5	67	3476	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
15666	5	68	3476	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
15667	5	69	3476	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/35	\N
15668	3	302	3476	http://www.mycancergenome.org/content/disease/lung-cancer/kras/35	\N
15669	3	303	3476	http://www.mycancergenome.org/content/disease/lung-cancer/kras/35	\N
15670	7	355	3476	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35	\N
15671	7	356	3476	http://www.mycancergenome.org/content/disease/ovarian-cancer/kras/35	\N
15672	4	476	3476	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35	\N
15673	4	471	3476	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35	\N
15674	4	473	3476	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35	\N
15675	4	472	3476	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/35	\N
15676	5	3	3476	\N	\N
15677	5	605	3476	\N	\N
15678	5	603	3476	\N	\N
15679	5	62	3477	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
15680	5	63	3477	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
15681	5	64	3477	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
15682	5	65	3477	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
15683	5	66	3477	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
15684	5	67	3477	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
15685	5	68	3477	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
15686	5	69	3477	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/36	\N
15687	3	302	3477	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36	\N
15688	3	303	3477	http://www.mycancergenome.org/content/disease/lung-cancer/kras/36	\N
15689	4	476	3477	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36	\N
15690	4	471	3477	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36	\N
15691	4	473	3477	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36	\N
15692	4	472	3477	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/36	\N
15693	3	3	3477	\N	\N
15694	3	606	3477	\N	\N
15695	2	161	3478	\N	\N
15696	2	162	3478	\N	\N
15697	5	49	3478	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77	\N
15698	5	73	3478	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77	\N
15699	5	74	3478	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77	\N
15700	5	75	3478	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77	\N
15701	5	76	3478	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77	\N
15702	5	77	3478	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77	\N
15703	5	78	3478	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/77	\N
15704	2	163	3478	\N	\N
15705	2	164	3478	\N	\N
15706	2	160	3478	\N	\N
15707	3	302	3478	http://www.mycancergenome.org/content/disease/lung-cancer/nras/77	\N
15708	3	255	3478	http://www.mycancergenome.org/content/disease/lung-cancer/nras/77	\N
15709	3	307	3478	http://www.mycancergenome.org/content/disease/lung-cancer/nras/77	\N
15710	1	465	3478	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
15711	1	456	3478	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
15712	1	461	3478	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
15713	1	462	3478	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
15714	1	463	3478	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
15715	1	464	3478	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
15716	1	457	3478	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
15717	1	458	3478	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
15718	1	459	3478	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
15719	1	460	3478	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
15720	1	446	3478	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
15721	1	383	3478	http://www.mycancergenome.org/content/disease/melanoma/nras/77	\N
15722	4	476	3478	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/77	\N
15723	4	471	3478	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/77	\N
15724	4	473	3478	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/77	\N
15725	4	472	3478	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/77	\N
15726	1	3	3478	\N	\N
15727	5	49	3479	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
15728	5	73	3479	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
15729	5	74	3479	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
15730	5	75	3479	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
15731	5	76	3479	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
15732	5	77	3479	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
15733	5	78	3479	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/75	\N
15734	2	133	3479	\N	\N
15735	3	302	3479	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75	\N
15736	3	255	3479	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75	\N
15737	3	307	3479	http://www.mycancergenome.org/content/disease/lung-cancer/nras/75	\N
15738	1	465	3479	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
15739	1	456	3479	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
15740	1	461	3479	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
15741	1	462	3479	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
15742	1	463	3479	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
15743	1	464	3479	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
15744	1	457	3479	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
15745	1	458	3479	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
15746	1	459	3479	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
15747	1	460	3479	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
15748	1	446	3479	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
15749	1	383	3479	http://www.mycancergenome.org/content/disease/melanoma/nras/75	\N
15750	4	476	3479	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75	\N
15751	4	471	3479	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75	\N
15752	4	473	3479	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75	\N
15753	4	472	3479	http://www.mycancergenome.org/content/disease/thyroid-cancer/nras/75	\N
15754	5	49	3480	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
15755	5	73	3480	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
15756	5	74	3480	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
15757	5	75	3480	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
15758	5	76	3480	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
15759	5	77	3480	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
15760	5	78	3480	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/90	\N
15761	2	133	3480	\N	\N
15762	1	456	3480	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
15763	1	461	3480	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
15764	1	462	3480	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
15765	1	463	3480	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
15766	1	464	3480	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
15767	1	457	3480	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
15768	1	458	3480	http://www.mycancergenome.org/content/disease/melanoma/nras/90	\N
15769	2	3	3480	\N	\N
15770	5	49	3481	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
15771	5	73	3481	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
15772	5	74	3481	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
15773	5	75	3481	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
15774	5	76	3481	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
15775	5	77	3481	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
15776	5	78	3481	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/85	\N
15777	3	302	3481	http://www.mycancergenome.org/content/disease/lung-cancer/nras/85	\N
15778	3	255	3481	http://www.mycancergenome.org/content/disease/lung-cancer/nras/85	\N
15779	3	307	3481	http://www.mycancergenome.org/content/disease/lung-cancer/nras/85	\N
15780	1	456	3481	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
15781	1	461	3481	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
15782	1	462	3481	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
15783	1	463	3481	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
15784	1	464	3481	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
15785	1	457	3481	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
15786	1	458	3481	http://www.mycancergenome.org/content/disease/melanoma/nras/85	\N
15787	5	3	3481	\N	\N
15788	5	49	3482	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
15789	5	73	3482	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
15790	5	74	3482	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
15791	5	75	3482	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
15792	5	76	3482	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
15793	5	77	3482	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
15794	5	78	3482	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/87	\N
15795	2	133	3482	\N	\N
15796	2	160	3482	\N	\N
15797	2	161	3482	\N	\N
15798	2	162	3482	\N	\N
15799	2	163	3482	\N	\N
15800	2	164	3482	\N	\N
15801	3	302	3482	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87	\N
15802	3	255	3482	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87	\N
15803	3	307	3482	http://www.mycancergenome.org/content/disease/lung-cancer/nras/87	\N
15804	1	456	3482	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
15805	1	461	3482	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
15806	1	462	3482	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
15807	1	463	3482	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
15808	1	464	3482	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
15809	1	457	3482	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
15810	1	458	3482	http://www.mycancergenome.org/content/disease/melanoma/nras/87	\N
15811	2	3	3482	\N	\N
15812	2	619	3482	\N	\N
15813	5	49	3483	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86	\N
15814	5	73	3483	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86	\N
15815	5	74	3483	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86	\N
15816	5	75	3483	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86	\N
15817	5	76	3483	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86	\N
15818	5	77	3483	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86	\N
15819	5	78	3483	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/86	\N
15820	2	133	3483	\N	\N
15821	2	160	3483	\N	\N
15822	2	161	3483	\N	\N
15823	2	162	3483	\N	\N
15824	2	163	3483	\N	\N
15825	2	164	3483	\N	\N
15826	3	302	3483	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86	\N
15827	3	255	3483	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86	\N
15828	3	307	3483	http://www.mycancergenome.org/content/disease/lung-cancer/nras/86	\N
15829	1	456	3483	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
15830	1	461	3483	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
15831	1	462	3483	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
15832	1	463	3483	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
15833	1	464	3483	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
15834	1	457	3483	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
15835	1	458	3483	http://www.mycancergenome.org/content/disease/melanoma/nras/86	\N
15836	1	383	3483	\N	\N
15837	5	3	3483	\N	\N
15838	5	618	3483	\N	\N
15839	5	49	3484	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
15840	5	73	3484	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
15841	5	74	3484	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
15842	5	75	3484	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
15843	5	76	3484	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
15844	5	77	3484	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
15845	5	78	3484	http://www.mycancergenome.org/content/disease/colorectal-cancer/nras/89	\N
15846	2	133	3484	\N	\N
15847	3	302	3484	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
15848	3	303	3484	http://www.mycancergenome.org/content/disease/lung-cancer/kras/41	\N
15849	1	456	3484	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
15850	1	461	3484	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
15851	1	462	3484	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
15852	1	463	3484	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
15853	1	464	3484	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
15854	1	457	3484	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
15855	1	458	3484	http://www.mycancergenome.org/content/disease/melanoma/nras/89	\N
15856	5	3	3484	\N	\N
15857	5	79	3485	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
15858	5	80	3485	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
15859	5	81	3485	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
15860	5	82	3485	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
15861	5	83	3485	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
15862	5	84	3485	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
15863	5	85	3485	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
15864	5	86	3485	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
15865	5	49	3485	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
15866	5	87	3485	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/7	\N
15867	3	309	3485	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
15868	3	79	3485	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
15869	3	80	3485	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
15870	3	81	3485	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
15871	3	82	3485	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
15872	3	83	3485	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
15873	3	84	3485	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
15874	3	310	3485	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
15875	3	311	3485	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
15876	3	312	3485	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
15877	3	281	3485	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/7	\N
15878	7	80	3485	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7	\N
15879	7	358	3485	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/7	\N
15880	8	82	3485	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
15881	8	501	3485	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
15882	8	502	3485	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
15884	8	81	3485	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
15885	8	83	3485	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
15886	8	84	3485	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
15887	8	85	3485	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	\N
15888	8	3	3485	\N	\N
15889	8	628	3485	\N	\N
15890	5	79	3486	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
15891	5	80	3486	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
15892	5	81	3486	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
15893	5	82	3486	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
15894	5	83	3486	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
15895	5	84	3486	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
15896	5	85	3486	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
15897	5	86	3486	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
15898	5	49	3486	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
15899	5	87	3486	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/8	\N
15900	3	309	3486	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
15901	3	79	3486	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
15902	3	80	3486	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
15903	3	81	3486	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
15904	3	82	3486	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
15905	3	83	3486	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
15906	3	84	3486	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
15907	3	310	3486	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
15908	3	311	3486	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
15909	3	312	3486	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
15910	3	281	3486	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/8	\N
15911	7	80	3486	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/8	\N
15912	7	358	3486	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/8	\N
15913	8	82	3486	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
15914	8	501	3486	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
15915	8	502	3486	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
15916	8	80	3486	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
15917	8	81	3486	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
15918	8	83	3486	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
15919	8	84	3486	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
15920	8	85	3486	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/8	\N
15921	8	3	3486	\N	\N
15922	8	628	3486	\N	\N
15923	5	79	3487	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
15924	5	80	3487	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
15925	5	81	3487	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
15926	5	82	3487	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
15927	5	83	3487	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
15928	5	84	3487	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
15929	5	85	3487	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
15930	5	86	3487	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
15931	5	49	3487	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
15932	5	87	3487	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/9	\N
15933	3	309	3487	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
15934	3	79	3487	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
15935	3	80	3487	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
15936	3	81	3487	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
15937	3	82	3487	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
15938	3	83	3487	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
15939	3	84	3487	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
15940	3	310	3487	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
15941	3	311	3487	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
15942	3	312	3487	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
15943	3	281	3487	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/9	\N
15944	8	82	3487	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
15945	8	501	3487	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
15946	8	502	3487	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
15947	8	80	3487	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
15948	8	81	3487	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
15949	8	83	3487	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
15950	8	84	3487	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
15951	8	85	3487	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/9	\N
15952	39	3	3487	\N	\N
15953	39	630	3487	\N	\N
15954	5	79	3488	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
15955	5	80	3488	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
15956	5	81	3488	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
15957	5	82	3488	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
15958	5	83	3488	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
15959	5	84	3488	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
15960	5	85	3488	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
15961	5	86	3488	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
15962	5	49	3488	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
15963	5	87	3488	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/12	\N
15964	7	80	3488	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/12	\N
15965	7	358	3488	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/12	\N
15966	8	82	3488	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
15967	8	501	3488	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
15968	8	502	3488	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
15969	8	80	3488	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
15970	8	81	3488	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
15971	8	83	3488	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
15972	8	84	3488	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
15973	8	85	3488	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/12	\N
15974	8	3	3488	\N	\N
15975	5	79	3489	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
15976	5	80	3489	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
15977	5	81	3489	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
15978	5	82	3489	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
15979	5	83	3489	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
15980	5	84	3489	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
15981	5	85	3489	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
15982	5	86	3489	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
15983	5	49	3489	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
15984	5	87	3489	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/13	\N
15985	8	82	3489	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
15986	8	501	3489	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
15987	8	502	3489	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
15988	8	80	3489	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
15989	8	81	3489	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
15990	8	83	3489	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
15991	8	84	3489	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
15992	8	85	3489	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/13	\N
15993	5	3	3489	\N	\N
15994	1	3	3489	\N	\N
15995	1	629	3489	\N	\N
15996	5	79	3490	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
15997	5	80	3490	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
15998	5	81	3490	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
15999	5	82	3490	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
16000	5	83	3490	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
16001	5	84	3490	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
16002	5	85	3490	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
16003	5	86	3490	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
16004	5	49	3490	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
16005	5	87	3490	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/14	\N
16006	8	82	3490	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
16007	8	501	3490	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
16008	8	502	3490	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
16009	8	80	3490	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
16010	8	81	3490	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
16011	8	83	3490	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
16012	8	84	3490	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
16013	8	85	3490	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/14	\N
16014	5	79	3491	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
16015	5	80	3491	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
16016	5	81	3491	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
16017	5	82	3491	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
16018	5	83	3491	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
16019	5	84	3491	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
16020	5	85	3491	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
16021	5	86	3491	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
16022	5	49	3491	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
16023	5	87	3491	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/16	\N
16024	7	80	3491	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/16	\N
16025	7	358	3491	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/16	\N
16026	8	82	3491	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
16027	8	501	3491	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
16028	8	502	3491	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
16029	8	80	3491	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
16030	8	81	3491	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
16031	8	83	3491	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
16032	8	84	3491	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
16033	8	85	3491	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/16	\N
16034	16	3	3491	\N	\N
16035	5	79	3492	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
16036	5	80	3492	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
16037	5	81	3492	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
16038	5	82	3492	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
16039	5	83	3492	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
16040	5	84	3492	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
16041	5	85	3492	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
16042	5	86	3492	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
16043	5	49	3492	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
16044	5	87	3492	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/15	\N
16045	8	82	3492	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
16046	8	501	3492	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
16047	8	502	3492	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
16048	8	80	3492	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
16049	8	81	3492	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
16050	8	83	3492	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
16051	8	84	3492	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
16052	8	85	3492	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/15	\N
16053	5	79	3493	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
16054	5	80	3493	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
16055	5	81	3493	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
16056	5	82	3493	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
16057	5	83	3493	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
16058	5	84	3493	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
16059	5	85	3493	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
16060	5	86	3493	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
16061	5	49	3493	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
16062	5	87	3493	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/18	\N
16063	8	82	3493	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
16064	8	501	3493	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
16065	8	502	3493	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
16066	8	80	3493	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
16067	8	81	3493	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
16068	8	83	3493	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
16069	8	84	3493	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
16070	8	85	3493	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/18	\N
16071	5	79	3494	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
16072	5	80	3494	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
16073	5	81	3494	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
16074	5	82	3494	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
16075	5	83	3494	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
16076	5	84	3494	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
16077	5	85	3494	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
16078	5	86	3494	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
16079	5	49	3494	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
16080	5	87	3494	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/19	\N
16081	8	82	3494	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
16082	8	501	3494	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
16083	8	502	3494	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
16084	8	80	3494	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
16085	8	81	3494	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
16086	8	83	3494	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
16087	8	84	3494	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
16088	8	85	3494	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/19	\N
16089	5	79	3495	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
16090	5	80	3495	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
16091	5	81	3495	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
16092	5	82	3495	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
16093	5	83	3495	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
16094	5	84	3495	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
16095	5	85	3495	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
16096	5	86	3495	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
16097	5	49	3495	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
16098	5	87	3495	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/20	\N
16099	8	82	3495	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
16100	8	501	3495	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
16101	8	502	3495	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
16102	8	80	3495	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
16103	8	81	3495	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
16104	8	83	3495	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
16105	8	84	3495	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
16106	8	85	3495	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/20	\N
16107	5	79	3496	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16108	5	80	3496	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16109	5	81	3496	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16110	5	82	3496	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16111	5	83	3496	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16112	5	84	3496	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16113	5	85	3496	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16114	5	86	3496	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16115	5	49	3496	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16116	5	87	3496	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16117	3	309	3496	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
16118	3	79	3496	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
16119	3	80	3496	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
16120	3	81	3496	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
16121	3	82	3496	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
16122	3	83	3496	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
16123	3	84	3496	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
16124	3	310	3496	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
16125	3	311	3496	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
16126	3	312	3496	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
16127	3	281	3496	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/11	\N
16128	7	80	3496	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/11	\N
16129	7	358	3496	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/11	\N
16130	8	82	3496	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
16131	8	501	3496	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
16132	8	502	3496	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
16133	8	80	3496	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
16134	8	81	3496	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
16135	8	83	3496	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
16136	8	84	3496	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
16137	8	85	3496	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/11	\N
16138	37	3	3496	\N	\N
16139	5	79	3497	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16140	5	80	3497	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16141	5	81	3497	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16142	5	82	3497	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16143	5	83	3497	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16144	5	84	3497	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16145	5	85	3497	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16146	5	86	3497	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16147	5	49	3497	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16148	5	87	3497	http://www.mycancergenome.org/content/disease/colorectal-cancer/pik3ca/10	\N
16149	3	309	3497	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
16150	3	79	3497	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
16151	3	80	3497	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
16152	3	81	3497	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
16153	3	82	3497	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
16154	3	83	3497	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
16155	3	84	3497	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
16156	3	310	3497	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
16157	3	311	3497	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
16158	3	312	3497	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
16159	3	281	3497	http://www.mycancergenome.org/content/disease/lung-cancer/pik3ca/10	\N
16160	7	80	3497	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/10	\N
16161	7	358	3497	http://www.mycancergenome.org/content/disease/ovarian-cancer/pik3ca/10	\N
16162	8	82	3497	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
16163	8	501	3497	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
16164	8	502	3497	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
16165	8	80	3497	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
16166	8	81	3497	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
16167	8	83	3497	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
16168	8	84	3497	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
16169	8	85	3497	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/10	\N
16170	5	3	3497	\N	\N
16171	5	79	3498	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
16172	5	80	3498	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
16173	5	81	3498	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
16174	5	82	3498	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
16175	5	83	3498	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
16176	5	84	3498	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
16177	5	85	3498	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
16178	5	86	3498	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
16179	5	49	3498	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
16180	5	87	3498	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/24	\N
16181	8	82	3498	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
16182	8	316	3498	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
16183	8	317	3498	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
16184	8	318	3498	http://www.mycancergenome.org/content/disease/breast-cancer/pten/24	\N
16185	5	79	3499	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
16186	5	80	3499	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
16187	5	81	3499	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
16188	5	82	3499	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
16189	5	83	3499	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
16190	5	84	3499	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
16191	5	85	3499	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
16192	5	86	3499	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
16193	5	49	3499	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
16194	5	87	3499	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/25	\N
16195	3	313	3499	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
16196	3	314	3499	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
16197	3	315	3499	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
16198	3	316	3499	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
16199	3	317	3499	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
16200	3	318	3499	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
16201	3	319	3499	http://www.mycancergenome.org/content/disease/lung-cancer/pten/25	\N
16202	8	82	3499	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25	\N
16203	8	316	3499	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25	\N
16204	8	317	3499	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25	\N
16205	8	318	3499	http://www.mycancergenome.org/content/disease/breast-cancer/pten/25	\N
16206	5	79	3500	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
16207	5	80	3500	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
16208	5	81	3500	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
16209	5	82	3500	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
16210	5	83	3500	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
16211	5	84	3500	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
16212	5	85	3500	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
16213	5	86	3500	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
16214	5	49	3500	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
16215	5	87	3500	http://www.mycancergenome.org/content/disease/colorectal-cancer/pten/26	\N
16216	8	82	3500	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26	\N
16217	8	316	3500	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26	\N
16218	8	317	3500	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26	\N
16219	8	318	3500	http://www.mycancergenome.org/content/disease/breast-cancer/pten/26	\N
16220	5	88	3501	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
16221	5	89	3501	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
16222	5	90	3501	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
16223	5	91	3501	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
16224	5	92	3501	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
16225	5	93	3501	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
16226	5	94	3501	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/151	\N
16227	5	88	3502	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154	\N
16228	5	89	3502	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154	\N
16229	5	90	3502	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154	\N
16230	5	91	3502	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154	\N
16231	5	92	3502	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154	\N
16232	5	93	3502	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154	\N
16233	5	94	3502	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/154	\N
16234	5	88	3503	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152	\N
16235	5	89	3503	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152	\N
16236	5	90	3503	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152	\N
16237	5	91	3503	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152	\N
16238	5	92	3503	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152	\N
16239	5	93	3503	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152	\N
16240	5	94	3503	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/152	\N
16241	5	88	3504	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155	\N
16242	5	89	3504	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155	\N
16243	5	90	3504	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155	\N
16244	5	91	3504	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155	\N
16245	5	92	3504	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155	\N
16246	5	93	3504	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155	\N
16247	5	94	3504	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/155	\N
16248	5	88	3505	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156	\N
16249	5	89	3505	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156	\N
16250	5	90	3505	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156	\N
16251	5	91	3505	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156	\N
16252	5	92	3505	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156	\N
16253	5	93	3505	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156	\N
16254	5	94	3505	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/156	\N
16255	5	88	3506	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
16256	5	89	3506	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
16257	5	90	3506	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
16258	5	91	3506	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
16259	5	92	3506	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
16260	5	93	3506	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
16261	5	94	3506	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/157	\N
16262	5	88	3507	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
16263	5	89	3507	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
16264	5	90	3507	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
16265	5	91	3507	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
16266	5	92	3507	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
16267	5	93	3507	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
16268	5	94	3507	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/158	\N
16269	5	88	3508	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153	\N
16270	5	89	3508	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153	\N
16271	5	90	3508	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153	\N
16272	5	91	3508	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153	\N
16273	5	92	3508	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153	\N
16274	5	93	3508	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153	\N
16275	5	94	3508	http://www.mycancergenome.org/content/disease/colorectal-cancer/smad4/153	\N
16276	11	99	3509	\N	\N
16277	11	100	3509	\N	\N
16278	11	101	3509	\N	\N
16279	33	3	3509	\N	\N
16280	33	590	3509	\N	\N
16281	11	99	3510	\N	\N
16282	11	100	3510	\N	\N
16283	11	101	3510	\N	\N
16284	1	419	3510	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16285	1	420	3510	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16286	1	421	3510	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16287	1	422	3510	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16288	1	334	3510	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16289	1	423	3510	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16290	1	433	3510	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16291	1	427	3510	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16292	1	429	3510	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16293	1	430	3510	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16294	1	431	3510	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16295	1	424	3510	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16296	1	3	3510	\N	\N
16297	1	588	3510	\N	\N
16298	11	99	3511	\N	\N
16299	11	100	3511	\N	\N
16300	11	101	3511	\N	\N
16301	11	102	3511	\N	\N
16302	1	437	3511	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16303	1	438	3511	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16304	11	3	3511	\N	\N
16306	11	595	3511	\N	\N
16307	11	596	3511	\N	\N
16308	11	103	3512	\N	\N
16309	11	99	3512	\N	\N
16310	11	100	3512	\N	\N
16311	11	101	3512	\N	\N
16312	11	3	3512	\N	\N
16313	11	108	3512	\N	\N
16314	11	595	3512	\N	\N
16315	11	597	3512	\N	\N
16316	11	104	3513	\N	\N
16317	1	419	3513	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
16318	1	420	3513	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
16319	1	421	3513	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
16320	1	422	3513	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
16321	1	440	3513	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
16322	1	431	3513	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
16323	1	424	3513	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
16324	11	3	3513	\N	\N
16325	11	598	3513	\N	\N
16326	11	104	3514	\N	\N
16327	2	104	3514	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/274	\N
16328	2	128	3514	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/274	\N
16329	1	441	3514	\N	\N
16330	11	3	3514	\N	\N
16331	11	591	3514	\N	\N
16332	11	419	3514	\N	\N
16333	11	104	3515	\N	\N
16334	11	99	3515	\N	\N
16335	11	100	3515	\N	\N
16336	11	101	3515	\N	\N
16337	2	104	3515	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275	\N
16338	2	128	3515	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275	\N
16339	2	157	3515	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275	\N
16340	2	158	3515	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/275	\N
16341	2	121	3515	\N	\N
16342	59	3	3515	\N	\N
16343	59	599	3515	\N	\N
16344	59	600	3515	\N	\N
16345	59	601	3515	\N	\N
16346	11	99	3516	\N	\N
16347	11	100	3516	\N	\N
16348	11	101	3516	\N	\N
16349	1	444	3516	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16350	11	99	3517	\N	\N
16351	11	100	3517	\N	\N
16352	11	101	3517	\N	\N
16353	11	99	3518	\N	\N
16354	11	100	3518	\N	\N
16355	11	101	3518	\N	\N
16356	1	99	3518	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16357	11	105	3519	http://www.mycancergenome.org/content/disease/gist/pdgfra/48	\N
16358	11	106	3519	http://www.mycancergenome.org/content/disease/gist/pdgfra/48	\N
16359	11	3	3519	\N	\N
16360	11	626	3519	\N	\N
16361	11	627	3519	\N	\N
16362	11	105	3520	http://www.mycancergenome.org/content/disease/gist/pdgfra/51	\N
16363	11	106	3520	http://www.mycancergenome.org/content/disease/gist/pdgfra/51	\N
16364	11	105	3521	http://www.mycancergenome.org/content/disease/gist/pdgfra/51	\N
16365	11	106	3521	http://www.mycancergenome.org/content/disease/gist/pdgfra/51	\N
16366	11	105	3522	http://www.mycancergenome.org/content/disease/gist/pdgfra/45	\N
16368	11	107	3522	http://www.mycancergenome.org/content/disease/gist/pdgfra/45	\N
16369	11	108	3522	http://www.mycancergenome.org/content/disease/gist/pdgfra/45	\N
16370	11	109	3522	http://www.mycancergenome.org/content/disease/gist/pdgfra/45	\N
16372	11	3	3522	\N	\N
16374	11	595	3522	\N	\N
16375	2	111	3523	\N	\N
16376	21	242	3523	\N	\N
16377	2	112	3524	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296	\N
16378	2	113	3524	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/296	\N
16379	2	114	3525	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294	\N
16380	2	112	3525	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294	\N
16381	2	115	3525	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/294	\N
16382	2	114	3526	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
16383	2	112	3526	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
16384	2	116	3526	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
16385	2	117	3526	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
16386	2	118	3526	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
16387	2	119	3526	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
16388	2	120	3526	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/293	\N
16389	2	114	3527	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291	\N
16390	2	112	3527	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291	\N
16391	2	116	3527	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291	\N
16392	2	118	3527	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291	\N
16393	2	119	3527	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291	\N
16394	2	120	3527	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/291	\N
16395	2	112	3528	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295	\N
16396	2	116	3528	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/295	\N
16397	2	114	3529	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292	\N
16398	2	112	3529	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292	\N
16399	2	113	3529	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292	\N
16400	2	119	3529	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292	\N
16401	2	120	3529	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/dnmt3a/292	\N
16402	2	121	3530	\N	\N
16403	2	122	3530	\N	\N
16404	2	123	3530	\N	\N
16405	2	121	3531	\N	\N
16406	2	122	3531	\N	\N
16407	2	123	3531	\N	\N
16408	2	124	3532	\N	\N
16409	2	125	3533	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
16410	2	126	3533	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
16411	2	127	3533	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
16412	2	16	3533	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
16413	2	128	3533	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
16414	2	129	3533	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/290	\N
16415	2	3	3533	\N	\N
16416	2	125	3534	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284	\N
16417	2	126	3534	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284	\N
16418	2	127	3534	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284	\N
16419	2	16	3534	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284	\N
16420	2	128	3534	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284	\N
16421	2	129	3534	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/284	\N
16422	2	125	3535	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
16423	2	126	3535	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
16424	2	127	3535	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
16425	2	16	3535	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
16426	2	128	3535	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
16427	2	130	3535	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
16428	2	131	3535	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
16429	2	132	3535	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
16430	2	133	3535	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
16431	2	121	3535	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
16432	2	122	3535	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
16433	2	134	3535	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
16434	2	135	3535	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/283	\N
16435	2	3	3535	\N	\N
16436	2	567	3535	\N	\N
16437	2	125	3536	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
16438	2	126	3536	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
16439	2	127	3536	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
16440	2	16	3536	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
16441	2	128	3536	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
16442	2	130	3536	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
16443	2	131	3536	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
16444	2	132	3536	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
16445	2	133	3536	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
16446	2	121	3536	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
16447	2	122	3536	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
16448	2	134	3536	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
16449	2	135	3536	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/288	\N
16450	2	3	3536	\N	\N
16451	2	567	3536	\N	\N
16452	2	125	3537	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
16453	2	126	3537	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
16454	2	127	3537	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
16455	2	16	3537	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
16456	2	128	3537	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
16457	2	130	3537	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
16458	2	131	3537	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
16459	2	132	3537	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
16460	2	133	3537	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
16461	2	121	3537	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
16462	2	122	3537	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
16463	2	134	3537	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
16464	2	135	3537	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/282	\N
16465	2	3	3537	\N	\N
16466	2	570	3537	\N	\N
16467	2	568	3537	\N	\N
16468	2	571	3537	\N	\N
16469	2	125	3538	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
16470	2	126	3538	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
16471	2	127	3538	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
16472	2	16	3538	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
16473	2	128	3538	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
16474	2	130	3538	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
16475	2	121	3538	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
16476	2	122	3538	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
16477	2	134	3538	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
16478	2	135	3538	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/281	\N
16479	2	121	3539	\N	\N
16480	2	125	3540	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
16481	2	126	3540	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
16482	2	127	3540	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
16483	2	16	3540	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
16484	2	128	3540	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
16485	2	130	3540	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
16486	2	131	3540	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
16487	2	132	3540	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
16488	2	133	3540	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
16489	2	121	3540	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
16490	2	122	3540	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
16491	2	134	3540	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
16492	2	135	3540	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/280	\N
16493	2	3	3540	\N	\N
16494	2	572	3540	\N	\N
16495	2	125	3541	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
16496	2	126	3541	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
16497	2	127	3541	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
16498	2	16	3541	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
16499	2	128	3541	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
16500	2	121	3541	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
16501	2	131	3541	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
16502	2	132	3541	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
16503	2	122	3541	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
16504	2	134	3541	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
16505	2	135	3541	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/278	\N
16506	2	3	3541	\N	\N
16507	2	568	3541	\N	\N
16508	2	569	3541	\N	\N
16509	2	570	3541	\N	\N
16510	2	125	3542	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
16511	2	126	3542	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
16512	2	127	3542	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
16513	2	16	3542	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
16514	2	128	3542	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
16515	2	136	3542	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
16516	2	131	3542	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
16517	2	132	3542	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
16518	2	121	3542	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
16519	2	122	3542	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
16520	2	134	3542	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
16521	2	135	3542	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/flt3/279	\N
16522	2	121	3543	\N	\N
16523	2	121	3544	\N	\N
16524	2	121	3545	\N	\N
16525	2	122	3545	\N	\N
16526	2	123	3545	\N	\N
16527	2	137	3546	\N	\N
16528	2	123	3546	\N	\N
16529	2	137	3547	\N	\N
16530	2	123	3547	\N	\N
16531	2	121	3548	\N	\N
16532	2	122	3548	\N	\N
16533	2	123	3548	\N	\N
16534	2	121	3549	\N	\N
16535	2	122	3549	\N	\N
16536	2	123	3549	\N	\N
16537	2	121	3550	\N	\N
16538	2	122	3550	\N	\N
16539	2	123	3550	\N	\N
16540	2	138	3551	\N	\N
16541	2	139	3551	\N	\N
16542	2	138	3552	\N	\N
16543	2	139	3552	\N	\N
16544	2	112	3553	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264	\N
16545	2	116	3553	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264	\N
16546	2	140	3553	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264	\N
16547	2	141	3553	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/264	\N
16548	2	112	3554	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/265	\N
16549	2	116	3554	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/265	\N
16550	2	140	3554	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/265	\N
16551	2	133	3555	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263	\N
16552	2	112	3555	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263	\N
16553	2	116	3555	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263	\N
16554	2	140	3555	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263	\N
16555	2	118	3555	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263	\N
16556	2	141	3555	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/263	\N
16557	38	507	3555	\N	\N
16558	58	3	3555	\N	\N
16559	58	579	3555	\N	\N
16560	58	580	3555	\N	\N
16561	2	133	3556	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260	\N
16562	2	112	3556	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260	\N
16563	2	116	3556	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260	\N
16564	2	140	3556	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260	\N
16565	2	141	3556	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260	\N
16566	2	142	3556	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/260	\N
16567	58	3	3556	\N	\N
16568	2	112	3557	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261	\N
16569	2	116	3557	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261	\N
16570	2	140	3557	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261	\N
16571	2	141	3557	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261	\N
16572	2	142	3557	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/261	\N
16573	2	133	3558	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262	\N
16574	2	112	3558	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262	\N
16575	2	116	3558	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262	\N
16576	2	140	3558	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh1/262	\N
16577	58	3	3558	\N	\N
16578	58	581	3558	\N	\N
16579	2	112	3559	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272	\N
16580	2	116	3559	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272	\N
16581	2	140	3559	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272	\N
16582	2	118	3559	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/272	\N
16583	2	112	3560	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271	\N
16584	2	116	3560	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271	\N
16585	2	140	3560	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/271	\N
16586	2	112	3561	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
16587	2	140	3561	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
16588	2	118	3561	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
16589	2	143	3561	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
16590	2	141	3561	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
16591	2	142	3561	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/270	\N
16592	2	3	3561	\N	\N
16593	2	583	3561	\N	\N
16594	2	112	3562	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268	\N
16595	2	140	3562	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/268	\N
16596	2	112	3563	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266	\N
16597	2	118	3563	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266	\N
16598	2	143	3563	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266	\N
16599	2	144	3563	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266	\N
16600	2	141	3563	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266	\N
16601	2	142	3563	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/266	\N
16602	2	3	3563	\N	\N
16603	2	582	3563	\N	\N
16604	2	112	3564	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
16605	2	116	3564	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
16606	2	140	3564	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/idh2/267	\N
16607	2	146	3565	\N	\N
16608	2	147	3565	\N	\N
16609	2	148	3565	\N	\N
16610	2	149	3565	\N	\N
16611	2	150	3565	\N	\N
16612	2	151	3565	\N	\N
16613	2	152	3565	\N	\N
16614	2	153	3565	\N	\N
16615	2	154	3565	\N	\N
16616	2	155	3565	\N	\N
16617	2	156	3565	\N	\N
16618	23	246	3565	\N	\N
16619	23	3	3565	\N	\N
16620	23	584	3565	\N	\N
16621	2	128	3566	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/276	\N
16622	2	104	3566	http://www.mycancergenome.org/content/disease/acute-myeloid-leukemia/kit/276	\N
16623	2	159	3567	\N	\N
16624	1	424	3567	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16625	1	437	3567	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16626	11	3	3567	\N	\N
16627	11	339	3567	\N	\N
16628	11	595	3567	\N	\N
16629	2	159	3568	\N	\N
16630	1	424	3568	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16631	1	437	3568	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
16632	11	3	3568	\N	\N
16633	11	339	3568	\N	\N
16634	11	595	3568	\N	\N
16635	2	133	3569	\N	\N
16636	2	133	3570	\N	\N
16637	2	133	3571	\N	\N
16638	2	133	3572	\N	\N
16639	2	133	3573	\N	\N
16640	1	456	3573	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
16641	1	461	3573	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
16642	1	462	3573	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
16643	1	463	3573	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
16644	1	464	3573	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
16645	1	457	3573	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
16646	1	458	3573	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
16647	1	459	3573	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
16648	1	460	3573	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
16649	1	446	3573	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
16650	1	383	3573	http://www.mycancergenome.org/content/disease/melanoma/nras/81	\N
16651	1	3	3573	\N	\N
16652	1	623	3573	\N	\N
16653	2	133	3574	\N	\N
16654	3	302	3574	http://www.mycancergenome.org/content/disease/lung-cancer/nras/80	\N
16655	3	255	3574	http://www.mycancergenome.org/content/disease/lung-cancer/nras/80	\N
16656	3	307	3574	http://www.mycancergenome.org/content/disease/lung-cancer/nras/80	\N
16657	1	456	3574	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
16658	1	461	3574	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
16659	1	462	3574	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
16660	1	463	3574	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
16661	1	464	3574	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
16662	1	457	3574	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
16663	1	458	3574	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
16664	1	459	3574	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
16665	1	460	3574	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
16666	1	446	3574	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
16667	1	383	3574	http://www.mycancergenome.org/content/disease/melanoma/nras/80	\N
16668	1	3	3574	\N	\N
16669	1	623	3574	\N	\N
16670	2	133	3575	\N	\N
16671	1	456	3575	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
16672	1	461	3575	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
16673	1	462	3575	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
16674	1	463	3575	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
16675	1	464	3575	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
16676	1	457	3575	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
16677	1	458	3575	http://www.mycancergenome.org/content/disease/melanoma/nras/94	\N
16678	37	3	3575	\N	\N
16679	2	133	3576	\N	\N
16680	1	456	3576	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
16681	1	461	3576	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
16682	1	462	3576	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
16683	1	463	3576	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
16684	1	464	3576	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
16685	1	457	3576	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
16686	1	458	3576	http://www.mycancergenome.org/content/disease/melanoma/nras/92	\N
16687	1	3	3576	\N	\N
16688	1	621	3576	\N	\N
16689	2	165	3577	\N	\N
16690	2	166	3578	\N	\N
16691	2	167	3578	\N	\N
16692	2	168	3578	\N	\N
16693	2	166	3579	\N	\N
16694	2	167	3579	\N	\N
16695	2	168	3579	\N	\N
16696	2	166	3580	\N	\N
16697	2	169	3580	\N	\N
16698	2	166	3581	\N	\N
16699	2	169	3581	\N	\N
16700	2	170	3582	\N	\N
16701	2	170	3583	\N	\N
16702	2	170	3584	\N	\N
16703	2	170	3585	\N	\N
16704	2	170	3586	\N	\N
16705	2	170	3587	\N	\N
16706	2	170	3588	\N	\N
16707	2	170	3589	\N	\N
16708	2	170	3590	\N	\N
16709	2	170	3591	\N	\N
16710	2	111	3592	\N	\N
16711	2	111	3593	\N	\N
16712	2	111	3594	\N	\N
16713	2	171	3595	\N	\N
16714	2	172	3595	\N	\N
16715	2	173	3595	\N	\N
16716	37	3	3595	\N	\N
16717	2	171	3596	\N	\N
16718	2	172	3596	\N	\N
16719	2	173	3596	\N	\N
16720	49	3	3596	\N	\N
16721	49	645	3596	\N	\N
16722	37	3	3596	\N	\N
16723	2	171	3597	\N	\N
16724	2	172	3597	\N	\N
16725	2	173	3597	\N	\N
16726	2	171	3598	\N	\N
16727	2	172	3598	\N	\N
16728	2	173	3598	\N	\N
16729	2	171	3599	\N	\N
16730	2	172	3599	\N	\N
16731	2	173	3599	\N	\N
16732	37	3	3599	\N	\N
16733	37	644	3599	\N	\N
16734	49	3	3599	\N	\N
16735	49	645	3599	\N	\N
16736	2	171	3600	\N	\N
16737	2	172	3600	\N	\N
16738	2	173	3600	\N	\N
16739	2	171	3601	\N	\N
16740	2	172	3601	\N	\N
16741	2	173	3601	\N	\N
16742	2	171	3602	\N	\N
16743	2	172	3602	\N	\N
16744	2	173	3602	\N	\N
16745	2	174	3603	\N	\N
16746	2	174	3604	\N	\N
16747	2	174	3605	\N	\N
16748	2	175	3605	\N	\N
16749	2	174	3606	\N	\N
16750	2	175	3606	\N	\N
16751	2	166	3607	\N	\N
16752	2	176	3607	\N	\N
16753	2	177	3607	\N	\N
16754	2	178	3607	\N	\N
16755	2	179	3607	\N	\N
16756	2	180	3607	\N	\N
16757	20	182	3608	\N	\N
16758	20	182	3609	\N	\N
16759	20	182	3610	\N	\N
16760	20	182	3611	\N	\N
16761	21	183	3612	\N	\N
16762	21	184	3612	\N	\N
16763	21	185	3612	\N	\N
16764	21	186	3612	\N	\N
16765	21	187	3612	\N	\N
16766	21	188	3612	\N	\N
16767	21	189	3612	\N	\N
16768	21	190	3612	\N	\N
16769	21	3	3612	\N	\N
16770	21	191	3613	\N	\N
16771	21	192	3613	\N	\N
16772	21	193	3613	\N	\N
16773	21	188	3613	\N	\N
16774	21	186	3613	\N	\N
16775	21	3	3613	\N	\N
16776	21	194	3614	\N	\N
16777	21	195	3614	\N	\N
16778	21	188	3614	\N	\N
16779	21	186	3614	\N	\N
16780	21	184	3614	\N	\N
16781	21	196	3614	\N	\N
16782	21	183	3614	\N	\N
16783	21	3	3614	\N	\N
16784	21	197	3615	\N	\N
16785	21	198	3615	\N	\N
16786	21	186	3615	\N	\N
16787	21	188	3615	\N	\N
16788	21	190	3615	\N	\N
16789	21	3	3615	\N	\N
16790	21	188	3616	\N	\N
16791	21	197	3616	\N	\N
16792	21	3	3616	\N	\N
16793	21	186	3617	\N	\N
16794	21	188	3617	\N	\N
16795	21	190	3617	\N	\N
16796	21	3	3617	\N	\N
16797	21	206	3618	\N	\N
16798	21	207	3618	\N	\N
16799	21	208	3618	\N	\N
16800	21	209	3618	\N	\N
16801	21	210	3618	\N	\N
16802	21	211	3618	\N	\N
16803	21	202	3618	\N	\N
16804	21	188	3618	\N	\N
16805	21	195	3618	\N	\N
16806	21	190	3618	\N	\N
16807	21	4	3618	\N	\N
16808	21	2	3618	\N	\N
16809	21	183	3618	\N	\N
16810	21	212	3618	\N	\N
16811	21	213	3618	\N	\N
16812	21	214	3618	\N	\N
16813	21	3	3618	\N	\N
16814	21	183	3619	\N	\N
16815	21	202	3619	\N	\N
16816	21	188	3619	\N	\N
16817	21	190	3619	\N	\N
16818	21	2	3619	\N	\N
16819	21	215	3619	\N	\N
16820	21	207	3619	\N	\N
16821	21	216	3619	\N	\N
16822	21	217	3619	\N	\N
16823	21	3	3619	\N	\N
16824	21	184	3620	\N	\N
16825	21	202	3620	\N	\N
16826	21	204	3620	\N	\N
16827	21	218	3620	\N	\N
16828	21	3	3620	\N	\N
16829	21	184	3621	\N	\N
16830	21	227	3621	\N	\N
16831	21	228	3621	\N	\N
16832	21	229	3621	\N	\N
16833	21	188	3621	\N	\N
16834	21	186	3621	\N	\N
16835	21	3	3621	\N	\N
16836	21	210	3621	\N	\N
16837	21	183	3622	\N	\N
16838	21	230	3622	\N	\N
16839	21	227	3622	\N	\N
16840	21	186	3622	\N	\N
16841	21	188	3622	\N	\N
16842	21	195	3622	\N	\N
16843	21	3	3622	\N	\N
16844	21	210	3622	\N	\N
16845	21	183	3623	\N	\N
16846	21	220	3623	\N	\N
16847	21	202	3623	\N	\N
16848	21	188	3623	\N	\N
16849	21	195	3623	\N	\N
16850	21	190	3623	\N	\N
16851	21	225	3623	\N	\N
16852	21	231	3623	\N	\N
16853	21	232	3623	\N	\N
16854	21	233	3623	\N	\N
16855	21	234	3623	\N	\N
16856	21	235	3623	\N	\N
16857	21	201	3623	\N	\N
16858	21	236	3623	\N	\N
16859	21	3	3623	\N	\N
16860	21	183	3624	\N	\N
16861	21	188	3624	\N	\N
16862	21	190	3624	\N	\N
16863	21	204	3624	\N	\N
16864	21	237	3624	\N	\N
16865	21	238	3624	\N	\N
16866	21	235	3624	\N	\N
16867	21	3	3624	\N	\N
16868	21	183	3625	\N	\N
16869	21	188	3625	\N	\N
16870	21	184	3625	\N	\N
16871	21	186	3625	\N	\N
16872	21	202	3625	\N	\N
16873	21	210	3625	\N	\N
16874	21	239	3625	\N	\N
16875	21	231	3625	\N	\N
16876	21	240	3625	\N	\N
16877	21	3	3625	\N	\N
16878	21	227	3626	\N	\N
16879	21	183	3626	\N	\N
16880	21	241	3626	\N	\N
16881	21	202	3626	\N	\N
16882	21	188	3626	\N	\N
16883	21	190	3626	\N	\N
16884	21	3	3626	\N	\N
16885	21	210	3627	\N	\N
16886	21	210	3628	\N	\N
16887	21	210	3629	\N	\N
16888	21	210	3630	\N	\N
16889	21	210	3631	\N	\N
16890	21	210	3632	\N	\N
16891	21	210	3633	\N	\N
16892	21	210	3634	\N	\N
16893	21	210	3635	\N	\N
16894	21	242	3636	\N	\N
16895	9	243	3637	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/184	\N
16896	9	244	3637	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/184	\N
16898	9	244	3638	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/183	\N
16899	38	243	3638	\N	\N
16900	9	243	3639	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/181	\N
16901	9	244	3639	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/181	\N
16902	9	244	3640	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180	\N
16903	9	243	3640	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/180	\N
16904	9	243	3641	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/182	\N
16905	9	244	3641	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/182	\N
16907	9	244	3642	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/178	\N
16908	26	256	3642	\N	\N
16909	26	258	3642	\N	\N
16910	9	243	3643	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/176	\N
16911	9	244	3643	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/176	\N
16912	9	243	3644	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/179	\N
16913	9	244	3644	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/179	\N
16914	9	243	3645	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177	\N
16915	9	244	3645	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/177	\N
16916	9	244	3646	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175	\N
16917	9	243	3646	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/175	\N
16918	9	243	3647	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174	\N
16919	9	244	3647	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/174	\N
16920	9	243	3648	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173	\N
16921	9	244	3648	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/173	\N
16922	23	247	3649	\N	\N
16923	23	248	3649	\N	\N
16924	33	248	3649	\N	\N
16925	33	360	3649	\N	\N
16926	33	361	3649	\N	\N
16927	34	247	3649	\N	\N
16928	34	360	3649	\N	\N
16929	34	248	3649	\N	\N
16930	34	363	3649	\N	\N
16931	24	249	3650	\N	\N
16932	24	3	3650	\N	\N
16933	24	250	3651	\N	\N
16934	24	3	3651	\N	\N
16935	24	251	3652	\N	\N
16936	24	252	3653	\N	\N
16937	24	251	3654	\N	\N
16938	24	251	3655	\N	\N
16939	25	253	3656	\N	\N
16940	25	253	3657	\N	\N
16941	26	256	3658	\N	\N
16942	26	257	3658	\N	\N
16943	26	256	3659	\N	\N
16944	26	257	3659	\N	\N
16945	26	256	3660	\N	\N
16946	26	256	3661	\N	\N
16947	26	257	3661	\N	\N
16948	26	258	3661	\N	\N
16949	26	256	3662	\N	\N
16950	26	258	3662	\N	\N
16951	26	256	3663	\N	\N
16952	26	259	3664	\N	\N
16953	26	261	3665	\N	\N
16955	3	264	3667	\N	\N
16956	3	3	3667	\N	\N
16957	3	268	3668	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
16959	3	270	3668	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
16960	3	271	3668	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
16961	3	272	3668	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
16962	3	273	3668	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
16963	3	274	3668	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
16964	3	275	3668	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
16965	3	276	3668	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
16966	3	277	3668	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	\N
16967	3	3	3668	\N	\N
16968	3	543	3668	\N	\N
16969	3	544	3668	\N	\N
16970	3	268	3669	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
16971	3	269	3669	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
16972	3	270	3669	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
16973	3	271	3669	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
16974	3	272	3669	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
16975	3	273	3669	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
16976	3	274	3669	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
16977	3	275	3669	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
16978	3	276	3669	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
16979	3	277	3669	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/2	\N
16980	3	3	3669	\N	\N
16981	3	540	3669	\N	\N
16982	3	541	3669	\N	\N
16983	3	268	3670	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
16984	3	269	3670	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
16985	3	270	3670	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
16986	3	271	3670	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
16987	3	272	3670	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
16988	3	273	3670	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
16989	3	274	3670	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
16990	3	275	3670	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
16991	3	276	3670	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
16992	3	277	3670	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/1	\N
16993	3	3	3670	\N	\N
16994	3	537	3670	\N	\N
16995	3	538	3670	\N	\N
16996	3	539	3670	\N	\N
16997	3	268	3671	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
16998	3	269	3671	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
16999	3	270	3671	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
17000	3	278	3671	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
17002	3	280	3671	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
17004	3	282	3671	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
17005	3	283	3671	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
17006	3	284	3671	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
17007	3	285	3671	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
17008	3	286	3671	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
17009	3	287	3671	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
17010	3	288	3671	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
17012	3	277	3671	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	\N
17013	3	3	3671	\N	\N
17014	3	558	3671	\N	\N
17015	3	559	3671	\N	\N
17016	3	560	3671	\N	\N
17017	3	268	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17018	3	269	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17019	3	270	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17020	3	271	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17021	3	290	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17022	3	291	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17023	3	292	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17024	3	293	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17025	3	294	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17026	3	295	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17027	3	296	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17028	3	297	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17029	3	298	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17030	3	299	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17031	3	300	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17032	3	301	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17033	3	276	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17034	3	275	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17035	3	277	3672	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/5	\N
17036	3	3	3672	\N	\N
17037	3	543	3672	\N	\N
17038	3	546	3672	\N	\N
17039	3	268	3673	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6	\N
17040	3	269	3673	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6	\N
17041	3	270	3673	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6	\N
17042	3	271	3673	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6	\N
17043	3	276	3673	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6	\N
17044	3	277	3673	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/6	\N
17045	3	304	3674	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/74	\N
17046	3	305	3674	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/74	\N
17047	1	446	3674	\N	\N
17049	3	3	3674	\N	\N
17050	3	304	3675	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/72	\N
17051	1	448	3675	\N	\N
17052	26	3	3675	\N	\N
17053	3	306	3676	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60	\N
17054	3	304	3676	http://www.mycancergenome.org/content/disease/lung-cancer/mek1/60	\N
17055	1	3	3676	\N	\N
17056	1	446	3676	\N	\N
17057	3	302	3677	http://www.mycancergenome.org/content/disease/lung-cancer/nras/76	\N
17058	3	255	3677	http://www.mycancergenome.org/content/disease/lung-cancer/nras/76	\N
17059	3	307	3677	http://www.mycancergenome.org/content/disease/lung-cancer/nras/76	\N
17060	1	456	3677	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
17061	1	461	3677	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
17062	1	462	3677	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
17063	1	463	3677	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
17064	1	464	3677	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
17065	1	457	3677	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
17066	1	458	3677	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
17067	1	459	3677	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
17068	1	460	3677	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
17069	1	446	3677	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
17070	1	383	3677	http://www.mycancergenome.org/content/disease/melanoma/nras/76	\N
17071	1	3	3677	\N	\N
17072	1	624	3677	\N	\N
17073	1	625	3677	\N	\N
17074	3	308	3678	\N	\N
17075	3	307	3678	\N	\N
17076	1	456	3678	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
17077	1	461	3678	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
17078	1	462	3678	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
17079	1	463	3678	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
17080	1	464	3678	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
17081	1	457	3678	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
17082	1	458	3678	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
17083	1	459	3678	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
17084	1	460	3678	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
17085	1	446	3678	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
17086	1	383	3678	http://www.mycancergenome.org/content/disease/melanoma/nras/98	\N
17087	1	3	3678	\N	\N
17088	3	307	3679	\N	\N
17089	1	3	3679	\N	\N
17090	1	623	3679	\N	\N
17091	3	302	3680	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88	\N
17092	3	255	3680	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88	\N
17093	3	307	3680	http://www.mycancergenome.org/content/disease/lung-cancer/nras/88	\N
17094	1	456	3680	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
17095	1	461	3680	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
17096	1	462	3680	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
17097	1	463	3680	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
17098	1	464	3680	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
17099	1	457	3680	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
17100	1	458	3680	http://www.mycancergenome.org/content/disease/melanoma/nras/88	\N
17101	21	3	3680	\N	\N
17102	21	620	3680	\N	\N
17103	5	3	3680	\N	\N
17104	27	320	3681	\N	\N
17105	27	320	3682	\N	\N
17106	27	320	3683	\N	\N
17107	27	320	3684	\N	\N
17108	27	320	3685	\N	\N
17109	27	320	3686	\N	\N
17110	27	276	3687	\N	\N
17111	27	277	3687	\N	\N
17112	3	3	3687	\N	\N
17113	3	542	3687	\N	\N
17114	27	276	3688	\N	\N
17115	27	277	3688	\N	\N
17116	27	276	3689	\N	\N
17117	27	277	3689	\N	\N
17118	53	3	3689	\N	\N
17119	53	555	3689	\N	\N
17120	3	3	3689	\N	\N
17121	3	556	3689	\N	\N
17122	3	547	3689	\N	\N
17123	27	276	3690	\N	\N
17124	27	277	3690	\N	\N
17125	27	276	3691	\N	\N
17126	27	277	3691	\N	\N
17127	27	321	3692	\N	\N
17128	27	321	3693	\N	\N
17129	27	322	3694	\N	\N
17130	27	322	3695	\N	\N
17131	29	324	3696	\N	\N
17132	12	326	3697	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/218	\N
17133	12	327	3697	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/218	\N
17134	12	328	3698	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/124	\N
17135	12	326	3698	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/124	\N
17136	12	329	3698	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/124	\N
17137	1	328	3698	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17138	1	326	3698	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17139	12	330	3699	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/110	\N
17140	12	326	3699	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/110	\N
17141	1	419	3699	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17142	1	420	3699	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17143	1	421	3699	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17144	1	422	3699	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17145	1	334	3699	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17146	1	423	3699	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17147	1	424	3699	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17148	1	425	3699	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17149	1	426	3699	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17150	1	427	3699	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17151	1	428	3699	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17152	1	429	3699	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17153	1	430	3699	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17154	1	431	3699	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17155	11	3	3699	\N	\N
17156	12	331	3700	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112	\N
17157	12	330	3700	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112	\N
17158	12	326	3700	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/112	\N
17159	1	419	3700	\N	\N
17160	1	420	3700	\N	\N
17161	1	421	3700	\N	\N
17162	1	422	3700	\N	\N
17163	1	334	3700	\N	\N
17164	1	423	3700	\N	\N
17165	1	433	3700	\N	\N
17166	1	427	3700	\N	\N
17167	1	429	3700	\N	\N
17168	1	430	3700	\N	\N
17169	1	431	3700	\N	\N
17170	1	424	3700	\N	\N
17171	1	434	3700	\N	\N
17172	1	3	3700	\N	\N
17173	1	444	3700	\N	\N
17174	12	332	3701	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123	\N
17175	12	333	3701	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123	\N
17176	12	334	3701	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123	\N
17177	12	335	3701	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/123	\N
17178	12	326	3702	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96	\N
17179	12	334	3702	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96	\N
17180	12	336	3702	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/96	\N
17181	1	419	3702	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
17182	1	420	3702	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
17183	1	421	3702	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
17184	1	422	3702	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
17185	1	334	3702	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
17186	1	423	3702	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
17187	1	433	3702	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
17188	1	424	3702	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
17189	1	435	3702	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
17191	1	428	3702	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
17192	1	431	3702	http://www.mycancergenome.org/content/disease/melanoma/kit/96	\N
17193	1	3	3702	\N	\N
17194	12	337	3703	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/122	\N
17195	12	332	3704	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/121	\N
17196	12	338	3705	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/120	\N
17197	12	326	3705	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/120	\N
17198	12	339	3705	http://www.mycancergenome.org/content/disease/thymic-carcinoma/kit/120	\N
17199	10	340	3706	http://www.mycancergenome.org/content/disease/rhabdomyosarcoma/alk/187	\N
17200	10	341	3707	\N	\N
17201	10	341	3708	\N	\N
17202	10	341	3709	\N	\N
17203	31	343	3710	\N	\N
17204	31	344	3711	\N	\N
17205	31	344	3712	\N	\N
17206	31	344	3713	\N	\N
17207	31	344	3714	\N	\N
17208	31	345	3715	\N	\N
17209	31	346	3715	\N	\N
17210	31	347	3715	\N	\N
17211	31	344	3715	\N	\N
17212	31	345	3716	\N	\N
17213	31	346	3716	\N	\N
17214	31	347	3716	\N	\N
17215	31	344	3716	\N	\N
17216	31	344	3717	\N	\N
17217	31	344	3718	\N	\N
17218	31	344	3719	\N	\N
17219	31	344	3720	\N	\N
17220	31	344	3721	\N	\N
17221	31	344	3722	\N	\N
17222	31	344	3723	\N	\N
17223	31	344	3724	\N	\N
17224	31	345	3725	\N	\N
17225	31	346	3725	\N	\N
17226	31	347	3725	\N	\N
17227	46	3	3725	\N	\N
17228	46	345	3725	\N	\N
17229	46	565	3725	\N	\N
17230	31	348	3726	\N	\N
17231	32	349	3727	\N	\N
17232	32	349	3728	\N	\N
17233	32	350	3729	\N	\N
17234	32	351	3730	\N	\N
17235	14	352	3731	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/163	\N
17236	14	353	3731	http://www.mycancergenome.org/content/disease/basal-cell-carcinoma/smo/163	\N
17237	15	352	3731	http://www.mycancergenome.org/content/disease/medulloblastoma/smo/163	\N
17238	15	353	3731	http://www.mycancergenome.org/content/disease/medulloblastoma/smo/163	\N
17239	7	3	3732	\N	\N
17240	7	354	3733	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138	\N
17241	7	355	3733	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138	\N
17242	7	41	3733	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138	\N
17243	7	357	3733	http://www.mycancergenome.org/content/disease/ovarian-cancer/braf/138	\N
17244	1	302	3733	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
17245	1	387	3733	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
17246	1	41	3733	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
17247	1	388	3733	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
17248	1	389	3733	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
17249	1	390	3733	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
17250	1	391	3733	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
17251	1	392	3733	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
17252	1	357	3733	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
17253	1	370	3733	http://www.mycancergenome.org/content/disease/melanoma/braf/138	\N
17255	1	3	3733	\N	\N
17256	7	359	3734	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145	\N
17257	7	317	3734	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145	\N
17258	7	318	3734	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/145	\N
17259	62	3	3734	\N	\N
17260	62	632	3734	\N	\N
17261	7	359	3735	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137	\N
17262	7	317	3735	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137	\N
17263	7	318	3735	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/137	\N
17264	38	3	3735	\N	\N
17265	38	635	3735	\N	\N
17266	7	359	3736	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144	\N
17267	7	317	3736	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144	\N
17268	7	318	3736	http://www.mycancergenome.org/content/disease/ovarian-cancer/pten/144	\N
17269	37	3	3736	\N	\N
17270	33	362	3737	\N	\N
17271	35	364	3738	\N	\N
17272	40	364	3738	\N	\N
17273	1	365	3739	\N	\N
17274	1	366	3740	\N	\N
17275	1	367	3741	\N	\N
17276	1	41	3741	\N	\N
17277	1	357	3741	\N	\N
17278	1	96	3741	\N	\N
17279	1	97	3741	\N	\N
17280	1	368	3741	\N	\N
17281	1	369	3741	\N	\N
17282	1	370	3741	\N	\N
17283	1	371	3741	\N	\N
17284	1	372	3741	\N	\N
17285	1	3	3741	\N	\N
17286	1	41	3742	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
17287	1	367	3742	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
17288	1	371	3742	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
17289	1	372	3742	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
17290	1	369	3742	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
17291	1	370	3742	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
17292	1	373	3742	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
17293	1	97	3742	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
17294	1	51	3742	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
17295	1	374	3742	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
17296	1	96	3742	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
17297	1	375	3742	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
17298	1	368	3742	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
17299	1	376	3742	http://www.mycancergenome.org/content/disease/melanoma/braf/114	\N
17300	1	3	3742	\N	\N
17301	1	530	3742	\N	\N
17302	1	41	3743	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
17303	1	367	3743	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
17304	1	97	3743	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
17305	1	51	3743	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
17306	1	374	3743	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
17307	1	96	3743	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
17308	1	375	3743	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
17309	1	368	3743	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
17310	1	369	3743	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
17311	1	370	3743	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
17312	1	371	3743	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
17313	1	372	3743	http://www.mycancergenome.org/content/disease/melanoma/braf/115	\N
17314	1	41	3744	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
17315	1	367	3744	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
17316	1	384	3744	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
17317	1	376	3744	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
17318	1	97	3744	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
17319	1	51	3744	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
17320	1	374	3744	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
17321	1	96	3744	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
17322	1	375	3744	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
17323	1	368	3744	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
17324	1	369	3744	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
17325	1	370	3744	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
17326	1	371	3744	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
17327	1	372	3744	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
17328	1	366	3744	http://www.mycancergenome.org/content/disease/melanoma/braf/118	\N
17329	1	3	3744	\N	\N
17330	1	530	3744	\N	\N
17331	1	41	3745	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
17332	1	367	3745	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
17333	1	377	3745	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
17334	1	373	3745	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
17335	1	51	3745	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
17336	1	96	3745	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
17337	1	375	3745	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
17338	1	368	3745	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
17339	1	97	3745	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
17340	1	369	3745	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
17341	1	370	3745	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
17342	1	372	3745	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
17343	1	371	3745	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
17344	1	385	3745	http://www.mycancergenome.org/content/disease/melanoma/braf/116	\N
17345	1	3	3745	\N	\N
17346	1	531	3745	\N	\N
17347	1	532	3745	\N	\N
17348	1	386	3746	\N	\N
17349	1	378	3746	\N	\N
17350	1	3	3746	\N	\N
17351	1	446	3746	\N	\N
17352	1	302	3747	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
17353	1	387	3747	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
17354	1	41	3747	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
17355	1	388	3747	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
17356	1	389	3747	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
17357	1	390	3747	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
17358	1	391	3747	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
17359	1	392	3747	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
17360	1	393	3747	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
17361	1	394	3747	http://www.mycancergenome.org/content/disease/melanoma/braf/117	\N
17362	1	3	3747	\N	\N
17363	1	533	3747	\N	\N
17364	1	302	3748	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
17365	1	387	3748	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
17366	1	41	3748	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
17367	1	388	3748	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
17368	1	389	3748	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
17369	1	390	3748	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
17370	1	391	3748	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
17371	1	392	3748	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
17372	1	357	3748	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
17373	1	370	3748	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
17374	1	395	3748	http://www.mycancergenome.org/content/disease/melanoma/braf/188	\N
17375	1	3	3748	\N	\N
17376	1	529	3748	\N	\N
17377	1	302	3749	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
17378	1	387	3749	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
17379	1	41	3749	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
17380	1	388	3749	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
17381	1	389	3749	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
17382	1	390	3749	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
17383	1	391	3749	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
17384	1	392	3749	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
17385	1	357	3749	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
17386	1	370	3749	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
17387	1	395	3749	http://www.mycancergenome.org/content/disease/melanoma/braf/189	\N
17388	1	3	3749	\N	\N
17389	1	302	3750	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
17390	1	387	3750	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
17391	1	41	3750	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
17392	1	388	3750	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
17393	1	389	3750	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
17394	1	390	3750	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
17395	1	391	3750	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
17396	1	392	3750	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
17397	1	357	3750	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
17398	1	370	3750	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
17399	1	395	3750	http://www.mycancergenome.org/content/disease/melanoma/braf/73	\N
17400	16	302	3750	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
17401	16	387	3750	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
17402	16	41	3750	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
17403	16	388	3750	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
17404	16	389	3750	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
17405	16	390	3750	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
17406	16	391	3750	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
17407	16	392	3750	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
17408	16	357	3750	http://www.mycancergenome.org/content/disease/lung-cancer/braf/73	\N
17409	1	3	3750	\N	\N
17410	1	41	3751	http://www.mycancergenome.org/content/disease/melanoma/braf/302	\N
17411	1	367	3751	http://www.mycancergenome.org/content/disease/melanoma/braf/302	\N
17412	1	41	3752	http://www.mycancergenome.org/content/disease/melanoma/braf/301	\N
17413	1	367	3752	http://www.mycancergenome.org/content/disease/melanoma/braf/301	\N
17414	1	3	3752	\N	\N
17415	1	528	3752	\N	\N
17416	1	397	3753	\N	\N
17417	1	41	3754	http://www.mycancergenome.org/content/disease/melanoma/braf/300	\N
17418	1	367	3754	http://www.mycancergenome.org/content/disease/melanoma/braf/300	\N
17419	1	41	3755	http://www.mycancergenome.org/content/disease/melanoma/braf/298	\N
17420	1	367	3755	http://www.mycancergenome.org/content/disease/melanoma/braf/298	\N
17421	1	41	3756	http://www.mycancergenome.org/content/disease/melanoma/braf/299	\N
17422	1	367	3756	http://www.mycancergenome.org/content/disease/melanoma/braf/299	\N
17423	1	398	3756	http://www.mycancergenome.org/content/disease/melanoma/braf/299	\N
17424	1	399	3757	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105	\N
17425	1	400	3757	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105	\N
17426	1	401	3757	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105	\N
17427	1	402	3757	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105	\N
17428	1	403	3757	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105	\N
17429	1	404	3757	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105	\N
17430	1	405	3757	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/105	\N
17431	40	3	3757	\N	\N
17432	1	399	3758	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104	\N
17433	1	400	3758	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104	\N
17434	1	401	3758	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104	\N
17435	1	402	3758	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104	\N
17436	1	403	3758	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104	\N
17437	1	404	3758	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104	\N
17438	1	405	3758	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/104	\N
17439	7	3	3758	\N	\N
17440	1	399	3759	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107	\N
17441	1	400	3759	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107	\N
17442	1	401	3759	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107	\N
17443	1	402	3759	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107	\N
17444	1	403	3759	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107	\N
17445	1	404	3759	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107	\N
17446	1	405	3759	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/107	\N
17447	51	3	3759	\N	\N
17448	51	536	3759	\N	\N
17449	1	399	3760	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108	\N
17450	1	400	3760	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108	\N
17451	1	401	3760	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108	\N
17452	1	402	3760	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108	\N
17453	1	403	3760	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108	\N
17454	1	404	3760	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108	\N
17455	1	405	3760	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/108	\N
17456	1	3	3760	\N	\N
17457	1	446	3760	\N	\N
17458	1	399	3761	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106	\N
17459	1	400	3761	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106	\N
17460	1	401	3761	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106	\N
17461	1	402	3761	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106	\N
17462	1	403	3761	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106	\N
17463	1	404	3761	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106	\N
17464	1	405	3761	http://www.mycancergenome.org/content/disease/melanoma/ctnnb1/106	\N
17465	51	3	3761	\N	\N
17466	51	536	3761	\N	\N
17467	1	406	3762	\N	\N
17468	1	406	3763	\N	\N
17469	1	406	3764	\N	\N
17470	1	406	3765	\N	\N
17471	1	406	3766	\N	\N
17472	1	406	3767	\N	\N
17473	1	407	3768	http://www.mycancergenome.org/content/disease/melanoma/gna11/101	\N
17474	1	410	3768	http://www.mycancergenome.org/content/disease/melanoma/gna11/101	\N
17475	1	411	3768	http://www.mycancergenome.org/content/disease/melanoma/gna11/101	\N
17476	1	408	3768	http://www.mycancergenome.org/content/disease/melanoma/gna11/101	\N
17477	1	409	3768	http://www.mycancergenome.org/content/disease/melanoma/gna11/101	\N
17478	56	3	3768	\N	\N
17479	56	408	3768	\N	\N
17480	1	407	3769	http://www.mycancergenome.org/content/disease/melanoma/gna11/99	\N
17481	1	410	3769	http://www.mycancergenome.org/content/disease/melanoma/gna11/99	\N
17482	1	411	3769	http://www.mycancergenome.org/content/disease/melanoma/gna11/99	\N
17483	1	408	3769	http://www.mycancergenome.org/content/disease/melanoma/gna11/99	\N
17484	1	409	3769	http://www.mycancergenome.org/content/disease/melanoma/gna11/99	\N
17485	56	3	3769	\N	\N
17486	56	408	3769	\N	\N
17487	56	573	3769	\N	\N
17488	56	574	3769	\N	\N
17489	1	412	3770	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
17490	1	415	3770	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
17491	1	407	3770	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
17492	1	411	3770	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
17493	1	410	3770	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
17494	1	408	3770	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
17495	1	409	3770	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
17496	1	413	3770	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
17497	1	414	3770	http://www.mycancergenome.org/content/disease/melanoma/gnaq/100	\N
17498	56	3	3770	\N	\N
17499	56	408	3770	\N	\N
17500	1	412	3771	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
17501	1	415	3771	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
17502	1	407	3771	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
17503	1	411	3771	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
17504	1	410	3771	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
17505	1	408	3771	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
17506	1	409	3771	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
17507	1	413	3771	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
17508	1	414	3771	http://www.mycancergenome.org/content/disease/melanoma/gnaq/103	\N
17509	1	412	3772	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
17510	1	415	3772	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
17511	1	407	3772	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
17512	1	411	3772	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
17513	1	410	3772	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
17514	1	408	3772	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
17515	1	409	3772	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
17516	1	413	3772	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
17517	1	414	3772	http://www.mycancergenome.org/content/disease/melanoma/gnaq/102	\N
17518	56	3	3772	\N	\N
17519	56	408	3772	\N	\N
17520	1	416	3773	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17521	1	417	3774	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17522	1	418	3774	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17523	1	417	3775	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17524	1	418	3775	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17525	1	419	3776	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17526	1	420	3776	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17527	1	421	3776	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17528	1	422	3776	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17529	1	334	3776	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17530	1	423	3776	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17531	1	424	3776	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17532	1	425	3776	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17533	1	426	3776	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17534	1	427	3776	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17535	1	428	3776	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17536	1	429	3776	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17537	1	430	3776	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17538	1	431	3776	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17539	11	3	3776	\N	\N
17540	1	432	3777	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17541	1	432	3778	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17542	1	417	3779	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17543	1	418	3779	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17544	11	3	3779	\N	\N
17545	11	589	3779	\N	\N
17546	1	430	3780	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17547	1	3	3780	\N	\N
17548	1	429	3780	\N	\N
17549	11	3	3780	\N	\N
17550	11	104	3780	\N	\N
17551	1	430	3781	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17552	1	430	3782	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17553	11	3	3782	\N	\N
17554	11	591	3782	\N	\N
17555	11	592	3782	\N	\N
17556	1	417	3783	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17557	1	418	3783	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17558	1	417	3784	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17559	1	418	3784	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17560	1	419	3785	\N	\N
17561	1	420	3785	\N	\N
17562	1	421	3785	\N	\N
17563	1	422	3785	\N	\N
17564	1	334	3785	\N	\N
17565	1	423	3785	\N	\N
17566	1	433	3785	\N	\N
17567	1	424	3785	\N	\N
17568	1	426	3785	\N	\N
17569	1	436	3785	\N	\N
17570	11	3	3785	\N	\N
17571	11	593	3785	\N	\N
17572	11	594	3785	\N	\N
17573	1	437	3786	\N	\N
17574	1	417	3787	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17575	1	418	3787	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17576	1	417	3788	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17577	1	418	3788	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17578	1	439	3789	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17579	1	419	3790	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
17580	1	420	3790	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
17581	1	421	3790	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
17582	1	422	3790	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
17583	1	440	3790	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
17584	1	431	3790	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
17585	1	424	3790	http://www.mycancergenome.org/content/disease/melanoma/kit/84	\N
17586	1	442	3791	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17587	1	424	3791	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17588	1	443	3791	http://www.mycancergenome.org/content/disease/melanoma/kit/132	\N
17589	1	445	3792	http://www.mycancergenome.org/content/disease/melanoma/mek1/210	\N
17590	1	446	3793	\N	\N
17591	1	448	3794	\N	\N
17592	26	3	3794	\N	\N
17593	1	445	3795	http://www.mycancergenome.org/content/disease/melanoma/mek1/211	\N
17594	1	449	3795	http://www.mycancergenome.org/content/disease/melanoma/mek1/211	\N
17595	1	445	3796	http://www.mycancergenome.org/content/disease/melanoma/mek1/212	\N
17596	1	450	3796	http://www.mycancergenome.org/content/disease/melanoma/mek1/212	\N
17597	1	449	3796	http://www.mycancergenome.org/content/disease/melanoma/mek1/212	\N
17598	1	451	3796	http://www.mycancergenome.org/content/disease/melanoma/mek1/212	\N
17599	26	3	3796	\N	\N
17600	1	445	3797	http://www.mycancergenome.org/content/disease/melanoma/mek1/214	\N
17601	1	449	3797	http://www.mycancergenome.org/content/disease/melanoma/mek1/214	\N
17602	1	445	3798	http://www.mycancergenome.org/content/disease/melanoma/mek1/213	\N
17603	1	447	3798	http://www.mycancergenome.org/content/disease/melanoma/mek1/213	\N
17604	1	452	3798	http://www.mycancergenome.org/content/disease/melanoma/mek1/213	\N
17605	1	3	3798	\N	\N
17606	1	447	3799	\N	\N
17607	1	447	3800	\N	\N
17608	1	383	3800	\N	\N
17609	1	445	3801	http://www.mycancergenome.org/content/disease/melanoma/mek1/215	\N
17610	1	446	3801	http://www.mycancergenome.org/content/disease/melanoma/mek1/215	\N
17611	1	447	3801	http://www.mycancergenome.org/content/disease/melanoma/mek1/215	\N
17612	1	445	3802	http://www.mycancergenome.org/content/disease/melanoma/mek1/216	\N
17613	1	453	3802	http://www.mycancergenome.org/content/disease/melanoma/mek1/216	\N
17614	1	445	3803	http://www.mycancergenome.org/content/disease/melanoma/mek1/217	\N
17615	1	454	3804	\N	\N
17616	1	454	3805	\N	\N
17617	1	455	3806	\N	\N
17618	1	454	3807	\N	\N
17619	1	454	3808	\N	\N
17620	1	456	3809	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
17621	1	461	3809	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
17622	1	462	3809	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
17623	1	463	3809	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
17624	1	464	3809	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
17625	1	457	3809	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
17626	1	458	3809	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
17627	1	459	3809	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
17628	1	460	3809	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
17629	1	446	3809	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
17630	1	383	3809	http://www.mycancergenome.org/content/disease/melanoma/nras/83	\N
17631	1	3	3809	\N	\N
17632	1	624	3809	\N	\N
17633	1	625	3809	\N	\N
17634	1	456	3810	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
17635	1	461	3810	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
17636	1	462	3810	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
17637	1	463	3810	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
17638	1	464	3810	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
17639	1	457	3810	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
17640	1	458	3810	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
17641	1	459	3810	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
17642	1	460	3810	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
17643	1	446	3810	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
17644	1	383	3810	http://www.mycancergenome.org/content/disease/melanoma/nras/82	\N
17645	1	456	3811	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
17646	1	461	3811	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
17647	1	462	3811	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
17648	1	463	3811	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
17649	1	464	3811	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
17650	1	457	3811	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
17651	1	458	3811	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
17652	1	459	3811	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
17653	1	460	3811	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
17654	1	446	3811	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
17655	1	383	3811	http://www.mycancergenome.org/content/disease/melanoma/nras/97	\N
17656	1	3	3811	\N	\N
17657	1	456	3812	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
17658	1	461	3812	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
17659	1	462	3812	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
17660	1	463	3812	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
17661	1	464	3812	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
17662	1	457	3812	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
17663	1	458	3812	http://www.mycancergenome.org/content/disease/melanoma/nras/91	\N
17664	1	3	3812	\N	\N
17665	1	456	3813	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
17666	1	461	3813	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
17667	1	462	3813	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
17668	1	463	3813	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
17669	1	464	3813	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
17670	1	457	3813	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
17671	1	458	3813	http://www.mycancergenome.org/content/disease/melanoma/nras/297	\N
17672	1	3	3813	\N	\N
17673	1	456	3814	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
17674	1	461	3814	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
17675	1	462	3814	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
17676	1	463	3814	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
17677	1	464	3814	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
17678	1	457	3814	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
17679	1	458	3814	http://www.mycancergenome.org/content/disease/melanoma/nras/93	\N
17680	1	3	3814	\N	\N
17681	1	622	3814	\N	\N
17682	1	466	3815	\N	\N
17683	1	466	3816	\N	\N
17684	1	466	3817	\N	\N
17685	1	466	3818	\N	\N
17686	1	466	3819	\N	\N
17687	1	467	3820	\N	\N
17688	1	467	3821	\N	\N
17689	36	468	3822	\N	\N
17690	36	468	3823	\N	\N
17691	4	476	3824	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307	\N
17692	4	471	3824	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307	\N
17693	4	473	3824	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307	\N
17694	4	472	3824	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/307	\N
17695	37	3	3824	\N	\N
17696	4	476	3825	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305	\N
17697	4	471	3825	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305	\N
17698	4	473	3825	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305	\N
17699	4	472	3825	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/305	\N
17700	37	3	3825	\N	\N
17701	4	476	3826	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306	\N
17702	4	471	3826	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306	\N
17703	4	473	3826	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306	\N
17704	4	472	3826	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/306	\N
17705	4	3	3826	\N	\N
17706	4	476	3827	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304	\N
17707	4	471	3827	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304	\N
17708	4	473	3827	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304	\N
17709	4	472	3827	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/304	\N
17710	1	3	3827	\N	\N
17711	4	476	3828	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303	\N
17712	4	471	3828	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303	\N
17713	4	473	3828	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303	\N
17714	4	472	3828	http://www.mycancergenome.org/content/disease/thyroid-cancer/hras/303	\N
17715	5	3	3828	\N	\N
17716	5	575	3828	\N	\N
17717	4	476	3829	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
17718	4	471	3829	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
17719	4	473	3829	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
17720	4	472	3829	http://www.mycancergenome.org/content/disease/thyroid-cancer/kras/308	\N
17721	5	3	3829	\N	\N
17722	4	477	3830	\N	\N
17723	4	478	3830	\N	\N
17724	4	479	3830	\N	\N
17725	4	480	3830	\N	\N
17726	64	3	3830	\N	\N
17727	64	639	3830	\N	\N
17728	4	481	3831	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
17729	4	474	3831	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
17730	4	472	3831	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
17731	4	475	3831	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
17732	4	482	3831	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
17733	4	477	3831	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
17734	4	478	3831	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
17735	4	483	3831	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
17736	4	479	3831	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
17737	4	480	3831	http://www.mycancergenome.org/content/disease/thyroid-cancer/ret/128	\N
17738	64	3	3831	\N	\N
17739	64	640	3831	\N	\N
17740	6	484	3832	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78	\N
17741	6	485	3832	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78	\N
17742	6	320	3832	http://www.mycancergenome.org/content/disease/lung-cancer/ddr2/78	\N
17743	37	261	3833	\N	\N
17744	37	261	3834	\N	\N
17745	37	364	3835	\N	\N
17746	37	364	3836	\N	\N
17747	37	486	3837	\N	\N
17748	37	3	3837	\N	\N
17749	37	486	3838	\N	\N
17750	37	3	3838	\N	\N
17751	37	486	3839	\N	\N
17752	37	447	3840	\N	\N
17753	37	447	3841	\N	\N
17754	37	383	3841	\N	\N
17755	37	447	3842	\N	\N
17756	37	447	3843	\N	\N
17757	37	447	3844	\N	\N
17758	37	447	3845	\N	\N
17759	37	447	3846	\N	\N
17760	37	447	3847	\N	\N
17761	37	383	3847	\N	\N
17762	37	487	3848	\N	\N
17763	37	487	3849	\N	\N
17764	37	487	3850	\N	\N
17765	37	487	3851	\N	\N
17766	24	3	3851	\N	\N
17767	24	615	3851	\N	\N
17768	37	487	3852	\N	\N
17769	37	487	3853	\N	\N
17770	37	487	3854	\N	\N
17771	37	487	3855	\N	\N
17772	8	488	3856	\N	\N
17773	8	41	3856	\N	\N
17774	8	3	3856	\N	\N
17775	8	495	3857	\N	\N
17776	8	495	3858	\N	\N
17778	8	496	3860	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242/	\N
17780	8	497	3861	http://www.mycancergenome.org/content/disease/breast-cancer/her2/240	\N
17781	8	3	3861	\N	\N
17783	8	497	3862	http://www.mycancergenome.org/content/disease/breast-cancer/her2/241	\N
17785	8	497	3863	http://www.mycancergenome.org/content/disease/breast-cancer/her2/247	\N
17786	8	3	3863	\N	\N
17787	8	562	3863	\N	\N
17788	8	564	3863	\N	\N
17789	8	496	3864	http://www.mycancergenome.org/content/disease/breast-cancer/her2/243/	\N
17791	8	497	3865	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244	\N
17793	8	497	3866	http://www.mycancergenome.org/content/disease/breast-cancer/her2/245	\N
17794	8	498	3867	\N	\N
17795	8	499	3867	\N	\N
17796	8	500	3867	\N	\N
17797	8	496	3868	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242	\N
17798	8	497	3868	http://www.mycancergenome.org/content/disease/breast-cancer/her2/242	\N
17799	8	496	3869	http://www.mycancergenome.org/content/disease/breast-cancer/her2/246	\N
17800	8	496	3870	http://www.mycancergenome.org/content/disease/breast-cancer/her2/239	\N
17801	8	82	3871	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
17802	8	501	3871	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
17803	8	502	3871	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
17804	8	80	3871	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
17805	8	81	3871	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
17806	8	83	3871	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
17807	8	84	3871	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
17808	8	85	3871	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/17	\N
17809	16	302	3872	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
17810	16	387	3872	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
17811	16	41	3872	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
17812	16	388	3872	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
17813	16	389	3872	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
17814	16	390	3872	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
17815	16	391	3872	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
17816	16	392	3872	http://www.mycancergenome.org/content/disease/lung-cancer/braf/209	\N
17817	16	302	3873	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
17818	16	387	3873	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
17819	16	41	3873	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
17820	16	388	3873	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
17821	16	389	3873	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
17822	16	390	3873	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
17823	16	503	3873	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
17824	16	391	3873	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
17825	16	392	3873	http://www.mycancergenome.org/content/disease/lung-cancer/braf/310	\N
17826	38	243	3874	\N	\N
17827	38	243	3875	\N	\N
17828	38	506	3876	\N	\N
17829	38	506	3877	\N	\N
17830	38	506	3878	\N	\N
17831	38	506	3879	\N	\N
17832	39	508	3880	\N	\N
17833	39	509	3881	\N	\N
17834	3	3	3881	\N	\N
17835	3	551	3881	\N	\N
17836	39	510	3882	\N	\N
17837	39	322	3883	\N	\N
17838	41	306	3884	\N	\N
17839	41	3	3884	\N	\N
17840	41	495	3885	\N	\N
17841	41	495	3886	\N	\N
17842	41	495	3887	\N	\N
17843	43	514	3888	\N	\N
17844	43	515	3888	\N	\N
17845	43	516	3888	\N	\N
17846	55	3	3888	\N	\N
17847	55	566	3888	\N	\N
17848	43	516	3889	\N	\N
17849	13	498	3890	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
17850	13	498	3891	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
17851	13	498	3892	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
17852	13	498	3893	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
17853	13	499	3893	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
17854	13	498	3894	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
17855	13	500	3894	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
17856	13	498	3895	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
17857	13	500	3895	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
17858	13	499	3895	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
17859	13	498	3896	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
17860	13	500	3896	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
17861	13	498	3897	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
17862	13	500	3897	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
17863	13	499	3897	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
17864	13	517	3897	http://www.mycancergenome.org/content/disease/breast-cancer/er/314/	\N
17865	44	518	3898	\N	\N
17866	44	518	3899	\N	\N
17867	44	518	3900	\N	\N
17868	44	519	3900	\N	\N
17869	44	518	3901	\N	\N
17870	44	518	3902	\N	\N
17871	44	520	3903	\N	\N
17872	5	3	3904	\N	\N
17873	5	521	3904	\N	\N
17874	37	3	3905	\N	\N
17875	37	3	3906	\N	\N
17876	37	3	3907	\N	\N
17877	37	3	3908	\N	\N
17878	1	306	3909	\N	\N
17879	1	3	3909	\N	\N
17880	1	3	3910	\N	\N
17881	1	522	3910	\N	\N
17882	1	3	3911	\N	\N
17883	1	3	3912	\N	\N
17884	1	523	3912	\N	\N
17885	1	3	3913	\N	\N
17886	1	3	3914	\N	\N
17887	1	3	3915	\N	\N
17888	1	524	3915	\N	\N
17889	1	3	3916	\N	\N
17890	21	3	3917	\N	\N
17891	21	525	3917	\N	\N
17892	1	3	3918	\N	\N
17893	1	463	3918	\N	\N
17894	1	526	3918	\N	\N
17895	37	3	3919	\N	\N
17896	37	3	3920	\N	\N
17897	37	3	3921	\N	\N
17898	37	3	3922	\N	\N
17899	1	3	3923	\N	\N
17900	1	527	3923	\N	\N
17901	1	3	3924	\N	\N
17902	1	446	3924	\N	\N
17903	1	3	3925	\N	\N
17904	1	3	3926	\N	\N
17905	1	446	3926	\N	\N
17906	1	3	3927	\N	\N
17907	1	3	3928	\N	\N
17908	1	3	3929	\N	\N
17909	1	3	3930	\N	\N
17910	1	97	3930	\N	\N
17911	1	531	3930	\N	\N
17912	1	532	3930	\N	\N
17913	1	533	3930	\N	\N
17914	35	3	3930	\N	\N
17915	35	46	3930	\N	\N
17916	1	3	3931	\N	\N
17917	1	446	3931	\N	\N
17918	1	3	3932	\N	\N
17919	1	3	3933	\N	\N
17920	1	3	3934	\N	\N
17921	1	3	3935	\N	\N
17922	1	3	3936	\N	\N
17923	1	3	3937	\N	\N
17924	37	3	3938	\N	\N
17925	37	3	3939	\N	\N
17926	37	3	3940	\N	\N
17927	1	3	3941	\N	\N
17928	1	534	3941	\N	\N
17929	37	3	3942	\N	\N
17930	37	3	3943	\N	\N
17931	37	3	3944	\N	\N
17932	37	3	3945	\N	\N
17933	37	3	3946	\N	\N
17934	37	3	3947	\N	\N
17935	1	3	3948	\N	\N
17936	37	3	3949	\N	\N
17937	37	3	3950	\N	\N
17938	37	3	3951	\N	\N
17939	37	3	3952	\N	\N
17940	37	3	3953	\N	\N
17941	37	3	3954	\N	\N
17942	37	3	3955	\N	\N
17943	1	3	3956	\N	\N
17944	1	3	3957	\N	\N
17945	1	3	3958	\N	\N
17946	1	3	3959	\N	\N
17947	1	3	3960	\N	\N
17948	1	3	3961	\N	\N
17949	1	3	3962	\N	\N
17950	1	3	3963	\N	\N
17951	1	535	3963	\N	\N
17952	45	3	3964	\N	\N
17953	46	3	3964	\N	\N
17954	46	3	3965	\N	\N
17955	15	3	3966	\N	\N
17956	47	3	3966	\N	\N
17957	7	3	3967	\N	\N
17958	38	3	3967	\N	\N
17959	48	3	3967	\N	\N
17960	15	3	3968	\N	\N
17961	46	3	3968	\N	\N
17962	49	3	3969	\N	\N
17963	7	3	3969	\N	\N
17964	47	3	3970	\N	\N
17965	50	3	3970	\N	\N
17966	47	3	3971	\N	\N
17967	50	3	3971	\N	\N
17968	1	3	3972	\N	\N
17969	47	3	3972	\N	\N
17970	48	3	3973	\N	\N
17971	7	3	3974	\N	\N
17972	26	3	3974	\N	\N
17973	40	3	3975	\N	\N
17974	40	3	3976	\N	\N
17975	1	3	3977	\N	\N
17976	37	3	3978	\N	\N
17977	37	3	3979	\N	\N
17978	37	3	3980	\N	\N
17979	38	3	3981	\N	\N
17980	51	3	3981	\N	\N
17981	51	3	3982	\N	\N
17982	3	3	3983	\N	\N
17983	45	3	3984	\N	\N
17984	3	3	3984	\N	\N
17985	3	545	3984	\N	\N
17986	3	3	3985	\N	\N
17987	3	546	3985	\N	\N
17988	42	3	3986	\N	\N
17989	3	3	3986	\N	\N
17990	3	545	3986	\N	\N
17991	3	3	3987	\N	\N
17992	3	547	3987	\N	\N
17993	52	3	3988	\N	\N
17994	52	548	3988	\N	\N
17995	52	549	3988	\N	\N
17996	3	3	3989	\N	\N
17997	26	3	3990	\N	\N
17998	26	280	3990	\N	\N
17999	3	3	3990	\N	\N
18000	3	550	3990	\N	\N
18001	3	3	3991	\N	\N
18002	3	3	3992	\N	\N
18003	3	547	3992	\N	\N
18004	3	552	3992	\N	\N
18005	3	3	3993	\N	\N
18006	3	553	3993	\N	\N
18007	3	554	3993	\N	\N
18008	3	3	3994	\N	\N
18009	3	557	3994	\N	\N
18010	54	3	3995	\N	\N
18011	54	3	3996	\N	\N
18012	3	3	3997	\N	\N
18013	3	561	3997	\N	\N
18014	3	546	3997	\N	\N
18015	3	3	3998	\N	\N
18016	3	3	3999	\N	\N
18017	3	3	4000	\N	\N
18018	8	3	4001	\N	\N
18019	8	3	4002	\N	\N
18020	8	562	4002	\N	\N
18021	8	563	4002	\N	\N
18022	37	3	4003	\N	\N
18023	8	3	4004	\N	\N
18024	8	3	4005	\N	\N
18025	8	562	4005	\N	\N
18026	8	564	4005	\N	\N
18027	37	3	4006	\N	\N
18028	37	3	4007	\N	\N
18029	46	3	4008	\N	\N
18030	46	345	4008	\N	\N
18031	46	3	4009	\N	\N
18032	46	565	4009	\N	\N
18033	46	3	4010	\N	\N
18034	46	565	4010	\N	\N
18035	46	3	4011	\N	\N
18036	46	3	4012	\N	\N
18037	26	3	4013	\N	\N
18038	26	322	4013	\N	\N
18039	55	3	4014	\N	\N
18040	55	566	4014	\N	\N
18041	55	3	4015	\N	\N
18042	55	566	4015	\N	\N
18043	55	3	4016	\N	\N
18044	55	3	4017	\N	\N
18045	55	3	4018	\N	\N
18046	2	3	4019	\N	\N
18047	2	3	4020	\N	\N
18048	2	3	4021	\N	\N
18049	56	3	4022	\N	\N
18050	37	3	4023	\N	\N
18051	55	3	4024	\N	\N
18052	8	3	4025	\N	\N
18053	37	3	4026	\N	\N
18054	12	3	4027	\N	\N
18055	12	576	4027	\N	\N
18056	37	3	4028	\N	\N
18057	37	3	4029	\N	\N
18058	8	3	4030	\N	\N
18059	57	3	4031	\N	\N
18060	57	577	4031	\N	\N
18061	57	578	4031	\N	\N
18062	37	3	4032	\N	\N
18063	37	3	4033	\N	\N
18064	37	3	4034	\N	\N
18065	18	3	4035	\N	\N
18066	18	585	4035	\N	\N
18067	33	3	4036	\N	\N
18068	33	586	4036	\N	\N
18069	33	585	4036	\N	\N
18070	33	587	4036	\N	\N
18071	18	3	4037	\N	\N
18072	37	3	4038	\N	\N
18073	1	3	4039	\N	\N
18074	1	3	4040	\N	\N
18075	1	429	4040	\N	\N
18076	1	446	4040	\N	\N
18077	11	3	4041	\N	\N
18078	11	419	4041	\N	\N
18079	60	3	4042	\N	\N
18080	60	613	4042	\N	\N
18081	60	3	4043	\N	\N
18082	60	613	4043	\N	\N
18083	5	3	4044	\N	\N
18084	5	3	4045	\N	\N
18085	5	609	4045	\N	\N
18086	5	3	4046	\N	\N
18087	26	3	4047	\N	\N
18088	24	3	4048	\N	\N
18089	24	614	4048	\N	\N
18090	24	3	4049	\N	\N
18091	24	615	4049	\N	\N
18092	24	616	4049	\N	\N
18093	61	3	4050	\N	\N
18094	26	3	4050	\N	\N
18095	26	617	4050	\N	\N
18096	37	3	4051	\N	\N
18097	37	3	4052	\N	\N
18098	37	3	4053	\N	\N
18099	37	3	4054	\N	\N
18100	37	3	4055	\N	\N
18101	37	3	4056	\N	\N
18102	40	3	4057	\N	\N
18103	1	3	4058	\N	\N
18104	1	522	4058	\N	\N
18105	1	3	4059	\N	\N
18106	11	3	4060	\N	\N
18107	11	3	4061	\N	\N
18108	11	626	4061	\N	\N
18109	11	627	4061	\N	\N
18110	11	110	4061	\N	\N
18111	11	3	4062	\N	\N
18113	11	3	4063	\N	\N
18114	11	3	4064	\N	\N
18115	11	3	4065	\N	\N
18116	11	3	4066	\N	\N
18117	11	106	4066	\N	\N
18118	8	3	4067	\N	\N
18119	5	3	4067	\N	\N
18120	5	87	4067	\N	\N
18121	8	3	4068	\N	\N
18122	5	3	4068	\N	\N
18123	5	87	4068	\N	\N
18124	8	3	4069	\N	\N
18125	5	3	4069	\N	\N
18126	5	87	4069	\N	\N
18127	8	3	4070	\N	\N
18128	5	3	4070	\N	\N
18129	8	3	4071	\N	\N
18130	3	3	4072	\N	\N
18131	8	3	4073	\N	\N
18132	8	3	4074	\N	\N
18133	8	3	4075	\N	\N
18134	8	502	4075	\N	\N
18135	8	3	4076	\N	\N
18136	5	3	4077	\N	\N
18137	5	631	4077	\N	\N
18138	5	3	4078	\N	\N
18139	5	631	4078	\N	\N
18140	62	3	4079	\N	\N
18141	62	632	4079	\N	\N
18142	5	3	4080	\N	\N
18143	5	49	4080	\N	\N
18144	62	3	4081	\N	\N
18145	62	632	4081	\N	\N
18146	37	3	4082	\N	\N
18147	37	633	4082	\N	\N
18148	37	3	4083	\N	\N
18149	37	633	4083	\N	\N
18150	37	3	4084	\N	\N
18151	37	3	4085	\N	\N
18152	37	3	4086	\N	\N
18153	37	3	4087	\N	\N
18154	37	3	4088	\N	\N
18155	37	3	4089	\N	\N
18156	37	634	4089	\N	\N
18157	37	3	4090	\N	\N
18158	37	634	4090	\N	\N
18159	37	3	4091	\N	\N
18160	37	3	4092	\N	\N
18161	38	3	4093	\N	\N
18162	38	3	4094	\N	\N
18163	38	636	4094	\N	\N
18164	37	3	4095	\N	\N
18165	38	3	4096	\N	\N
18166	37	3	4097	\N	\N
18167	63	3	4098	\N	\N
18168	63	3	4099	\N	\N
18169	63	637	4099	\N	\N
18170	63	3	4100	\N	\N
18171	63	637	4100	\N	\N
18172	63	3	4101	\N	\N
18173	63	3	4102	\N	\N
18174	63	637	4102	\N	\N
18175	37	3	4103	\N	\N
18176	63	3	4104	\N	\N
18177	22	3	4105	\N	\N
18178	37	3	4106	\N	\N
18179	64	3	4107	\N	\N
18180	64	3	4108	\N	\N
18181	64	3	4109	\N	\N
18182	64	3	4110	\N	\N
18183	64	638	4110	\N	\N
18184	37	3	4111	\N	\N
18185	37	3	4112	\N	\N
18186	64	3	4113	\N	\N
18187	64	638	4113	\N	\N
18188	64	3	4114	\N	\N
18189	37	3	4115	\N	\N
18190	37	3	4116	\N	\N
18191	37	3	4117	\N	\N
18192	37	3	4118	\N	\N
18193	37	3	4119	\N	\N
18194	3	3	4120	\N	\N
18195	37	3	4121	\N	\N
18196	37	3	4122	\N	\N
18197	37	3	4123	\N	\N
18198	37	3	4124	\N	\N
18199	37	3	4125	\N	\N
18200	37	641	4125	\N	\N
18201	37	642	4125	\N	\N
18202	37	3	4126	\N	\N
18203	37	643	4126	\N	\N
18204	2	3	4127	\N	\N
18205	2	646	4127	\N	\N
18206	37	3	4127	\N	\N
18207	5	3	4128	\N	\N
18208	39	3	4128	\N	\N
18209	37	3	4129	\N	\N
18210	37	3	4130	\N	\N
18211	65	3	4131	\N	\N
18212	65	647	4131	\N	\N
18213	65	3	4132	\N	\N
18214	65	647	4132	\N	\N
18215	65	3	4133	\N	\N
18216	65	3	4134	\N	\N
18217	65	648	4134	\N	\N
18218	21	209	4135	\N	https://civic.genome.wustl.edu/#/events/genes/4/summary/variants/3/summary/evidence/233/summary#evidence
18219	1	649	4136	\N	https://civic.genome.wustl.edu/#/events/genes/4753/summary/variants/367/summary/evidence/873/summary#evidence
18220	8	498	3897	\N	https://civic.genome.wustl.edu/#/events/genes/21/summary/variants/47/summary/evidence/243/summary#evidence
18221	8	499	3897	\N	https://civic.genome.wustl.edu/#/events/genes/21/summary/variants/47/summary/evidence/291/summary#evidence
18222	3	650	4137	\N	https://civic.genome.wustl.edu/#/events/genes/50/summary/variants/135/summary/evidence/380/summary#evidence
18223	26	651	3473	\N	https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/148/summary/evidence/251/summary#evidence
18224	66	652	3642	\N	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/8/summary/evidence/32/summary#evidence
18225	3	652	3642	\N	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/8/summary/evidence/33/summary#evidence
18226	9	653	3642	\N	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/8/summary/evidence/37/summary#evidence
18227	9	654	3642	\N	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/8/summary/evidence/38/summary#evidence
16906	9	243	3642	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/178	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/8/summary/evidence/125/summary#evidence
18228	9	655	3642	\N	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/8/summary/evidence/142/summary#evidence
18229	8	496	4002	\N	https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/39/summary/evidence/283/summary#evidence
17792	8	496	3866	http://www.mycancergenome.org/content/disease/breast-cancer/her2/245	https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/43/summary/evidence/287/summary#evidence
18230	42	656	4138	\N	https://civic.genome.wustl.edu/#/events/genes/67/summary/variants/175/summary/evidence/447/summary#evidence
18231	1	657	3478	\N	https://civic.genome.wustl.edu/#/events/genes/36/summary/variants/96/summary/evidence/23/summary#evidence
18232	8	317	4139	\N	https://civic.genome.wustl.edu/#/events/genes/41/summary/variants/110/summary/evidence/317/summary#evidence
18233	67	658	4139	\N	https://civic.genome.wustl.edu/#/events/genes/41/summary/variants/110/summary/evidence/343/summary#evidence
18234	64	659	3830	\N	https://civic.genome.wustl.edu/#/events/genes/42/summary/variants/112/summary/evidence/75/summary#evidence
18235	21	660	4140	\N	https://civic.genome.wustl.edu/#/events/genes/10024/summary/variants/351/summary/evidence/840/summary#evidence
18236	8	661	3485	\N	https://civic.genome.wustl.edu/#/events/genes/37/summary/variants/103/summary/evidence/310/summary#evidence
15883	8	80	3485	http://www.mycancergenome.org/content/disease/breast-cancer/pik3ca/7	https://civic.genome.wustl.edu/#/events/genes/37/summary/variants/103/summary/evidence/311/summary#evidence
18238	5	663	3485	\N	https://civic.genome.wustl.edu/#/events/genes/37/summary/variants/103/summary/evidence/384/summary#evidence
18237	5	662	3485	\N	https://civic.genome.wustl.edu/#/events/genes/37/summary/variants/103/summary/evidence/256/summary#evidence
18239	5	664	3485	\N	https://civic.genome.wustl.edu/#/events/genes/37/summary/variants/103/summary/evidence/83/summary#evidence
18240	3	256	3660	\N	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/171/summary/evidence/441/summary#evidence
18241	21	665	4141	\N	https://civic.genome.wustl.edu/#/events/genes/29/summary/variants/201/summary/evidence/485/summary#evidence
18242	11	666	4142	\N	https://civic.genome.wustl.edu/#/events/genes/38/summary/variants/247/summary/evidence/652/summary#evidence
18243	3	667	4143	\N	https://civic.genome.wustl.edu/#/events/genes/6144/summary/variants/249/summary/evidence/659/summary#evidence
18244	5	668	4144	\N	https://civic.genome.wustl.edu/#/events/genes/2473/summary/variants/259/summary/evidence/670/summary#evidence
18245	30	669	4145	\N	https://civic.genome.wustl.edu/#/events/genes/1736/summary/variants/264/summary/evidence/676/summary#evidence
18246	3	670	4145	\N	https://civic.genome.wustl.edu/#/events/genes/1736/summary/variants/264/summary/evidence/677/summary#evidence
18247	5	671	4146	\N	https://civic.genome.wustl.edu/#/events/genes/2747/summary/variants/274/summary/evidence/699/summary#evidence
18248	68	672	4147	\N	https://civic.genome.wustl.edu/#/events/genes/2073/summary/variants/470/summary/evidence/1110/summary#evidence
18249	1	657	3677	\N	https://civic.genome.wustl.edu/#/events/genes/36/summary/variants/95/summary/evidence/22/summary#evidence
18250	3	673	3456	\N	https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/322/summary/evidence/794/summary#evidence
18251	8	674	4148	\N	https://civic.genome.wustl.edu/#/events/genes/4244/summary/variants/451/summary/evidence/1075/summary#evidence
18252	8	496	4149	\N	https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/40/summary/evidence/284/summary#evidence
18253	2	675	4150	\N	https://civic.genome.wustl.edu/#/events/genes/24/summary/variants/56/summary/evidence/373/summary#evidence
18255	2	676	4150	\N	https://civic.genome.wustl.edu/#/events/genes/24/summary/variants/56/summary/evidence/248/summary#evidence
18254	2	132	4150	\N	https://civic.genome.wustl.edu/#/events/genes/24/summary/variants/56/summary/evidence/214/summary#evidence
18257	2	677	4150	\N	https://civic.genome.wustl.edu/#/events/genes/24/summary/variants/56/summary/evidence/171/summary#evidence
18258	3	320	4151	\N	https://civic.genome.wustl.edu/#/events/genes/51/summary/variants/142/summary/evidence/267/summary#evidence
17782	8	496	3862	http://www.mycancergenome.org/content/disease/breast-cancer/her2/241	https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/36/summary/evidence/280/summary#evidence
18259	8	498	3896	\N	https://civic.genome.wustl.edu/#/events/genes/21/summary/variants/48/summary/evidence/244/summary#evidence
18260	8	499	3896	\N	https://civic.genome.wustl.edu/#/events/genes/21/summary/variants/48/summary/evidence/292/summary#evidence
18261	8	498	3895	\N	https://civic.genome.wustl.edu/#/events/genes/21/summary/variants/50/summary/evidence/246/summary#evidence
18262	8	499	3895	\N	https://civic.genome.wustl.edu/#/events/genes/21/summary/variants/50/summary/evidence/294/summary#evidence
18263	11	626	3511	\N	https://civic.genome.wustl.edu/#/events/genes/29/summary/variants/73/summary/evidence/249/summary#evidence
16305	11	108	3511	\N	https://civic.genome.wustl.edu/#/events/genes/29/summary/variants/73/summary/evidence/304/summary#evidence
17048	1	447	3674	\N	https://civic.genome.wustl.edu/#/events/genes/31/summary/variants/83/summary/evidence/13/summary#evidence
18264	83	678	3731	\N	https://civic.genome.wustl.edu/#/events/genes/5365/summary/variants/299/summary/evidence/1099/summary#evidence
18265	14	679	3731	\N	https://civic.genome.wustl.edu/#/events/genes/5365/summary/variants/299/summary/evidence/755/summary#evidence
18266	83	352	3731	\N	https://civic.genome.wustl.edu/#/events/genes/5365/summary/variants/299/summary/evidence/745/summary#evidence
18267	8	661	3496	\N	https://civic.genome.wustl.edu/#/events/genes/37/summary/variants/107/summary/evidence/314/summary#evidence
18268	5	662	3496	\N	https://civic.genome.wustl.edu/#/events/genes/37/summary/variants/107/summary/evidence/258/summary#evidence
18269	8	680	3597	\N	https://civic.genome.wustl.edu/#/events/genes/45/summary/variants/119/summary/evidence/393/summary#evidence
18270	8	681	4152	\N	https://civic.genome.wustl.edu/#/events/genes/2/summary/variants/4/summary/evidence/231/summary#evidence
18271	1	682	4152	\N	https://civic.genome.wustl.edu/#/events/genes/2/summary/variants/4/summary/evidence/707/summary#evidence
18272	8	683	4152	\N	https://civic.genome.wustl.edu/#/events/genes/2/summary/variants/4/summary/evidence/709/summary#evidence
18273	8	680	3596	\N	https://civic.genome.wustl.edu/#/events/genes/45/summary/variants/121/summary/evidence/396/summary#evidence
18274	8	684	3596	\N	https://civic.genome.wustl.edu/#/events/genes/45/summary/variants/121/summary/evidence/395/summary#evidence
18275	1	365	4153	\N	https://civic.genome.wustl.edu/#/events/genes/2/summary/variants/169/summary/evidence/439/summary#evidence
18276	3	685	3666	\N	https://civic.genome.wustl.edu/#/events/genes/4941/summary/variants/465/summary/evidence/1101/summary#evidence
16954	26	262	3666	\N	https://civic.genome.wustl.edu/#/events/genes/4941/summary/variants/465/summary/evidence/1100/summary#evidence
18277	21	207	4154	\N	https://civic.genome.wustl.edu/#/events/genes/4/summary/variants/241/summary/evidence/638/summary#evidence
18278	21	686	4154	\N	https://civic.genome.wustl.edu/#/events/genes/4/summary/variants/241/summary/evidence/639/summary#evidence
18279	21	687	4154	\N	https://civic.genome.wustl.edu/#/events/genes/4/summary/variants/241/summary/evidence/637/summary#evidence
16371	11	110	3522	http://www.mycancergenome.org/content/disease/gist/pdgfra/45	https://civic.genome.wustl.edu/#/events/genes/38/summary/variants/99/summary/evidence/44/summary#evidence
18280	11	666	3522	\N	https://civic.genome.wustl.edu/#/events/genes/38/summary/variants/99/summary/evidence/651/summary#evidence
18281	11	688	3522	\N	https://civic.genome.wustl.edu/#/events/genes/38/summary/variants/99/summary/evidence/738/summary#evidence
16373	11	626	3522	\N	https://civic.genome.wustl.edu/#/events/genes/38/summary/variants/99/summary/evidence/16/summary#evidence
16367	11	106	3522	http://www.mycancergenome.org/content/disease/gist/pdgfra/45	https://civic.genome.wustl.edu/#/events/genes/38/summary/variants/99/summary/evidence/15/summary#evidence
18282	11	689	3522	\N	https://civic.genome.wustl.edu/#/events/genes/38/summary/variants/99/summary/evidence/2/summary#evidence
18283	7	690	4155	\N	https://civic.genome.wustl.edu/#/events/genes/4244/summary/variants/262/summary/evidence/674/summary#evidence
18284	1	691	4156	\N	https://civic.genome.wustl.edu/#/events/genes/2073/summary/variants/284/summary/evidence/722/summary#evidence
18285	70	692	4157	\N	https://civic.genome.wustl.edu/#/events/genes/37/summary/variants/294/summary/evidence/739/summary#evidence
18286	8	680	3595	\N	https://civic.genome.wustl.edu/#/events/genes/45/summary/variants/122/summary/evidence/398/summary#evidence
18287	8	684	3595	\N	https://civic.genome.wustl.edu/#/events/genes/45/summary/variants/122/summary/evidence/397/summary#evidence
18288	3	653	3661	\N	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/7/summary/evidence/141/summary#evidence
18289	3	256	3661	\N	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/7/summary/evidence/442/summary#evidence
18290	3	693	3661	\N	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/7/summary/evidence/237/summary#evidence
18291	5	694	4158	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/454/summary/evidence/1081/summary#evidence
18293	5	694	4159	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/453/summary/evidence/1079/summary#evidence
18292	5	61	4159	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/453/summary/evidence/1078/summary#evidence
17190	1	429	3702	http://www.mycancergenome.org/content/disease/melanoma/kit/96	https://civic.genome.wustl.edu/#/events/genes/29/summary/variants/72/summary/evidence/42/summary#evidence
18294	3	334	3702	\N	https://civic.genome.wustl.edu/#/events/genes/29/summary/variants/72/summary/evidence/303/summary#evidence
18295	3	320	4160	\N	https://civic.genome.wustl.edu/#/events/genes/51/summary/variants/141/summary/evidence/266/summary#evidence
18296	3	320	4161	\N	https://civic.genome.wustl.edu/#/events/genes/51/summary/variants/144/summary/evidence/268/summary#evidence
18297	71	695	4162	\N	https://civic.genome.wustl.edu/#/events/genes/39/summary/variants/462/summary/evidence/1093/summary#evidence
18298	5	696	4163	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/317/summary/evidence/786/summary#evidence
18299	2	697	3515	\N	https://civic.genome.wustl.edu/#/events/genes/29/summary/variants/65/summary/evidence/26/summary#evidence
18300	1	447	3797	\N	https://civic.genome.wustl.edu/#/events/genes/31/summary/variants/82/summary/evidence/12/summary#evidence
18301	8	674	4164	\N	https://civic.genome.wustl.edu/#/events/genes/4244/summary/variants/263/summary/evidence/1076/summary#evidence
18302	3	699	4164	\N	https://civic.genome.wustl.edu/#/events/genes/4244/summary/variants/263/summary/evidence/675/summary#evidence
18303	72	700	3590	\N	https://civic.genome.wustl.edu/#/events/genes/44/summary/variants/114/summary/evidence/352/summary#evidence
17779	8	496	3861	http://www.mycancergenome.org/content/disease/breast-cancer/her2/240	https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/35/summary/evidence/279/summary#evidence
18305	72	701	3604	\N	https://civic.genome.wustl.edu/#/events/genes/48/summary/variants/127/summary/evidence/339/summary#evidence
18306	72	702	3604	\N	https://civic.genome.wustl.edu/#/events/genes/48/summary/variants/127/summary/evidence/400/summary#evidence
18304	2	701	3604	\N	https://civic.genome.wustl.edu/#/events/genes/48/summary/variants/127/summary/evidence/217/summary#evidence
17784	8	496	3863	http://www.mycancergenome.org/content/disease/breast-cancer/her2/247	https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/44/summary/evidence/288/summary#evidence
18307	73	703	4165	\N	https://civic.genome.wustl.edu/#/events/genes/9189/summary/variants/239/summary/evidence/636/summary#evidence
18308	18	703	4165	\N	https://civic.genome.wustl.edu/#/events/genes/9189/summary/variants/239/summary/evidence/667/summary#evidence
17254	1	395	3733	http://www.mycancergenome.org/content/disease/melanoma/braf/138	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/288/summary/evidence/728/summary#evidence
18309	3	704	3663	\N	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/307/summary/evidence/763/summary#evidence
18310	21	209	4166	\N	https://civic.genome.wustl.edu/#/events/genes/4/summary/variants/2/summary/evidence/235/summary#evidence
18311	21	705	4166	\N	https://civic.genome.wustl.edu/#/events/genes/4/summary/variants/2/summary/evidence/234/summary#evidence
18313	3	707	3671	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/34/summary/evidence/963/summary#evidence
18314	16	708	3671	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/34/summary/evidence/642/summary#evidence
18315	3	709	3671	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/34/summary/evidence/762/summary#evidence
18316	3	710	3671	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/34/summary/evidence/967/summary#evidence
18317	3	711	3671	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/34/summary/evidence/277/summary#evidence
18318	3	712	3671	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/34/summary/evidence/966/summary#evidence
18312	3	706	3671	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/34/summary/evidence/965/summary#evidence
18319	3	713	3671	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/34/summary/evidence/646/summary#evidence
18320	3	714	3671	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/34/summary/evidence/238/summary#evidence
17011	3	289	3671	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/34/summary/evidence/370/summary#evidence
18321	3	715	3671	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/34/summary/evidence/369/summary#evidence
18322	3	716	3671	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/34/summary/evidence/278/summary#evidence
17003	3	281	3671	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/34/summary/evidence/240/summary#evidence
17001	3	279	3671	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/4	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/34/summary/evidence/239/summary#evidence
18323	3	717	4167	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/415/summary/evidence/964/summary#evidence
18324	68	672	4168	\N	https://civic.genome.wustl.edu/#/events/genes/47/summary/variants/469/summary/evidence/1108/summary#evidence
18325	3	718	3472	\N	https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/425/summary/evidence/795/summary#evidence
18326	3	719	3472	\N	https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/425/summary/evidence/987/summary#evidence
18327	2	720	4150	\N	https://civic.genome.wustl.edu/#/events/genes/24/summary/variants/437/summary/evidence/1037/summary#evidence
18328	2	122	4150	\N	https://civic.genome.wustl.edu/#/events/genes/24/summary/variants/437/summary/evidence/1036/summary#evidence
18256	2	16	4150	\N	https://civic.genome.wustl.edu/#/events/genes/24/summary/variants/437/summary/evidence/1039/summary#evidence
18329	2	121	4150	\N	https://civic.genome.wustl.edu/#/events/genes/24/summary/variants/437/summary/evidence/1038/summary#evidence
18330	8	496	4169	\N	https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/42/summary/evidence/286/summary#evidence
16958	3	269	3668	http://www.mycancergenome.org/content/disease/lung-cancer/egfr/3	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/134/summary/evidence/274/summary#evidence
18331	5	696	3668	\N	https://civic.genome.wustl.edu/#/events/genes/19/summary/variants/134/summary/evidence/787/summary#evidence
18332	3	650	4170	\N	https://civic.genome.wustl.edu/#/events/genes/50/summary/variants/136/summary/evidence/381/summary#evidence
18333	3	320	4171	\N	https://civic.genome.wustl.edu/#/events/genes/51/summary/variants/139/summary/evidence/271/summary#evidence
18334	3	320	4172	\N	https://civic.genome.wustl.edu/#/events/genes/51/summary/variants/143/summary/evidence/269/summary#evidence
18335	3	259	3664	\N	https://civic.genome.wustl.edu/#/events/genes/3/summary/variants/10/summary/evidence/17/summary#evidence
18336	8	498	3894	\N	https://civic.genome.wustl.edu/#/events/genes/21/summary/variants/49/summary/evidence/245/summary#evidence
18337	8	499	3894	\N	https://civic.genome.wustl.edu/#/events/genes/21/summary/variants/49/summary/evidence/293/summary#evidence
18338	3	721	3475	\N	https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/78/summary/evidence/1142/summary#evidence
18339	16	722	3475	\N	https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/78/summary/evidence/227/summary#evidence
18340	3	311	3474	\N	https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/79/summary/evidence/305/summary#evidence
18341	74	723	3474	\N	https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/79/summary/evidence/937/summary#evidence
18342	16	722	3474	\N	https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/79/summary/evidence/228/summary#evidence
18343	5	724	3468	\N	https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/81/summary/evidence/806/summary#evidence
15518	5	71	3468	http://www.mycancergenome.org/content/disease/colorectal-cancer/kras/39	https://civic.genome.wustl.edu/#/events/genes/30/summary/variants/81/summary/evidence/306/summary#evidence
18344	64	659	3831	\N	https://civic.genome.wustl.edu/#/events/genes/42/summary/variants/113/summary/evidence/76/summary#evidence
18345	64	480	3831	\N	https://civic.genome.wustl.edu/#/events/genes/42/summary/variants/113/summary/evidence/77/summary#evidence
18346	64	725	3831	\N	https://civic.genome.wustl.edu/#/events/genes/42/summary/variants/113/summary/evidence/78/summary#evidence
18347	64	726	3831	\N	https://civic.genome.wustl.edu/#/events/genes/42/summary/variants/113/summary/evidence/74/summary#evidence
18348	8	727	4125	\N	https://civic.genome.wustl.edu/#/events/genes/45/summary/variants/116/summary/evidence/319/summary#evidence
18349	8	684	4125	\N	https://civic.genome.wustl.edu/#/events/genes/45/summary/variants/116/summary/evidence/389/summary#evidence
18350	8	680	3599	\N	https://civic.genome.wustl.edu/#/events/genes/45/summary/variants/117/summary/evidence/391/summary#evidence
18351	8	684	3599	\N	https://civic.genome.wustl.edu/#/events/genes/45/summary/variants/117/summary/evidence/390/summary#evidence
18352	41	495	3858	\N	https://civic.genome.wustl.edu/#/events/genes/65/summary/variants/168/summary/evidence/436/summary#evidence
18353	3	256	3659	\N	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/172/summary/evidence/443/summary#evidence
18354	55	728	3888	\N	https://civic.genome.wustl.edu/#/events/genes/23/summary/variants/196/summary/evidence/477/summary#evidence
18355	5	729	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/816/summary#evidence
18357	5	731	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/89/summary#evidence
18358	5	732	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/96/summary#evidence
18359	5	733	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/97/summary#evidence
18356	1	730	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/90/summary#evidence
15205	5	48	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/99/summary#evidence
18360	1	734	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/1005/summary#evidence
18361	3	394	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/91/summary#evidence
18362	1	735	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/757/summary#evidence
18363	75	736	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/656/summary#evidence
18364	1	737	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/95/summary#evidence
18365	84	513	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/463/summary#evidence
15206	5	49	3447	http://www.mycancergenome.org/content/disease/colorectal-cancer/braf/54	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/126/summary#evidence
18367	4	739	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/106/summary#evidence
18368	1	740	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/104/summary#evidence
18369	5	741	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/103/summary#evidence
18370	4	742	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/102/summary#evidence
18371	1	743	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/82/summary#evidence
18372	4	744	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/80/summary#evidence
18366	4	738	3447	\N	https://civic.genome.wustl.edu/#/events/genes/5/summary/variants/12/summary/evidence/79/summary#evidence
18373	77	745	4173	\N	https://civic.genome.wustl.edu/#/events/genes/524/summary/variants/271/summary/evidence/690/summary#evidence
18374	2	746	3561	\N	https://civic.genome.wustl.edu/#/events/genes/27/summary/variants/63/summary/evidence/375/summary#evidence
18375	72	747	3561	\N	https://civic.genome.wustl.edu/#/events/genes/27/summary/variants/63/summary/evidence/332/summary#evidence
18376	2	748	3561	\N	https://civic.genome.wustl.edu/#/events/genes/27/summary/variants/63/summary/evidence/331/summary#evidence
18112	11	110	4062	\N	https://civic.genome.wustl.edu/#/events/genes/38/summary/variants/100/summary/evidence/45/summary#evidence
18377	3	608	3658	\N	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/308/summary/evidence/764/summary#evidence
18378	3	749	3658	\N	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/308/summary/evidence/765/summary#evidence
18379	78	507	4174	\N	https://civic.genome.wustl.edu/#/events/genes/26/summary/variants/420/summary/evidence/979/summary#evidence
18380	9	750	3479	\N	https://civic.genome.wustl.edu/#/events/genes/36/summary/variants/427/summary/evidence/1002/summary#evidence
18381	2	751	4175	\N	https://civic.genome.wustl.edu/#/events/genes/26/summary/variants/59/summary/evidence/732/summary#evidence
18382	2	752	4175	\N	https://civic.genome.wustl.edu/#/events/genes/26/summary/variants/59/summary/evidence/224/summary#evidence
18383	3	753	4176	\N	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/6/summary/evidence/841/summary#evidence
18384	3	693	4176	\N	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/6/summary/evidence/236/summary#evidence
17777	8	496	3859	\N	https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/38/summary/evidence/282/summary#evidence
18385	71	695	4177	\N	https://civic.genome.wustl.edu/#/events/genes/39/summary/variants/463/summary/evidence/1094/summary#evidence
18386	1	698	3576	\N	https://civic.genome.wustl.edu/#/events/genes/36/summary/variants/93/summary/evidence/21/summary#evidence
18387	8	684	4127	\N	https://civic.genome.wustl.edu/#/events/genes/45/summary/variants/118/summary/evidence/392/summary#evidence
18388	73	703	4178	\N	https://civic.genome.wustl.edu/#/events/genes/9189/summary/variants/238/summary/evidence/633/summary#evidence
18389	73	703	4179	\N	https://civic.genome.wustl.edu/#/events/genes/9189/summary/variants/240/summary/evidence/635/summary#evidence
18390	79	754	4180	\N	https://civic.genome.wustl.edu/#/events/genes/72/summary/variants/198/summary/evidence/479/summary#evidence
18391	42	755	4181	\N	https://civic.genome.wustl.edu/#/events/genes/69/summary/variants/244/summary/evidence/648/summary#evidence
18392	1	691	4182	\N	https://civic.genome.wustl.edu/#/events/genes/2073/summary/variants/283/summary/evidence/713/summary#evidence
18394	72	702	3605	\N	https://civic.genome.wustl.edu/#/events/genes/48/summary/variants/128/summary/evidence/401/summary#evidence
18393	2	701	3605	\N	https://civic.genome.wustl.edu/#/events/genes/48/summary/variants/128/summary/evidence/218/summary#evidence
18395	3	320	4183	\N	https://civic.genome.wustl.edu/#/events/genes/51/summary/variants/145/summary/evidence/272/summary#evidence
18396	9	655	3638	\N	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/9/summary/evidence/48/summary#evidence
16897	9	243	3638	http://www.mycancergenome.org/content/disease/neuroblastoma/alk/183	https://civic.genome.wustl.edu/#/events/genes/1/summary/variants/9/summary/evidence/143/summary#evidence
17790	8	496	3865	http://www.mycancergenome.org/content/disease/breast-cancer/her2/244	https://civic.genome.wustl.edu/#/events/genes/20/summary/variants/45/summary/evidence/289/summary#evidence
18397	19	756	3565	\N	https://civic.genome.wustl.edu/#/events/genes/28/summary/variants/64/summary/evidence/20/summary#evidence
18398	19	757	3565	\N	https://civic.genome.wustl.edu/#/events/genes/28/summary/variants/64/summary/evidence/19/summary#evidence
18399	80	758	3565	\N	https://civic.genome.wustl.edu/#/events/genes/28/summary/variants/64/summary/evidence/7/summary#evidence
18400	21	759	3565	\N	https://civic.genome.wustl.edu/#/events/genes/28/summary/variants/64/summary/evidence/5/summary#evidence
18401	81	759	3565	\N	https://civic.genome.wustl.edu/#/events/genes/28/summary/variants/64/summary/evidence/1/summary#evidence
18402	8	681	3486	\N	https://civic.genome.wustl.edu/#/events/genes/37/summary/variants/104/summary/evidence/710/summary#evidence
18403	5	662	3486	\N	https://civic.genome.wustl.edu/#/events/genes/37/summary/variants/104/summary/evidence/387/summary#evidence
18404	7	760	4184	\N	https://civic.genome.wustl.edu/#/events/genes/7451/summary/variants/260/summary/evidence/671/summary#evidence
\.


--
-- Name: disease_source_variants_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('disease_source_variants_id_seq', 18404, true);


--
-- Name: diseases_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('diseases_id_seq', 84, true);


--
-- Data for Name: drug_interactions; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY drug_interactions (id, effect, pathway, therapeutic_context, status, evidence, variant_id, source_id, clinical_association) FROM stdin;
1	gain-of-function	activation	AURK inhibitors + BCR-ABL1 inhibitors	case report	emerging	309	5	response
2	gain-of-function	activation	ruxolitinib (in SH2B3 deleted)	preclinical	emerging	311	10	sensitivity
3	gain-of-function	activation	ruxolitinib (in SH2B3 deleted)	preclinical	emerging	311	11	sensitivity
4	gain-of-function	activation	mTOR inhibitors  (in SH2B3 deleted)	preclinical	emerging	311	11	sensitivity
5	gain-of-function	activation	ruxolitinib	preclinical	emerging	312	11	sensitivity
6	gain-of-function	activation	ruxolitinib	preclinical	emerging	314	17	sensitivity
7	gain-of-function	activation	ruxolitinib	preclinical	emerging	314	11	sensitivity
8	gain-of-function	activation	ruxolitinib	preclinical	emerging	315	17	sensitivity
9	gain-of-function	activation	ruxolitinib	preclinical	emerging	315	11	sensitivity
10	gain-of-function	activation	ruxolitinib	preclinical	emerging	316	17	sensitivity
11	gain-of-function	activation	ruxolitinib	preclinical	emerging	316	11	sensitivity
12	gain-of-function	activation	ruxolitinib	preclinical	emerging	317	17	sensitivity
13	gain-of-function	activation	ruxolitinib	preclinical	emerging	317	11	sensitivity
14	gain-of-function	activation	cetuximab, panitumumab	late trials	emerging	328	49	resistance
15	gain-of-function	activation	cetuximab, panitumumab	late trials	emerging	328	42	resistance
16	gain-of-function	activation	cetuximab, panitumumab	late trials	emerging	328	50	resistance
17	gain-of-function	activation	BRAF inhibitors +/- MEK inhibitors	early trials	emerging	328	51	response
18	gain-of-function	activation	BRAF inhibitors + EGFR inhibitors	preclinical	emerging	328	46	sensitivity
19	gain-of-function	activation	BRAF inhibitors + PI3K pathway inhibitors	preclinical	emerging	328	52	sensitivity
20	gain-of-function	activation	BRAF inhibitors + PI3K pathway inhibitors	preclinical	emerging	328	53	sensitivity
21	gain-of-function	activation	proteosome inhibitors	preclinical	emerging	328	54	sensitivity
22	gain-of-function	activation	preclinical	preclinical	emerging	328	55	mTOR inhibitors + BH3 mimetics
23	gain-of-function	activation	cetuximab	case report	emerging	336	61	resistance
24	gain-of-function	activation	panitumumab	case report	emerging	336	61	response
25	gain-of-function	activation	cetuximab	late trials	emerging	349	70	response
26	gain-of-function	activation	cetuximab	late trials	emerging	349	71	response
27	gain-of-function	activation	MEK inhibitors + PI3K pathway inhibitors	preclinical	emerging	349	72	sensitivity
28	gain-of-function	activation	dabrafenib	case report	emerging	328	98	response
29	gain-of-function	activation	dabrafenib	case report	emerging	328	51	response
30	gain-of-function	activation	imatinib	preclinical	emerging	390	99	resistance
31	gain-of-function	activation	imatinib	preclinical	emerging	390	100	resistance
32	gain-of-function	activation	imatinib	preclinical	emerging	390	101	resistance
33	gain-of-function	activation	imatinib	preclinical	emerging	391	99	resistance
34	gain-of-function	activation	imatinib	preclinical	emerging	391	100	resistance
35	gain-of-function	activation	imatinib	preclinical	emerging	391	101	resistance
36	gain-of-function	activation	imatinib	preclinical	emerging	392	99	resistance
37	gain-of-function	activation	imatinib	preclinical	emerging	392	100	resistance
38	gain-of-function	activation	imatinib	preclinical	emerging	392	101	resistance
39	gain-of-function	activation	imatinib	preclinical	emerging	392	102	decreased sensitivity
40	gain-of-function	activation	imatinib	case report	emerging	393	103	resistance
41	gain-of-function	activation	imatinib	preclinical	emerging	393	99	resistance
42	gain-of-function	activation	imatinib	preclinical	emerging	393	100	resistance
43	gain-of-function	activation	imatinib	preclinical	emerging	393	101	resistance
44	gain-of-function	activation	imatinib	preclinical	emerging	396	99	resistance
45	gain-of-function	activation	imatinib	preclinical	emerging	396	100	resistance
46	gain-of-function	activation	imatinib	preclinical	emerging	396	101	resistance
47	gain-of-function	activation	imatinib	preclinical	emerging	397	99	resistance
48	gain-of-function	activation	imatinib	preclinical	emerging	397	100	resistance
49	gain-of-function	activation	imatinib	preclinical	emerging	397	101	resistance
50	gain-of-function	activation	imatinib	preclinical	emerging	398	99	resistance
51	gain-of-function	activation	imatinib	preclinical	emerging	398	100	resistance
52	gain-of-function	activation	imatinib	preclinical	emerging	398	101	resistance
53	gain-of-function	activation	imatinib	preclinical	emerging	399	99	resistance
54	gain-of-function	activation	imatinib	preclinical	emerging	399	100	resistance
55	gain-of-function	activation	imatinib	preclinical	emerging	399	101	resistance
56	gain-of-function	activation	imatinib, sunitinib	late trials, preclinical	emerging	403	107	resistance
57	gain-of-function	activation	imatinib, sunitinib	late trials, preclinical	emerging	403	108	resistance
58	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	403	109	sensitivity
59	gain-of-function	activation	crenolanib	preclinical	emerging	403	110	sensitivity
60	gain-of-function	activation	dasatinib	preclinical	emerging	403	109	sensitivity
61	gain-of-function	activation	quizartinib	preclinical	emerging	411	121	resistance
62	gain-of-function	activation	ponatinib	preclinical	emerging	411	122	resistance
63	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	411	123	sensitivity
64	gain-of-function	activation	quizartinib	preclinical	emerging	412	121	resistance
65	gain-of-function	activation	ponatinib	preclinical	emerging	412	122	resistance
66	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	412	123	sensitivity
67	gain-of-function	activation	quizartinib	preclinical	emerging	416	121	resistance
68	gain-of-function	activation	ponatinib	preclinical	emerging	416	122	resistance
69	gain-of-function	activation	sorafenib	case report	emerging	416	16	resistance
70	gain-of-function	activation	midostaurin	case report	emerging	416	134	response
71	gain-of-function	activation	lestaurtinib	case report	emerging	416	135	response
72	gain-of-function	activation	quizartinib	preclinical	emerging	417	121	resistance
73	gain-of-function	activation	ponatinib	preclinical	emerging	417	122	resistance
74	gain-of-function	activation	sorafenib	case report	emerging	417	16	resistance
75	gain-of-function	activation	midostaurin	case report	emerging	417	134	response
76	gain-of-function	activation	lestaurtinib	case report	emerging	417	135	response
77	gain-of-function	activation	quizartinib	preclinical	emerging	418	121	resistance
78	gain-of-function	activation	ponatinib	preclinical	emerging	418	122	resistance
79	gain-of-function	activation	sorafenib	case report	emerging	418	16	resistance
80	gain-of-function	activation	midostaurin	case report	emerging	418	134	response
81	gain-of-function	activation	lestaurtinib	case report	emerging	418	135	response
82	gain-of-function	activation	quizartinib	preclinical	emerging	419	121	resistance
83	gain-of-function	activation	ponatinib	preclinical	emerging	419	122	resistance
84	gain-of-function	activation	sorafenib	case report	emerging	419	16	resistance
85	gain-of-function	activation	midostaurin	case report	emerging	419	134	response
86	gain-of-function	activation	lestaurtinib	case report	emerging	419	135	response
87	gain-of-function	activation	quizartinib	preclinical	emerging	420	121	resistance
88	gain-of-function	activation	quizartinib	preclinical	emerging	421	121	resistance
89	gain-of-function	activation	ponatinib	preclinical	emerging	421	122	resistance
90	gain-of-function	activation	sorafenib	case report	emerging	421	16	resistance
91	gain-of-function	activation	midostaurin	case report	emerging	421	134	response
92	gain-of-function	activation	lestaurtinib	case report	emerging	421	135	response
93	gain-of-function	activation	quizartinib	preclinical	emerging	422	121	resistance
94	gain-of-function	activation	ponatinib	preclinical	emerging	422	122	resistance
95	gain-of-function	activation	sorafenib	case report	emerging	422	16	resistance
96	gain-of-function	activation	midostaurin	case report	emerging	422	134	response
97	gain-of-function	activation	lestaurtinib	case report	emerging	422	135	response
98	gain-of-function	activation	quizartinib	preclinical	emerging	423	121	resistance
99	gain-of-function	activation	ponatinib	preclinical	emerging	423	122	resistance
100	gain-of-function	activation	sorafenib	case report	emerging	423	16	resistance
101	gain-of-function	activation	midostaurin	case report	emerging	423	134	response
102	gain-of-function	activation	lestaurtinib	case report	emerging	423	135	response
103	gain-of-function	activation	quizartinib	preclinical	emerging	424	121	resistance
104	gain-of-function	activation	quizartinib	preclinical	emerging	425	121	resistance
105	gain-of-function	activation	quizartinib	preclinical	emerging	426	121	resistance
106	gain-of-function	activation	ponatinib	preclinical	emerging	426	122	resistance
107	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	426	123	sensitivity
108	gain-of-function	activation	quizartinib	preclinical	emerging	427	137	resistance
109	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	427	123	sensitivity
110	gain-of-function	activation	quizartinib	preclinical	emerging	428	137	resistance
111	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	428	123	sensitivity
112	gain-of-function	activation	quizartinib	preclinical	emerging	429	121	resistance
113	gain-of-function	activation	ponatinib	preclinical	emerging	429	122	resistance
114	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	429	123	sensitivity
115	gain-of-function	activation	quizartinib	preclinical	emerging	430	121	resistance
116	gain-of-function	activation	ponatinib	preclinical	emerging	430	122	resistance
117	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	430	123	sensitivity
118	gain-of-function	activation	quizartinib	preclinical	emerging	431	121	resistance
119	gain-of-function	activation	ponatinib	preclinical	emerging	431	122	resistance
120	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	431	123	sensitivity
121	gain-of-function	activation	ruxolitinib	early trials	emerging	446	156	response
122	gain-of-function	activation	JAK inhibitors (alone or in combination)	preclinical	emerging	446	148	response
123	gain-of-function	activation	dasatinib	case report	emerging	396	158	response
124	gain-of-function	activation	quizartinib	preclinical	emerging	396	121	resistance
125	gain-of-function	activation	dasatinib	preclinical	emerging	448	159	sensitivity
126	gain-of-function	activation	dasatinib	preclinical	emerging	449	159	sensitivity
127	gain-of-function	activation	JAK inhibitors	preclinical	emerging	489	182	sensitivity
128	gain-of-function	activation	JAK inhibitors	preclinical	emerging	490	182	sensitivity
129	gain-of-function	activation	JAK inhibitors	preclinical	emerging	491	182	sensitivity
130	gain-of-function	activation	JAK inhibitors	preclinical	emerging	492	182	sensitivity
131	gain-of-function	activation	dasatinib, bosutinib, ponatinib	NCCN guidelines	consensus	508	210	response
132	gain-of-function	activation	dasatinib, bosutinib, ponatinib	NCCN guidelines	consensus	308	210	response
133	gain-of-function	activation	nilotinib, ponatinib	NCCN guidelines	consensus	509	210	response
134	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	510	210	response
135	gain-of-function	activation	ponatinib	NCCN guidelines	consensus	309	210	response
136	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	511	210	response
137	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	512	210	response
138	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	513	210	response
139	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	502	210	response
140	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	503	210	response
141	gain-of-function	activation	dasatinib, bosutinib, ponatinib	NCCN guidelines	consensus	514	210	response
142	gain-of-function	activation	dasatinib, bosutinib, ponatinib	NCCN guidelines	consensus	515	210	response
143	gain-of-function	activation	dasatinib, bosutinib, ponatinib	NCCN guidelines	consensus	516	210	response
144	gain-of-function	activation	ruxolitinib	case report	emerging	404	242	response
145	gain-of-function	activation	ruxolitinib	preclinical	emerging	517	242	sensitivity
146	gain-of-function	activation	crizotinib	preclinical	emerging	521	243	sensitivity
147	gain-of-function	activation	crizotinib	preclinical	emerging	523	243	reduced sensitivity
148	gain-of-function	activation	crizotinib	preclinical	emerging	527	243	sensitivity
149	gain-of-function	activation	MET inhibitors	early trials	emerging	531	249	response
150	gain-of-function	activation	MET inhibitors	case report	emerging	532	250	response
151	gain-of-function	activation	rapamycin	preclinical	emerging	533	251	sensitivity
152	gain-of-function	activation	everolimus	case report	emerging	534	252	response
153	gain-of-function	activation	rapamycin	preclinical	emerging	535	251	sensitivity
154	gain-of-function	activation	rapamycin	preclinical	emerging	536	251	sensitivity
155	gain-of-function	activation	everolimus	case report	emerging	537	253	sensitivity
156	gain-of-function	activation	everolimus	case report	emerging	538	253	sensitivity
157	gain-of-function	activation	crizotinib	case report	emerging	539	256	resistance
158	gain-of-function	activation	ceritinib	FDA-approved	consensus	539	257	response
159	gain-of-function	activation	crizotinib	case report	emerging	540	256	resistance
160	gain-of-function	activation	ceritinib	FDA-approved	consensus	540	257	response
161	gain-of-function	activation	crizotinib	case report	emerging	541	256	resistance
162	gain-of-function	activation	crizotinib	case report	emerging	542	256	resistance
163	gain-of-function	activation	ceritinib	FDA-approved	consensus	542	257	response
164	gain-of-function	activation	ceritinib	FDA-approved	consensus	542	258	response
165	gain-of-function	activation	crizotinib	case report	emerging	543	256	resistance
166	gain-of-function	activation	novel ALK inhibiors	preclinical	emerging	543	258	response
167	gain-of-function	activation	crizotinib	case report	emerging	523	256	resistance
168	gain-of-function	activation	novel ALK inhibiors	preclinical	emerging	523	258	response
169	gain-of-function	activation	crizotinib	case report	emerging	544	256	resistance
170	gain-of-function	activation	sorafenib	case report	emerging	545	259	response
171	gain-of-function	activation	EGFR TKIs	case report	emerging	333	260	resistance
172	gain-of-function	activation	EGFR TKIs + MEK inhibitors in EGFR mutant	preclinical	emerging	333	260	sensitivity
173	gain-of-function	activation	ERBB2 TKIs, trastuzumab	preclinical	emerging	546	261	sensitivity
174	gain-of-function	activation	crizotinib	case report	emerging	547	262	resistance
175	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	549	276	response
176	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	549	277	sensitivity
177	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	550	276	response
178	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	550	277	sensitivity
179	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	551	276	response
180	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	551	277	sensitivity
181	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	552	277	sensitivity
182	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	553	276	response
183	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	553	277	sensitivity
184	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	554	276	response
185	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	554	277	sensitivity
186	gain-of-function	activation	dasatinib	preclinical	emerging	562	320	sensitivity
187	gain-of-function	activation	dasatinib	preclinical	emerging	563	320	sensitivity
188	gain-of-function	activation	dasatinib	preclinical	emerging	564	320	sensitivity
189	gain-of-function	activation	dasatinib	preclinical	emerging	565	320	sensitivity
190	gain-of-function	activation	dasatinib	preclinical	emerging	566	320	sensitivity
191	gain-of-function	activation	dasatinib	preclinical	emerging	567	320	sensitivity
192	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	568	276	response
193	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	568	277	sensitivity
194	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	569	276	response
195	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	569	277	sensitivity
196	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	570	276	response
197	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	570	277	sensitivity
198	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	571	276	response
199	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	571	277	sensitivity
200	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	572	276	response
201	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	572	277	sensitivity
202	gain-of-function	activation	mTOR inhibitors, dasatinib	preclinical	emerging	573	321	sensitivity
203	gain-of-function	activation	mTOR inhibitors, dasatinib	preclinical	emerging	574	321	sensitivity
204	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	575	322	sensitivity
205	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	576	322	sensitivity
206	gain-of-function	activation	dasatinib	early trials	emerging	577	324	response
207	gain-of-function	activation	imatinib	case report	emerging	579	328	response
208	gain-of-function	activation	sunitinib	case report	emerging	579	329	response
209	gain-of-function	activation	imatinib	case report	emerging	582	333	response
210	gain-of-function	activation	sunitinib	preclinical	emerging	585	332	sensitivity
211	gain-of-function	activation	sorafenib	case report	emerging	586	338	response
212	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	588	341	sensitivity
213	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	589	341	sensitivity
214	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	590	341	sensitivity
215	gain-of-function	activation	lapatinib	case report	emerging	591	343	response
216	gain-of-function	activation	dovitinib	preclinical	emerging	592	344	resistance
217	gain-of-function	activation	ponatinib	preclinical	emerging	592	344	sensitivity
218	gain-of-function	activation	dovitinib	preclinical	emerging	593	344	resistance
219	gain-of-function	activation	ponatinib	preclinical	emerging	593	344	sensitivity
220	gain-of-function	activation	dovitinib	preclinical	emerging	594	344	resistance
221	gain-of-function	activation	ponatinib	preclinical	emerging	594	344	sensitivity
222	gain-of-function	activation	dovitinib	preclinical	emerging	595	344	resistance
223	gain-of-function	activation	ponatinib	preclinical	emerging	595	344	sensitivity
224	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	596	345	sensitivity
225	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	596	346	sensitivity
226	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	596	347	sensitivity
227	gain-of-function	activation	dovitinib	preclinical	emerging	596	344	resistance
228	gain-of-function	activation	ponatinib	preclinical	emerging	596	344	sensitivity
229	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	597	345	sensitivity
230	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	597	346	sensitivity
231	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	597	347	sensitivity
232	gain-of-function	activation	dovitinib	preclinical	emerging	597	344	resistance
233	gain-of-function	activation	ponatinib	preclinical	emerging	597	344	sensitivity
234	gain-of-function	activation	dovitinib	preclinical	emerging	598	344	resistance
235	gain-of-function	activation	ponatinib	preclinical	emerging	598	344	sensitivity
236	gain-of-function	activation	dovitinib	preclinical	emerging	599	344	resistance
237	gain-of-function	activation	ponatinib	preclinical	emerging	599	344	sensitivity
238	gain-of-function	activation	dovitinib	preclinical	emerging	600	344	resistance
239	gain-of-function	activation	ponatinib	preclinical	emerging	600	344	sensitivity
240	gain-of-function	activation	dovitinib	preclinical	emerging	601	344	resistance
241	gain-of-function	activation	ponatinib	preclinical	emerging	601	344	sensitivity
242	gain-of-function	activation	dovitinib	preclinical	emerging	602	344	resistance
243	gain-of-function	activation	ponatinib	preclinical	emerging	602	344	sensitivity
244	gain-of-function	activation	dovitinib	preclinical	emerging	603	344	resistance
245	gain-of-function	activation	ponatinib	preclinical	emerging	603	344	sensitivity
246	gain-of-function	activation	dovitinib	preclinical	emerging	604	344	resistance
247	gain-of-function	activation	ponatinib	preclinical	emerging	604	344	sensitivity
248	gain-of-function	activation	dovitinib	preclinical	emerging	605	344	resistance
249	gain-of-function	activation	ponatinib	preclinical	emerging	605	344	sensitivity
250	loss-of-function	activation	mTOR inhibitors	preclinical	emerging	607	348	sensitivity
251	gain-of-function	activation	JAK inhibitors, dasatinib	preclinical	emerging	608	349	sensitivity
372	gain-of-function	activation	preclinical	preclinical	emerging	559	383	ERK inhibitors
252	gain-of-function	activation	JAK inhibitors, dasatinib	preclinical	emerging	609	349	sensitivity
253	gain-of-function	activation	imatinib	preclinical	emerging	610	350	sensitivity
254	gain-of-function	activation	JAK inhibitors	preclinical	emerging	611	351	sensitivity
255	gain-of-function	activation	BRAF inhibitors	case report	emerging	328	51	response
256	gain-of-function	activation	MEK inhibitors	preclinical	emerging	328	356	sensitivity
257	gain-of-function	activation	trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	619	364	sensitivity
258	gain-of-function	activation	BRAF inhibitors	preclinical	emerging	620	365	resistance
259	gain-of-function	activation	MEK inhibitors	case report	emerging	621	366	response
260	gain-of-function	activation	BRAF inhibitors + PI3K pathway inhibitors	preclinical	emerging	328	379	sensitivity
261	gain-of-function	activation	BRAF inhibitors + PI3K pathway inhibitors	preclinical	emerging	328	380	sensitivity
262	gain-of-function	activation	BRAF inhibitors + HSP90 inhibitors	preclinical	emerging	328	381	sensitivity
263	gain-of-function	activation	BRAF inhibitors + CDK2/4 inhibitors	preclinical	emerging	328	382	sensitivity
264	gain-of-function	activation	preclinical	preclinical	emerging	328	383	ERK inhibitors
265	gain-of-function	activation	preclinical	preclinical	emerging	328	382	ERK inhibitors
266	gain-of-function	activation	BRAF inhibitors	early trials	emerging	625	384	response
267	gain-of-function	activation	MEK inhibitors	case report	emerging	625	366	response
268	gain-of-function	activation	vemurafenib	late trials	emerging	626	368	response
269	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	614	370	response
270	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	614	357	response
271	gain-of-function	activation	BRAF inhibitors	case report	emerging	614	395	response
272	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	629	370	response
273	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	629	357	response
274	gain-of-function	activation	BRAF inhibitors	case report	emerging	629	395	response
275	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	630	370	response
276	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	630	357	response
277	gain-of-function	activation	BRAF inhibitors	case report	emerging	630	395	response
278	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	631	370	response
279	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	631	357	response
280	gain-of-function	activation	BRAF inhibitors	case report	emerging	631	395	response
281	gain-of-function (low activity)	activation	sorafenib	preclinical	emerging	331	396	sensitivity
282	gain-of-function (low activity)	activation	sorafenib	preclinical	emerging	334	396	sensitivity
283	gain-of-function	activation	lapatinib	preclinical	emerging	643	406	sensitivity
284	gain-of-function	activation	lapatinib	preclinical	emerging	644	406	sensitivity
285	gain-of-function	activation	lapatinib	preclinical	emerging	645	406	sensitivity
286	gain-of-function	activation	lapatinib	preclinical	emerging	646	406	sensitivity
287	gain-of-function	activation	lapatinib	preclinical	emerging	647	406	sensitivity
288	gain-of-function	activation	lapatinib	preclinical	emerging	648	406	sensitivity
289	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	649	408	response
290	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	649	409	response
291	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	650	408	response
292	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	650	409	response
293	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	651	408	response
294	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	651	409	response
295	gain-of-function	activation	PKC inhibitor	preclinical	emerging	651	413	sensitivity
296	gain-of-function	activation	PKC inhibitor	preclinical	emerging	651	414	sensitivity
297	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	652	408	response
298	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	652	409	response
299	gain-of-function	activation	PKC inhibitor	preclinical	emerging	652	413	sensitivity
300	gain-of-function	activation	PKC inhibitor	preclinical	emerging	652	414	sensitivity
301	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	653	408	response
302	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	653	409	response
303	gain-of-function	activation	PKC inhibitor	preclinical	emerging	653	413	sensitivity
304	gain-of-function	activation	PKC inhibitor	preclinical	emerging	653	414	sensitivity
305	gain-of-function	activation	imatinib	case report	emerging	672	443	response
306	gain-of-function	activation	vemurafenib	case report	emerging	555	446	resistance
307	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	555	447	resistance
308	gain-of-function	activation	vemurafenib	case report	emerging	674	446	resistance
309	gain-of-function	activation	MEK inhibitors	case report	emerging	675	448	resistance
310	gain-of-function	activation	MEK inhibitors	case report	emerging	556	448	resistance
311	gain-of-function	activation	BRAF inhibitors in BRAF mutant tumor	case report	emerging	676	449	sensitivity
312	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	case report	emerging	677	450	resistance
313	gain-of-function	activation	novel MEK inhibitors	preclinical	emerging	677	451	sensitivity
314	gain-of-function	activation	BRAF inhibitors in BRAF mutant tumor	case report	emerging	678	449	sensitivity
315	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	case report	emerging	679	447	resistance
316	gain-of-function	activation	MEK inhibitors	preclinical	emerging	680	447	resistance
317	gain-of-function	activation	MEK inhibitors	preclinical	emerging	681	447	resistance
318	gain-of-function	activation	ERK inhibitors	preclinical	emerging	681	383	sensitivity
319	gain-of-function	activation	vemurafenib	case report	emerging	682	446	resistance
320	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	682	447	resistance
321	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	685	454	resistance
322	gain-of-function	activation	ERK inhibitors	preclinical	emerging	685	454	sensitivity
323	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	686	454	resistance
324	gain-of-function	activation	ERK inhibitors	preclinical	emerging	686	454	sensitivity
325	gain-of-function	activation	BRAF + MEK inhibitors	case report	emerging	687	455	resistance
326	gain-of-function	activation	ERK inhibitors	preclinical	emerging	687	455	sensitivity
327	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	688	454	resistance
328	gain-of-function	activation	ERK inhibitors	preclinical	emerging	688	454	sensitivity
329	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	689	454	resistance
330	gain-of-function	activation	ERK inhibitors	preclinical	emerging	689	454	sensitivity
331	gain-of-function	activation	MEK inhibitors	late trials	emerging	454	457	response
332	gain-of-function	activation	MEK inhibitors	early trials	emerging	454	458	response
333	gain-of-function	activation	MEK inhibitors	early trials	emerging	454	459	response
334	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	454	460	sensitivity
335	gain-of-function	activation	BRAF inhibitors	case report	emerging	454	446	resistance
336	gain-of-function	activation	preclinical	preclinical	emerging	454	383	ERK inhibitors
337	gain-of-function	activation	MEK inhibitors	late trials	emerging	455	457	response
338	gain-of-function	activation	MEK inhibitors	early trials	emerging	455	458	response
339	gain-of-function	activation	MEK inhibitors	early trials	emerging	455	459	response
340	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	455	460	sensitivity
341	gain-of-function	activation	BRAF inhibitors	case report	emerging	455	446	resistance
342	gain-of-function	activation	preclinical	preclinical	emerging	455	383	ERK inhibitors
343	gain-of-function	activation	MEK inhibitors	late trials	emerging	690	457	response
344	gain-of-function	activation	MEK inhibitors	early trials	emerging	690	458	response
345	gain-of-function	activation	MEK inhibitors	early trials	emerging	690	459	response
346	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	690	460	sensitivity
347	gain-of-function	activation	BRAF inhibitors	case report	emerging	690	446	resistance
348	gain-of-function	activation	preclinical	preclinical	emerging	690	383	ERK inhibitors
349	gain-of-function	activation	MEK inhibitors	late trials	emerging	691	457	response
350	gain-of-function	activation	MEK inhibitors	early trials	emerging	691	458	response
351	gain-of-function	activation	MEK inhibitors	early trials	emerging	691	459	response
352	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	691	460	sensitivity
353	gain-of-function	activation	BRAF inhibitors	case report	emerging	691	446	resistance
354	gain-of-function	activation	preclinical	preclinical	emerging	691	383	ERK inhibitors
355	gain-of-function	activation	MEK inhibitors	late trials	emerging	558	457	response
356	gain-of-function	activation	MEK inhibitors	early trials	emerging	558	458	response
357	gain-of-function	activation	MEK inhibitors	early trials	emerging	558	459	response
358	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	558	460	sensitivity
359	gain-of-function	activation	BRAF inhibitors	case report	emerging	558	446	resistance
360	gain-of-function	activation	preclinical	preclinical	emerging	558	383	ERK inhibitors
361	gain-of-function	activation	MEK inhibitors	late trials	emerging	359	457	response
362	gain-of-function	activation	MEK inhibitors	early trials	emerging	359	458	response
363	gain-of-function	activation	MEK inhibitors	early trials	emerging	359	459	response
364	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	359	460	sensitivity
365	gain-of-function	activation	BRAF inhibitors	case report	emerging	359	446	resistance
366	gain-of-function	activation	preclinical	preclinical	emerging	359	383	ERK inhibitors
367	gain-of-function	activation	MEK inhibitors	late trials	emerging	559	457	response
368	gain-of-function	activation	MEK inhibitors	early trials	emerging	559	458	response
369	gain-of-function	activation	MEK inhibitors	early trials	emerging	559	459	response
370	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	559	460	sensitivity
371	gain-of-function	activation	BRAF inhibitors	case report	emerging	559	446	resistance
373	gain-of-function	activation	MEK inhibitors	late trials	emerging	692	457	response
374	gain-of-function	activation	MEK inhibitors	early trials	emerging	692	458	response
375	gain-of-function	activation	MEK inhibitors	early trials	emerging	692	459	response
376	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	692	460	sensitivity
377	gain-of-function	activation	BRAF inhibitors	case report	emerging	692	446	resistance
378	gain-of-function	activation	preclinical	preclinical	emerging	692	383	ERK inhibitors
379	gain-of-function	activation	MEK inhibitors	late trials	emerging	360	457	response
380	gain-of-function	activation	MEK inhibitors	early trials	emerging	360	458	response
381	gain-of-function	activation	MEK inhibitors	early trials	emerging	360	459	response
382	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	360	460	sensitivity
383	gain-of-function	activation	BRAF inhibitors	case report	emerging	360	446	resistance
384	gain-of-function	activation	preclinical	preclinical	emerging	360	383	ERK inhibitors
385	gain-of-function	activation	ERK inhibitors	preclinical	emerging	364	383	sensitivity
386	gain-of-function	activation	imatinib, crenolanib	preclinical	emerging	696	466	sensitivity
387	gain-of-function	activation	crenolanib	preclinical	emerging	697	466	sensitivity
388	gain-of-function	activation	imatinib	preclinical	emerging	697	466	resistance
389	gain-of-function	activation	imatinib, crenolanib	preclinical	emerging	698	466	sensitivity
390	gain-of-function	activation	imatinib, crenolanib	preclinical	emerging	699	466	sensitivity
391	gain-of-function	activation	imatinib, crenolanib	preclinical	emerging	700	466	sensitivity
392	gain-of-function	activation	BRAF inhibitors in BRAF mutant tumors	preclinical	emerging	701	467	resistance
393	gain-of-function	activation	BRAF inhibitors in BRAF mutant tumors	preclinical	emerging	702	467	resistance
394	loss-of-function	activation	everolimus	case report	emerging	703	468	response
395	loss-of-function	activation	everolimus	case report	emerging	704	468	response
396	gain-of-function	activation	vemurafenib, dabrafenib	early trials	emerging	328	51	response
397	gain-of-function	activation	vemurafenib, dabrafenib	early trials	emerging	328	96	response
398	gain-of-function	activation	vemurafenib, dabrafenib	early trials	emerging	328	469	response
399	gain-of-function	activation	MEK inhibitors	early trials	emerging	328	470	response
400	gain-of-function	activation	MEK-enhanced radioiodine uptake	early trials	emerging	328	471	response
401	gain-of-function	activation	vandetanib	FDA-approved	consensus	711	477	response
402	gain-of-function	activation	vandetanib	FDA-approved	consensus	711	478	response
403	gain-of-function	activation	cabozantinib, sunitinib	preclinical	emerging	711	479	sensitivity
404	gain-of-function	activation	RET inhibitors	preclinical	emerging	711	480	sensitivity
405	gain-of-function	activation	vandetanib	FDA-approved	consensus	712	477	response
406	gain-of-function	activation	vandetanib	FDA-approved	consensus	712	478	response
407	gain-of-function	activation	cabozantinib, sunitinib	preclinical	emerging	712	479	sensitivity
408	gain-of-function	activation	RET inhibitors	preclinical	emerging	712	480	sensitivity
409	gain-of-function	activation	dasatinib + erlotinib	case report	emerging	713	320	response
410	gain-of-function	activation	dasatinib	preclinical	emerging	713	320	sensitivity
411	gain-of-function	activation	ERBB2 TKIs, trastuzumab	preclinical	emerging	714	261	sensitivity
412	gain-of-function	activation	ERBB2 TKIs, trastuzumab	preclinical	emerging	715	261	sensitivity
413	gain-of-function	activation	trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	716	364	sensitivity
414	gain-of-function	activation	trastuzumab, lapatinib, PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	717	364	sensitivity
415	gain-of-function	activation	JAK inhibitors	preclinical	emerging	718	486	sensitivity
416	gain-of-function	activation	JAK inhibitors	preclinical	emerging	719	486	sensitivity
417	gain-of-function	activation	JAK inhibitors	preclinical	emerging	720	486	sensitivity
418	gain-of-function	activation	MEK inhibitors	preclinical	emerging	721	447	resistance
419	gain-of-function	activation	MEK inhibitors	preclinical	emerging	722	447	resistance
420	gain-of-function	activation	ERK inhibitors	preclinical	emerging	722	383	sensitivity
421	gain-of-function	activation	MEK inhibitors	preclinical	emerging	723	447	resistance
422	gain-of-function	activation	MEK inhibitors	preclinical	emerging	724	447	resistance
423	gain-of-function	activation	MEK inhibitors	preclinical	emerging	725	447	resistance
424	gain-of-function	activation	MEK inhibitors	preclinical	emerging	726	447	resistance
425	gain-of-function	activation	MEK inhibitors	preclinical	emerging	727	447	resistance
426	gain-of-function	activation	MEK inhibitors	preclinical	emerging	728	447	resistance
427	gain-of-function	activation	ERK inhibitors	preclinical	emerging	728	383	sensitivity
428	gain-of-function	activation	crizotinib	preclinical	emerging	729	487	sensitivity
429	gain-of-function	activation	crizotinib	preclinical	emerging	730	487	sensitivity
430	gain-of-function	activation	crizotinib	preclinical	emerging	731	487	sensitivity
431	gain-of-function	activation	crizotinib	preclinical	emerging	732	487	reduced sensitivity
432	gain-of-function	activation	crizotinib	preclinical	emerging	733	487	reduced sensitivity
433	gain-of-function	activation	crizotinib	preclinical	emerging	734	487	sensitivity
434	gain-of-function	activation	crizotinib	preclinical	emerging	735	487	sensitivity
435	gain-of-function	activation	crizotinib	preclinical	emerging	736	487	sensitivity
436	gain-of-function	activation	allosteric AKT inhibitors	preclinical	emerging	318	494	sensitivity
437	gain-of-function	activation	allosteric AKT inhibitors	preclinical	emerging	318	20	sensitivity
438	gain-of-function	activation	ibrutinib	early trials	emerging	738	495	resistance
439	gain-of-function	activation	ibrutinib	early trials	emerging	739	495	resistance
440	gain-of-function	activation	lapatinib, neratinib	preclinical	emerging	740	496	sensitivity
441	gain-of-function	activation	trastuzumab, lapatinib, neratinib	preclinical	emerging	742	496	sensitivity
442	gain-of-function	activation	trastuzumab, lapatinib, neratinib	preclinical	emerging	743	496	sensitivity
443	gain-of-function	activation	lapatinib, neratinib	preclinical	emerging	744	496	sensitivity
444	gain-of-function	activation	lapatinib, neratinib	preclinical	emerging	746	496	sensitivity
445	gain-of-function	activation	trastuzumab, lapatinib, neratinib	preclinical	emerging	747	496	sensitivity
446	gain-of-function	activation	anti-estrogens	early trials	emerging	748	498	resistance
447	gain-of-function	activation	anti-estrogens	early trials	emerging	748	499	resistance
448	gain-of-function	activation	anti-estrogens	early trials	emerging	748	500	resistance
449	gain-of-function	activation	neratinib	preclinical	emerging	750	496	sensitivity
450	gain-of-function	activation	EGFR TKIs	case report	emerging	328	260	resistance
451	gain-of-function	activation	dabrafenib	early trials	emerging	328	394	response
452	gain-of-function	activation	dabrafenib	early trials	emerging	328	51	response
453	gain-of-function	activation	vemurafenib	case report	emerging	328	393	response
454	gain-of-function	activation	BRAF inhibitors +/- MEK inhibitors	preclinical	emerging	328	390	sensitivity
455	reduced kinase activity	activation	dasatinib	case report	emerging	753	391	response
456	reduced kinase activity	activation	dasatinib	preclinical	emerging	335	391	sensitivity
457	gain-of-function	activation	crizotinib	preclinical	emerging	519	243	sensitivity
458	gain-of-function	activation	crizotinib	preclinical	emerging	755	243	sensitivity
459	gain-of-function	activation	crizotinib	preclinical	emerging	756	243	sensitivity
460	gain-of-function	activation	BRAF inhibitors	preclinical	emerging	328	504	sensitivity
461	gain-of-function	activation	BRAF inhibitors	preclinical	emerging	328	505	sensitivity
462	gain-of-function	activation	erlotinib	preclinical	emerging	757	506	sensitivity
463	gain-of-function	activation	erlotinib	preclinical	emerging	758	506	sensitivity
464	gain-of-function	activation	erlotinib	preclinical	emerging	759	506	sensitivity
465	gain-of-function	activation	erlotinib	preclinical	emerging	760	506	sensitivity
466	switch-of-function	activation	IDH inhibitors	preclinical	emerging	436	507	sensitivity
467	gain-of-function	activation	cetuximab	case report	emerging	761	508	response
468	gain-of-function	activation	cetuximab plus sirolimus	case report	emerging	762	509	response
469	gain-of-function	activation	gefitinib	case report	emerging	763	510	no response
470	gain-of-function	activation	pazopanib	case report	emerging	764	322	response
471	gain-of-function	activation	ibrutinib	early trials	emerging	766	495	resistance
472	gain-of-function	activation	ibrutinib	early trials	emerging	767	495	resistance
473	gain-of-function	activation	ibrutinib	early trials	emerging	768	495	resistance
474	gain-of-function	activation	vemurafenib	case report	emerging	328	513	response
475	gain-of-function	activation	bortezomib	preclinical	emerging	769	514	resistance
476	gain-of-function	activation	bortezomib	preclinical	emerging	769	515	resistance
477	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	769	516	sensitivity
478	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	770	516	resistance
479	gain-of-function	activation	anti-estrogens	early trials	emerging	773	498	resistance
480	gain-of-function	activation	anti-estrogens	early trials	emerging	774	498	resistance
481	gain-of-function	activation	anti-estrogens	early trials	emerging	774	499	resistance
482	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	779	518	sensitivity
483	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	780	518	sensitivity
484	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	781	518	sensitivity
485	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	782	518	sensitivity
486	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	783	518	sensitivity
487	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	781	519	sensitivity
488	gain-of-function	activation	JAK inhibitors	preclinical	emerging	784	520	sensitivity
489	gain-of-function	activation	vismodegib	case report	emerging	612	352	resistance
1468	gain-of-function	activation	dasatinib, bosutinib, ponatinib	NCCN guidelines	consensus	3427	210	response
1469	gain-of-function	activation	AURK inhibitors + BCR-ABL1 inhibitors	case report	emerging	3428	5	response
1470	gain-of-function	activation	ponatinib	NCCN guidelines	consensus	3428	210	response
1471	gain-of-function	activation	ruxolitinib (in SH2B3 deleted)	preclinical	emerging	3430	10	sensitivity
1472	gain-of-function	activation	ruxolitinib (in SH2B3 deleted)	preclinical	emerging	3430	11	sensitivity
1473	gain-of-function	activation	mTOR inhibitors  (in SH2B3 deleted)	preclinical	emerging	3430	11	sensitivity
1474	gain-of-function	activation	ruxolitinib	preclinical	emerging	3431	11	sensitivity
1475	gain-of-function	activation	ruxolitinib	preclinical	emerging	3433	17	sensitivity
1476	gain-of-function	activation	ruxolitinib	preclinical	emerging	3433	11	sensitivity
1477	gain-of-function	activation	ruxolitinib	preclinical	emerging	3434	17	sensitivity
1478	gain-of-function	activation	ruxolitinib	preclinical	emerging	3434	11	sensitivity
1479	gain-of-function	activation	ruxolitinib	preclinical	emerging	3435	17	sensitivity
1480	gain-of-function	activation	ruxolitinib	preclinical	emerging	3435	11	sensitivity
1481	gain-of-function	activation	ruxolitinib	preclinical	emerging	3436	17	sensitivity
1482	gain-of-function	activation	ruxolitinib	preclinical	emerging	3436	11	sensitivity
1483	gain-of-function	activation	allosteric AKT inhibitors	preclinical	emerging	3437	494	sensitivity
1484	gain-of-function	activation	allosteric AKT inhibitors	preclinical	emerging	3437	20	sensitivity
1485	gain-of-function	activation	cetuximab, panitumumab	late trials	emerging	3447	49	resistance
1486	gain-of-function	activation	cetuximab, panitumumab	late trials	emerging	3447	42	resistance
1487	gain-of-function	activation	cetuximab, panitumumab	late trials	emerging	3447	50	resistance
1488	gain-of-function	activation	BRAF inhibitors +/- MEK inhibitors	early trials	emerging	3447	51	response
1489	gain-of-function	activation	BRAF inhibitors + EGFR inhibitors	preclinical	emerging	3447	46	sensitivity
1490	gain-of-function	activation	BRAF inhibitors + PI3K pathway inhibitors	preclinical	emerging	3447	52	sensitivity
1491	gain-of-function	activation	BRAF inhibitors + PI3K pathway inhibitors	preclinical	emerging	3447	53	sensitivity
1492	gain-of-function	activation	proteosome inhibitors	preclinical	emerging	3447	54	sensitivity
1493	gain-of-function	activation	preclinical	preclinical	emerging	3447	55	mTOR inhibitors + BH3 mimetics
1494	gain-of-function	activation	dabrafenib	case report	emerging	3447	98	response
1495	gain-of-function	activation	dabrafenib	case report	emerging	3447	51	response
1496	gain-of-function	activation	BRAF inhibitors	case report	emerging	3447	51	response
1497	gain-of-function	activation	MEK inhibitors	preclinical	emerging	3447	356	sensitivity
1498	gain-of-function	activation	BRAF inhibitors + PI3K pathway inhibitors	preclinical	emerging	3447	379	sensitivity
1499	gain-of-function	activation	BRAF inhibitors + PI3K pathway inhibitors	preclinical	emerging	3447	380	sensitivity
1500	gain-of-function	activation	BRAF inhibitors + HSP90 inhibitors	preclinical	emerging	3447	381	sensitivity
1501	gain-of-function	activation	BRAF inhibitors + CDK2/4 inhibitors	preclinical	emerging	3447	382	sensitivity
1502	gain-of-function	activation	preclinical	preclinical	emerging	3447	383	ERK inhibitors
1503	gain-of-function	activation	preclinical	preclinical	emerging	3447	382	ERK inhibitors
1504	gain-of-function	activation	vemurafenib, dabrafenib	early trials	emerging	3447	51	response
1505	gain-of-function	activation	vemurafenib, dabrafenib	early trials	emerging	3447	96	response
1506	gain-of-function	activation	vemurafenib, dabrafenib	early trials	emerging	3447	469	response
1507	gain-of-function	activation	MEK inhibitors	early trials	emerging	3447	470	response
1508	gain-of-function	activation	MEK-enhanced radioiodine uptake	early trials	emerging	3447	471	response
1509	gain-of-function	activation	EGFR TKIs	case report	emerging	3447	260	resistance
1510	gain-of-function	activation	dabrafenib	early trials	emerging	3447	394	response
1511	gain-of-function	activation	dabrafenib	early trials	emerging	3447	51	response
1512	gain-of-function	activation	vemurafenib	case report	emerging	3447	393	response
1513	gain-of-function	activation	BRAF inhibitors +/- MEK inhibitors	preclinical	emerging	3447	390	sensitivity
1514	gain-of-function	activation	BRAF inhibitors	preclinical	emerging	3447	504	sensitivity
1515	gain-of-function	activation	BRAF inhibitors	preclinical	emerging	3447	505	sensitivity
1516	gain-of-function	activation	vemurafenib	case report	emerging	3447	513	response
1517	gain-of-function (low activity)	activation	sorafenib	preclinical	emerging	3450	396	sensitivity
1518	gain-of-function	activation	EGFR TKIs	case report	emerging	3452	260	resistance
1519	gain-of-function	activation	EGFR TKIs + MEK inhibitors in EGFR mutant	preclinical	emerging	3452	260	sensitivity
1520	gain-of-function (low activity)	activation	sorafenib	preclinical	emerging	3453	396	sensitivity
1521	reduced kinase activity	activation	dasatinib	preclinical	emerging	3454	391	sensitivity
1522	gain-of-function	activation	cetuximab	case report	emerging	3455	61	resistance
1523	gain-of-function	activation	panitumumab	case report	emerging	3455	61	response
1524	gain-of-function	activation	cetuximab	late trials	emerging	3468	70	response
1525	gain-of-function	activation	cetuximab	late trials	emerging	3468	71	response
1526	gain-of-function	activation	MEK inhibitors + PI3K pathway inhibitors	preclinical	emerging	3468	72	sensitivity
1527	gain-of-function	activation	MEK inhibitors	late trials	emerging	3478	457	response
1528	gain-of-function	activation	MEK inhibitors	early trials	emerging	3478	458	response
1529	gain-of-function	activation	MEK inhibitors	early trials	emerging	3478	459	response
1530	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	3478	460	sensitivity
1531	gain-of-function	activation	BRAF inhibitors	case report	emerging	3478	446	resistance
1532	gain-of-function	activation	preclinical	preclinical	emerging	3478	383	ERK inhibitors
1533	gain-of-function	activation	MEK inhibitors	late trials	emerging	3479	457	response
1534	gain-of-function	activation	MEK inhibitors	early trials	emerging	3479	458	response
1535	gain-of-function	activation	MEK inhibitors	early trials	emerging	3479	459	response
1536	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	3479	460	sensitivity
1537	gain-of-function	activation	BRAF inhibitors	case report	emerging	3479	446	resistance
1538	gain-of-function	activation	preclinical	preclinical	emerging	3479	383	ERK inhibitors
1539	gain-of-function	activation	ERK inhibitors	preclinical	emerging	3483	383	sensitivity
1540	gain-of-function	activation	imatinib	preclinical	emerging	3509	99	resistance
1541	gain-of-function	activation	imatinib	preclinical	emerging	3509	100	resistance
1542	gain-of-function	activation	imatinib	preclinical	emerging	3509	101	resistance
1543	gain-of-function	activation	imatinib	preclinical	emerging	3510	99	resistance
1544	gain-of-function	activation	imatinib	preclinical	emerging	3510	100	resistance
1545	gain-of-function	activation	imatinib	preclinical	emerging	3510	101	resistance
1546	gain-of-function	activation	imatinib	preclinical	emerging	3511	99	resistance
1547	gain-of-function	activation	imatinib	preclinical	emerging	3511	100	resistance
1548	gain-of-function	activation	imatinib	preclinical	emerging	3511	101	resistance
1549	gain-of-function	activation	imatinib	preclinical	emerging	3511	102	decreased sensitivity
1550	gain-of-function	activation	imatinib	case report	emerging	3512	103	resistance
1551	gain-of-function	activation	imatinib	preclinical	emerging	3512	99	resistance
1552	gain-of-function	activation	imatinib	preclinical	emerging	3512	100	resistance
1553	gain-of-function	activation	imatinib	preclinical	emerging	3512	101	resistance
1554	gain-of-function	activation	imatinib	preclinical	emerging	3515	99	resistance
1555	gain-of-function	activation	imatinib	preclinical	emerging	3515	100	resistance
1556	gain-of-function	activation	imatinib	preclinical	emerging	3515	101	resistance
1557	gain-of-function	activation	dasatinib	case report	emerging	3515	158	response
1558	gain-of-function	activation	quizartinib	preclinical	emerging	3515	121	resistance
1559	gain-of-function	activation	imatinib	preclinical	emerging	3516	99	resistance
1560	gain-of-function	activation	imatinib	preclinical	emerging	3516	100	resistance
1561	gain-of-function	activation	imatinib	preclinical	emerging	3516	101	resistance
1562	gain-of-function	activation	imatinib	preclinical	emerging	3517	99	resistance
1563	gain-of-function	activation	imatinib	preclinical	emerging	3517	100	resistance
1564	gain-of-function	activation	imatinib	preclinical	emerging	3517	101	resistance
1565	gain-of-function	activation	imatinib	preclinical	emerging	3518	99	resistance
1566	gain-of-function	activation	imatinib	preclinical	emerging	3518	100	resistance
1567	gain-of-function	activation	imatinib	preclinical	emerging	3518	101	resistance
1568	gain-of-function	activation	imatinib, sunitinib	late trials, preclinical	emerging	3522	107	resistance
1569	gain-of-function	activation	imatinib, sunitinib	late trials, preclinical	emerging	3522	108	resistance
1570	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	3522	109	sensitivity
1571	gain-of-function	activation	crenolanib	preclinical	emerging	3522	110	sensitivity
1572	gain-of-function	activation	dasatinib	preclinical	emerging	3522	109	sensitivity
1573	gain-of-function	activation	ruxolitinib	case report	emerging	3523	242	response
1574	gain-of-function	activation	quizartinib	preclinical	emerging	3530	121	resistance
1575	gain-of-function	activation	ponatinib	preclinical	emerging	3530	122	resistance
1576	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	3530	123	sensitivity
1577	gain-of-function	activation	quizartinib	preclinical	emerging	3531	121	resistance
1578	gain-of-function	activation	ponatinib	preclinical	emerging	3531	122	resistance
1579	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	3531	123	sensitivity
1580	gain-of-function	activation	quizartinib	preclinical	emerging	3535	121	resistance
1581	gain-of-function	activation	ponatinib	preclinical	emerging	3535	122	resistance
1582	gain-of-function	activation	sorafenib	case report	emerging	3535	16	resistance
1583	gain-of-function	activation	midostaurin	case report	emerging	3535	134	response
1584	gain-of-function	activation	lestaurtinib	case report	emerging	3535	135	response
1585	gain-of-function	activation	quizartinib	preclinical	emerging	3536	121	resistance
1586	gain-of-function	activation	ponatinib	preclinical	emerging	3536	122	resistance
1587	gain-of-function	activation	sorafenib	case report	emerging	3536	16	resistance
1588	gain-of-function	activation	midostaurin	case report	emerging	3536	134	response
1589	gain-of-function	activation	lestaurtinib	case report	emerging	3536	135	response
1590	gain-of-function	activation	quizartinib	preclinical	emerging	3537	121	resistance
1591	gain-of-function	activation	ponatinib	preclinical	emerging	3537	122	resistance
1592	gain-of-function	activation	sorafenib	case report	emerging	3537	16	resistance
1593	gain-of-function	activation	midostaurin	case report	emerging	3537	134	response
1594	gain-of-function	activation	lestaurtinib	case report	emerging	3537	135	response
1595	gain-of-function	activation	quizartinib	preclinical	emerging	3538	121	resistance
1596	gain-of-function	activation	ponatinib	preclinical	emerging	3538	122	resistance
1597	gain-of-function	activation	sorafenib	case report	emerging	3538	16	resistance
1598	gain-of-function	activation	midostaurin	case report	emerging	3538	134	response
1599	gain-of-function	activation	lestaurtinib	case report	emerging	3538	135	response
1600	gain-of-function	activation	quizartinib	preclinical	emerging	3539	121	resistance
1601	gain-of-function	activation	quizartinib	preclinical	emerging	3540	121	resistance
1602	gain-of-function	activation	ponatinib	preclinical	emerging	3540	122	resistance
1603	gain-of-function	activation	sorafenib	case report	emerging	3540	16	resistance
1604	gain-of-function	activation	midostaurin	case report	emerging	3540	134	response
1605	gain-of-function	activation	lestaurtinib	case report	emerging	3540	135	response
1606	gain-of-function	activation	quizartinib	preclinical	emerging	3541	121	resistance
1607	gain-of-function	activation	ponatinib	preclinical	emerging	3541	122	resistance
1608	gain-of-function	activation	sorafenib	case report	emerging	3541	16	resistance
1609	gain-of-function	activation	midostaurin	case report	emerging	3541	134	response
1610	gain-of-function	activation	lestaurtinib	case report	emerging	3541	135	response
1611	gain-of-function	activation	quizartinib	preclinical	emerging	3542	121	resistance
1612	gain-of-function	activation	ponatinib	preclinical	emerging	3542	122	resistance
1613	gain-of-function	activation	sorafenib	case report	emerging	3542	16	resistance
1614	gain-of-function	activation	midostaurin	case report	emerging	3542	134	response
1615	gain-of-function	activation	lestaurtinib	case report	emerging	3542	135	response
1616	gain-of-function	activation	quizartinib	preclinical	emerging	3543	121	resistance
1617	gain-of-function	activation	quizartinib	preclinical	emerging	3544	121	resistance
1618	gain-of-function	activation	quizartinib	preclinical	emerging	3545	121	resistance
1619	gain-of-function	activation	ponatinib	preclinical	emerging	3545	122	resistance
1620	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	3545	123	sensitivity
1621	gain-of-function	activation	quizartinib	preclinical	emerging	3546	137	resistance
1622	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	3546	123	sensitivity
1623	gain-of-function	activation	quizartinib	preclinical	emerging	3547	137	resistance
1624	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	3547	123	sensitivity
1625	gain-of-function	activation	quizartinib	preclinical	emerging	3548	121	resistance
1626	gain-of-function	activation	ponatinib	preclinical	emerging	3548	122	resistance
1627	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	3548	123	sensitivity
1628	gain-of-function	activation	quizartinib	preclinical	emerging	3549	121	resistance
1629	gain-of-function	activation	ponatinib	preclinical	emerging	3549	122	resistance
1630	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	3549	123	sensitivity
1631	gain-of-function	activation	quizartinib	preclinical	emerging	3550	121	resistance
1632	gain-of-function	activation	ponatinib	preclinical	emerging	3550	122	resistance
1633	gain-of-function	activation	crenolanib, PKC412	preclinical	emerging	3550	123	sensitivity
1634	switch-of-function	activation	IDH inhibitors	preclinical	emerging	3555	507	sensitivity
1635	gain-of-function	activation	ruxolitinib	early trials	emerging	3565	156	response
1636	gain-of-function	activation	JAK inhibitors (alone or in combination)	preclinical	emerging	3565	148	response
1637	gain-of-function	activation	dasatinib	preclinical	emerging	3567	159	sensitivity
1638	gain-of-function	activation	dasatinib	preclinical	emerging	3568	159	sensitivity
1639	gain-of-function	activation	MEK inhibitors	late trials	emerging	3573	457	response
1640	gain-of-function	activation	MEK inhibitors	early trials	emerging	3573	458	response
1641	gain-of-function	activation	MEK inhibitors	early trials	emerging	3573	459	response
1642	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	3573	460	sensitivity
1643	gain-of-function	activation	BRAF inhibitors	case report	emerging	3573	446	resistance
1644	gain-of-function	activation	preclinical	preclinical	emerging	3573	383	ERK inhibitors
1645	gain-of-function	activation	MEK inhibitors	late trials	emerging	3574	457	response
1646	gain-of-function	activation	MEK inhibitors	early trials	emerging	3574	458	response
1647	gain-of-function	activation	MEK inhibitors	early trials	emerging	3574	459	response
1648	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	3574	460	sensitivity
1649	gain-of-function	activation	BRAF inhibitors	case report	emerging	3574	446	resistance
1650	gain-of-function	activation	preclinical	preclinical	emerging	3574	383	ERK inhibitors
1651	gain-of-function	activation	JAK inhibitors	preclinical	emerging	3608	182	sensitivity
1652	gain-of-function	activation	JAK inhibitors	preclinical	emerging	3609	182	sensitivity
1653	gain-of-function	activation	JAK inhibitors	preclinical	emerging	3610	182	sensitivity
1654	gain-of-function	activation	JAK inhibitors	preclinical	emerging	3611	182	sensitivity
1655	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	3621	210	response
1656	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	3622	210	response
1657	gain-of-function	activation	dasatinib, bosutinib, ponatinib	NCCN guidelines	consensus	3627	210	response
1658	gain-of-function	activation	nilotinib, ponatinib	NCCN guidelines	consensus	3628	210	response
1659	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	3629	210	response
1660	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	3630	210	response
1661	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	3631	210	response
1662	gain-of-function	activation	nilotinib, bosutinib, ponatinib	NCCN guidelines	consensus	3632	210	response
1663	gain-of-function	activation	dasatinib, bosutinib, ponatinib	NCCN guidelines	consensus	3633	210	response
1664	gain-of-function	activation	dasatinib, bosutinib, ponatinib	NCCN guidelines	consensus	3634	210	response
1665	gain-of-function	activation	dasatinib, bosutinib, ponatinib	NCCN guidelines	consensus	3635	210	response
1666	gain-of-function	activation	ruxolitinib	preclinical	emerging	3636	242	sensitivity
1667	gain-of-function	activation	crizotinib	preclinical	emerging	3638	243	sensitivity
1668	gain-of-function	activation	crizotinib	preclinical	emerging	3640	243	sensitivity
1669	gain-of-function	activation	crizotinib	preclinical	emerging	3642	243	reduced sensitivity
1670	gain-of-function	activation	crizotinib	case report	emerging	3642	256	resistance
1671	gain-of-function	activation	novel ALK inhibiors	preclinical	emerging	3642	258	response
1672	gain-of-function	activation	crizotinib	preclinical	emerging	3646	243	sensitivity
1673	gain-of-function	activation	MET inhibitors	early trials	emerging	3650	249	response
1674	gain-of-function	activation	MET inhibitors	case report	emerging	3651	250	response
1675	gain-of-function	activation	rapamycin	preclinical	emerging	3652	251	sensitivity
1676	gain-of-function	activation	everolimus	case report	emerging	3653	252	response
1677	gain-of-function	activation	rapamycin	preclinical	emerging	3654	251	sensitivity
1678	gain-of-function	activation	rapamycin	preclinical	emerging	3655	251	sensitivity
1679	gain-of-function	activation	everolimus	case report	emerging	3656	253	sensitivity
1680	gain-of-function	activation	everolimus	case report	emerging	3657	253	sensitivity
1681	gain-of-function	activation	crizotinib	case report	emerging	3658	256	resistance
1682	gain-of-function	activation	ceritinib	FDA-approved	consensus	3658	257	response
1683	gain-of-function	activation	crizotinib	case report	emerging	3659	256	resistance
1684	gain-of-function	activation	ceritinib	FDA-approved	consensus	3659	257	response
1685	gain-of-function	activation	crizotinib	case report	emerging	3660	256	resistance
1686	gain-of-function	activation	crizotinib	case report	emerging	3661	256	resistance
1687	gain-of-function	activation	ceritinib	FDA-approved	consensus	3661	257	response
1688	gain-of-function	activation	ceritinib	FDA-approved	consensus	3661	258	response
1689	gain-of-function	activation	crizotinib	case report	emerging	3662	256	resistance
1690	gain-of-function	activation	novel ALK inhibiors	preclinical	emerging	3662	258	response
1691	gain-of-function	activation	crizotinib	case report	emerging	3663	256	resistance
1692	gain-of-function	activation	sorafenib	case report	emerging	3664	259	response
1693	gain-of-function	activation	ERBB2 TKIs, trastuzumab	preclinical	emerging	3665	261	sensitivity
1694	gain-of-function	activation	crizotinib	case report	emerging	3666	262	resistance
1695	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	3668	276	response
1696	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	3668	277	sensitivity
1697	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	3669	276	response
1698	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	3669	277	sensitivity
1699	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	3670	276	response
1700	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	3670	277	sensitivity
1701	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	3671	277	sensitivity
1702	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	3672	276	response
1703	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	3672	277	sensitivity
1704	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	3673	276	response
1705	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	3673	277	sensitivity
1706	gain-of-function	activation	vemurafenib	case report	emerging	3674	446	resistance
1707	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	3674	447	resistance
1708	gain-of-function	activation	MEK inhibitors	case report	emerging	3675	448	resistance
1709	gain-of-function	activation	MEK inhibitors	late trials	emerging	3677	457	response
1710	gain-of-function	activation	MEK inhibitors	early trials	emerging	3677	458	response
1711	gain-of-function	activation	MEK inhibitors	early trials	emerging	3677	459	response
1712	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	3677	460	sensitivity
1713	gain-of-function	activation	BRAF inhibitors	case report	emerging	3677	446	resistance
1714	gain-of-function	activation	preclinical	preclinical	emerging	3677	383	ERK inhibitors
1715	gain-of-function	activation	preclinical	preclinical	emerging	3678	383	ERK inhibitors
1716	gain-of-function	activation	MEK inhibitors	late trials	emerging	3678	457	response
1717	gain-of-function	activation	MEK inhibitors	early trials	emerging	3678	458	response
1718	gain-of-function	activation	MEK inhibitors	early trials	emerging	3678	459	response
1719	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	3678	460	sensitivity
1720	gain-of-function	activation	BRAF inhibitors	case report	emerging	3678	446	resistance
1721	gain-of-function	activation	dasatinib	preclinical	emerging	3681	320	sensitivity
1722	gain-of-function	activation	dasatinib	preclinical	emerging	3682	320	sensitivity
1723	gain-of-function	activation	dasatinib	preclinical	emerging	3683	320	sensitivity
1724	gain-of-function	activation	dasatinib	preclinical	emerging	3684	320	sensitivity
1725	gain-of-function	activation	dasatinib	preclinical	emerging	3685	320	sensitivity
1726	gain-of-function	activation	dasatinib	preclinical	emerging	3686	320	sensitivity
1727	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	3687	276	response
1728	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	3687	277	sensitivity
1729	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	3688	276	response
1730	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	3688	277	sensitivity
1731	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	3689	276	response
1732	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	3689	277	sensitivity
1733	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	3690	276	response
1734	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	3690	277	sensitivity
1735	gain-of-function	activation	irreversible EGFR TKIs	late trials	emerging	3691	276	response
1736	gain-of-function	activation	MEK inhibitors (alone or in combination)	preclinical	emerging	3691	277	sensitivity
1737	gain-of-function	activation	mTOR inhibitors, dasatinib	preclinical	emerging	3692	321	sensitivity
1738	gain-of-function	activation	mTOR inhibitors, dasatinib	preclinical	emerging	3693	321	sensitivity
1739	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	3694	322	sensitivity
1740	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	3695	322	sensitivity
1741	gain-of-function	activation	dasatinib	early trials	emerging	3696	324	response
1742	gain-of-function	activation	imatinib	case report	emerging	3698	328	response
1743	gain-of-function	activation	sunitinib	case report	emerging	3698	329	response
1744	gain-of-function	activation	imatinib	case report	emerging	3701	333	response
1745	gain-of-function	activation	sunitinib	preclinical	emerging	3704	332	sensitivity
1746	gain-of-function	activation	sorafenib	case report	emerging	3705	338	response
1747	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	3707	341	sensitivity
1748	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	3708	341	sensitivity
1749	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	3709	341	sensitivity
1750	gain-of-function	activation	lapatinib	case report	emerging	3710	343	response
1751	gain-of-function	activation	dovitinib	preclinical	emerging	3711	344	resistance
1752	gain-of-function	activation	ponatinib	preclinical	emerging	3711	344	sensitivity
1753	gain-of-function	activation	dovitinib	preclinical	emerging	3712	344	resistance
1754	gain-of-function	activation	ponatinib	preclinical	emerging	3712	344	sensitivity
1755	gain-of-function	activation	dovitinib	preclinical	emerging	3713	344	resistance
1756	gain-of-function	activation	ponatinib	preclinical	emerging	3713	344	sensitivity
1757	gain-of-function	activation	dovitinib	preclinical	emerging	3714	344	resistance
1758	gain-of-function	activation	ponatinib	preclinical	emerging	3714	344	sensitivity
1759	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	3715	345	sensitivity
1760	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	3715	346	sensitivity
1761	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	3715	347	sensitivity
1762	gain-of-function	activation	dovitinib	preclinical	emerging	3715	344	resistance
1763	gain-of-function	activation	ponatinib	preclinical	emerging	3715	344	sensitivity
1764	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	3716	345	sensitivity
1765	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	3716	346	sensitivity
1766	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	3716	347	sensitivity
1767	gain-of-function	activation	dovitinib	preclinical	emerging	3716	344	resistance
1768	gain-of-function	activation	ponatinib	preclinical	emerging	3716	344	sensitivity
1769	gain-of-function	activation	dovitinib	preclinical	emerging	3717	344	resistance
1770	gain-of-function	activation	ponatinib	preclinical	emerging	3717	344	sensitivity
1771	gain-of-function	activation	dovitinib	preclinical	emerging	3718	344	resistance
1772	gain-of-function	activation	ponatinib	preclinical	emerging	3718	344	sensitivity
1773	gain-of-function	activation	dovitinib	preclinical	emerging	3719	344	resistance
1774	gain-of-function	activation	ponatinib	preclinical	emerging	3719	344	sensitivity
1775	gain-of-function	activation	dovitinib	preclinical	emerging	3720	344	resistance
1776	gain-of-function	activation	ponatinib	preclinical	emerging	3720	344	sensitivity
1777	gain-of-function	activation	dovitinib	preclinical	emerging	3721	344	resistance
1778	gain-of-function	activation	ponatinib	preclinical	emerging	3721	344	sensitivity
1779	gain-of-function	activation	dovitinib	preclinical	emerging	3722	344	resistance
1780	gain-of-function	activation	ponatinib	preclinical	emerging	3722	344	sensitivity
1781	gain-of-function	activation	dovitinib	preclinical	emerging	3723	344	resistance
1782	gain-of-function	activation	ponatinib	preclinical	emerging	3723	344	sensitivity
1783	gain-of-function	activation	dovitinib	preclinical	emerging	3724	344	resistance
1784	gain-of-function	activation	ponatinib	preclinical	emerging	3724	344	sensitivity
1785	loss-of-function	activation	mTOR inhibitors	preclinical	emerging	3726	348	sensitivity
1786	gain-of-function	activation	JAK inhibitors, dasatinib	preclinical	emerging	3727	349	sensitivity
1787	gain-of-function	activation	JAK inhibitors, dasatinib	preclinical	emerging	3728	349	sensitivity
1788	gain-of-function	activation	imatinib	preclinical	emerging	3729	350	sensitivity
1789	gain-of-function	activation	JAK inhibitors	preclinical	emerging	3730	351	sensitivity
1790	gain-of-function	activation	vismodegib	case report	emerging	3731	352	resistance
1791	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	3733	370	response
1792	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	3733	357	response
1793	gain-of-function	activation	BRAF inhibitors	case report	emerging	3733	395	response
1794	gain-of-function	activation	trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	3738	364	sensitivity
1795	gain-of-function	activation	BRAF inhibitors	preclinical	emerging	3739	365	resistance
1796	gain-of-function	activation	MEK inhibitors	case report	emerging	3740	366	response
1797	gain-of-function	activation	BRAF inhibitors	early trials	emerging	3744	384	response
1798	gain-of-function	activation	MEK inhibitors	case report	emerging	3744	366	response
1799	gain-of-function	activation	vemurafenib	late trials	emerging	3745	368	response
1800	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	3748	370	response
1801	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	3748	357	response
1802	gain-of-function	activation	BRAF inhibitors	case report	emerging	3748	395	response
1803	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	3749	370	response
1804	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	3749	357	response
1805	gain-of-function	activation	BRAF inhibitors	case report	emerging	3749	395	response
1806	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	3750	370	response
1807	gain-of-function	activation	trametinib, MEK inhibitors	case report	emerging	3750	357	response
1808	gain-of-function	activation	BRAF inhibitors	case report	emerging	3750	395	response
1809	gain-of-function	activation	lapatinib	preclinical	emerging	3762	406	sensitivity
1810	gain-of-function	activation	lapatinib	preclinical	emerging	3763	406	sensitivity
1811	gain-of-function	activation	lapatinib	preclinical	emerging	3764	406	sensitivity
1812	gain-of-function	activation	lapatinib	preclinical	emerging	3765	406	sensitivity
1813	gain-of-function	activation	lapatinib	preclinical	emerging	3766	406	sensitivity
1814	gain-of-function	activation	lapatinib	preclinical	emerging	3767	406	sensitivity
1815	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	3768	408	response
1816	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	3768	409	response
1817	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	3769	408	response
1818	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	3769	409	response
1819	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	3770	408	response
1820	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	3770	409	response
1821	gain-of-function	activation	PKC inhibitor	preclinical	emerging	3770	413	sensitivity
1822	gain-of-function	activation	PKC inhibitor	preclinical	emerging	3770	414	sensitivity
1823	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	3771	408	response
1824	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	3771	409	response
1825	gain-of-function	activation	PKC inhibitor	preclinical	emerging	3771	413	sensitivity
1826	gain-of-function	activation	PKC inhibitor	preclinical	emerging	3771	414	sensitivity
1827	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	3772	408	response
1828	gain-of-function	activation	PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	3772	409	response
1829	gain-of-function	activation	PKC inhibitor	preclinical	emerging	3772	413	sensitivity
1830	gain-of-function	activation	PKC inhibitor	preclinical	emerging	3772	414	sensitivity
1831	gain-of-function	activation	imatinib	case report	emerging	3791	443	response
1832	gain-of-function	activation	vemurafenib	case report	emerging	3793	446	resistance
1833	gain-of-function	activation	MEK inhibitors	case report	emerging	3794	448	resistance
1834	gain-of-function	activation	BRAF inhibitors in BRAF mutant tumor	case report	emerging	3795	449	sensitivity
1835	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	case report	emerging	3796	450	resistance
1836	gain-of-function	activation	novel MEK inhibitors	preclinical	emerging	3796	451	sensitivity
1837	gain-of-function	activation	BRAF inhibitors in BRAF mutant tumor	case report	emerging	3797	449	sensitivity
1838	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	case report	emerging	3798	447	resistance
1839	gain-of-function	activation	MEK inhibitors	preclinical	emerging	3799	447	resistance
1840	gain-of-function	activation	MEK inhibitors	preclinical	emerging	3800	447	resistance
1841	gain-of-function	activation	ERK inhibitors	preclinical	emerging	3800	383	sensitivity
1842	gain-of-function	activation	vemurafenib	case report	emerging	3801	446	resistance
1843	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	3801	447	resistance
1844	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	3804	454	resistance
1845	gain-of-function	activation	ERK inhibitors	preclinical	emerging	3804	454	sensitivity
1846	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	3805	454	resistance
1847	gain-of-function	activation	ERK inhibitors	preclinical	emerging	3805	454	sensitivity
1848	gain-of-function	activation	BRAF + MEK inhibitors	case report	emerging	3806	455	resistance
1849	gain-of-function	activation	ERK inhibitors	preclinical	emerging	3806	455	sensitivity
1850	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	3807	454	resistance
1851	gain-of-function	activation	ERK inhibitors	preclinical	emerging	3807	454	sensitivity
1852	gain-of-function	activation	BRAF inhibitors, MEK inhibitors	preclinical	emerging	3808	454	resistance
1853	gain-of-function	activation	ERK inhibitors	preclinical	emerging	3808	454	sensitivity
1854	gain-of-function	activation	MEK inhibitors	late trials	emerging	3809	457	response
1855	gain-of-function	activation	MEK inhibitors	early trials	emerging	3809	458	response
1856	gain-of-function	activation	MEK inhibitors	early trials	emerging	3809	459	response
1857	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	3809	460	sensitivity
1858	gain-of-function	activation	BRAF inhibitors	case report	emerging	3809	446	resistance
1859	gain-of-function	activation	preclinical	preclinical	emerging	3809	383	ERK inhibitors
1860	gain-of-function	activation	MEK inhibitors	late trials	emerging	3810	457	response
1861	gain-of-function	activation	MEK inhibitors	early trials	emerging	3810	458	response
1862	gain-of-function	activation	MEK inhibitors	early trials	emerging	3810	459	response
1863	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	3810	460	sensitivity
1864	gain-of-function	activation	BRAF inhibitors	case report	emerging	3810	446	resistance
1865	gain-of-function	activation	preclinical	preclinical	emerging	3810	383	ERK inhibitors
1866	gain-of-function	activation	MEK inhibitors	late trials	emerging	3811	457	response
1867	gain-of-function	activation	MEK inhibitors	early trials	emerging	3811	458	response
1868	gain-of-function	activation	MEK inhibitors	early trials	emerging	3811	459	response
1869	gain-of-function	activation	HSP90 inhibitors	preclinical	emerging	3811	460	sensitivity
1870	gain-of-function	activation	BRAF inhibitors	case report	emerging	3811	446	resistance
1871	gain-of-function	activation	preclinical	preclinical	emerging	3811	383	ERK inhibitors
1872	gain-of-function	activation	imatinib, crenolanib	preclinical	emerging	3815	466	sensitivity
1873	gain-of-function	activation	crenolanib	preclinical	emerging	3816	466	sensitivity
1874	gain-of-function	activation	imatinib	preclinical	emerging	3816	466	resistance
1875	gain-of-function	activation	imatinib, crenolanib	preclinical	emerging	3817	466	sensitivity
1876	gain-of-function	activation	imatinib, crenolanib	preclinical	emerging	3818	466	sensitivity
1877	gain-of-function	activation	imatinib, crenolanib	preclinical	emerging	3819	466	sensitivity
1878	gain-of-function	activation	BRAF inhibitors in BRAF mutant tumors	preclinical	emerging	3820	467	resistance
1879	gain-of-function	activation	BRAF inhibitors in BRAF mutant tumors	preclinical	emerging	3821	467	resistance
1880	loss-of-function	activation	everolimus	case report	emerging	3822	468	response
1881	loss-of-function	activation	everolimus	case report	emerging	3823	468	response
1882	gain-of-function	activation	vandetanib	FDA-approved	consensus	3830	477	response
1883	gain-of-function	activation	vandetanib	FDA-approved	consensus	3830	478	response
1884	gain-of-function	activation	cabozantinib, sunitinib	preclinical	emerging	3830	479	sensitivity
1885	gain-of-function	activation	RET inhibitors	preclinical	emerging	3830	480	sensitivity
1886	gain-of-function	activation	vandetanib	FDA-approved	consensus	3831	477	response
1887	gain-of-function	activation	vandetanib	FDA-approved	consensus	3831	478	response
1888	gain-of-function	activation	cabozantinib, sunitinib	preclinical	emerging	3831	479	sensitivity
1889	gain-of-function	activation	RET inhibitors	preclinical	emerging	3831	480	sensitivity
1890	gain-of-function	activation	dasatinib + erlotinib	case report	emerging	3832	320	response
1891	gain-of-function	activation	dasatinib	preclinical	emerging	3832	320	sensitivity
1892	gain-of-function	activation	ERBB2 TKIs, trastuzumab	preclinical	emerging	3833	261	sensitivity
1893	gain-of-function	activation	ERBB2 TKIs, trastuzumab	preclinical	emerging	3834	261	sensitivity
1894	gain-of-function	activation	trastuzumab, pertuzumab, lapatinib, anti-HER3 mAbs, PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	3835	364	sensitivity
1895	gain-of-function	activation	trastuzumab, lapatinib, PI3K pathway inhibitors + MEK inhibitors	preclinical	emerging	3836	364	sensitivity
1896	gain-of-function	activation	JAK inhibitors	preclinical	emerging	3837	486	sensitivity
1897	gain-of-function	activation	JAK inhibitors	preclinical	emerging	3838	486	sensitivity
1898	gain-of-function	activation	JAK inhibitors	preclinical	emerging	3839	486	sensitivity
1899	gain-of-function	activation	MEK inhibitors	preclinical	emerging	3840	447	resistance
1900	gain-of-function	activation	MEK inhibitors	preclinical	emerging	3841	447	resistance
1901	gain-of-function	activation	ERK inhibitors	preclinical	emerging	3841	383	sensitivity
1902	gain-of-function	activation	MEK inhibitors	preclinical	emerging	3842	447	resistance
1903	gain-of-function	activation	MEK inhibitors	preclinical	emerging	3843	447	resistance
1904	gain-of-function	activation	MEK inhibitors	preclinical	emerging	3844	447	resistance
1905	gain-of-function	activation	MEK inhibitors	preclinical	emerging	3845	447	resistance
1906	gain-of-function	activation	MEK inhibitors	preclinical	emerging	3846	447	resistance
1907	gain-of-function	activation	MEK inhibitors	preclinical	emerging	3847	447	resistance
1908	gain-of-function	activation	ERK inhibitors	preclinical	emerging	3847	383	sensitivity
1909	gain-of-function	activation	crizotinib	preclinical	emerging	3848	487	sensitivity
1910	gain-of-function	activation	crizotinib	preclinical	emerging	3849	487	sensitivity
1911	gain-of-function	activation	crizotinib	preclinical	emerging	3850	487	sensitivity
1912	gain-of-function	activation	crizotinib	preclinical	emerging	3851	487	reduced sensitivity
1913	gain-of-function	activation	crizotinib	preclinical	emerging	3852	487	reduced sensitivity
1914	gain-of-function	activation	crizotinib	preclinical	emerging	3853	487	sensitivity
1915	gain-of-function	activation	crizotinib	preclinical	emerging	3854	487	sensitivity
1916	gain-of-function	activation	crizotinib	preclinical	emerging	3855	487	sensitivity
1917	gain-of-function	activation	ibrutinib	early trials	emerging	3857	495	resistance
1918	gain-of-function	activation	ibrutinib	early trials	emerging	3858	495	resistance
1919	gain-of-function	activation	lapatinib, neratinib	preclinical	emerging	3859	496	sensitivity
1920	gain-of-function	activation	trastuzumab, lapatinib, neratinib	preclinical	emerging	3861	496	sensitivity
1921	gain-of-function	activation	trastuzumab, lapatinib, neratinib	preclinical	emerging	3862	496	sensitivity
1922	gain-of-function	activation	lapatinib, neratinib	preclinical	emerging	3863	496	sensitivity
1923	gain-of-function	activation	lapatinib, neratinib	preclinical	emerging	3865	496	sensitivity
1924	gain-of-function	activation	trastuzumab, lapatinib, neratinib	preclinical	emerging	3866	496	sensitivity
1925	gain-of-function	activation	anti-estrogens	early trials	emerging	3867	498	resistance
1926	gain-of-function	activation	anti-estrogens	early trials	emerging	3867	499	resistance
1927	gain-of-function	activation	anti-estrogens	early trials	emerging	3867	500	resistance
1928	gain-of-function	activation	neratinib	preclinical	emerging	3869	496	sensitivity
1929	reduced kinase activity	activation	dasatinib	case report	emerging	3872	391	response
1930	gain-of-function	activation	crizotinib	preclinical	emerging	3874	243	sensitivity
1931	gain-of-function	activation	crizotinib	preclinical	emerging	3875	243	sensitivity
1932	gain-of-function	activation	erlotinib	preclinical	emerging	3876	506	sensitivity
1933	gain-of-function	activation	erlotinib	preclinical	emerging	3877	506	sensitivity
1934	gain-of-function	activation	erlotinib	preclinical	emerging	3878	506	sensitivity
1935	gain-of-function	activation	erlotinib	preclinical	emerging	3879	506	sensitivity
1936	gain-of-function	activation	cetuximab	case report	emerging	3880	508	response
1937	gain-of-function	activation	cetuximab plus sirolimus	case report	emerging	3881	509	response
1938	gain-of-function	activation	gefitinib	case report	emerging	3882	510	no response
1939	gain-of-function	activation	pazopanib	case report	emerging	3883	322	response
1940	gain-of-function	activation	ibrutinib	early trials	emerging	3885	495	resistance
1941	gain-of-function	activation	ibrutinib	early trials	emerging	3886	495	resistance
1942	gain-of-function	activation	ibrutinib	early trials	emerging	3887	495	resistance
1943	gain-of-function	activation	bortezomib	preclinical	emerging	3888	514	resistance
1944	gain-of-function	activation	bortezomib	preclinical	emerging	3888	515	resistance
1945	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	3888	516	sensitivity
1946	gain-of-function	activation	FGFR inhibitors	preclinical	emerging	3889	516	resistance
1947	gain-of-function	activation	anti-estrogens	early trials	emerging	3892	498	resistance
1948	gain-of-function	activation	anti-estrogens	early trials	emerging	3893	498	resistance
1949	gain-of-function	activation	anti-estrogens	early trials	emerging	3893	499	resistance
1950	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	3898	518	sensitivity
1951	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	3899	518	sensitivity
1952	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	3900	518	sensitivity
1953	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	3900	519	sensitivity
1954	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	3901	518	sensitivity
1955	gain-of-function	activation	EZH2 inhibitor	preclinical	emerging	3902	518	sensitivity
1956	gain-of-function	activation	JAK inhibitors	preclinical	emerging	3903	520	sensitivity
\.


--
-- Name: drug_interactions_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('drug_interactions_id_seq', 1956, true);


--
-- Name: genes_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('genes_id_seq', 130, true);


--
-- Name: locations_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('locations_id_seq', 583, true);


--
-- Name: mutation_types_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('mutation_types_id_seq', 9, true);


--
-- Data for Name: schema_migrations; Type: TABLE DATA; Schema: public; Owner: acoffman
--

COPY schema_migrations (version) FROM stdin;
20140224185736
20140307221921
20140328160937
20140328183844
20140401211108
20140402163345
20140709150748
20140908201835
20140909212322
20140910203359
20140917182544
20140917193015
20140917201703
20140924205020
20140925154732
20150206205847
20150617174045
20150715153937
20151209194223
20160203194352
20160203214847
20160209164657
20160309160747
\.


--
-- Name: sources_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('sources_id_seq', 760, true);


--
-- Name: transcripts_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('transcripts_id_seq', 97, true);


--
-- Name: variant_types_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('variant_types_id_seq', 4, true);


--
-- Name: variants_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('variants_id_seq', 4184, true);


--
-- Name: versions_id_seq; Type: SEQUENCE SET; Schema: public; Owner: acoffman
--

SELECT pg_catalog.setval('versions_id_seq', 6, true);


--
-- PostgreSQL database dump complete
--

